ontology	ID	Description	Count	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	log10q	geneID	cluster
BP	GO:0045165	cell fate commitment	12	12/103	144/10965	9.127243965062547e-9	7.935318566595422e-6	6.318414754970217e-6	5.19939186942757	SOX2/FEZF2/SFRP2/DLL1/TGFBR1/FGF8/PAX6/WNT5B/SOX5/FOXG1/ZNF521/ETS2	16
BP	GO:0003208	cardiac ventricle morphogenesis	8	8/103	47/10965	1.0697107064165557e-8	7.935318566595422e-6	6.318414754970217e-6	5.19939186942757	COL11A1/SOX11/LRP2/SFRP2/SOX4/TGFBR1/TPM1/TNNI3	16
BP	GO:0007389	pattern specification process	16	16/103	290/10965	1.0737914163187309e-8	7.935318566595422e-6	6.318414754970217e-6	5.19939186942757	LRP2/ZIC1/FEZF2/SPRY1/SFRP2/DLL1/LFNG/FEZF1/TGFBR1/EMX2/FGF8/PAX6/FOXG1/OTX2/RAX/ETS2	16
BP	GO:0007423	sensory organ development	18	18/103	385/10965	1.5767956556887378e-8	8.484562801683065e-6	6.755744756272108e-6	5.170326767188152	COL11A1/SOX11/EPHA4/ZIC1/SOX2/SPRY1/DLL1/FZD3/TGFBR1/FGF8/PAX6/WNT5B/FOXG1/SMOC1/SERPINF1/RAX/GNG8/SOX3	16
BP	GO:0003002	regionalization	14	14/103	223/10965	1.9135234103931135e-8	8.484562801683065e-6	6.755744756272108e-6	5.170326767188152	LRP2/FEZF2/SPRY1/SFRP2/DLL1/LFNG/FEZF1/TGFBR1/EMX2/FGF8/PAX6/FOXG1/OTX2/ETS2	16
BP	GO:0048598	embryonic morphogenesis	18	18/103	401/10965	2.9555948690836366e-8	1.008639632684485e-5	8.031188016104653e-6	5.095220206816483	COL11A1/SOX11/LRP2/ZIC1/SOX2/SFRP2/SOX4/GJA1/RSPO3/DLL1/FZD3/SULF1/TGFBR1/FGF8/PAX6/FOXG1/OTX2/ETS2	16
BP	GO:0008285	negative regulation of cell population proliferation	19	19/103	451/10965	3.2099013250234665e-8	1.008639632684485e-5	8.031188016104653e-6	5.095220206816483	SOX11/IGFBP5/SOX2/FEZF2/SPRY1/SFRP2/SOX4/GJA1/DLL1/FEZF1/SULF1/TGFBR1/CDKN1C/PAX6/TP53I11/BTG1/TPM1/SERPINF1/CXADR	16
BP	GO:0009952	anterior/posterior pattern specification	11	11/103	131/10965	3.639655868956193e-8	1.008639632684485e-5	8.031188016104653e-6	5.095220206816483	FEZF2/SFRP2/DLL1/LFNG/FEZF1/TGFBR1/EMX2/FGF8/PAX6/OTX2/ETS2	16
BP	GO:0048729	tissue morphogenesis	19	19/103	488/10965	1.1190084977010659e-7	2.7379933242646793e-5	2.1800986657132052e-5	4.6615238508884485	COL11A1/SOX11/LRP2/IGFBP5/EPHA4/SPRY1/SFRP2/SOX4/GJA1/RSPO3/DLL1/FZD3/SULF1/CA2/GCNT1/TGFBR1/FGF8/TPM1/TNNI3	16
BP	GO:0003206	cardiac chamber morphogenesis	9	9/103	88/10965	1.2349992441428414e-7	2.7379933242646793e-5	2.1800986657132052e-5	4.6615238508884485	COL11A1/SOX11/LRP2/SFRP2/SOX4/TGFBR1/FGF8/TPM1/TNNI3	16
BP	GO:0090287	regulation of cellular response to growth factor stimulus	12	12/103	198/10965	3.1286726558070493e-7	6.305697525385662e-5	5.0208459749171504e-5	4.299223101324234	SOX11/LRP2/SPRY1/SFRP2/NREP/DLL1/SULF1/TGFBR1/CDKN1C/SHISA2/OTX2/NPTN	16
BP	GO:0021871	forebrain regionalization	5	5/103	17/10965	3.7527406533505476e-7	6.933188357065137e-5	5.520479013744622e-5	4.258023236763512	FEZF2/FEZF1/EMX2/FGF8/PAX6	16
BP	GO:0048663	neuron fate commitment	6	6/103	32/10965	4.4103967117285905e-7	7.356491005416354e-5	5.857529338405729e-5	4.232285527489718	FEZF2/DLL1/TGFBR1/PAX6/FOXG1/ZNF521	16
BP	GO:0045665	negative regulation of neuron differentiation	11	11/103	168/10965	4.6455062731542153e-7	7.356491005416354e-5	5.857529338405729e-5	4.232285527489718	EPHA4/NLGN1/SOX2/FEZF2/CRMP1/NR2F1/DPYSL3/DLL1/PAX6/FOXG1/SOX3	16
BP	GO:0050768	negative regulation of neurogenesis	12	12/103	213/10965	6.855677370561793e-7	9.39861435235125e-5	7.483548782799443e-5	4.125892405972658	SOX11/EPHA4/NLGN1/SOX2/FEZF2/CRMP1/NR2F1/DPYSL3/DLL1/PAX6/FOXG1/SOX3	16
BP	GO:0051962	positive regulation of nervous system development	16	16/103	393/10965	7.07091876418169e-7	9.39861435235125e-5	7.483548782799443e-5	4.125892405972658	SOX11/LRP2/EPHA4/NLGN1/FEZF2/DPYSL3/TPBG/TUBB2B/FEZF1/FZD3/PAX6/MAP6/SYT1/FOXG1/NPTN/SERPINF1	16
BP	GO:0072001	renal system development	12	12/103	214/10965	7.20687613847412e-7	9.39861435235125e-5	7.483548782799443e-5	4.125892405972658	SOX11/EPHA4/SPRY1/SOX4/DLL1/SULF1/CA2/GCNT1/TGFBR1/EMX2/FGF8/SERPINF1	16
BP	GO:0003007	heart morphogenesis	11	11/103	179/10965	8.750947766607783e-7	1.077825066587192e-4	8.582069827252195e-5	4.066407956190326	COL11A1/SOX11/LRP2/SPRY1/SFRP2/SOX4/DLL1/TGFBR1/FGF8/TPM1/TNNI3	16
BP	GO:0007411	axon guidance	12	12/103	220/10965	9.670416438815582e-7	1.1247617315772707e-4	8.955798133347972e-5	4.047895704123947	EPHA4/FEZF2/CRMP1/PDLIM7/TUBB2B/FEZF1/FZD3/FGF8/PAX6/FOXG1/OTX2/NPTN	16
BP	GO:0097485	neuron projection guidance	12	12/103	221/10965	1.0146700329970869e-6	1.1247617315772707e-4	8.955798133347972e-5	4.047895704123947	EPHA4/FEZF2/CRMP1/PDLIM7/TUBB2B/FEZF1/FZD3/FGF8/PAX6/FOXG1/OTX2/NPTN	16
BP	GO:0050769	positive regulation of neurogenesis	15	15/103	358/10965	1.1409993707573296e-6	1.2045693356995237e-4	9.591257868471388e-5	4.018124432504773	SOX11/LRP2/EPHA4/NLGN1/FEZF2/DPYSL3/TUBB2B/FEZF1/FZD3/PAX6/MAP6/SYT1/FOXG1/NPTN/SERPINF1	16
BP	GO:0051961	negative regulation of nervous system development	12	12/103	229/10965	1.4770703077659266e-6	1.4884840328713904e-4	1.1851899072361048e-4	3.9262120555132234	SOX11/EPHA4/NLGN1/SOX2/FEZF2/CRMP1/NR2F1/DPYSL3/DLL1/PAX6/FOXG1/SOX3	16
BP	GO:0050680	negative regulation of epithelial cell proliferation	8	8/103	88/10965	1.5927927131290317e-6	1.5353136717422014e-4	1.2224775194129913e-4	3.91275911853126	SOX2/SFRP2/GJA1/SULF1/TGFBR1/CDKN1C/PAX6/SERPINF1	16
BP	GO:0003231	cardiac ventricle development	8	8/103	90/10965	1.8914044558143861e-6	1.7471848660585392e-4	1.39117775105295e-4	3.856617376571904	COL11A1/SOX11/LRP2/SFRP2/SOX4/TGFBR1/TPM1/TNNI3	16
BP	GO:0010721	negative regulation of cell development	12	12/103	236/10965	2.025758811826812e-6	1.796442914328017e-4	1.4303989589193952e-4	3.8445428146385705	SOX11/EPHA4/NLGN1/SOX2/FEZF2/CRMP1/NR2F1/DPYSL3/DLL1/PAX6/FOXG1/SOX3	16
BP	GO:0001655	urogenital system development	12	12/103	237/10965	2.1173169818550943e-6	1.8054199033741325e-4	1.437546792943722e-4	3.842378009882504	SOX11/EPHA4/SPRY1/SOX4/DLL1/SULF1/CA2/GCNT1/TGFBR1/EMX2/FGF8/SERPINF1	16
BP	GO:0003205	cardiac chamber development	9	9/103	124/10965	2.3203252264056825e-6	1.9052448247931105e-4	1.5170313468547094e-4	3.8190054451688584	COL11A1/SOX11/LRP2/SFRP2/SOX4/TGFBR1/FGF8/TPM1/TNNI3	16
BP	GO:0040036	regulation of fibroblast growth factor receptor signaling pathway	5	5/103	24/10965	2.4464614600191304e-6	1.9370732345937186e-4	1.542374386636121e-4	3.8118101954711707	SPRY1/SULF1/SHISA2/OTX2/NPTN	16
BP	GO:0001822	kidney development	11	11/103	210/10965	4.178603713116932e-6	3.1944704937862895e-4	2.5435638573129203e-4	3.5945573547377556	SOX11/EPHA4/SPRY1/SOX4/DLL1/SULF1/CA2/GCNT1/TGFBR1/FGF8/SERPINF1	16
BP	GO:0010720	positive regulation of cell development	15	15/103	405/10965	5.233505211409591e-6	3.867560351231688e-4	3.0795046454504856e-4	3.5115191364375065	SOX11/LRP2/EPHA4/NLGN1/FEZF2/DPYSL3/TUBB2B/FEZF1/FZD3/PAX6/MAP6/SYT1/FOXG1/NPTN/SERPINF1	16
BP	GO:0007507	heart development	15	15/103	408/10965	5.723616120733333e-6	4.093308690214774e-4	3.2592544089880474e-4	3.4868817383052386	COL11A1/SOX11/LRP2/TFDP2/SPRY1/SFRP2/PDLIM7/SOX4/GJA1/DLL1/TGFBR1/FGF8/TPM1/TNNI3/CXADR	16
BP	GO:0048738	cardiac muscle tissue development	9	9/103	139/10965	5.965300091929951e-6	4.132834469940219e-4	3.290726399396884e-4	3.4827082247161694	COL11A1/LRP2/GJA1/DLL1/TGFBR1/FGF8/TPM1/TNNI3/CXADR	16
BP	GO:0061564	axon development	15	15/103	413/10965	6.6321787688931554e-6	4.4556182820109475e-4	3.5477396476662907e-4	3.4500482585501784	EPHA4/FEZF2/CRMP1/NREP/PDLIM7/TUBB2B/FEZF1/FZD3/FGF8/PAX6/MAP6/FOXG1/OTX2/NPTN/CDH2	16
BP	GO:2000648	positive regulation of stem cell proliferation	5	5/103	30/10965	7.84353221724269e-6	5.065102246181248e-4	4.0330349057977606e-4	3.3943680191702263	SOX11/GJA1/FZD3/PAX6/FOXG1	16
BP	GO:0035270	endocrine system development	7	7/103	78/10965	8.038723088813117e-6	5.065102246181248e-4	4.0330349057977606e-4	3.3943680191702263	SOX2/SOX4/DLL1/TGFBR1/FGF8/PAX6/SOX3	16
BP	GO:0001501	skeletal system development	13	13/103	318/10965	8.224793904489171e-6	5.065102246181248e-4	4.0330349057977606e-4	3.3943680191702263	COL11A1/SOX11/SFRP2/SOX4/GJA1/COL1A2/SULF1/TGFBR1/PLEKHA1/FGF8/WNT5B/SOX5/ETS2	16
BP	GO:0045596	negative regulation of cell differentiation	16	16/103	480/10965	9.40756156223635e-6	5.636909184723781e-4	4.488330224714185e-4	3.3479151977645456	SOX11/IGFBP5/EPHA4/NLGN1/SOX2/FEZF2/SPRY1/CRMP1/SFRP2/NR2F1/DPYSL3/DLL1/TGFBR1/PAX6/FOXG1/SOX3	16
BP	GO:0055010	ventricular cardiac muscle tissue morphogenesis	5	5/103	32/10965	1.091976673723402e-5	6.322919223790888e-4	5.034558572892396e-4	3.2980386021235173	COL11A1/LRP2/TGFBR1/TPM1/TNNI3	16
BP	GO:0007409	axonogenesis	14	14/103	378/10965	1.112286196336692e-5	6.322919223790888e-4	5.034558572892396e-4	3.2980386021235173	EPHA4/FEZF2/CRMP1/PDLIM7/TUBB2B/FEZF1/FZD3/FGF8/PAX6/MAP6/FOXG1/OTX2/NPTN/CDH2	16
BP	GO:0061351	neural precursor cell proliferation	8	8/103	115/10965	1.1899195680939762e-5	6.595129206160863e-4	5.251302936035785e-4	3.27973292750349	LRP2/FZD3/EMX2/FGF8/PAX6/SOX5/FOXG1/CDH2	16
BP	GO:0061061	muscle structure development	15	15/103	435/10965	1.2351653879418063e-5	6.678930890407279e-4	5.318029154244953e-4	3.2742492861294985	COL11A1/SOX11/LRP2/IGFBP5/PDLIM7/GJA1/DLL1/TGFBR1/FGF8/BTG1/TPM1/CDH2/TNNT1/TNNI3/CXADR	16
BP	GO:0030900	forebrain development	12	12/103	284/10965	1.3517174104899505e-5	7.13513690251481e-4	5.681278439578063e-4	3.2455539254192765	LRP2/SOX2/FEZF2/FEZF1/EMX2/FGF8/PAX6/FOXG1/OTX2/CDH2/RAX/SOX3	16
BP	GO:0071363	cellular response to growth factor stimulus	16	16/103	496/10965	1.4171103238213096e-5	7.306357181190333e-4	5.817610803055903e-4	3.2352553363270093	SOX11/LRP2/SPRY1/SFRP2/NREP/DLL1/COL1A2/SULF1/TGFBR1/DDIT4/FGF8/CDKN1C/SOX5/SHISA2/OTX2/NPTN	16
BP	GO:0001764	neuron migration	8	8/103	119/10965	1.5297448612021723e-5	7.707828084739127e-4	6.137277828315892e-4	3.212024216202233	NAV1/FEZF2/TUBB2B/FEZF1/FZD3/DDIT4/PAX6/FOXG1	16
BP	GO:0045666	positive regulation of neuron differentiation	12	12/103	292/10965	1.7845488294277028e-5	8.622712574340434e-4	6.865745073792895e-4	3.1633123260341267	SOX11/EPHA4/NLGN1/FEZF2/DPYSL3/TUBB2B/FEZF1/MAP6/SYT1/FOXG1/NPTN/SERPINF1	16
BP	GO:0072089	stem cell proliferation	7	7/103	88/10965	1.7891059017576e-5	8.622712574340434e-4	6.865745073792895e-4	3.1633123260341267	SOX11/SFRP2/GJA1/FZD3/PAX6/SOX5/FOXG1	16
BP	GO:0003229	ventricular cardiac muscle tissue development	5	5/103	37/10965	2.2772763205861094e-5	0.001074196085689235	8.553174444844134e-4	3.0678726702998125	COL11A1/LRP2/TGFBR1/TPM1/TNNI3	16
BP	GO:0060537	muscle tissue development	11	11/103	253/10965	2.431466270315109e-5	0.001123033483601791	8.942037138856224e-4	3.048563530714148	COL11A1/SOX11/LRP2/IGFBP5/GJA1/DLL1/TGFBR1/FGF8/TPM1/TNNI3/CXADR	16
BP	GO:0042063	gliogenesis	10	10/103	210/10965	2.6813949165667947e-5	0.0012131943938833846	9.659933995880805e-4	3.015025841009215	SOX11/LRP2/EPHA4/SOX2/SOX4/DLL1/CLU/PAX6/FOXG1/CDH2	16
BP	GO:0045995	regulation of embryonic development	7	7/103	94/10965	2.755076150520518e-5	0.0012216007651407977	9.726868851416649e-4	3.012026939731595	SFRP2/GJA1/DLL1/LFNG/FZD3/SULF1/OTX2	16
BP	GO:1901862	negative regulation of muscle tissue development	5	5/103	39/10965	2.963500113868658e-5	0.0012882509318523166	0.0010257563861625883	2.9889557705184573	IGFBP5/GJA1/DLL1/FGF8/CXADR	16
BP	GO:0002009	morphogenesis of an epithelium	14	14/103	416/10965	3.24066283185088e-5	0.0013800262921264453	0.0010988315608556128	2.959068875181043	SOX11/LRP2/IGFBP5/EPHA4/SPRY1/SFRP2/SOX4/GJA1/RSPO3/DLL1/FZD3/SULF1/CA2/FGF8	16
BP	GO:0048667	cell morphogenesis involved in neuron differentiation	15	15/103	473/10965	3.299115628448426e-5	0.0013800262921264453	0.0010988315608556128	2.959068875181043	EPHA4/NLGN1/FEZF2/CRMP1/PDLIM7/TUBB2B/FEZF1/FZD3/FGF8/PAX6/MAP6/FOXG1/OTX2/NPTN/CDH2	16
BP	GO:0055008	cardiac muscle tissue morphogenesis	5	5/103	41/10965	3.8002667057566525e-5	0.0015602206086412036	0.0012423094084900404	2.9057702256852806	COL11A1/LRP2/TGFBR1/TPM1/TNNI3	16
BP	GO:0002062	chondrocyte differentiation	6	6/103	68/10965	4.0538344874667985e-5	0.0016340638288570714	0.001301106303441497	2.885687219109419	COL11A1/SFRP2/SULF1/TGFBR1/WNT5B/SOX5	16
BP	GO:0048839	inner ear development	8	8/103	137/10965	4.243100513577193e-5	0.0016654098530027612	0.0013260652486696727	2.8774351060669785	COL11A1/EPHA4/ZIC1/SOX2/DLL1/FZD3/FGF8/FOXG1	16
BP	GO:0060563	neuroepithelial cell differentiation	5	5/103	42/10965	4.281838593647154e-5	0.0016654098530027612	0.0013260652486696727	2.8774351060669785	SOX11/SOX4/DLL1/FGF8/CDH2	16
BP	GO:0001709	cell fate determination	4	4/103	22/10965	4.7162606114900505e-5	0.0017721948772327868	0.001411091711948049	2.8504447589610407	FEZF2/DLL1/PAX6/FOXG1	16
BP	GO:0045992	negative regulation of embryonic development	4	4/103	22/10965	4.7162606114900505e-5	0.0017721948772327868	0.001411091711948049	2.8504447589610407	SFRP2/LFNG/FZD3/SULF1	16
BP	GO:0021536	diencephalon development	5	5/103	44/10965	5.3856980192368644e-5	0.0019900154181080217	0.0015845290488175827	2.8000997945768424	SOX2/FGF8/PAX6/RAX/SOX3	16
BP	GO:0048562	embryonic organ morphogenesis	9	9/103	186/10965	6.1022698285218005e-5	0.0022178249524316116	0.0017659200176757652	2.753028970446267	COL11A1/SOX11/ZIC1/DLL1/FZD3/TGFBR1/FGF8/PAX6/FOXG1	16
BP	GO:0014706	striated muscle tissue development	10	10/103	238/10965	7.741543379074108e-5	0.0027647337007158826	0.0022013904119367257	2.657302929407624	COL11A1/SOX11/LRP2/GJA1/DLL1/TGFBR1/FGF8/TPM1/TNNI3/CXADR	16
BP	GO:0021983	pituitary gland development	4	4/103	25/10965	7.981188851863621e-5	0.0027647337007158826	0.0022013904119367257	2.657302929407624	SOX2/FGF8/PAX6/SOX3	16
BP	GO:0055026	negative regulation of cardiac muscle tissue development	4	4/103	25/10965	7.981188851863621e-5	0.0027647337007158826	0.0022013904119367257	2.657302929407624	GJA1/DLL1/FGF8/CXADR	16
BP	GO:0072091	regulation of stem cell proliferation	5	5/103	48/10965	8.242773332282463e-5	0.0028114197657954187	0.002238563704977764	2.650030541965531	SOX11/GJA1/FZD3/PAX6/FOXG1	16
BP	GO:0006935	chemotaxis	13	13/103	398/10965	8.598583324777267e-5	0.0028883423077320004	0.0022998124777753553	2.6383075740639423	EPHA4/FEZF2/CRMP1/PDLIM7/TUBB2B/FEZF1/FZD3/FGF8/PAX6/FOXG1/OTX2/NPTN/CXADR	16
BP	GO:0042330	taxis	13	13/103	400/10965	9.045146661685238e-5	0.0029706102028981673	0.002365317432405207	2.6261105674458323	EPHA4/FEZF2/CRMP1/PDLIM7/TUBB2B/FEZF1/FZD3/FGF8/PAX6/FOXG1/OTX2/NPTN/CXADR	16
BP	GO:0060415	muscle tissue morphogenesis	5	5/103	49/10965	9.111479196981298e-5	0.0029706102028981673	0.002365317432405207	2.6261105674458323	COL11A1/LRP2/TGFBR1/TPM1/TNNI3	16
BP	GO:0002065	columnar/cuboidal epithelial cell differentiation	6	6/103	80/10965	1.0163248231864636e-4	0.0032637508534360507	0.0025987276220650274	2.585239237402858	SOX11/SOX4/DLL1/FGF8/PAX6/CDH2	16
BP	GO:0001568	blood vessel development	14	14/103	463/10965	1.0305032013555416e-4	0.0032637508534360507	0.0025987276220650274	2.585239237402858	LRP2/SFRP2/SOX4/RSPO3/DLL1/COL1A2/SULF1/TGFBR1/FGF8/PAX6/BTG1/SERPINF1/CDH2/TNNI3	16
BP	GO:0048568	embryonic organ development	11	11/103	299/10965	1.1056767913305918e-4	0.0034221819994603975	0.002724876771880012	2.5646531332048155	COL11A1/SOX11/ZIC1/RSPO3/TUBB2B/DLL1/FZD3/TGFBR1/FGF8/PAX6/FOXG1	16
BP	GO:0043583	ear development	8	8/103	157/10965	1.1113987548991819e-4	0.0034221819994603975	0.002724876771880012	2.5646531332048155	COL11A1/EPHA4/ZIC1/SOX2/DLL1/FZD3/FGF8/FOXG1	16
BP	GO:0048608	reproductive structure development	11	11/103	301/10965	1.1729271060149278e-4	0.0035589314451591513	0.002833762093645703	2.547636613423031	LRP2/SFRP2/GJA1/RSPO3/LFNG/SULF1/DMRTA1/TGFBR1/PLEKHA1/FGF8/SERPINF1	16
BP	GO:0010975	regulation of neuron projection development	13	13/103	411/10965	1.1879157733052648e-4	0.0035589314451591513	0.002833762093645703	2.547636613423031	EPHA4/NLGN1/FEZF2/CRMP1/SFRP2/NR2F1/DPYSL3/TUBB2B/MAP6/SYT1/NPTN/SERPINF1/CDH2	16
BP	GO:0007517	muscle organ development	10	10/103	252/10965	1.243259742851259e-4	0.0036750757998683216	0.0029262408263320164	2.5336899347919886	COL11A1/SOX11/LRP2/GJA1/DLL1/TGFBR1/FGF8/TPM1/TNNI3/CXADR	16
BP	GO:0061458	reproductive system development	11	11/103	305/10965	1.3179680266379686e-4	0.003783236378555626	0.003012362560519329	2.5210927587140692	LRP2/SFRP2/GJA1/RSPO3/LFNG/SULF1/DMRTA1/TGFBR1/PLEKHA1/FGF8/SERPINF1	16
BP	GO:0010001	glial cell differentiation	8	8/103	161/10965	1.323982151146995e-4	0.003783236378555626	0.003012362560519329	2.5210927587140692	SOX11/EPHA4/SOX2/SOX4/DLL1/CLU/PAX6/CDH2	16
BP	GO:0048644	muscle organ morphogenesis	5	5/103	53/10965	1.331043922089936e-4	0.003783236378555626	0.003012362560519329	2.5210927587140692	COL11A1/LRP2/TGFBR1/TPM1/TNNI3	16
BP	GO:0060411	cardiac septum morphogenesis	5	5/103	54/10965	1.456011212044867e-4	0.003998205561189295	0.003183529533088549	2.4970911169017893	SOX11/LRP2/SOX4/TGFBR1/FGF8	16
BP	GO:0001654	eye development	10	10/103	257/10965	1.46077875713276e-4	0.003998205561189295	0.003183529533088549	2.4970911169017893	SOX11/SOX2/SPRY1/DLL1/TGFBR1/PAX6/WNT5B/SMOC1/SERPINF1/RAX	16
BP	GO:0150063	visual system development	10	10/103	257/10965	1.46077875713276e-4	0.003998205561189295	0.003183529533088549	2.4970911169017893	SOX11/SOX2/SPRY1/DLL1/TGFBR1/PAX6/WNT5B/SMOC1/SERPINF1/RAX	16
BP	GO:0008543	fibroblast growth factor receptor signaling pathway	6	6/103	86/10965	1.5195757269068614e-4	0.004108413886039648	0.0032712817638290204	2.4852820473742425	SPRY1/SULF1/FGF8/SHISA2/OTX2/NPTN	16
BP	GO:0048880	sensory system development	10	10/103	259/10965	1.5563697982642313e-4	0.00415719499126723	0.0033101232107661588	2.4801558404357738	SOX11/SOX2/SPRY1/DLL1/TGFBR1/PAX6/WNT5B/SMOC1/SERPINF1/RAX	16
BP	GO:0008217	regulation of blood pressure	6	6/103	87/10965	1.619844591110268e-4	0.0042752326886803145	0.003404109497859549	2.467996478683998	GJA1/DLL1/COL1A2/NCALD/TPM1/TNNI3	16
BP	GO:0001944	vasculature development	14	14/103	486/10965	1.7155929447979474e-4	0.00446676734306882	0.0035566169714058406	2.4489629034849774	LRP2/SFRP2/SOX4/RSPO3/DLL1/COL1A2/SULF1/TGFBR1/FGF8/PAX6/BTG1/SERPINF1/CDH2/TNNI3	16
BP	GO:0055024	regulation of cardiac muscle tissue development	5	5/103	56/10965	1.732710832223358e-4	0.00446676734306882	0.0035566169714058406	2.4489629034849774	GJA1/DLL1/TGFBR1/FGF8/CXADR	16
BP	GO:0050673	epithelial cell proliferation	10	10/103	263/10965	1.7634739460167182e-4	0.004493818090021913	0.0035781558469086955	2.446340747620388	SOX11/IGFBP5/SOX2/SFRP2/GJA1/SULF1/TGFBR1/CDKN1C/PAX6/SERPINF1	16
BP	GO:0043009	chordate embryonic development	14	14/103	488/10965	1.790522146068033e-4	0.004510894997537305	0.0035917531566460425	2.4446935178817344	COL11A1/SOX11/LRP2/SFRP2/SOX4/RSPO3/DLL1/LFNG/FZD3/SULF1/TGFBR1/FGF8/PAX6/TPM1	16
BP	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	8	8/103	169/10965	1.8505202144790072e-4	0.004602289005424894	0.0036645246834734226	2.435982348644044	SOX11/LRP2/SPRY1/SFRP2/NREP/SULF1/TGFBR1/CDKN1C	16
BP	GO:0016331	morphogenesis of embryonic epithelium	7	7/103	127/10965	1.8683175935419057e-4	0.004602289005424894	0.0036645246834734226	2.435982348644044	SOX11/LRP2/SFRP2/SOX4/FZD3/SULF1/FGF8	16
BP	GO:0021953	central nervous system neuron differentiation	7	7/103	129/10965	2.0580949751508885e-4	0.005014062153746725	0.003992394763826536	2.3987665226764623	EPHA4/FEZF2/SFRP2/SOX4/FGF8/PAX6/FOXG1	16
BP	GO:0007369	gastrulation	7	7/103	130/10965	2.158659358079498e-4	0.005123220360574655	0.004079310849029602	2.38941319959231	COL11A1/SOX2/SFRP2/GJA1/FGF8/OTX2/ETS2	16
BP	GO:0009792	embryo development ending in birth or egg hatching	14	14/103	497/10965	2.1638820982809514e-4	0.005123220360574655	0.004079310849029602	2.38941319959231	COL11A1/SOX11/LRP2/SFRP2/SOX4/RSPO3/DLL1/LFNG/FZD3/SULF1/TGFBR1/FGF8/PAX6/TPM1	16
BP	GO:1903532	positive regulation of secretion by cell	8	8/103	173/10965	2.1722269458458168e-4	0.005123220360574655	0.004079310849029602	2.38941319959231	SOX11/VSNL1/NLGN1/SOX4/GJA1/SYT1/MAP2K6/NNAT	16
BP	GO:2000179	positive regulation of neural precursor cell proliferation	4	4/103	33/10965	2.4370381881533382e-4	0.005687277540143107	0.004528435503083821	2.3440518133809247	LRP2/FZD3/PAX6/FOXG1	16
BP	GO:0002088	lens development in camera-type eye	5	5/103	61/10965	2.600305784360108e-4	0.005936874424423917	0.004727174422410042	2.325398372883744	SOX11/SPRY1/TGFBR1/PAX6/WNT5B	16
BP	GO:0048705	skeletal system morphogenesis	7	7/103	134/10965	2.6013811919943367e-4	0.005936874424423917	0.004727174422410042	2.325398372883744	COL11A1/SOX11/SFRP2/TGFBR1/PLEKHA1/FGF8/SOX5	16
BP	GO:1901861	regulation of muscle tissue development	6	6/103	95/10965	2.624328793836463e-4	0.005936874424423917	0.004727174422410042	2.325398372883744	IGFBP5/GJA1/DLL1/TGFBR1/FGF8/CXADR	16
BP	GO:0048485	sympathetic nervous system development	3	3/103	14/10965	2.717814221943801e-4	0.006072467960194865	0.004835139362935588	2.3155910037564396	SOX11/SOX4/FZD3	16
BP	GO:0030199	collagen fibril organization	4	4/103	34/10965	2.742155960238993e-4	0.006072467960194865	0.004835139362935588	2.3155910037564396	COL11A1/SFRP2/COL1A2/TGFBR1	16
BP	GO:0050678	regulation of epithelial cell proliferation	9	9/103	227/10965	2.7664378167779945e-4	0.006072467960194865	0.004835139362935588	2.3155910037564396	SOX11/SOX2/SFRP2/GJA1/SULF1/TGFBR1/CDKN1C/PAX6/SERPINF1	16
BP	GO:0090596	sensory organ morphogenesis	8	8/103	180/10965	2.845276505599918e-4	0.006184292169524527	0.004924178224861778	2.3076662366762912	COL11A1/SOX11/ZIC1/DLL1/FZD3/FGF8/PAX6/FOXG1	16
BP	GO:2000177	regulation of neural precursor cell proliferation	5	5/103	64/10965	3.2592647385407483e-4	0.006982916507598512	0.005560074535642146	2.254919386439324	LRP2/FZD3/PAX6/FOXG1/CDH2	16
BP	GO:0051047	positive regulation of secretion	8	8/103	184/10965	3.3008521056080933e-4	0.006982916507598512	0.005560074535642146	2.254919386439324	SOX11/VSNL1/NLGN1/SOX4/GJA1/SYT1/MAP2K6/NNAT	16
BP	GO:0048514	blood vessel morphogenesis	12	12/103	397/10965	3.346813619957376e-4	0.006982916507598512	0.005560074535642146	2.254919386439324	LRP2/SFRP2/SOX4/RSPO3/DLL1/SULF1/TGFBR1/FGF8/BTG1/SERPINF1/CDH2/TNNI3	16
BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	3	3/103	15/10965	3.3741241960462545e-4	0.006982916507598512	0.005560074535642146	2.254919386439324	SPRY1/SULF1/SHISA2	16
BP	GO:0008038	neuron recognition	4	4/103	36/10965	3.433188540046179e-4	0.006982916507598512	0.005560074535642146	2.254919386439324	EPHA4/FEZF2/FOXG1/NPTN	16
BP	GO:0021879	forebrain neuron differentiation	4	4/103	36/10965	3.433188540046179e-4	0.006982916507598512	0.005560074535642146	2.254919386439324	FEZF2/FGF8/PAX6/FOXG1	16
BP	GO:0051489	regulation of filopodium assembly	4	4/103	36/10965	3.433188540046179e-4	0.006982916507598512	0.005560074535642146	2.254919386439324	NLGN1/MYO10/DPYSL3/TGFBR1	16
BP	GO:0045843	negative regulation of striated muscle tissue development	4	4/103	37/10965	3.8217292561658903e-4	0.007702521600836163	0.006133052595780094	2.212323310877627	GJA1/DLL1/FGF8/CXADR	16
BP	GO:0044344	cellular response to fibroblast growth factor stimulus	6	6/103	102/10965	3.856678518833457e-4	0.0077029335822106065	0.006133380631658329	2.212300082581483	SPRY1/SULF1/FGF8/SHISA2/OTX2/NPTN	16
BP	GO:0002052	positive regulation of neuroblast proliferation	3	3/103	16/10965	4.124489129556424e-4	0.008164278928773742	0.006500722058520792	2.1870384020317624	FZD3/PAX6/FOXG1	16
BP	GO:0048635	negative regulation of muscle organ development	4	4/103	38/10965	4.240722490894359e-4	0.00832007235602902	0.0066247709522401855	2.17882913262101	GJA1/DLL1/FGF8/CXADR	16
BP	GO:0006941	striated muscle contraction	6	6/103	104/10965	4.28086325113788e-4	0.00832515248050235	0.00662881594843788	2.1785640391643195	GJA1/AKAP9/TPM1/MAP2K6/TNNT1/TNNI3	16
BP	GO:0021915	neural tube development	7	7/103	146/10965	4.384393910861543e-4	0.008452348956852209	0.006730094817862524	2.1719788171156367	SOX11/LRP2/SFRP2/SOX4/FZD3/FGF8/PAX6	16
BP	GO:0071774	response to fibroblast growth factor	6	6/103	105/10965	4.5061804933455284e-4	0.008612243235988824	0.006857408972178268	2.163839948673205	SPRY1/SULF1/FGF8/SHISA2/OTX2/NPTN	16
BP	GO:0021510	spinal cord development	5	5/103	69/10965	4.629385702121723e-4	0.008772092394533214	0.006984687199692425	2.155853038438754	SOX11/ZIC1/SOX4/DLL1/PAX6	16
BP	GO:0046887	positive regulation of hormone secretion	5	5/103	70/10965	4.948698793763827e-4	0.00913529451559657	0.0072738831055031445	2.138233682528333	SOX11/VSNL1/SOX4/GJA1/NNAT	16
BP	GO:0008406	gonad development	7	7/103	149/10965	4.955571163894804e-4	0.00913529451559657	0.0072738831055031445	2.138233682528333	LRP2/SFRP2/LFNG/DMRTA1/TGFBR1/PLEKHA1/FGF8	16
BP	GO:0072337	modified amino acid transport	3	3/103	17/10965	4.974216740808798e-4	0.00913529451559657	0.0072738831055031445	2.138233682528333	LRP2/GJA1/SLC6A8	16
BP	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	9	9/103	246/10965	4.985884692770342e-4	0.00913529451559657	0.0072738831055031445	2.138233682528333	SOX11/LRP2/SPRY1/SFRP2/NREP/COL1A2/SULF1/TGFBR1/CDKN1C	16
BP	GO:0003073	regulation of systemic arterial blood pressure	4	4/103	40/10965	5.175433869952029e-4	0.009404866303019383	0.007488526833399098	2.125603609677321	GJA1/NCALD/TPM1/TNNI3	16
BP	GO:0048706	embryonic skeletal system development	5	5/103	71/10965	5.284317915034585e-4	0.009524660827342823	0.0075839119756208806	2.1201067163772658	COL11A1/SOX11/SULF1/TGFBR1/FGF8	16
BP	GO:0060562	epithelial tube morphogenesis	9	9/103	249/10965	5.442914887273833e-4	0.009731405084746845	0.007748529937146195	2.1107806846865347	SOX11/LRP2/EPHA4/SPRY1/SFRP2/SOX4/DLL1/FZD3/FGF8	16
BP	GO:0070252	actin-mediated cell contraction	5	5/103	72/10965	5.636774595776248e-4	0.009997383423068754	0.007960312418624648	2.0990698871590467	GJA1/AKAP9/TPM1/TNNT1/TNNI3	16
BP	GO:0045137	development of primary sexual characteristics	7	7/103	153/10965	5.807913519640541e-4	0.010219162121462762	0.008136901397190633	2.0895409467443975	LRP2/SFRP2/LFNG/DMRTA1/TGFBR1/PLEKHA1/FGF8	16
BP	GO:0042472	inner ear morphogenesis	5	5/103	74/10965	6.394357672372391e-4	0.01116243382649574	0.008887971667276005	2.0511973384917277	COL11A1/ZIC1/FZD3/FGF8/FOXG1	16
BP	GO:0090288	negative regulation of cellular response to growth factor stimulus	6	6/103	113/10965	6.660206977995639e-4	0.01153568661735651	0.009185170314225895	2.0369127864629375	LRP2/SPRY1/SFRP2/SULF1/TGFBR1/SHISA2	16
BP	GO:0006936	muscle contraction	8	8/103	205/10965	6.77496323837369e-4	0.011575186773047653	0.009216621901764317	2.035428228431273	GJA1/AKAP9/SULF1/TPM1/MAP2K6/TNNT1/TNNI3/SLC6A8	16
BP	GO:0021872	forebrain generation of neurons	4	4/103	43/10965	6.839645770271731e-4	0.011575186773047653	0.009216621901764317	2.035428228431273	FEZF2/FGF8/PAX6/FOXG1	16
BP	GO:0048645	animal organ formation	4	4/103	43/10965	6.839645770271731e-4	0.011575186773047653	0.009216621901764317	2.035428228431273	LRP2/SPRY1/SULF1/FGF8	16
BP	GO:0048844	artery morphogenesis	4	4/103	44/10965	7.469753367106526e-4	0.01254579031429937	0.009989454861752508	2.0004582111726705	LRP2/SOX4/TGFBR1/FGF8	16
BP	GO:0003012	muscle system process	9	9/103	263/10965	8.054976680344628e-4	0.013125485164214913	0.0104510308479398	1.980840870367094	IGFBP5/GJA1/AKAP9/SULF1/TPM1/MAP2K6/TNNT1/TNNI3/SLC6A8	16
BP	GO:0045667	regulation of osteoblast differentiation	5	5/103	78/10965	8.135629990178601e-4	0.013125485164214913	0.0104510308479398	1.980840870367094	SOX11/IGFBP5/SFRP2/PDLIM7/SMOC1	16
BP	GO:0007405	neuroblast proliferation	4	4/103	45/10965	8.13983645645473e-4	0.013125485164214913	0.0104510308479398	1.980840870367094	FZD3/PAX6/SOX5/FOXG1	16
BP	GO:0032024	positive regulation of insulin secretion	4	4/103	45/10965	8.13983645645473e-4	0.013125485164214913	0.0104510308479398	1.980840870367094	VSNL1/SOX4/GJA1/NNAT	16
BP	GO:0009268	response to pH	3	3/103	20/10965	8.170126083273154e-4	0.013125485164214913	0.0104510308479398	1.980840870367094	GJA1/CA2/SERPINF1	16
BP	GO:0071542	dopaminergic neuron differentiation	3	3/103	20/10965	8.170126083273154e-4	0.013125485164214913	0.0104510308479398	1.980840870367094	SFRP2/FGF8/OTX2	16
BP	GO:0051216	cartilage development	6	6/103	118/10965	8.365044478534095e-4	0.013341945042381358	0.01062338477130002	1.9737370884058598	COL11A1/SFRP2/SULF1/TGFBR1/WNT5B/SOX5	16
BP	GO:0001937	negative regulation of endothelial cell proliferation	3	3/103	21/10965	9.467034898034028e-4	0.014575289145098223	0.011605422166668908	1.935339056731547	GJA1/SULF1/TGFBR1	16
BP	GO:0002063	chondrocyte development	3	3/103	21/10965	9.467034898034028e-4	0.014575289145098223	0.011605422166668908	1.935339056731547	COL11A1/SFRP2/SULF1	16
BP	GO:0030049	muscle filament sliding	3	3/103	21/10965	9.467034898034028e-4	0.014575289145098223	0.011605422166668908	1.935339056731547	TPM1/TNNT1/TNNI3	16
BP	GO:0033275	actin-myosin filament sliding	3	3/103	21/10965	9.467034898034028e-4	0.014575289145098223	0.011605422166668908	1.935339056731547	TPM1/TNNT1/TNNI3	16
BP	GO:0097150	neuronal stem cell population maintenance	3	3/103	21/10965	9.467034898034028e-4	0.014575289145098223	0.011605422166668908	1.935339056731547	SOX2/DLL1/CDH2	16
BP	GO:0072175	epithelial tube formation	6	6/103	121/10965	9.538646941233937e-4	0.014584262254286646	0.011612566911396957	1.9350717705942755	SOX11/LRP2/SFRP2/SOX4/FZD3/FGF8	16
BP	GO:0046847	filopodium assembly	4	4/103	47/10965	9.605445782225699e-4	0.014585803629585187	0.011613794215423575	1.9350258734893468	NLGN1/MYO10/DPYSL3/TGFBR1	16
BP	GO:0043010	camera-type eye development	8	8/103	218/10965	0.001011015392793596	0.015247762760703415	0.01214087227865994	1.9157501096199274	SOX11/SPRY1/DLL1/TGFBR1/PAX6/WNT5B/SERPINF1/RAX	16
BP	GO:0048736	appendage development	6	6/103	123/10965	0.001038884232475615	0.015457760693949251	0.012308080945684256	1.9098096562214262	SOX11/SFRP2/SOX4/FGF8/SMOC1/RAX	16
BP	GO:0060173	limb development	6	6/103	123/10965	0.001038884232475615	0.015457760693949251	0.012308080945684256	1.9098096562214262	SOX11/SFRP2/SOX4/FGF8/SMOC1/RAX	16
BP	GO:0060048	cardiac muscle contraction	5	5/103	83/10965	0.001078295641250157	0.01593720957767732	0.012689837125449216	1.8965439520560117	GJA1/AKAP9/TPM1/MAP2K6/TNNI3	16
BP	GO:0060795	cell fate commitment involved in formation of primary germ layer	3	3/103	22/10965	0.0010887362609121145	0.015984955565842104	0.012727854371206803	1.8952448024173447	SOX2/SFRP2/ETS2	16
BP	GO:0001708	cell fate specification	4	4/103	49/10965	0.0011247519236674375	0.016405098781386244	0.01306238903040369	1.883977386013812	SOX2/SFRP2/DLL1/PAX6	16
BP	GO:0001704	formation of primary germ layer	5	5/103	84/10965	0.0011381004514895074	0.016491298699034235	0.013131024816979043	1.8817013778716352	COL11A1/SOX2/SFRP2/GJA1/ETS2	16
BP	GO:0009611	response to wounding	11	11/103	396/10965	0.0011981840499188027	0.01724918206928562	0.013734481556485528	1.8621877295020308	EPHA4/SOX2/NREP/DPYSL3/GJA1/COL1A2/TGFBR1/PAX6/WNT5B/TPM1/LMAN1	16
BP	GO:0003156	regulation of animal organ formation	3	3/103	23/10965	0.001243544583204442	0.017560116821428332	0.013982060114206161	1.8544288350054734	SPRY1/SULF1/FGF8	16
BP	GO:0051491	positive regulation of filopodium assembly	3	3/103	23/10965	0.001243544583204442	0.017560116821428332	0.013982060114206161	1.8544288350054734	NLGN1/DPYSL3/TGFBR1	16
BP	GO:1902692	regulation of neuroblast proliferation	3	3/103	23/10965	0.001243544583204442	0.017560116821428332	0.013982060114206161	1.8544288350054734	FZD3/PAX6/FOXG1	16
BP	GO:0042471	ear morphogenesis	5	5/103	86/10965	0.0012650442805160638	0.017750652974076665	0.014133772541142167	1.8497419021907948	COL11A1/ZIC1/FZD3/FGF8/FOXG1	16
BP	GO:0048704	embryonic skeletal system morphogenesis	4	4/103	51/10965	0.001307710267981472	0.018233922415817127	0.014518570800429847	1.8380761332251954	COL11A1/SOX11/TGFBR1/FGF8	16
BP	GO:0003279	cardiac septum development	5	5/103	87/10965	0.001332304025723689	0.018460737656433867	0.014699170073280438	1.8327071851681267	SOX11/LRP2/SOX4/TGFBR1/FGF8	16
BP	GO:0010092	specification of animal organ identity	3	3/103	24/10965	0.0014115470033102282	0.019317282137893677	0.015381184694939914	1.813010212866162	LRP2/SPRY1/FGF8	16
BP	GO:0060317	cardiac epithelial to mesenchymal transition	3	3/103	24/10965	0.0014115470033102282	0.019317282137893677	0.015381184694939914	1.813010212866162	SPRY1/TGFBR1/FGF8	16
BP	GO:0021543	pallium development	6	6/103	131/10965	0.0014386256951068395	0.019567074638354987	0.015580079371612333	1.8074303341752995	FEZF2/EMX2/FGF8/PAX6/FOXG1/CDH2	16
BP	GO:0071560	cellular response to transforming growth factor beta stimulus	7	7/103	179/10965	0.0014587191485578768	0.0197193923923952	0.01570136079673658	1.8040627067688997	SOX11/SPRY1/NREP/COL1A2/TGFBR1/CDKN1C/SOX5	16
BP	GO:0035148	tube formation	6	6/103	132/10965	0.0014958378837673526	0.02009862174734679	0.01600331822059235	1.7957899588764985	SOX11/LRP2/SFRP2/SOX4/FZD3/FGF8	16
BP	GO:0030336	negative regulation of cell migration	7	7/103	180/10965	0.001506229787205192	0.020116333965264525	0.01601742138962021	1.7954073987634742	IGFBP5/SFRP2/DPYSL3/GJA1/SULF1/TPM1/SERPINF1	16
BP	GO:0007548	sex differentiation	7	7/103	181/10965	0.0015549412366801486	0.020642543243831673	0.016436410046723034	1.784193032729722	LRP2/SFRP2/LFNG/DMRTA1/TGFBR1/PLEKHA1/FGF8	16
BP	GO:0010470	regulation of gastrulation	3	3/103	25/10965	0.0015931472462363547	0.02102385383872618	0.016740024636205306	1.776243907193407	SFRP2/GJA1/OTX2	16
BP	GO:0003151	outflow tract morphogenesis	4	4/103	54/10965	0.0016197152735128407	0.021247980836556022	0.016918483423737363	1.7716385697970964	SOX11/LRP2/SFRP2/FGF8	16
BP	GO:0010976	positive regulation of neuron projection development	8	8/103	235/10965	0.0016333375481087297	0.021300643200923845	0.016960415282838016	1.7705635180676937	EPHA4/NLGN1/DPYSL3/TUBB2B/MAP6/SYT1/NPTN/SERPINF1	16
BP	GO:0071559	response to transforming growth factor beta	7	7/103	184/10965	0.0017084891891434278	0.022027257503313098	0.017538974352755532	1.7559958069769595	SOX11/SPRY1/NREP/COL1A2/TGFBR1/CDKN1C/SOX5	16
BP	GO:0016202	regulation of striated muscle tissue development	5	5/103	92/10965	0.0017089257061659237	0.022027257503313098	0.017538974352755532	1.7559958069769595	GJA1/DLL1/TGFBR1/FGF8/CXADR	16
BP	GO:0090277	positive regulation of peptide hormone secretion	4	4/103	55/10965	0.0017342830309280603	0.022224887165130113	0.01769633491248164	1.7521166710452465	VSNL1/SOX4/GJA1/NNAT	16
BP	GO:0008015	blood circulation	9	9/103	294/10965	0.001753916933197511	0.022347320924706215	0.017793821518283275	1.7497307699559883	GJA1/DLL1/AKAP9/COL1A2/NCALD/TPM1/MAP2K6/TNNI3/CXADR	16
BP	GO:0007157	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	3	3/103	26/10965	0.0017887345041370782	0.02245491733700821	0.017879494040862604	1.7476447751581368	NLGN1/CDH2/CXADR	16
BP	GO:0017015	regulation of transforming growth factor beta receptor signaling pathway	5	5/103	93/10965	0.0017927471216285312	0.02245491733700821	0.017879494040862604	1.7476447751581368	SOX11/SPRY1/NREP/TGFBR1/CDKN1C	16
BP	GO:0048634	regulation of muscle organ development	5	5/103	93/10965	0.0017927471216285312	0.02245491733700821	0.017879494040862604	1.7476447751581368	GJA1/DLL1/TGFBR1/FGF8/CXADR	16
BP	GO:0009798	axis specification	4	4/103	56/10965	0.001854360873059273	0.023096168851530385	0.018390083880073335	1.7354162898717695	DLL1/PAX6/OTX2/ETS2	16
BP	GO:1903844	regulation of cellular response to transforming growth factor beta stimulus	5	5/103	94/10965	0.0018795462691222078	0.023279073065049914	0.01853571945497173	1.7319905523773245	SOX11/SPRY1/NREP/TGFBR1/CDKN1C	16
BP	GO:0000132	establishment of mitotic spindle orientation	3	3/103	27/10965	0.001998683720618003	0.024346603344011605	0.01938572932027988	1.7125178555381277	SPRY1/GJA1/PAX6	16
BP	GO:0048854	brain morphogenesis	3	3/103	27/10965	0.001998683720618003	0.024346603344011605	0.01938572932027988	1.7125178555381277	FZD3/FGF8/CDH2	16
BP	GO:0060043	regulation of cardiac muscle cell proliferation	3	3/103	27/10965	0.001998683720618003	0.024346603344011605	0.01938572932027988	1.7125178555381277	GJA1/TGFBR1/CXADR	16
BP	GO:2000027	regulation of animal organ morphogenesis	7	7/103	190/10965	0.00205086295816418	0.0247106694470108	0.01967561316270784	1.7060717245835786	SPRY1/SFRP2/RSPO3/FZD3/SULF1/TGFBR1/FGF8	16
BP	GO:2000146	negative regulation of cell motility	7	7/103	190/10965	0.00205086295816418	0.0247106694470108	0.01967561316270784	1.7060717245835786	IGFBP5/SFRP2/DPYSL3/GJA1/SULF1/TPM1/SERPINF1	16
BP	GO:0003281	ventricular septum development	4	4/103	58/10965	0.002111587663338299	0.0253048099979514	0.020148691387871	1.6957531550554685	SOX11/LRP2/SOX4/TGFBR1	16
BP	GO:0030048	actin filament-based movement	5	5/103	97/10965	0.0021584385771540203	0.025589616714173598	0.020375465769137586	1.690892454801273	GJA1/AKAP9/TPM1/TNNT1/TNNI3	16
BP	GO:0048771	tissue remodeling	5	5/103	97/10965	0.0021584385771540203	0.025589616714173598	0.020375465769137586	1.690892454801273	IGFBP5/GJA1/RSPO3/CA2/FGF8	16
BP	GO:0045746	negative regulation of Notch signaling pathway	3	3/103	28/10965	0.0022233558706342576	0.026219042368064622	0.02087663938999804	1.6803394104515852	DLL1/LFNG/DLK1	16
BP	GO:0021537	telencephalon development	7	7/103	195/10965	0.002374909185032273	0.02785806171014047	0.022181691469223736	1.65400533971341	FEZF2/FEZF1/EMX2/FGF8/PAX6/FOXG1/CDH2	16
BP	GO:0003013	circulatory system process	9	9/103	308/10965	0.002406489903410563	0.028079937451901148	0.022358357717559636	1.650560099729954	GJA1/DLL1/AKAP9/COL1A2/NCALD/TPM1/MAP2K6/TNNI3/CXADR	16
BP	GO:0031018	endocrine pancreas development	3	3/103	29/10965	0.0024630982360428983	0.028479213743367388	0.022676277305807808	1.6444282407070974	SOX4/DLL1/PAX6	16
BP	GO:0001841	neural tube formation	5	5/103	100/10965	0.0024664001076799905	0.028479213743367388	0.022676277305807808	1.6444282407070974	SOX11/LRP2/SFRP2/SOX4/FZD3	16
BP	GO:0007179	transforming growth factor beta receptor signaling pathway	6	6/103	146/10965	0.0024930321537589	0.028637576605613894	0.022802372085375923	1.6420199718590403	SOX11/SPRY1/NREP/COL1A2/TGFBR1/CDKN1C	16
BP	GO:0031346	positive regulation of cell projection organization	9	9/103	311/10965	0.0025687344517028353	0.029355073605284464	0.02337367159796883	1.6312730621267015	EPHA4/NLGN1/DPYSL3/TUBB2B/TGFBR1/MAP6/SYT1/NPTN/SERPINF1	16
BP	GO:0061053	somite development	4	4/103	62/10965	0.0026980715485805115	0.030674998067707664	0.024424647702939367	1.6121716917554676	SOX11/SFRP2/DLL1/LFNG	16
BP	GO:0030510	regulation of BMP signaling pathway	4	4/103	63/10965	0.00286046964588431	0.03219117362906353	0.02563188670129836	1.5912194252708594	SOX11/LRP2/SFRP2/SULF1	16
BP	GO:0030901	midbrain development	4	4/103	63/10965	0.00286046964588431	0.03219117362906353	0.02563188670129836	1.5912194252708594	SFRP2/FZD3/OTX2/CKB	16
BP	GO:0002067	glandular epithelial cell differentiation	3	3/103	31/10965	0.0029891158983408324	0.033469040134452656	0.026649374596053037	1.5743129784824426	DLL1/FGF8/PAX6	16
BP	GO:0001649	osteoblast differentiation	6	6/103	152/10965	0.003047337058087743	0.0339494786823142	0.027031918785576012	1.5681231260211586	SOX11/IGFBP5/SOX2/SFRP2/PDLIM7/SMOC1	16
BP	GO:0021954	central nervous system neuron development	4	4/103	65/10965	0.0032051087073480394	0.03535187066761494	0.02814855879666228	1.5505438360765702	EPHA4/FEZF2/FGF8/FOXG1	16
BP	GO:0046620	regulation of organ growth	4	4/103	65/10965	0.0032051087073480394	0.03535187066761494	0.02814855879666228	1.5505438360765702	GJA1/TGFBR1/FGF8/CXADR	16
BP	GO:0014009	glial cell proliferation	3	3/103	32/10965	0.003276019713761101	0.03542895466052859	0.028209936123118697	1.5495978972338036	SOX11/SOX4/CLU	16
BP	GO:0040001	establishment of mitotic spindle localization	3	3/103	32/10965	0.003276019713761101	0.03542895466052859	0.028209936123118697	1.5495978972338036	SPRY1/GJA1/PAX6	16
BP	GO:0048483	autonomic nervous system development	3	3/103	32/10965	0.003276019713761101	0.03542895466052859	0.028209936123118697	1.5495978972338036	SOX11/SOX4/FZD3	16
BP	GO:0051294	establishment of spindle orientation	3	3/103	32/10965	0.003276019713761101	0.03542895466052859	0.028209936123118697	1.5495978972338036	SPRY1/GJA1/PAX6	16
BP	GO:0001503	ossification	8	8/103	264/10965	0.0033618090111547	0.03618024552296102	0.028808143646941398	1.5404847260953085	COL11A1/SOX11/IGFBP5/SOX2/SFRP2/PDLIM7/COL1A2/SMOC1	16
BP	GO:0060840	artery development	4	4/103	66/10965	0.003387605628352928	0.0362817472369973	0.02888896332950857	1.5392680423839749	LRP2/SOX4/TGFBR1/FGF8	16
BP	GO:0060047	heart contraction	6	6/103	157/10965	0.0035757610249547798	0.03763517276210111	0.029966614306694	1.5233623218184826	GJA1/AKAP9/TPM1/MAP2K6/TNNI3/CXADR	16
BP	GO:2000242	negative regulation of reproductive process	3	3/103	33/10965	0.0035792513032556683	0.03763517276210111	0.029966614306694	1.5233623218184826	GJA1/SULF1/SERPINF1	16
BP	GO:0035265	organ growth	5	5/103	109/10965	0.003581877064863931	0.03763517276210111	0.029966614306694	1.5233623218184826	GJA1/DLL1/TGFBR1/FGF8/CXADR	16
BP	GO:0046661	male sex differentiation	5	5/103	109/10965	0.003581877064863931	0.03763517276210111	0.029966614306694	1.5233623218184826	LRP2/SFRP2/TGFBR1/PLEKHA1/FGF8	16
BP	GO:0014733	regulation of skeletal muscle adaptation	2	2/103	10/10965	0.0037438677914211032	0.038605371598049235	0.03073912502429959	1.5123084986621247	IGFBP5/TNNT1	16
BP	GO:0021781	glial cell fate commitment	2	2/103	10/10965	0.0037438677914211032	0.038605371598049235	0.03073912502429959	1.5123084986621247	SOX2/PAX6	16
BP	GO:0046629	gamma-delta T cell activation	2	2/103	10/10965	0.0037438677914211032	0.038605371598049235	0.03073912502429959	1.5123084986621247	SOX4/CXADR	16
BP	GO:0048505	regulation of timing of cell differentiation	2	2/103	10/10965	0.0037438677914211032	0.038605371598049235	0.03073912502429959	1.5123084986621247	DLL1/PAX6	16
BP	GO:0050806	positive regulation of synaptic transmission	5	5/103	111/10965	0.0038720642323849933	0.039652707429365386	0.03157305527101382	1.5006833901337684	EPHA4/NLGN1/CA2/SYT1/NPTN	16
BP	GO:0060038	cardiac muscle cell proliferation	3	3/103	34/10965	0.0038990934684716527	0.039652707429365386	0.03157305527101382	1.5006833901337684	GJA1/TGFBR1/CXADR	16
BP	GO:0060412	ventricular septum morphogenesis	3	3/103	34/10965	0.0038990934684716527	0.039652707429365386	0.03157305527101382	1.5006833901337684	SOX11/SOX4/TGFBR1	16
BP	GO:0061448	connective tissue development	6	6/103	160/10965	0.003923919238106929	0.039722963246041375	0.03162899573326277	1.4999145973484702	COL11A1/SFRP2/SULF1/TGFBR1/WNT5B/SOX5	16
BP	GO:0040013	negative regulation of locomotion	7	7/103	214/10965	0.003979703238820494	0.04010455491120471	0.031932834122018985	1.4957625349860175	IGFBP5/SFRP2/DPYSL3/GJA1/SULF1/TPM1/SERPINF1	16
BP	GO:1904705	regulation of vascular associated smooth muscle cell proliferation	3	3/103	35/10965	0.004235816883270861	0.04230092806401576	0.033681673367687216	1.4726063400851048	IGFBP5/GJA1/TPM1	16
BP	GO:1990874	vascular associated smooth muscle cell proliferation	3	3/103	35/10965	0.004235816883270861	0.04230092806401576	0.033681673367687216	1.4726063400851048	IGFBP5/GJA1/TPM1	16
BP	GO:0001838	embryonic epithelial tube formation	5	5/103	114/10965	0.004338417606937634	0.043131263832200596	0.03434281957438948	1.4641640517688705	SOX11/LRP2/SFRP2/SOX4/FZD3	16
BP	GO:0051271	negative regulation of cellular component movement	7	7/103	218/10965	0.0044031466664412044	0.0434224511663522	0.03457467445622232	1.4612419003735866	IGFBP5/SFRP2/DPYSL3/GJA1/SULF1/TPM1/SERPINF1	16
BP	GO:0090100	positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	4	4/103	71/10965	0.004406879347058748	0.0434224511663522	0.03457467445622232	1.4612419003735866	SOX11/SULF1/TGFBR1/CDKN1C	16
BP	GO:0001502	cartilage condensation	2	2/103	11/10965	0.004547893480731322	0.04422228002974272	0.03521152985773974	1.453315105451237	COL11A1/SOX5	16
BP	GO:0040034	regulation of development, heterochronic	2	2/103	11/10965	0.004547893480731322	0.04422228002974272	0.03521152985773974	1.453315105451237	DLL1/PAX6	16
BP	GO:0060044	negative regulation of cardiac muscle cell proliferation	2	2/103	11/10965	0.004547893480731322	0.04422228002974272	0.03521152985773974	1.453315105451237	GJA1/CXADR	16
BP	GO:0003015	heart process	6	6/103	166/10965	0.004694962069273444	0.045452973395542474	0.03619145663144825	1.4413939370833064	GJA1/AKAP9/TPM1/MAP2K6/TNNI3/CXADR	16
BP	GO:0060425	lung morphogenesis	3	3/103	37/10965	0.004960930994729257	0.04781906093615114	0.038075429190668024	1.4193551925463974	SOX11/SPRY1/FGF8	16
BP	GO:0021542	dentate gyrus development	2	2/103	12/10965	0.005424166977781911	0.051390505084369646	0.040919154393793365	1.3880733496887132	FEZF2/EMX2	16
BP	GO:0023019	signal transduction involved in regulation of gene expression	2	2/103	12/10965	0.005424166977781911	0.051390505084369646	0.040919154393793365	1.3880733496887132	FGF8/PAX6	16
BP	GO:0097104	postsynaptic membrane assembly	2	2/103	12/10965	0.005424166977781911	0.051390505084369646	0.040919154393793365	1.3880733496887132	NLGN1/CDH2	16
BP	GO:0098743	cell aggregation	2	2/103	12/10965	0.005424166977781911	0.051390505084369646	0.040919154393793365	1.3880733496887132	COL11A1/SOX5	16
BP	GO:0008037	cell recognition	4	4/103	76/10965	0.005615249478919095	0.05297450253090907	0.04218039586180211	1.3748893487361835	EPHA4/FEZF2/FOXG1/NPTN	16
BP	GO:0045669	positive regulation of osteoblast differentiation	3	3/103	39/10965	0.00575652575231389	0.05403447016062104	0.043024384046417154	1.366285338482261	SOX11/SFRP2/PDLIM7	16
BP	GO:0010977	negative regulation of neuron projection development	5	5/103	122/10965	0.0057763506666969715	0.05403447016062104	0.043024384046417154	1.366285338482261	EPHA4/NLGN1/CRMP1/NR2F1/DPYSL3	16
BP	GO:0051146	striated muscle cell differentiation	6	6/103	174/10965	0.005890036608879387	0.054866433453300854	0.04368682615254636	1.3596495056338536	IGFBP5/DLL1/TPM1/CDH2/TNNT1/CXADR	16
BP	GO:0030278	regulation of ossification	5	5/103	123/10965	0.00597709076984194	0.05544439429598152	0.04414702145353417	1.3550985924245984	SOX11/IGFBP5/SFRP2/PDLIM7/SMOC1	16
BP	GO:0021761	limbic system development	4	4/103	78/10965	0.00615481371503432	0.05662793418006372	0.04508940275857221	1.34592551719674	FEZF2/EMX2/RAX/SOX3	16
BP	GO:0051966	regulation of synaptic transmission, glutamatergic	3	3/103	40/10965	0.006181308106258647	0.05662793418006372	0.04508940275857221	1.34592551719674	NLGN1/SYT1/CDH2	16
BP	GO:0055021	regulation of cardiac muscle tissue growth	3	3/103	40/10965	0.006181308106258647	0.05662793418006372	0.04508940275857221	1.34592551719674	GJA1/TGFBR1/CXADR	16
BP	GO:0002313	mature B cell differentiation involved in immune response	2	2/103	13/10965	0.0063712868194186175	0.05777744352171648	0.046004687598660374	1.337197914089941	DLL1/LFNG	16
BP	GO:0060977	coronary vasculature morphogenesis	2	2/103	13/10965	0.0063712868194186175	0.05777744352171648	0.046004687598660374	1.337197914089941	LRP2/TGFBR1	16
BP	GO:0033002	muscle cell proliferation	5	5/103	125/10965	0.006393248278852137	0.05777744352171648	0.046004687598660374	1.337197914089941	IGFBP5/GJA1/TGFBR1/TPM1/CXADR	16
BP	GO:0007498	mesoderm development	4	4/103	79/10965	0.006437090008959843	0.05777744352171648	0.046004687598660374	1.337197914089941	SFRP2/GJA1/FGF8/ETS2	16
BP	GO:0014013	regulation of gliogenesis	4	4/103	79/10965	0.006437090008959843	0.05777744352171648	0.046004687598660374	1.337197914089941	SOX11/LRP2/EPHA4/CDH2	16
BP	GO:0021885	forebrain cell migration	3	3/103	41/10965	0.006624354617779972	0.05898069954866746	0.04696276767709581	1.3282463165417218	FEZF2/EMX2/FOXG1	16
BP	GO:0051293	establishment of spindle localization	3	3/103	41/10965	0.006624354617779972	0.05898069954866746	0.04696276767709581	1.3282463165417218	SPRY1/GJA1/PAX6	16
BP	GO:0046660	female sex differentiation	4	4/103	80/10965	0.0067278403645873	0.05966248835316018	0.04750563491121222	1.3232548732024807	LRP2/LFNG/DMRTA1/PLEKHA1	16
BP	GO:0030111	regulation of Wnt signaling pathway	8	8/103	298/10965	0.006915244949069532	0.060837690682885526	0.04844137752543695	1.3147835153392735	SOX2/SFRP2/SOX4/RSPO3/SULF1/WNT5B/SHISA2/CDH2	16
BP	GO:0050804	modulation of chemical synaptic transmission	8	8/103	298/10965	0.006915244949069532	0.060837690682885526	0.04844137752543695	1.3147835153392735	EPHA4/NLGN1/TUBB2B/AKAP9/CA2/SYT1/NPTN/CDH2	16
BP	GO:0021782	glial cell development	4	4/103	81/10965	0.007027171228416142	0.06154571817389095	0.04900513704038892	1.3097583919846147	SOX11/SOX4/DLL1/CLU	16
BP	GO:0099177	regulation of trans-synaptic signaling	8	8/103	299/10965	0.0070512460154119536	0.06154571817389095	0.04900513704038892	1.3097583919846147	EPHA4/NLGN1/TUBB2B/AKAP9/CA2/SYT1/NPTN/CDH2	16
BP	GO:0042698	ovulation cycle	3	3/103	42/10965	0.007085857760868778	0.061605281003317955	0.04905256332291823	1.3093382929137738	PLEKHA1/SERPINF1/MAP2K6	16
BP	GO:0003094	glomerular filtration	2	2/103	14/10965	0.0073878710522893255	0.06251492413330317	0.049776857190394534	1.302972527332831	GJA1/SULF1	16
BP	GO:0003198	epithelial to mesenchymal transition involved in endocardial cushion formation	2	2/103	14/10965	0.0073878710522893255	0.06251492413330317	0.049776857190394534	1.302972527332831	TGFBR1/FGF8	16
BP	GO:0021854	hypothalamus development	2	2/103	14/10965	0.0073878710522893255	0.06251492413330317	0.049776857190394534	1.302972527332831	RAX/SOX3	16
BP	GO:0043501	skeletal muscle adaptation	2	2/103	14/10965	0.0073878710522893255	0.06251492413330317	0.049776857190394534	1.302972527332831	IGFBP5/TNNT1	16
BP	GO:0048520	positive regulation of behavior	2	2/103	14/10965	0.0073878710522893255	0.06251492413330317	0.049776857190394534	1.302972527332831	NLGN1/GJA1	16
BP	GO:0097091	synaptic vesicle clustering	2	2/103	14/10965	0.0073878710522893255	0.06251492413330317	0.049776857190394534	1.302972527332831	NLGN1/CDH2	16
BP	GO:2000095	regulation of Wnt signaling pathway, planar cell polarity pathway	2	2/103	14/10965	0.0073878710522893255	0.06251492413330317	0.049776857190394534	1.302972527332831	SFRP2/RSPO3	16
BP	GO:0014855	striated muscle cell proliferation	3	3/103	43/10965	0.007565999749656898	0.06377878876421804	0.05078319623844153	1.2942799685856903	GJA1/TGFBR1/CXADR	16
BP	GO:0061138	morphogenesis of a branching epithelium	5	5/103	132/10965	0.008010249548931347	0.06721804608610579	0.05352166905794906	1.271470351679792	SPRY1/SFRP2/RSPO3/SULF1/FGF8	16
BP	GO:0035904	aorta development	3	3/103	44/10965	0.008064952755482246	0.06721804608610579	0.05352166905794906	1.271470351679792	LRP2/SOX4/FGF8	16
BP	GO:0060420	regulation of heart growth	3	3/103	44/10965	0.008064952755482246	0.06721804608610579	0.05352166905794906	1.271470351679792	GJA1/TGFBR1/CXADR	16
BP	GO:0048638	regulation of developmental growth	7	7/103	246/10965	0.008391079070869688	0.06931239431602466	0.05518927202144831	1.258145334493408	SFRP2/GJA1/DLL1/TGFBR1/FGF8/SYT1/CXADR	16
BP	GO:0001759	organ induction	2	2/103	15/10965	0.00847255699577929	0.06931239431602466	0.05518927202144831	1.258145334493408	SPRY1/FGF8	16
BP	GO:0036342	post-anal tail morphogenesis	2	2/103	15/10965	0.00847255699577929	0.06931239431602466	0.05518927202144831	1.258145334493408	SFRP2/FZD3	16
BP	GO:0048665	neuron fate specification	2	2/103	15/10965	0.00847255699577929	0.06931239431602466	0.05518927202144831	1.258145334493408	DLL1/PAX6	16
BP	GO:0097205	renal filtration	2	2/103	15/10965	0.00847255699577929	0.06931239431602466	0.05518927202144831	1.258145334493408	GJA1/SULF1	16
BP	GO:0031529	ruffle organization	3	3/103	45/10965	0.008582879120470586	0.06944614237256674	0.05529576751836026	1.2573081094505862	NLGN1/PLEKHA1/TPM1	16
BP	GO:0051653	spindle localization	3	3/103	45/10965	0.008582879120470586	0.06944614237256674	0.05529576751836026	1.2573081094505862	SPRY1/GJA1/PAX6	16
BP	GO:0086001	cardiac muscle cell action potential	3	3/103	45/10965	0.008582879120470586	0.06944614237256674	0.05529576751836026	1.2573081094505862	GJA1/AKAP9/CXADR	16
BP	GO:0022612	gland morphogenesis	4	4/103	86/10965	0.008656142948331674	0.06978425060527754	0.055564982676946297	1.2551988167127497	IGFBP5/SULF1/FGF8/PAX6	16
BP	GO:0019827	stem cell population maintenance	5	5/103	135/10965	0.008783209371398074	0.07055208397242584	0.05617636199784352	1.2504463892964226	SOX2/SOX4/DLL1/ZNF706/CDH2	16
BP	GO:0008016	regulation of heart contraction	5	5/103	136/10965	0.009051949245797917	0.07218766718681288	0.05747867809618745	1.2404932283967702	GJA1/AKAP9/TPM1/TNNI3/CXADR	16
BP	GO:0098727	maintenance of cell number	5	5/103	136/10965	0.009051949245797917	0.07218766718681288	0.05747867809618745	1.2404932283967702	SOX2/SOX4/DLL1/ZNF706/CDH2	16
BP	GO:0048732	gland development	8	8/103	314/10965	0.009344150104730052	0.07420148223721872	0.05908215735432699	1.2285436550328401	IGFBP5/SOX2/SULF1/TGFBR1/FGF8/PAX6/SERPINF1/SOX3	16
BP	GO:0007050	cell cycle arrest	6	6/103	192/10965	0.009371409574389374	0.07420148223721872	0.05908215735432699	1.2285436550328401	SOX2/TFDP2/SOX4/TGFBR1/CDKN1C/MAP2K6	16
BP	GO:0001956	positive regulation of neurotransmitter secretion	2	2/103	16/10965	0.009624001007611243	0.0756247829145354	0.0602154456936476	1.2202920948032332	NLGN1/SYT1	16
BP	GO:1902004	positive regulation of amyloid-beta formation	2	2/103	16/10965	0.009624001007611243	0.0756247829145354	0.0602154456936476	1.2202920948032332	EPHA4/CLU	16
BP	GO:0097120	receptor localization to synapse	3	3/103	47/10965	0.009676253407872933	0.0756247829145354	0.0602154456936476	1.2202920948032332	NLGN1/MAPK10/NPTN	16
BP	GO:0023061	signal release	8	8/103	316/10965	0.009687613147373953	0.0756247829145354	0.0602154456936476	1.2202920948032332	SOX11/VSNL1/NLGN1/SOX4/GJA1/SYT1/MAP2K6/NNAT	16
BP	GO:0001763	morphogenesis of a branching structure	5	5/103	139/10965	0.009892220174488615	0.07695106009417985	0.06127148008353613	1.212741628655336	SPRY1/SFRP2/RSPO3/SULF1/FGF8	16
BP	GO:2000241	regulation of reproductive process	4	4/103	90/10965	0.010124008426411037	0.07847876462011633	0.0624878988998576	1.2042040778536116	GJA1/LFNG/SULF1/SERPINF1	16
BP	GO:0051896	regulation of protein kinase B signaling	5	5/103	140/10965	0.010183846348139633	0.07864580232883502	0.06262090093557263	1.2032806884193097	LRP2/IGFBP5/TGFBR1/PLEKHA1/FGF8	16
BP	GO:0001756	somitogenesis	3	3/103	48/10965	0.010251978742910834	0.07864580232883502	0.06262090093557263	1.2032806884193097	SFRP2/DLL1/LFNG	16
BP	GO:0031016	pancreas development	3	3/103	48/10965	0.010251978742910834	0.07864580232883502	0.06262090093557263	1.2032806884193097	SOX4/DLL1/PAX6	16
BP	GO:0071900	regulation of protein serine/threonine kinase activity	9	9/103	387/10965	0.01047509804704686	0.08008031851828583	0.06376311950961011	1.1954304439226562	EPHA4/CCNG2/SPRY1/CCNI/MAPK10/SFRP2/TGFBR1/CDKN1C/MAP2K6	16
BP	GO:0002335	mature B cell differentiation	2	2/103	17/10965	0.01084087825208196	0.08012684212110889	0.06380016344377161	1.1951782086983176	DLL1/LFNG	16
BP	GO:0007413	axonal fasciculation	2	2/103	17/10965	0.01084087825208196	0.08012684212110889	0.06380016344377161	1.1951782086983176	EPHA4/FEZF2	16
BP	GO:0008356	asymmetric cell division	2	2/103	17/10965	0.01084087825208196	0.08012684212110889	0.06380016344377161	1.1951782086983176	PAX6/SOX5	16
BP	GO:0032228	regulation of synaptic transmission, GABAergic	2	2/103	17/10965	0.01084087825208196	0.08012684212110889	0.06380016344377161	1.1951782086983176	NLGN1/CA2	16
BP	GO:0051291	protein heterooligomerization	2	2/103	17/10965	0.01084087825208196	0.08012684212110889	0.06380016344377161	1.1951782086983176	COL1A2/SYT1	16
BP	GO:0086019	cell-cell signaling involved in cardiac conduction	2	2/103	17/10965	0.01084087825208196	0.08012684212110889	0.06380016344377161	1.1951782086983176	GJA1/CXADR	16
BP	GO:0106030	neuron projection fasciculation	2	2/103	17/10965	0.01084087825208196	0.08012684212110889	0.06380016344377161	1.1951782086983176	EPHA4/FEZF2	16
BP	GO:1904738	vascular associated smooth muscle cell migration	2	2/103	17/10965	0.01084087825208196	0.08012684212110889	0.06380016344377161	1.1951782086983176	IGFBP5/TPM1	16
BP	GO:1904752	regulation of vascular associated smooth muscle cell migration	2	2/103	17/10965	0.01084087825208196	0.08012684212110889	0.06380016344377161	1.1951782086983176	IGFBP5/TPM1	16
BP	GO:0021987	cerebral cortex development	4	4/103	92/10965	0.01091488783066075	0.08012684212110889	0.06380016344377161	1.1951782086983176	EMX2/PAX6/FOXG1/CDH2	16
BP	GO:0050714	positive regulation of protein secretion	4	4/103	92/10965	0.01091488783066075	0.08012684212110889	0.06380016344377161	1.1951782086983176	VSNL1/SOX4/GJA1/NNAT	16
BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	4	4/103	92/10965	0.01091488783066075	0.08012684212110889	0.06380016344377161	1.1951782086983176	LRP2/SPRY1/SFRP2/TGFBR1	16
BP	GO:0060541	respiratory system development	5	5/103	143/10965	0.011094097896755575	0.08117364698715218	0.06463367091491784	1.189541177315483	SOX11/IGFBP5/SPRY1/FGF8/GNG8	16
BP	GO:0007610	behavior	9	9/103	391/10965	0.011153749966503108	0.08134165682808352	0.06476744700078155	1.1886432216017342	EPHA4/ZIC1/NLGN1/FEZF2/GJA1/DMRTA1/NPTN/SERPINF1/GNG8	16
BP	GO:0031345	negative regulation of cell projection organization	5	5/103	144/10965	0.011409485029138244	0.08293386331016225	0.06603522482783378	1.1802243391933456	EPHA4/NLGN1/CRMP1/NR2F1/DPYSL3	16
BP	GO:0046883	regulation of hormone secretion	5	5/103	145/10965	0.011730945321795135	0.0845387010327415	0.06731306014856847	1.1719006653424164	SOX11/VSNL1/SOX4/GJA1/NNAT	16
BP	GO:0090257	regulation of muscle system process	5	5/103	145/10965	0.011730945321795135	0.0845387010327415	0.06731306014856847	1.1719006653424164	IGFBP5/AKAP9/TPM1/TNNT1/TNNI3	16
BP	GO:0008584	male gonad development	4	4/103	94/10965	0.011744663923357861	0.0845387010327415	0.06731306014856847	1.1719006653424164	LRP2/SFRP2/TGFBR1/PLEKHA1	16
BP	GO:0022604	regulation of cell morphogenesis	9	9/103	396/10965	0.012048069772393075	0.085586667000002975	0.06814749213446573	1.166550121813216	EPHA4/NLGN1/FEZF2/MYO10/TUBB2B/MAP6/SYT1/TPM1/CDH2	16
BP	GO:1905330	regulation of morphogenesis of an epithelium	5	5/103	146/10965	0.012058530895129763	0.085586667000002975	0.06814749213446573	1.166550121813216	SFRP2/GJA1/RSPO3/FZD3/SULF1	16
BP	GO:0003148	outflow tract septum morphogenesis	2	2/103	18/10965	0.012121882470907052	0.085586667000002975	0.06814749213446573	1.166550121813216	LRP2/FGF8	16
BP	GO:0003309	type B pancreatic cell differentiation	2	2/103	18/10965	0.012121882470907052	0.085586667000002975	0.06814749213446573	1.166550121813216	DLL1/PAX6	16
BP	GO:0055022	negative regulation of cardiac muscle tissue growth	2	2/103	18/10965	0.012121882470907052	0.085586667000002975	0.06814749213446573	1.166550121813216	GJA1/CXADR	16
BP	GO:0061117	negative regulation of heart growth	2	2/103	18/10965	0.012121882470907052	0.085586667000002975	0.06814749213446573	1.166550121813216	GJA1/CXADR	16
BP	GO:0046546	development of primary male sexual characteristics	4	4/103	95/10965	0.012174346473752231	0.08568420994383713	0.06822515968749371	1.1660554391492175	LRP2/SFRP2/TGFBR1/PLEKHA1	16
BP	GO:0001525	angiogenesis	8	8/103	331/10965	0.012572220927925858	0.08820447404180894	0.07023189372462246	1.153465621159882	SFRP2/RSPO3/DLL1/SULF1/TGFBR1/FGF8/BTG1/SERPINF1	16
BP	GO:0030856	regulation of epithelial cell differentiation	4	4/103	96/10965	0.012613999408913158	0.08821841226990684	0.07024299189356588	1.1533969985940735	SPRY1/DLL1/PAX6/BTG1	16
BP	GO:0045216	cell-cell junction organization	5	5/103	148/10965	0.012732283655020729	0.08876563793453131	0.07067871462916174	1.1507113572204268	EPHA4/GJA1/TGFBR1/CDH2/CXADR	16
BP	GO:0060070	canonical Wnt signaling pathway	7	7/103	268/10965	0.013034526177872511	0.09058791390703247	0.07212968289157631	1.1418859771228593	SOX2/SFRP2/SOX4/RSPO3/FZD3/WNT5B/CDH2	16
BP	GO:0035249	synaptic transmission, glutamatergic	3	3/103	53/10965	0.01342573172888908	0.09074016414129134	0.07225091055477796	1.1411566752645126	NLGN1/SYT1/CDH2	16
BP	GO:0048708	astrocyte differentiation	3	3/103	53/10965	0.01342573172888908	0.09074016414129134	0.07225091055477796	1.1411566752645126	EPHA4/DLL1/PAX6	16
BP	GO:0007628	adult walking behavior	2	2/103	19/10965	0.013465725756646302	0.09074016414129134	0.07225091055477796	1.1411566752645126	EPHA4/ZIC1	16
BP	GO:0014912	negative regulation of smooth muscle cell migration	2	2/103	19/10965	0.013465725756646302	0.09074016414129134	0.07225091055477796	1.1411566752645126	IGFBP5/TPM1	16
BP	GO:0021522	spinal cord motor neuron differentiation	2	2/103	19/10965	0.013465725756646302	0.09074016414129134	0.07225091055477796	1.1411566752645126	SOX4/PAX6	16
BP	GO:0035883	enteroendocrine cell differentiation	2	2/103	19/10965	0.013465725756646302	0.09074016414129134	0.07225091055477796	1.1411566752645126	DLL1/PAX6	16
BP	GO:0048333	mesodermal cell differentiation	2	2/103	19/10965	0.013465725756646302	0.09074016414129134	0.07225091055477796	1.1411566752645126	SFRP2/GJA1	16
BP	GO:0051590	positive regulation of neurotransmitter transport	2	2/103	19/10965	0.013465725756646302	0.09074016414129134	0.07225091055477796	1.1411566752645126	NLGN1/SYT1	16
BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	2	2/103	19/10965	0.013465725756646302	0.09074016414129134	0.07225091055477796	1.1411566752645126	EPHA4/CLU	16
BP	GO:1904861	excitatory synapse assembly	2	2/103	19/10965	0.013465725756646302	0.09074016414129134	0.07225091055477796	1.1411566752645126	NLGN1/NPTN	16
BP	GO:0098742	cell-cell adhesion via plasma-membrane adhesion molecules	5	5/103	151/10965	0.01379012386809664	0.09255420450033847	0.07369532129576127	1.1325600833747727	NLGN1/NPTN/CDH2/CXADR/PCDH19	16
BP	GO:0048589	developmental growth	10	10/103	476/10965	0.013818422052147962	0.09255420450033847	0.07369532129576127	1.1325600833747727	SOX2/SPRY1/SFRP2/GJA1/DLL1/TGFBR1/PLEKHA1/FGF8/SYT1/CXADR	16
BP	GO:0043410	positive regulation of MAPK cascade	8	8/103	337/10965	0.013887588247326868	0.09273729862748092	0.0738411080874038	1.1317017947471213	EPHA4/SOX2/MAPK10/TGFBR1/FGF8/NPTN/MAP2K6/CDH2	16
BP	GO:0006937	regulation of muscle contraction	4	4/103	99/10965	0.013993553427724254	0.092907880203752	0.07397693189074478	1.130903684517654	AKAP9/TPM1/TNNT1/TNNI3	16
BP	GO:0030855	epithelial cell differentiation	9	9/103	406/10965	0.013996947220592318	0.092907880203752	0.07397693189074478	1.130903684517654	SOX11/SPRY1/SOX4/DLL1/FGF8/PAX6/WNT5B/BTG1/CDH2	16
BP	GO:0007492	endoderm development	3	3/103	54/10965	0.014120203285087682	0.09316812703285533	0.0741841507177069	1.1296888708811612	COL11A1/SOX2/FGF8	16
BP	GO:0045778	positive regulation of ossification	3	3/103	54/10965	0.014120203285087682	0.09316812703285533	0.0741841507177069	1.1296888708811612	SOX11/SFRP2/PDLIM7	16
BP	GO:1905114	cell surface receptor signaling pathway involved in cell-cell signaling	10	10/103	479/10965	0.014386325098618483	0.09464238202859697	0.07535801090233703	1.122870573399093	NLGN1/SOX2/SFRP2/SOX4/RSPO3/FZD3/SULF1/WNT5B/SHISA2/CDH2	16
BP	GO:0002793	positive regulation of peptide secretion	4	4/103	100/10965	0.014473851482726103	0.09465642695340346	0.07536919402742331	1.122806128901146	VSNL1/SOX4/GJA1/NNAT	16
BP	GO:0051897	positive regulation of protein kinase B signaling	4	4/103	100/10965	0.014473851482726103	0.09465642695340346	0.07536919402742331	1.122806128901146	LRP2/IGFBP5/TGFBR1/FGF8	16
BP	GO:0043408	regulation of MAPK cascade	10	10/103	480/10965	0.014579477134800895	0.09473940711117064	0.07543526611373035	1.1224255732557733	EPHA4/SOX2/SPRY1/MAPK10/SFRP2/TGFBR1/FGF8/NPTN/MAP2K6/CDH2	16
BP	GO:0044057	regulation of system process	8	8/103	341/10965	0.014818860141668225	0.09473940711117064	0.07543526611373035	1.1224255732557733	IGFBP5/NLGN1/GJA1/AKAP9/TPM1/TNNT1/TNNI3/CXADR	16
BP	GO:0055017	cardiac muscle tissue growth	3	3/103	55/10965	0.014834775607443031	0.09473940711117064	0.07543526611373035	1.1224255732557733	GJA1/TGFBR1/CXADR	16
BP	GO:0001702	gastrulation with mouth forming second	2	2/103	20/10965	0.014871138328681725	0.09473940711117064	0.07543526611373035	1.1224255732557733	OTX2/ETS2	16
BP	GO:0002068	glandular epithelial cell development	2	2/103	20/10965	0.014871138328681725	0.09473940711117064	0.07543526611373035	1.1224255732557733	DLL1/PAX6	16
BP	GO:0003272	endocardial cushion formation	2	2/103	20/10965	0.014871138328681725	0.09473940711117064	0.07543526611373035	1.1224255732557733	TGFBR1/FGF8	16
BP	GO:0015701	bicarbonate transport	2	2/103	20/10965	0.014871138328681725	0.09473940711117064	0.07543526611373035	1.1224255732557733	CA2/CA4	16
BP	GO:0060037	pharyngeal system development	2	2/103	20/10965	0.014871138328681725	0.09473940711117064	0.07543526611373035	1.1224255732557733	TGFBR1/FGF8	16
BP	GO:0071549	cellular response to dexamethasone stimulus	2	2/103	20/10965	0.014871138328681725	0.09473940711117064	0.07543526611373035	1.1224255732557733	DDIT4/SERPINF1	16
BP	GO:0030509	BMP signaling pathway	4	4/103	101/10965	0.014964492371624984	0.09478937025112169	0.07547504874350405	1.1221965978275146	SOX11/LRP2/SFRP2/SULF1	16
BP	GO:0071322	cellular response to carbohydrate stimulus	4	4/103	101/10965	0.014964492371624984	0.09478937025112169	0.07547504874350405	1.1221965978275146	VSNL1/SOX4/SERPINF1/MAP2K6	16
BP	GO:0035107	appendage morphogenesis	4	4/103	102/10965	0.015465544964412877	0.09740657155142995	0.07755896801830262	1.1103679781768585	SOX11/SFRP2/SOX4/FGF8	16
BP	GO:0035108	limb morphogenesis	4	4/103	102/10965	0.015465544964412877	0.09740657155142995	0.07755896801830262	1.1103679781768585	SOX11/SFRP2/SOX4/FGF8	16
BP	GO:0060291	long-term synaptic potentiation	3	3/103	56/10965	0.015569516064106274	0.09750739297775031	0.0776392460288618	1.1099186907887595	EPHA4/NLGN1/NPTN	16
BP	GO:0110110	positive regulation of animal organ morphogenesis	3	3/103	56/10965	0.015569516064106274	0.09750739297775031	0.0776392460288618	1.1099186907887595	SPRY1/TGFBR1/FGF8	16
BP	GO:0043491	protein kinase B signaling	5	5/103	156/10965	0.0156823460367609	0.09766225045926662	0.07776254968553528	1.10922950816145	LRP2/IGFBP5/TGFBR1/PLEKHA1/FGF8	16
BP	GO:0050770	regulation of axonogenesis	5	5/103	156/10965	0.0156823460367609	0.09766225045926662	0.07776254968553528	1.10922950816145	EPHA4/FEZF2/TUBB2B/MAP6/CDH2	16
BP	GO:0050807	regulation of synapse organization	5	5/103	157/10965	0.016080588964780818	0.09958286518133819	0.07929181915300626	1.1007716182307379	EPHA4/NLGN1/TPBG/TUBA1A/CDH2	16
BP	GO:1903522	regulation of blood circulation	5	5/103	157/10965	0.016080588964780818	0.09958286518133819	0.07929181915300626	1.1007716182307379	GJA1/AKAP9/TPM1/TNNI3/CXADR	16
BP	GO:0048678	response to axon injury	3	3/103	57/10965	0.0163244845022971	0.09966926023806165	0.07936061031703791	1.1003950009307104	EPHA4/NREP/DPYSL3	16
BP	GO:0003401	axis elongation	2	2/103	21/10965	0.016336868311721566	0.09966926023806165	0.07936061031703791	1.1003950009307104	SPRY1/SFRP2	16
BP	GO:0048596	embryonic camera-type eye morphogenesis	2	2/103	21/10965	0.016336868311721566	0.09966926023806165	0.07936061031703791	1.1003950009307104	SOX11/PAX6	16
BP	GO:0090659	walking behavior	2	2/103	21/10965	0.016336868311721566	0.09966926023806165	0.07936061031703791	1.1003950009307104	EPHA4/ZIC1	16
BP	GO:2000050	regulation of non-canonical Wnt signaling pathway	2	2/103	21/10965	0.016336868311721566	0.09966926023806165	0.07936061031703791	1.1003950009307104	SFRP2/RSPO3	16
BP	GO:0009743	response to carbohydrate	5	5/103	158/10965	0.01648553805609643	0.09966926023806165	0.07936061031703791	1.1003950009307104	VSNL1/SOX4/GJA1/SERPINF1/MAP2K6	16
BP	GO:0033500	carbohydrate homeostasis	5	5/103	158/10965	0.01648553805609643	0.09966926023806165	0.07936061031703791	1.1003950009307104	VSNL1/IGFBP5/SOX4/PAX6/SERPINF1	16
BP	GO:0042593	glucose homeostasis	5	5/103	158/10965	0.01648553805609643	0.09966926023806165	0.07936061031703791	1.1003950009307104	VSNL1/IGFBP5/SOX4/PAX6/SERPINF1	16
BP	GO:0072073	kidney epithelium development	4	4/103	104/10965	0.016499151333950666	0.09966926023806165	0.07936061031703791	1.1003950009307104	EPHA4/SPRY1/DLL1/FGF8	16
BP	GO:0016055	Wnt signaling pathway	9	9/103	418/10965	0.016634733734161605	0.10021523013216381	0.07979533315843539	1.0980225076819352	SOX2/SFRP2/SOX4/RSPO3/FZD3/SULF1/WNT5B/SHISA2/CDH2	16
BP	GO:0198738	cell-cell signaling by wnt	9	9/103	419/10965	0.016869990562405852	0.10135709776925142	0.08070453337085899	1.0931020692103857	SOX2/SFRP2/SOX4/RSPO3/FZD3/SULF1/WNT5B/SHISA2/CDH2	16
BP	GO:0021884	forebrain neuron development	2	2/103	22/10965	0.01786168151680249	0.10607994156498733	0.08446504855042791	1.0733229639711916	FGF8/FOXG1	16
BP	GO:0051932	synaptic transmission, GABAergic	2	2/103	22/10965	0.01786168151680249	0.10607994156498733	0.08446504855042791	1.0733229639711916	NLGN1/CA2	16
BP	GO:0097242	amyloid-beta clearance	2	2/103	22/10965	0.01786168151680249	0.10607994156498733	0.08446504855042791	1.0733229639711916	LRP2/CLU	16
BP	GO:0140058	neuron projection arborization	2	2/103	22/10965	0.01786168151680249	0.10607994156498733	0.08446504855042791	1.0733229639711916	LRP2/NLGN1	16
BP	GO:0006835	dicarboxylic acid transport	3	3/103	59/10965	0.017895308139515228	0.10607994156498733	0.08446504855042791	1.0733229639711916	LRP2/GJA1/SYT1	16
BP	GO:0015711	organic anion transport	7	7/103	286/10965	0.018027450896886444	0.10657828970239265	0.0848618530640802	1.0712874891058402	LRP2/GJA1/CA2/SYT1/CA4/MAP2K6/SLC6A8	16
BP	GO:0050796	regulation of insulin secretion	4	4/103	107/10965	0.018129262170055442	0.10689514423141733	0.08511414518248313	1.0699982581974299	VSNL1/SOX4/GJA1/NNAT	16
BP	GO:0050803	regulation of synapse structure or activity	5	5/103	163/10965	0.01861240938183505	0.10916535401188905	0.0869217760738494	1.0608714083157122	EPHA4/NLGN1/TPBG/TUBA1A/CDH2	16
BP	GO:0045921	positive regulation of exocytosis	3	3/103	60/10965	0.018711246966404076	0.10916535401188905	0.0869217760738494	1.0608714083157122	VSNL1/NLGN1/SYT1	16
BP	GO:0060419	heart growth	3	3/103	60/10965	0.018711246966404076	0.10916535401188905	0.0869217760738494	1.0608714083157122	GJA1/TGFBR1/CXADR	16
BP	GO:0098773	skin epidermis development	3	3/103	60/10965	0.018711246966404076	0.10916535401188905	0.0869217760738494	1.0608714083157122	IGFBP5/DLL1/FZD3	16
BP	GO:0021846	cell proliferation in forebrain	2	2/103	23/10965	0.01944436122476421	0.11196921775403183	0.08915432337369675	1.0498575916718775	EMX2/FGF8	16
BP	GO:0035909	aorta morphogenesis	2	2/103	23/10965	0.01944436122476421	0.11196921775403183	0.08915432337369675	1.0498575916718775	SOX4/FGF8	16
BP	GO:0045214	sarcomere organization	2	2/103	23/10965	0.01944436122476421	0.11196921775403183	0.08915432337369675	1.0498575916718775	TPM1/TNNT1	16
BP	GO:0051602	response to electrical stimulus	2	2/103	23/10965	0.01944436122476421	0.11196921775403183	0.08915432337369675	1.0498575916718775	AKAP9/FZD3	16
BP	GO:1902473	regulation of protein localization to synapse	2	2/103	23/10965	0.01944436122476421	0.11196921775403183	0.08915432337369675	1.0498575916718775	NLGN1/NPTN	16
BP	GO:0071772	response to BMP	4	4/103	110/10965	0.01985643012027577	0.11375117720064958	0.09057319002231054	1.0430003359705111	SOX11/LRP2/SFRP2/SULF1	16
BP	GO:0071773	cellular response to BMP stimulus	4	4/103	110/10965	0.01985643012027577	0.11375117720064958	0.09057319002231054	1.0430003359705111	SOX11/LRP2/SFRP2/SULF1	16
BP	GO:0048762	mesenchymal cell differentiation	5	5/103	166/10965	0.019971751370022772	0.11411694017355796	0.09086442497972923	1.0416061174280078	SOX11/SPRY1/SFRP2/TGFBR1/FGF8	16
BP	GO:0009953	dorsal/ventral pattern formation	3	3/103	62/10965	0.020404336097613614	0.11627298953739555	0.09258115682843687	1.033477396883649	FGF8/PAX6/FOXG1	16
BP	GO:0001837	epithelial to mesenchymal transition	4	4/103	111/10965	0.020453976508608147	0.11627298953739555	0.09258115682843687	1.033477396883649	SPRY1/SFRP2/TGFBR1/FGF8	16
BP	GO:0043588	skin development	5	5/103	168/10965	0.020913326500247444	0.1185801658594593	0.09441822194350508	1.0249441823351297	IGFBP5/DLL1/COL1A2/FZD3/PAX6	16
BP	GO:0001974	blood vessel remodeling	2	2/103	24/10965	0.021083707972169137	0.11863599130532734	0.09446267237330389	1.0247397722829001	RSPO3/FGF8	16
BP	GO:0040019	positive regulation of embryonic development	2	2/103	24/10965	0.021083707972169137	0.11863599130532734	0.09446267237330389	1.0247397722829001	GJA1/OTX2	16
BP	GO:0098901	regulation of cardiac muscle cell action potential	2	2/103	24/10965	0.021083707972169137	0.11863599130532734	0.09446267237330389	1.0247397722829001	AKAP9/CXADR	16
BP	GO:0035418	protein localization to synapse	3	3/103	63/10965	0.021281529420200077	0.11914432001157467	0.09486742381093974	1.022882892819595	NLGN1/MAPK10/NPTN	16
BP	GO:0060021	roof of mouth development	3	3/103	63/10965	0.021281529420200077	0.11914432001157467	0.09486742381093974	1.022882892819595	SOX11/TGFBR1/PLEKHA1	16
BP	GO:0030198	extracellular matrix organization	6	6/103	232/10965	0.02196028162846551	0.12232649339273376	0.09740119622040905	1.0114357093561626	COL11A1/SFRP2/COL1A2/SULF1/TGFBR1/SMOC1	16
BP	GO:0043062	extracellular structure organization	6	6/103	232/10965	0.02196028162846551	0.12232649339273376	0.09740119622040905	1.0114357093561626	COL11A1/SFRP2/COL1A2/SULF1/TGFBR1/SMOC1	16
BP	GO:1903530	regulation of secretion by cell	8	8/103	367/10965	0.022016029042449727	0.12232966513060413	0.097403721683651745	1.0114244489140503	SOX11/VSNL1/NLGN1/SOX4/GJA1/SYT1/MAP2K6/NNAT	16
BP	GO:0003009	skeletal muscle contraction	2	2/103	25/10965	0.02277853933964152	0.12317078467313476	0.09807345435835385	1.0084485276432642	TNNT1/TNNI3	16
BP	GO:0007435	salivary gland morphogenesis	2	2/103	25/10965	0.02277853933964152	0.12317078467313476	0.09807345435835385	1.0084485276432642	FGF8/PAX6	16
BP	GO:0008045	motor neuron axon guidance	2	2/103	25/10965	0.02277853933964152	0.12317078467313476	0.09807345435835385	1.0084485276432642	EPHA4/FGF8	16
BP	GO:0016339	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	2	2/103	25/10965	0.02277853933964152	0.12317078467313476	0.09807345435835385	1.0084485276432642	NLGN1/CDH2	16
BP	GO:0030513	positive regulation of BMP signaling pathway	2	2/103	25/10965	0.02277853933964152	0.12317078467313476	0.09807345435835385	1.0084485276432642	SOX11/SULF1	16
BP	GO:0031128	developmental induction	2	2/103	25/10965	0.02277853933964152	0.12317078467313476	0.09807345435835385	1.0084485276432642	SPRY1/FGF8	16
BP	GO:0046621	negative regulation of organ growth	2	2/103	25/10965	0.02277853933964152	0.12317078467313476	0.09807345435835385	1.0084485276432642	GJA1/CXADR	16
BP	GO:0071548	response to dexamethasone	2	2/103	25/10965	0.02277853933964152	0.12317078467313476	0.09807345435835385	1.0084485276432642	DDIT4/SERPINF1	16
BP	GO:0099068	postsynapse assembly	2	2/103	25/10965	0.02277853933964152	0.12317078467313476	0.09807345435835385	1.0084485276432642	NLGN1/CDH2	16
BP	GO:1904646	cellular response to amyloid-beta	2	2/103	25/10965	0.02277853933964152	0.12317078467313476	0.09807345435835385	1.0084485276432642	EPHA4/GJA1	16
BP	GO:1904707	positive regulation of vascular associated smooth muscle cell proliferation	2	2/103	25/10965	0.02277853933964152	0.12317078467313476	0.09807345435835385	1.0084485276432642	IGFBP5/GJA1	16
BP	GO:0051302	regulation of cell division	4	4/103	116/10965	0.023607597072563234	0.12724890616870907	0.10132061612179812	0.994302177966729	SFRP2/DLL1/FGF8/PAX6	16
BP	GO:0042692	muscle cell differentiation	6	6/103	236/10965	0.023647518873030283	0.12724890616870907	0.10132061612179812	0.994302177966729	IGFBP5/DLL1/TPM1/CDH2/TNNT1/CXADR	16
BP	GO:0046879	hormone secretion	5	5/103	174/10965	0.023911028262782612	0.12824973622486965	0.10211751662944542	0.990899755239138	SOX11/VSNL1/SOX4/GJA1/NNAT	16
BP	GO:0035282	segmentation	3	3/103	66/10965	0.024035828690620382	0.12824973622486965	0.10211751662944542	0.990899755239138	SFRP2/DLL1/LFNG	16
BP	GO:0060828	regulation of canonical Wnt signaling pathway	6	6/103	237/10965	0.024082594096656744	0.12824973622486965	0.10211751662944542	0.990899755239138	SOX2/SFRP2/SOX4/RSPO3/WNT5B/CDH2	16
BP	GO:0030178	negative regulation of Wnt signaling pathway	5	5/103	175/10965	0.02443624389387823	0.12824973622486965	0.10211751662944542	0.990899755239138	SOX2/SFRP2/WNT5B/SHISA2/CDH2	16
BP	GO:0001569	branching involved in blood vessel morphogenesis	2	2/103	26/10965	0.024527689742600244	0.12824973622486965	0.10211751662944542	0.990899755239138	SFRP2/FGF8	16
BP	GO:0014047	glutamate secretion	2	2/103	26/10965	0.024527689742600244	0.12824973622486965	0.10211751662944542	0.990899755239138	GJA1/SYT1	16
BP	GO:0021517	ventral spinal cord development	2	2/103	26/10965	0.024527689742600244	0.12824973622486965	0.10211751662944542	0.990899755239138	SOX4/PAX6	16
BP	GO:0022602	ovulation cycle process	2	2/103	26/10965	0.024527689742600244	0.12824973622486965	0.10211751662944542	0.990899755239138	PLEKHA1/MAP2K6	16
BP	GO:0048048	embryonic eye morphogenesis	2	2/103	26/10965	0.024527689742600244	0.12824973622486965	0.10211751662944542	0.990899755239138	SOX11/PAX6	16
BP	GO:0048806	genitalia development	2	2/103	26/10965	0.024527689742600244	0.12824973622486965	0.10211751662944542	0.990899755239138	LRP2/FGF8	16
BP	GO:0097106	postsynaptic density organization	2	2/103	26/10965	0.024527689742600244	0.12824973622486965	0.10211751662944542	0.990899755239138	NLGN1/CDH2	16
BP	GO:1902003	regulation of amyloid-beta formation	2	2/103	26/10965	0.024527689742600244	0.12824973622486965	0.10211751662944542	0.990899755239138	EPHA4/CLU	16
BP	GO:0051222	positive regulation of protein transport	6	6/103	239/10965	0.024968843761693376	0.1297741128794266	0.10333128566284379	0.9857681670222187	VSNL1/ZIC1/TFDP2/SOX4/GJA1/NNAT	16
BP	GO:0045926	negative regulation of growth	5	5/103	176/10965	0.024968863423192766	0.1297741128794266	0.10333128566284379	0.9857681670222187	IGFBP5/SFRP2/GJA1/BTG1/CXADR	16
BP	GO:0072395	signal transduction involved in cell cycle checkpoint	3	3/103	67/10965	0.024994833648856636	0.1297741128794266	0.10333128566284379	0.9857681670222187	SOX11/TFDP2/SOX4	16
BP	GO:0008585	female gonad development	3	3/103	68/10965	0.025974275862834267	0.13328393666430707	0.10612594629349427	0.9741784242560185	LFNG/DMRTA1/PLEKHA1	16
BP	GO:0009914	hormone transport	5	5/103	178/10965	0.026056441994814245	0.13328393666430707	0.10612594629349427	0.9741784242560185	SOX11/VSNL1/SOX4/GJA1/NNAT	16
BP	GO:0003203	endocardial cushion morphogenesis	2	2/103	27/10965	0.026330010224358835	0.13328393666430707	0.10612594629349427	0.9741784242560185	TGFBR1/FGF8	16
BP	GO:0006730	one-carbon metabolic process	2	2/103	27/10965	0.026330010224358835	0.13328393666430707	0.10612594629349427	0.9741784242560185	CA2/CA4	16
BP	GO:0009948	anterior/posterior axis specification	2	2/103	27/10965	0.026330010224358835	0.13328393666430707	0.10612594629349427	0.9741784242560185	OTX2/ETS2	16
BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	2	2/103	27/10965	0.026330010224358835	0.13328393666430707	0.10612594629349427	0.9741784242560185	SPRY1/SFRP2	16
BP	GO:0014888	striated muscle adaptation	2	2/103	27/10965	0.026330010224358835	0.13328393666430707	0.10612594629349427	0.9741784242560185	IGFBP5/TNNT1	16
BP	GO:0034405	response to fluid shear stress	2	2/103	27/10965	0.026330010224358835	0.13328393666430707	0.10612594629349427	0.9741784242560185	GJA1/CA2	16
BP	GO:0071320	cellular response to cAMP	2	2/103	27/10965	0.026330010224358835	0.13328393666430707	0.10612594629349427	0.9741784242560185	IGFBP5/AKAP9	16
BP	GO:1902230	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	2	2/103	27/10965	0.026330010224358835	0.13328393666430707	0.10612594629349427	0.9741784242560185	SFRP2/CLU	16
BP	GO:0030324	lung development	4	4/103	120/10965	0.02633214445600654	0.13328393666430707	0.10612594629349427	0.9741784242560185	SOX11/IGFBP5/SPRY1/FGF8	16
BP	GO:0010717	regulation of epithelial to mesenchymal transition	3	3/103	69/10965	0.02697413759254795	0.1356046781013125	0.10797381249004157	0.9666815636810953	SPRY1/SFRP2/TGFBR1	16
BP	GO:0032526	response to retinoic acid	3	3/103	69/10965	0.02697413759254795	0.1356046781013125	0.10797381249004157	0.9666815636810953	GJA1/WNT5B/SERPINF1	16
BP	GO:0060993	kidney morphogenesis	3	3/103	69/10965	0.02697413759254795	0.1356046781013125	0.10797381249004157	0.9666815636810953	SOX4/GCNT1/FGF8	16
BP	GO:0007416	synapse assembly	4	4/103	122/10965	0.027762461155595317	0.1389376442030583	0.11062765203263239	0.9561363050007162	NLGN1/TPBG/NPTN/CDH2	16
BP	GO:0090276	regulation of peptide hormone secretion	4	4/103	122/10965	0.027762461155595317	0.1389376442030583	0.11062765203263239	0.9561363050007162	VSNL1/SOX4/GJA1/NNAT	16
BP	GO:0007431	salivary gland development	2	2/103	28/10965	0.028184368251568406	0.13978690025442317	0.11130386331774454	0.95348976119575235	FGF8/PAX6	16
BP	GO:0019730	antimicrobial humoral response	2	2/103	28/10965	0.028184368251568406	0.13978690025442317	0.11130386331774454	0.95348976119575235	CLU/GALP	16
BP	GO:0070306	lens fiber cell differentiation	2	2/103	28/10965	0.028184368251568406	0.13978690025442317	0.11130386331774454	0.95348976119575235	SPRY1/WNT5B	16
BP	GO:0099084	postsynaptic specialization organization	2	2/103	28/10965	0.028184368251568406	0.13978690025442317	0.11130386331774454	0.95348976119575235	NLGN1/CDH2	16
BP	GO:0046545	development of primary female sexual characteristics	3	3/103	71/10965	0.029035021324834872	0.14368446936865828	0.11440726212816749	0.9415464073429144	LFNG/DMRTA1/PLEKHA1	16
BP	GO:0030323	respiratory tube development	4	4/103	124/10965	0.029238477164387263	0.1443690509430881	0.11495235307625706	0.9394821342896614	SOX11/IGFBP5/SPRY1/FGF8	16
BP	GO:0021515	cell differentiation in spinal cord	2	2/103	29/10965	0.030089647511977683	0.1466663769047939	0.11678157494449086	0.9326256720450891	SOX4/PAX6	16
BP	GO:0035987	endodermal cell differentiation	2	2/103	29/10965	0.030089647511977683	0.1466663769047939	0.11678157494449086	0.9326256720450891	COL11A1/SOX2	16
BP	GO:0048011	neurotrophin TRK receptor signaling pathway	2	2/103	29/10965	0.030089647511977683	0.1466663769047939	0.11678157494449086	0.9326256720450891	SPRY1/DDIT4	16
BP	GO:0048662	negative regulation of smooth muscle cell proliferation	2	2/103	29/10965	0.030089647511977683	0.1466663769047939	0.11678157494449086	0.9326256720450891	IGFBP5/TPM1	16
BP	GO:0048709	oligodendrocyte differentiation	3	3/103	72/10965	0.03009598094563976	0.1466663769047939	0.11678157494449086	0.9326256720450891	SOX11/CLU/PAX6	16
BP	GO:0046942	carboxylic acid transport	5	5/103	185/10965	0.03010067726282419	0.1466663769047939	0.11678157494449086	0.9326256720450891	LRP2/GJA1/SYT1/MAP2K6/SLC6A8	16
BP	GO:0043405	regulation of MAP kinase activity	6	6/103	250/10965	0.03023499299371484	0.14699776198917935	0.11704543686625064	0.931645513043283	EPHA4/SPRY1/MAPK10/SFRP2/TGFBR1/MAP2K6	16
BP	GO:0010769	regulation of cell morphogenesis involved in differentiation	6	6/103	251/10965	0.03074725143728965	0.14916117382159988	0.11876803100388056	0.9253004434206804	EPHA4/NLGN1/FEZF2/TUBB2B/MAP6/CDH2	16
BP	GO:0051046	regulation of secretion	8	8/103	392/10965	0.031003223503108936	0.15007455569081335	0.11949530180352488	0.9226491695352137	SOX11/VSNL1/NLGN1/SOX4/GJA1/SYT1/MAP2K6/NNAT	16
BP	GO:0045807	positive regulation of endocytosis	3	3/103	73/10965	0.031177235588187444	0.15058808561876158	0.11990419465976458	0.9211656235256394	NLGN1/DLL1/CLU	16
BP	GO:0015849	organic acid transport	5	5/103	187/10965	0.031325006277886015	0.15097291069146368	0.12021060761559461	0.9200572076606072	LRP2/GJA1/SYT1/MAP2K6/SLC6A8	16
BP	GO:0030073	insulin secretion	4	4/103	127/10965	0.031538654345488526	0.15167287783936673	0.12076794916630727	0.9180483086545473	VSNL1/SOX4/GJA1/NNAT	16
BP	GO:0045765	regulation of angiogenesis	5	5/103	188/10965	0.0319487707120392	0.15212677876448472	0.12112936305013455	0.9167505664780509	SFRP2/DLL1/SULF1/BTG1/SERPINF1	16
BP	GO:0045927	positive regulation of growth	5	5/103	188/10965	0.0319487707120392	0.15212677876448472	0.12112936305013455	0.9167505664780509	SFRP2/DLL1/TGFBR1/FGF8/SYT1	16
BP	GO:0000226	microtubule cytoskeleton organization	9	9/103	469/10965	0.03202623435050321	0.15212677876448472	0.12112936305013455	0.9167505664780509	NAV1/SPRY1/CRMP1/GJA1/TUBB2B/AKAP9/PAX6/MAP6/TUBA1A	16
BP	GO:0031076	embryonic camera-type eye development	2	2/103	30/10965	0.032044747714485504	0.15212677876448472	0.12112936305013455	0.9167505664780509	SOX11/PAX6	16
BP	GO:0048546	digestive tract morphogenesis	2	2/103	30/10965	0.032044747714485504	0.15212677876448472	0.12112936305013455	0.9167505664780509	SOX11/SFRP2	16
BP	GO:1904645	response to amyloid-beta	2	2/103	30/10965	0.032044747714485504	0.15212677876448472	0.12112936305013455	0.9167505664780509	EPHA4/GJA1	16
BP	GO:1904951	positive regulation of establishment of protein localization	6	6/103	254/10965	0.03231818591193035	0.15309704736484955	0.12190192931693025	0.9139894208371878	VSNL1/ZIC1/TFDP2/SOX4/GJA1/NNAT	16
BP	GO:0042493	response to drug	6	6/103	255/10965	0.032853283528003784	0.1553000630737407	0.1236560576286889	0.907784603683811	SFRP2/FZD3/EMX2/FGF8/SRP14/MAP2K6	16
BP	GO:0001508	action potential	3	3/103	75/10965	0.03340044978390334	0.15755063227853977	0.1254480499162506	0.9015360853832022	GJA1/AKAP9/CXADR	16
BP	GO:0030857	negative regulation of epithelial cell differentiation	2	2/103	31/10965	0.034048584391460975	0.1599273550759936	0.1273404906879573	0.8950334809786824	SPRY1/DLL1	16
BP	GO:0032330	regulation of chondrocyte differentiation	2	2/103	31/10965	0.034048584391460975	0.1599273550759936	0.1273404906879573	0.8950334809786824	TGFBR1/SOX5	16
BP	GO:0070997	neuron death	6	6/103	259/10965	0.035051446818387684	0.16428976236018075	0.13081401204948515	0.883345734376846	CLU/DDIT4/FGF8/TOX3/SERPINF1/NLRP1	16
BP	GO:0008593	regulation of Notch signaling pathway	3	3/103	77/10965	0.03570425613779613	0.1669964891508313	0.13296921506347795	0.8762488949397769	DLL1/LFNG/DLK1	16
BP	GO:0043065	positive regulation of apoptotic process	9	9/103	479/10965	0.03593305117743838	0.16771278833764397	0.13353956083005908	0.8743900563592053	MLLT11/TFDP2/SFRP2/SOX4/CLU/TGFBR1/BTG1/MAP2K6/NLRP1	16
BP	GO:0034205	amyloid-beta formation	2	2/103	32/10965	0.03610008870330765	0.1677859468663167	0.13359781254650102	0.8742006526895252	EPHA4/CLU	16
BP	GO:1902991	regulation of amyloid precursor protein catabolic process	2	2/103	32/10965	0.03610008870330765	0.1677859468663167	0.13359781254650102	0.8742006526895252	EPHA4/CLU	16
BP	GO:0120034	positive regulation of plasma membrane bounded cell projection assembly	3	3/103	78/10965	0.03688623383470657	0.1710811305680847	0.13622156824664813	0.8657541242226579	NLGN1/DPYSL3/TGFBR1	16
BP	GO:0060348	bone development	4	4/103	134/10965	0.037310655836590836	0.17177571087771096	0.13677462058349182	0.8639944812934972	SFRP2/GJA1/SULF1/FGF8	16
BP	GO:0043068	positive regulation of programmed cell death	9	9/103	483/10965	0.037584385843079604	0.17177571087771096	0.13677462058349182	0.8639944812934972	MLLT11/TFDP2/SFRP2/SOX4/CLU/TGFBR1/BTG1/MAP2K6/NLRP1	16
BP	GO:0000079	regulation of cyclin-dependent protein serine/threonine kinase activity	3	3/103	79/10965	0.03808817372256503	0.17177571087771096	0.13677462058349182	0.8639944812934972	CCNG2/CCNI/CDKN1C	16
BP	GO:0042476	odontogenesis	3	3/103	79/10965	0.03808817372256503	0.17177571087771096	0.13677462058349182	0.8639944812934972	COL1A2/CA2/FGF8	16
BP	GO:0098693	regulation of synaptic vesicle cycle	3	3/103	79/10965	0.03808817372256503	0.17177571087771096	0.13677462058349182	0.8639944812934972	NLGN1/SYT1/CDH2	16
BP	GO:1902414	protein localization to cell junction	3	3/103	79/10965	0.03808817372256503	0.17177571087771096	0.13677462058349182	0.8639944812934972	NLGN1/MAPK10/NPTN	16
BP	GO:0009749	response to glucose	4	4/103	135/10965	0.0381817229042303	0.17177571087771096	0.13677462058349182	0.8639944812934972	VSNL1/SOX4/GJA1/SERPINF1	16
BP	GO:0003197	endocardial cushion development	2	2/103	33/10965	0.03819820724524651	0.17177571087771096	0.13677462058349182	0.8639944812934972	TGFBR1/FGF8	16
BP	GO:0014003	oligodendrocyte development	2	2/103	33/10965	0.03819820724524651	0.17177571087771096	0.13677462058349182	0.8639944812934972	SOX11/CLU	16
BP	GO:0030850	prostate gland development	2	2/103	33/10965	0.03819820724524651	0.17177571087771096	0.13677462058349182	0.8639944812934972	SULF1/SERPINF1	16
BP	GO:0030858	positive regulation of epithelial cell differentiation	2	2/103	33/10965	0.03819820724524651	0.17177571087771096	0.13677462058349182	0.8639944812934972	PAX6/BTG1	16
BP	GO:0045661	regulation of myoblast differentiation	2	2/103	33/10965	0.03819820724524651	0.17177571087771096	0.13677462058349182	0.8639944812934972	DLL1/BTG1	16
BP	GO:0046888	negative regulation of hormone secretion	2	2/103	33/10965	0.03819820724524651	0.17177571087771096	0.13677462058349182	0.8639944812934972	VSNL1/GJA1	16
BP	GO:1902229	regulation of intrinsic apoptotic signaling pathway in response to DNA damage	2	2/103	33/10965	0.03819820724524651	0.17177571087771096	0.13677462058349182	0.8639944812934972	SFRP2/CLU	16
BP	GO:1903307	positive regulation of regulated secretory pathway	2	2/103	33/10965	0.03819820724524651	0.17177571087771096	0.13677462058349182	0.8639944812934972	NLGN1/SYT1	16
BP	GO:0040008	regulation of growth	9	9/103	487/10965	0.0392873285759961	0.17631580456069507	0.14038962288929357	0.8526649925514725	IGFBP5/SFRP2/GJA1/DLL1/TGFBR1/FGF8/SYT1/BTG1/CXADR	16
BP	GO:0009746	response to hexose	4	4/103	137/10965	0.03995882275566991	0.1778091380027949	0.14157867408811675	0.8490021592406112	VSNL1/SOX4/GJA1/SERPINF1	16
BP	GO:0001941	postsynaptic membrane organization	2	2/103	34/10965	0.04034190185629492	0.1778091380027949	0.14157867408811675	0.8490021592406112	NLGN1/CDH2	16
BP	GO:0017145	stem cell division	2	2/103	34/10965	0.04034190185629492	0.1778091380027949	0.14157867408811675	0.8490021592406112	SFRP2/SOX5	16
BP	GO:0021532	neural tube patterning	2	2/103	34/10965	0.04034190185629492	0.1778091380027949	0.14157867408811675	0.8490021592406112	FGF8/PAX6	16
BP	GO:0048701	embryonic cranial skeleton morphogenesis	2	2/103	34/10965	0.04034190185629492	0.1778091380027949	0.14157867408811675	0.8490021592406112	TGFBR1/FGF8	16
BP	GO:0050879	multicellular organismal movement	2	2/103	34/10965	0.04034190185629492	0.1778091380027949	0.14157867408811675	0.8490021592406112	TNNT1/TNNI3	16
BP	GO:0050881	musculoskeletal movement	2	2/103	34/10965	0.04034190185629492	0.1778091380027949	0.14157867408811675	0.8490021592406112	TNNT1/TNNI3	16
BP	GO:0098900	regulation of action potential	2	2/103	34/10965	0.04034190185629492	0.1778091380027949	0.14157867408811675	0.8490021592406112	AKAP9/CXADR	16
BP	GO:1903524	positive regulation of blood circulation	2	2/103	34/10965	0.04034190185629492	0.1778091380027949	0.14157867408811675	0.8490021592406112	GJA1/TPM1	16
BP	GO:0099175	regulation of postsynapse organization	3	3/103	81/10965	0.04055165234096944	0.17837899452366915	0.14203241640728018	0.8476125242076198	EPHA4/NLGN1/CDH2	16
BP	GO:0120032	regulation of plasma membrane bounded cell projection assembly	4	4/103	138/10965	0.04086486526224939	0.17940080452753843	0.14284602197976493	0.8451318494799962	NLGN1/MYO10/DPYSL3/TGFBR1	16
BP	GO:0034250	positive regulation of cellular amide metabolic process	4	4/103	139/10965	0.04178257326484973	0.18247933704315378	0.14529727142956053	0.8377425413400514	EPHA4/SOX4/CLU/CIRBP	16
BP	GO:0048640	negative regulation of developmental growth	3	3/103	82/10965	0.041813037085215214	0.18247933704315378	0.14529727142956053	0.8377425413400514	SFRP2/GJA1/CXADR	16
BP	GO:1904029	regulation of cyclin-dependent protein kinase activity	3	3/103	82/10965	0.041813037085215214	0.18247933704315378	0.14529727142956053	0.8377425413400514	CCNG2/CCNI/CDKN1C	16
BP	GO:0060485	mesenchyme development	5	5/103	203/10965	0.04224827546201461	0.1834422982241942	0.14606401923983273	0.8354567530601399	SOX11/SPRY1/SFRP2/TGFBR1/FGF8	16
BP	GO:0030514	negative regulation of BMP signaling pathway	2	2/103	35/10965	0.0425301494304176	0.1834422982241942	0.14606401923983273	0.8354567530601399	LRP2/SFRP2	16
BP	GO:0038179	neurotrophin signaling pathway	2	2/103	35/10965	0.0425301494304176	0.1834422982241942	0.14606401923983273	0.8354567530601399	SPRY1/DDIT4	16
BP	GO:0050795	regulation of behavior	2	2/103	35/10965	0.0425301494304176	0.1834422982241942	0.14606401923983273	0.8354567530601399	NLGN1/GJA1	16
BP	GO:0071709	membrane assembly	2	2/103	35/10965	0.0425301494304176	0.1834422982241942	0.14606401923983273	0.8354567530601399	NLGN1/CDH2	16
BP	GO:1900271	regulation of long-term synaptic potentiation	2	2/103	35/10965	0.0425301494304176	0.1834422982241942	0.14606401923983273	0.8354567530601399	EPHA4/NPTN	16
BP	GO:0060491	regulation of cell projection assembly	4	4/103	140/10965	0.04271194758592946	0.18386871417088466	0.1464035484958686	0.8344483968193052	NLGN1/MYO10/DPYSL3/TGFBR1	16
BP	GO:0034284	response to monosaccharide	4	4/103	141/10965	0.043652987457479954	0.18755556820394004	0.14933916761769458	0.8258262736589586	VSNL1/SOX4/GJA1/SERPINF1	16
BP	GO:0003158	endothelium development	3	3/103	84/10965	0.044394683297453046	0.19000581635222663	0.1512901521841674	0.8201893402601368	GJA1/DLL1/BTG1	16
BP	GO:0048593	camera-type eye morphogenesis	3	3/103	84/10965	0.044394683297453046	0.19000581635222663	0.1512901521841674	0.8201893402601368	SOX11/DLL1/PAX6	16
BP	GO:0001706	endoderm formation	2	2/103	36/10965	0.04476194172982586	0.1908408169519691	0.15195501271440887	0.818284968777199	COL11A1/SOX2	16
BP	GO:1902667	regulation of axon guidance	2	2/103	36/10965	0.04476194172982586	0.1908408169519691	0.15195501271440887	0.818284968777199	FEZF2/TUBB2B	16
BP	GO:0001936	regulation of endothelial cell proliferation	3	3/103	85/10965	0.04571476789672807	0.19452906032062597	0.15489173808023635	0.8099717468751149	GJA1/SULF1/TGFBR1	16
BP	GO:0035272	exocrine system development	2	2/103	37/10965	0.04703628520040281	0.19870331772751806	0.15821544706172297	0.8007511172595314	FGF8/PAX6	16
BP	GO:0060976	coronary vasculature development	2	2/103	37/10965	0.04703628520040281	0.19870331772751806	0.15821544706172297	0.8007511172595314	LRP2/TGFBR1	16
BP	GO:0086065	cell communication involved in cardiac conduction	2	2/103	37/10965	0.04703628520040281	0.19870331772751806	0.15821544706172297	0.8007511172595314	GJA1/CXADR	16
BP	GO:0007156	homophilic cell adhesion via plasma membrane adhesion molecules	3	3/103	86/10965	0.04705423626835679	0.19870331772751806	0.15821544706172297	0.8007511172595314	NPTN/CDH2/PCDH19	16
BP	GO:0001843	neural tube closure	3	3/103	87/10965	0.0484129911693343	0.20327954814851165	0.1618592228687672	0.7908625491072894	LRP2/SFRP2/FZD3	16
BP	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	3	3/103	87/10965	0.0484129911693343	0.20327954814851165	0.1618592228687672	0.7908625491072894	SFRP2/CLU/DDIT4	16
BP	GO:0060606	tube closure	3	3/103	87/10965	0.0484129911693343	0.20327954814851165	0.1618592228687672	0.7908625491072894	LRP2/SFRP2/FZD3	16
BP	GO:1901342	regulation of vasculature development	5	5/103	212/10965	0.04929098788464636	0.2037828701595396	0.16225998777748402	0.7897885610721525	SFRP2/DLL1/SULF1/BTG1/SERPINF1	16
BP	GO:0002931	response to ischemia	2	2/103	38/10965	0.04935220078923087	0.2037828701595396	0.16225998777748402	0.7897885610721525	GJA1/MAP2K6	16
BP	GO:0008347	glial cell migration	2	2/103	38/10965	0.04935220078923087	0.2037828701595396	0.16225998777748402	0.7897885610721525	EPHA4/FOXG1	16
BP	GO:0022029	telencephalon cell migration	2	2/103	38/10965	0.04935220078923087	0.2037828701595396	0.16225998777748402	0.7897885610721525	FEZF2/FOXG1	16
BP	GO:0030239	myofibril assembly	2	2/103	38/10965	0.04935220078923087	0.2037828701595396	0.16225998777748402	0.7897885610721525	TPM1/TNNT1	16
BP	GO:0071385	cellular response to glucocorticoid stimulus	2	2/103	38/10965	0.04935220078923087	0.2037828701595396	0.16225998777748402	0.7897885610721525	DDIT4/SERPINF1	16
BP	GO:0072132	mesenchyme morphogenesis	2	2/103	38/10965	0.04935220078923087	0.2037828701595396	0.16225998777748402	0.7897885610721525	TGFBR1/FGF8	16
BP	GO:2000677	regulation of transcription regulatory region DNA binding	2	2/103	38/10965	0.04935220078923087	0.2037828701595396	0.16225998777748402	0.7897885610721525	SOX11/PAX6	16
BP	GO:0006820	anion transport	7	7/103	355/10965	0.04948403485539399	0.2037828701595396	0.16225998777748402	0.7897885610721525	LRP2/GJA1/CA2/SYT1/CA4/MAP2K6/SLC6A8	16
BP	GO:1902903	regulation of supramolecular fiber organization	6	6/103	282/10965	0.04953142092842139	0.2037828701595396	0.16225998777748402	0.7897885610721525	AKAP9/CLU/TGFBR1/TPM1/COTL1/TMSB15A	16
BP	GO:0090090	negative regulation of canonical Wnt signaling pathway	4	4/103	147/10965	0.049543963471354015	0.2037828701595396	0.16225998777748402	0.7897885610721525	SOX2/SFRP2/WNT5B/CDH2	16
BP	GO:0035051	cardiocyte differentiation	3	3/103	88/10965	0.04979093201927206	0.20441943756801137	0.1627668479460414	0.7884340467456662	SPRY1/DLL1/CXADR	16
BP	GO:0010817	regulation of hormone levels	6	6/103	284/10965	0.05094192426526653	0.20837314777877472	0.1659149485198135	0.7801144833716627	SOX11/VSNL1/SOX4/GJA1/PLEKHA1/NNAT	16
BP	GO:0051098	regulation of binding	6	6/103	284/10965	0.05094192426526653	0.20837314777877472	0.1659149485198135	0.7801144833716627	SOX11/EPHA4/CRMP1/LFNG/TGFBR1/PAX6	16
BP	GO:0061337	cardiac conduction	3	3/103	89/10965	0.05118795500087888	0.2089939157218204	0.1664092285285914	0.7788225927814211	GJA1/AKAP9/CXADR	16
BP	GO:0030072	peptide hormone secretion	4	4/103	149/10965	0.05160066069258099	0.2091938696810764	0.16656843978594363	0.77840728219231	VSNL1/SOX4/GJA1/NNAT	16
BP	GO:0050435	amyloid-beta metabolic process	2	2/103	39/10965	0.05170872376419931	0.2091938696810764	0.16656843978594363	0.77840728219231	EPHA4/CLU	16
BP	GO:0051496	positive regulation of stress fiber assembly	2	2/103	39/10965	0.05170872376419931	0.2091938696810764	0.16656843978594363	0.77840728219231	TGFBR1/TPM1	16
BP	GO:0051965	positive regulation of synapse assembly	2	2/103	39/10965	0.05170872376419931	0.2091938696810764	0.16656843978594363	0.77840728219231	NLGN1/TPBG	16
BP	GO:0060324	face development	2	2/103	39/10965	0.05170872376419931	0.2091938696810764	0.16656843978594363	0.77840728219231	PLEKHA1/SOX3	16
BP	GO:0007268	chemical synaptic transmission	8	8/103	436/10965	0.05243272524347978	0.21135154884508123	0.16828646934605854	0.7739508009853833	EPHA4/NLGN1/TUBB2B/AKAP9/CA2/SYT1/NPTN/CDH2	16
BP	GO:0098916	anterograde trans-synaptic signaling	8	8/103	436/10965	0.05243272524347978	0.21135154884508123	0.16828646934605854	0.7739508009853833	EPHA4/NLGN1/TUBB2B/AKAP9/CA2/SYT1/NPTN/CDH2	16
BP	GO:0090087	regulation of peptide transport	8	8/103	438/10965	0.05358916406402233	0.21458062815488385	0.17085759011264165	0.7673657235036823	VSNL1/ZIC1/TFDP2/SOX4/GJA1/CA2/LMAN1/NNAT	16
BP	GO:0030177	positive regulation of Wnt signaling pathway	4	4/103	151/10965	0.05370371438669633	0.21458062815488385	0.17085759011264165	0.7673657235036823	SFRP2/SOX4/RSPO3/SULF1	16
BP	GO:1901652	response to peptide	7	7/103	362/10965	0.053906502595092734	0.21458062815488385	0.17085759011264165	0.7673657235036823	IGFBP5/EPHA4/GJA1/CA2/GCNT1/NLRP1/GALP	16
BP	GO:0048660	regulation of smooth muscle cell proliferation	3	3/103	91/10965	0.05403881649557696	0.21458062815488385	0.17085759011264165	0.7673657235036823	IGFBP5/GJA1/TPM1	16
BP	GO:0001947	heart looping	2	2/103	40/10965	0.05410490353566986	0.21458062815488385	0.17085759011264165	0.7673657235036823	DLL1/FGF8	16
BP	GO:0031103	axon regeneration	2	2/103	40/10965	0.05410490353566986	0.21458062815488385	0.17085759011264165	0.7673657235036823	EPHA4/NREP	16
BP	GO:0044091	membrane biogenesis	2	2/103	40/10965	0.05410490353566986	0.21458062815488385	0.17085759011264165	0.7673657235036823	NLGN1/CDH2	16
BP	GO:0071384	cellular response to corticosteroid stimulus	2	2/103	40/10965	0.05410490353566986	0.21458062815488385	0.17085759011264165	0.7673657235036823	DDIT4/SERPINF1	16
BP	GO:0090199	regulation of release of cytochrome c from mitochondria	2	2/103	40/10965	0.05410490353566986	0.21458062815488385	0.17085759011264165	0.7673657235036823	MLLT11/CLU	16
BP	GO:0048511	rhythmic process	5	5/103	218/10965	0.054350269578385145	0.21516883509871404	0.17132594376494717	0.7661768671523022	NLGN1/MAPK10/PLEKHA1/SERPINF1/MAP2K6	16
BP	GO:0099003	vesicle-mediated transport in synapse	4	4/103	152/10965	0.05477258437606647	0.2164542238177172	0.1723494211439412	0.7635901708833288	NLGN1/MAPK10/SYT1/CDH2	16
BP	GO:0048659	smooth muscle cell proliferation	3	3/103	92/10965	0.05549243206855167	0.2189087578220268	0.17430381827863112	0.7586930991827381	IGFBP5/GJA1/TPM1	16
BP	GO:0099537	trans-synaptic signaling	8	8/103	442/10965	0.05595132645639496	0.22032698180075955	0.17543306434958278	0.7558885505863758	EPHA4/NLGN1/TUBB2B/AKAP9/CA2/SYT1/NPTN/CDH2	16
BP	GO:0001541	ovarian follicle development	2	2/103	41/10965	0.056539803480177085	0.22107362313148607	0.1760275697322138	0.7544193069308873	LFNG/DMRTA1	16
BP	GO:0045747	positive regulation of Notch signaling pathway	2	2/103	41/10965	0.056539803480177085	0.22107362313148607	0.1760275697322138	0.7544193069308873	DLL1/LFNG	16
BP	GO:0061371	determination of heart left/right asymmetry	2	2/103	41/10965	0.056539803480177085	0.22107362313148607	0.1760275697322138	0.7544193069308873	DLL1/FGF8	16
BP	GO:0071300	cellular response to retinoic acid	2	2/103	41/10965	0.056539803480177085	0.22107362313148607	0.1760275697322138	0.7544193069308873	WNT5B/SERPINF1	16
BP	GO:0014020	primary neural tube formation	3	3/103	93/10965	0.05696468408141156	0.22234278980367858	0.1770381304754025	0.7519331852110709	LRP2/SFRP2/FZD3	16
BP	GO:0033135	regulation of peptidyl-serine phosphorylation	3	3/103	94/10965	0.05845545397673207	0.22736094994107894	0.18103378821602897	0.7422403606760879	SFRP2/AKAP9/DDIT4	16
BP	GO:0071333	cellular response to glucose stimulus	3	3/103	94/10965	0.05845545397673207	0.22736094994107894	0.18103378821602897	0.7422403606760879	VSNL1/SOX4/SERPINF1	16
BP	GO:0042987	amyloid precursor protein catabolic process	2	2/103	42/10965	0.059012500766142485	0.22832585374962983	0.1818020828232221	0.7404011455725191	EPHA4/CLU	16
BP	GO:0061001	regulation of dendritic spine morphogenesis	2	2/103	42/10965	0.059012500766142485	0.22832585374962983	0.1818020828232221	0.7404011455725191	EPHA4/NLGN1	16
BP	GO:0086003	cardiac muscle cell contraction	2	2/103	42/10965	0.059012500766142485	0.22832585374962983	0.1818020828232221	0.7404011455725191	GJA1/AKAP9	16
BP	GO:0071326	cellular response to monosaccharide stimulus	3	3/103	95/10965	0.05996462052574228	0.23120271948794893	0.18409275720214155	0.7349632976938115	VSNL1/SOX4/SERPINF1	16
BP	GO:0071331	cellular response to hexose stimulus	3	3/103	95/10965	0.05996462052574228	0.23120271948794893	0.18409275720214155	0.7349632976938115	VSNL1/SOX4/SERPINF1	16
BP	GO:1901214	regulation of neuron death	5	5/103	225/10965	0.060622074964398906	0.2333318406181812	0.18578804772532342	0.7309822288456298	CLU/DDIT4/FGF8/TOX3/SERPINF1	16
BP	GO:0055002	striated muscle cell development	3	3/103	96/10965	0.06149205991660778	0.23597658315668624	0.18789389642416865	0.7260873273627881	TPM1/TNNT1/CXADR	16
BP	GO:0061035	regulation of cartilage development	2	2/103	43/10965	0.0615220861815808	0.23597658315668624	0.18789389642416865	0.7260873273627881	TGFBR1/SOX5	16
BP	GO:1902905	positive regulation of supramolecular fiber organization	4	4/103	159/10965	0.06257650789491635	0.23960642142146726	0.1907841173343782	0.7194577828874084	AKAP9/CLU/TGFBR1/TPM1	16
BP	GO:0001935	endothelial cell proliferation	3	3/103	97/10965	0.06303764584107194	0.2405412406706652	0.19152845742454508	0.7177666891404932	GJA1/SULF1/TGFBR1	16
BP	GO:0060041	retina development in camera-type eye	3	3/103	97/10965	0.06303764584107194	0.2405412406706652	0.19152845742454508	0.7177666891404932	DLL1/PAX6/SERPINF1	16
BP	GO:0002066	columnar/cuboidal epithelial cell development	2	2/103	44/10965	0.06406766396377597	0.24405156530531155	0.19432351685160482	0.7114746383046928	DLL1/PAX6	16
BP	GO:0099536	synaptic signaling	8	8/103	457/10965	0.06540061466556497	0.2487018228362908	0.19802623597391436	0.7032772673956642	EPHA4/NLGN1/TUBB2B/AKAP9/CA2/SYT1/NPTN/CDH2	16
BP	GO:0043393	regulation of protein binding	4	4/103	162/10965	0.06609209332273001	0.2504396535012197	0.19940996553975043	0.7002531415570845	EPHA4/CRMP1/LFNG/TGFBR1	16
BP	GO:0060071	Wnt signaling pathway, planar cell polarity pathway	3	3/103	99/10965	0.06618274008422467	0.2504396535012197	0.19940996553975043	0.7002531415570845	SFRP2/RSPO3/FZD3	16
BP	GO:0003143	embryonic heart tube morphogenesis	2	2/103	45/10965	0.06664835163090646	0.2504396535012197	0.19940996553975043	0.7002531415570845	DLL1/FGF8	16
BP	GO:0015800	acidic amino acid transport	2	2/103	45/10965	0.06664835163090646	0.2504396535012197	0.19940996553975043	0.7002531415570845	GJA1/SYT1	16
BP	GO:0031102	neuron projection regeneration	2	2/103	45/10965	0.06664835163090646	0.2504396535012197	0.19940996553975043	0.7002531415570845	EPHA4/NREP	16
BP	GO:0032233	positive regulation of actin filament bundle assembly	2	2/103	45/10965	0.06664835163090646	0.2504396535012197	0.19940996553975043	0.7002531415570845	TGFBR1/TPM1	16
BP	GO:1904888	cranial skeletal system development	2	2/103	45/10965	0.06664835163090646	0.2504396535012197	0.19940996553975043	0.7002531415570845	TGFBR1/FGF8	16
BP	GO:0010821	regulation of mitochondrion organization	4	4/103	163/10965	0.06728655078036258	0.2520003264469289	0.2006526351169194	0.6975551324204362	MLLT11/TFDP2/CLU/LMAN1	16
BP	GO:0097193	intrinsic apoptotic signaling pathway	5	5/103	232/10965	0.06729102086449341	0.2520003264469289	0.2006526351169194	0.6975551324204362	MLLT11/ZNF385B/SFRP2/CLU/DDIT4	16
BP	GO:0050808	synapse organization	6	6/103	306/10965	0.068089463495768	0.2545604394099792	0.2026910983978041	0.6931653238358637	EPHA4/NLGN1/TPBG/TUBA1A/NPTN/CDH2	16
BP	GO:0055082	cellular chemical homeostasis	8	8/103	462/10965	0.06875974697351907	0.25663360107793226	0.20434183178201576	0.6896427177903984	VSNL1/SOX4/GJA1/CA2/CKB/NPTN/SERPINF1/TNNI3	16
BP	GO:0002312	B cell activation involved in immune response	2	2/103	46/10965	0.06926327981559849	0.2576454552872179	0.20514751015676205	0.6879337496292691	DLL1/LFNG	16
BP	GO:0043113	receptor clustering	2	2/103	46/10965	0.06926327981559849	0.2576454552872179	0.20514751015676205	0.6879337496292691	NLGN1/CDH2	16
BP	GO:0090175	regulation of establishment of planar polarity	3	3/103	101/10965	0.06939884605209973	0.2577173227763905	0.20520473389644933	0.6878126246450572	SFRP2/RSPO3/FZD3	16
BP	GO:0008637	apoptotic mitochondrial changes	3	3/103	102/10965	0.07103318850930238	0.26334544970756413	0.20968607134324957	0.6784304171248963	MLLT11/TFDP2/CLU	16
BP	GO:0018105	peptidyl-serine phosphorylation	5	5/103	236/10965	0.07127937677393223	0.26381699216662396	0.21006153211472517	0.6776534712489996	SFRP2/AKAP9/TGFBR1/DDIT4/PNCK	16
BP	GO:0001707	mesoderm formation	2	2/103	47/10965	0.07191159210038625	0.2657133328109272	0.21157147360061007	0.674542889061272	SFRP2/GJA1	16
BP	GO:0048592	eye morphogenesis	3	3/103	103/10965	0.07268487187708386	0.26767834045098826	0.2131360904666369	0.6713430047043809	SOX11/DLL1/PAX6	16
BP	GO:0072006	nephron development	3	3/103	103/10965	0.07268487187708386	0.26767834045098826	0.2131360904666369	0.6713430047043809	DLL1/SULF1/FGF8	16
BP	GO:0001558	regulation of cell growth	6	6/103	313/10965	0.07417578294665896	0.2727159382964227	0.2171472252798238	0.6632457157070497	IGFBP5/SFRP2/GJA1/TGFBR1/SYT1/BTG1	16
BP	GO:0042391	regulation of membrane potential	5	5/103	239/10965	0.07435491304495116	0.272890181920241	0.21728596495038063	0.6629683249517053	MLLT11/NLGN1/GJA1/AKAP9/CXADR	16
BP	GO:0048332	mesoderm morphogenesis	2	2/103	48/10965	0.0745924448550591	0.272890181920241	0.21728596495038063	0.6629683249517053	SFRP2/GJA1	16
BP	GO:0097479	synaptic vesicle localization	2	2/103	48/10965	0.0745924448550591	0.272890181920241	0.21728596495038063	0.6629683249517053	NLGN1/CDH2	16
BP	GO:0008344	adult locomotory behavior	2	2/103	49/10965	0.07730500707587418	0.28142069078360105	0.22407829377969235	0.6496002110609862	EPHA4/ZIC1	16
BP	GO:0014910	regulation of smooth muscle cell migration	2	2/103	49/10965	0.07730500707587418	0.28142069078360105	0.22407829377969235	0.6496002110609862	IGFBP5/TPM1	16
BP	GO:0099601	regulation of neurotransmitter receptor activity	2	2/103	49/10965	0.07730500707587418	0.28142069078360105	0.22407829377969235	0.6496002110609862	NLGN1/AKAP9	16
BP	GO:0001678	cellular glucose homeostasis	3	3/103	106/10965	0.0777425433200497	0.2820871007210314	0.22460891575109548	0.6485730086059417	VSNL1/SOX4/SERPINF1	16
BP	GO:0055001	muscle cell development	3	3/103	106/10965	0.0777425433200497	0.2820871007210314	0.22460891575109548	0.6485730086059417	TPM1/TNNT1/CXADR	16
BP	GO:0045766	positive regulation of angiogenesis	3	3/103	107/10965	0.0794621571993764	0.2871641364440235	0.22865145256350564	0.6408260353140829	SFRP2/DLL1/BTG1	16
BP	GO:0052548	regulation of endopeptidase activity	5	5/103	244/10965	0.07964032189803286	0.2871641364440235	0.22865145256350564	0.6408260353140829	EPHA4/SOX2/SFRP2/SERPINF1/NLRP1	16
BP	GO:0001836	release of cytochrome c from mitochondria	2	2/103	50/10965	0.08004846022661548	0.2871641364440235	0.22865145256350564	0.6408260353140829	MLLT11/CLU	16
BP	GO:0002027	regulation of heart rate	2	2/103	50/10965	0.08004846022661548	0.2871641364440235	0.22865145256350564	0.6408260353140829	AKAP9/TPM1	16
BP	GO:0034332	adherens junction organization	2	2/103	50/10965	0.08004846022661548	0.2871641364440235	0.22865145256350564	0.6408260353140829	EPHA4/CDH2	16
BP	GO:0055006	cardiac cell development	2	2/103	50/10965	0.08004846022661548	0.2871641364440235	0.22865145256350564	0.6408260353140829	SPRY1/CXADR	16
BP	GO:2000300	regulation of synaptic vesicle exocytosis	2	2/103	50/10965	0.08004846022661548	0.2871641364440235	0.22865145256350564	0.6408260353140829	NLGN1/SYT1	16
BP	GO:0048609	multicellular organismal reproductive process	8	8/103	479/10965	0.08097098159871172	0.29000430727680754	0.23091290900610414	0.636551787509819	CCNI/GJA1/DMRTA1/TGFBR1/PLEKHA1/SERPINF1/MAP2K6/CXADR	16
BP	GO:0048754	branching morphogenesis of an epithelial tube	3	3/103	108/10965	0.08119838666738022	0.2903497149057773	0.23118793623293146	0.6360348318612067	SPRY1/SFRP2/FGF8	16
BP	GO:0042060	wound healing	6	6/103	321/10965	0.08150330865318561	0.29097074924977856	0.23168242836069547	0.6351069034364903	GJA1/COL1A2/TGFBR1/WNT5B/TPM1/LMAN1	16
BP	GO:0006898	receptor-mediated endocytosis	4	4/103	175/10965	0.08248639259391774	0.2914461933805691	0.23206099579764708	0.6343978484856183	LRP2/PDLIM7/DLL1/CLU	16
BP	GO:0035050	embryonic heart tube development	2	2/103	51/10965	0.08282199808147885	0.2914461933805691	0.23206099579764708	0.6343978484856183	DLL1/FGF8	16
BP	GO:0044070	regulation of anion transport	2	2/103	51/10965	0.08282199808147885	0.2914461933805691	0.23206099579764708	0.6343978484856183	CA2/MAP2K6	16
BP	GO:0045600	positive regulation of fat cell differentiation	2	2/103	51/10965	0.08282199808147885	0.2914461933805691	0.23206099579764708	0.6343978484856183	SFRP2/WNT5B	16
BP	GO:0048488	synaptic vesicle endocytosis	2	2/103	51/10965	0.08282199808147885	0.2914461933805691	0.23206099579764708	0.6343978484856183	NLGN1/SYT1	16
BP	GO:0051591	response to cAMP	2	2/103	51/10965	0.08282199808147885	0.2914461933805691	0.23206099579764708	0.6343978484856183	IGFBP5/AKAP9	16
BP	GO:0140238	presynaptic endocytosis	2	2/103	51/10965	0.08282199808147885	0.2914461933805691	0.23206099579764708	0.6343978484856183	NLGN1/SYT1	16
BP	GO:0007601	visual perception	3	3/103	109/10965	0.08295108165229549	0.2914461933805691	0.23206099579764708	0.6343978484856183	COL11A1/PAX6/RAX	16
BP	GO:0050953	sensory perception of light stimulus	3	3/103	109/10965	0.08295108165229549	0.2914461933805691	0.23206099579764708	0.6343978484856183	COL11A1/PAX6/RAX	16
BP	GO:0071901	negative regulation of protein serine/threonine kinase activity	3	3/103	109/10965	0.08295108165229549	0.2914461933805691	0.23206099579764708	0.6343978484856183	SPRY1/SFRP2/CDKN1C	16
BP	GO:0032504	multicellular organism reproduction	8	8/103	482/10965	0.08325301651739833	0.2920442050934685	0.2325371563951982	0.6335076426531362	CCNI/GJA1/DMRTA1/TGFBR1/PLEKHA1/SERPINF1/MAP2K6/CXADR	16
BP	GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	2	2/103	52/10965	0.08562482656976268	0.2972423065689112	0.23667609055198544	0.625845613071393	TFDP2/SOX4	16
BP	GO:0010823	negative regulation of mitochondrion organization	2	2/103	52/10965	0.08562482656976268	0.2972423065689112	0.23667609055198544	0.625845613071393	CLU/LMAN1	16
BP	GO:0055117	regulation of cardiac muscle contraction	2	2/103	52/10965	0.08562482656976268	0.2972423065689112	0.23667609055198544	0.625845613071393	AKAP9/TNNI3	16
BP	GO:0060997	dendritic spine morphogenesis	2	2/103	52/10965	0.08562482656976268	0.2972423065689112	0.23667609055198544	0.625845613071393	EPHA4/NLGN1	16
BP	GO:0018209	peptidyl-serine modification	5	5/103	250/10965	0.08624365853355004	0.2972423065689112	0.23667609055198544	0.625845613071393	SFRP2/AKAP9/TGFBR1/DDIT4/PNCK	16
BP	GO:0001736	establishment of planar polarity	3	3/103	112/10965	0.08830643675718537	0.2972423065689112	0.23667609055198544	0.625845613071393	SFRP2/RSPO3/FZD3	16
BP	GO:0007164	establishment of tissue polarity	3	3/103	112/10965	0.08830643675718537	0.2972423065689112	0.23667609055198544	0.625845613071393	SFRP2/RSPO3/FZD3	16
BP	GO:0007224	smoothened signaling pathway	3	3/103	112/10965	0.08830643675718537	0.2972423065689112	0.23667609055198544	0.625845613071393	ZIC1/PAX6/OTX2	16
BP	GO:0072431	signal transduction involved in mitotic G1 DNA damage checkpoint	2	2/103	53/10965	0.08845616362234603	0.2972423065689112	0.23667609055198544	0.625845613071393	TFDP2/SOX4	16
BP	GO:1902400	intracellular signal transduction involved in G1 DNA damage checkpoint	2	2/103	53/10965	0.08845616362234603	0.2972423065689112	0.23667609055198544	0.625845613071393	TFDP2/SOX4	16
BP	GO:0044089	positive regulation of cellular component biogenesis	7	7/103	408/10965	0.0890580293249379	0.2972423065689112	0.23667609055198544	0.625845613071393	NLGN1/DPYSL3/TPBG/AKAP9/CLU/TGFBR1/TPM1	16
BP	GO:0001710	mesodermal cell fate commitment	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	SFRP2	16
BP	GO:0001711	endodermal cell fate commitment	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	SOX2	16
BP	GO:0002328	pro-B cell differentiation	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	SOX4	16
BP	GO:0003215	cardiac right ventricle morphogenesis	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	SOX4	16
BP	GO:0009415	response to water	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	MAPK10	16
BP	GO:0009950	dorsal/ventral axis specification	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	PAX6	16
BP	GO:0010447	response to acidic pH	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	SERPINF1	16
BP	GO:0022410	circadian sleep/wake cycle process	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	NLGN1	16
BP	GO:0030540	female genitalia development	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	LRP2	16
BP	GO:0031280	negative regulation of cyclase activity	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	AKAP9	16
BP	GO:0033630	positive regulation of cell adhesion mediated by integrin	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	SFRP2	16
BP	GO:0034350	regulation of glial cell apoptotic process	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	DLL1	16
BP	GO:0042659	regulation of cell fate specification	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	SFRP2	16
BP	GO:0044065	regulation of respiratory system process	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	NLGN1	16
BP	GO:0060601	lateral sprouting from an epithelium	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	SULF1	16
BP	GO:0060670	branching involved in labyrinthine layer morphogenesis	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	RSPO3	16
BP	GO:0061000	negative regulation of dendritic spine development	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	NLGN1	16
BP	GO:0061029	eyelid development in camera-type eye	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	SOX11	16
BP	GO:0086014	atrial cardiac muscle cell action potential	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	GJA1	16
BP	GO:0086026	atrial cardiac muscle cell to AV node cell signaling	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	GJA1	16
BP	GO:0086066	atrial cardiac muscle cell to AV node cell communication	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	GJA1	16
BP	GO:0097090	presynaptic membrane organization	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	NLGN1	16
BP	GO:0097105	presynaptic membrane assembly	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	NLGN1	16
BP	GO:0098814	spontaneous synaptic transmission	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	SYT1	16
BP	GO:1901626	regulation of postsynaptic membrane organization	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	CDH2	16
BP	GO:1904350	regulation of protein catabolic process in the vacuole	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	LRP2	16
BP	GO:1904706	negative regulation of vascular associated smooth muscle cell proliferation	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	TPM1	16
BP	GO:1905245	regulation of aspartic-type peptidase activity	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	EPHA4	16
BP	GO:1990403	embryonic brain development	1	1/103	10/10965	0.09009780334429784	0.2972423065689112	0.23667609055198544	0.625845613071393	TUBB2B	16
BP	GO:0014909	smooth muscle cell migration	2	2/103	54/10965	0.09131523901993284	0.2985927506005769	0.2377513675460757	0.6238769763211213	IGFBP5/TPM1	16
BP	GO:0045445	myoblast differentiation	2	2/103	54/10965	0.09131523901993284	0.2985927506005769	0.2377513675460757	0.6238769763211213	DLL1/BTG1	16
BP	GO:0072413	signal transduction involved in mitotic cell cycle checkpoint	2	2/103	54/10965	0.09131523901993284	0.2985927506005769	0.2377513675460757	0.6238769763211213	TFDP2/SOX4	16
BP	GO:0120193	tight junction organization	2	2/103	54/10965	0.09131523901993284	0.2985927506005769	0.2377513675460757	0.6238769763211213	GJA1/TGFBR1	16
BP	GO:1902402	signal transduction involved in mitotic DNA damage checkpoint	2	2/103	54/10965	0.09131523901993284	0.2985927506005769	0.2377513675460757	0.6238769763211213	TFDP2/SOX4	16
BP	GO:1902403	signal transduction involved in mitotic DNA integrity checkpoint	2	2/103	54/10965	0.09131523901993284	0.2985927506005769	0.2377513675460757	0.6238769763211213	TFDP2/SOX4	16
BP	GO:0007029	endoplasmic reticulum organization	2	2/103	55/10965	0.09420129424304567	0.30419088321427207	0.24220882233000227	0.6158100419549126	RTN3/LMAN1	16
BP	GO:0046849	bone remodeling	2	2/103	55/10965	0.09420129424304567	0.30419088321427207	0.24220882233000227	0.6158100419549126	GJA1/CA2	16
BP	GO:1903035	negative regulation of response to wounding	2	2/103	55/10965	0.09420129424304567	0.30419088321427207	0.24220882233000227	0.6158100419549126	EPHA4/GJA1	16
BP	GO:0006939	smooth muscle contraction	2	2/103	56/10965	0.09711358232374707	0.30419088321427207	0.24220882233000227	0.6158100419549126	SULF1/TNNI3	16
BP	GO:0071277	cellular response to calcium ion	2	2/103	56/10965	0.09711358232374707	0.30419088321427207	0.24220882233000227	0.6158100419549126	NLGN1/SYT1	16
BP	GO:0035637	multicellular organismal signaling	3	3/103	117/10965	0.0975469236379878	0.30419088321427207	0.24220882233000227	0.6158100419549126	GJA1/AKAP9/CXADR	16
BP	GO:0003071	renal system process involved in regulation of systemic arterial blood pressure	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	GJA1	16
BP	GO:0003283	atrial septum development	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	SOX4	16
BP	GO:0006958	complement activation, classical pathway	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	CLU	16
BP	GO:0007379	segment specification	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	DLL1	16
BP	GO:0010649	regulation of cell communication by electrical coupling	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	GJA1	16
BP	GO:0010669	epithelial structure maintenance	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	CXADR	16
BP	GO:0030539	male genitalia development	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	FGF8	16
BP	GO:0030878	thyroid gland development	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	FGF8	16
BP	GO:0034982	mitochondrial protein processing	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	IMMP1L	16
BP	GO:0035461	vitamin transmembrane transport	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	LRP2	16
BP	GO:0043508	negative regulation of JUN kinase activity	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	SFRP2	16
BP	GO:0043901	negative regulation of multi-organism process	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	GJA1	16
BP	GO:0045777	positive regulation of blood pressure	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	TPM1	16
BP	GO:0045956	positive regulation of calcium ion-dependent exocytosis	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	SYT1	16
BP	GO:0051386	regulation of neurotrophin TRK receptor signaling pathway	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	SPRY1	16
BP	GO:0051764	actin crosslink formation	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	DPYSL3	16
BP	GO:0051767	nitric-oxide synthase biosynthetic process	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	MAP2K6	16
BP	GO:0051769	regulation of nitric-oxide synthase biosynthetic process	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	MAP2K6	16
BP	GO:0060019	radial glial cell differentiation	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	CDH2	16
BP	GO:0060391	positive regulation of SMAD protein signal transduction	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	TGFBR1	16
BP	GO:0061450	trophoblast cell migration	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	GJA1	16
BP	GO:0071481	cellular response to X-ray	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	SFRP2	16
BP	GO:0071679	commissural neuron axon guidance	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	FZD3	16
BP	GO:0072148	epithelial cell fate commitment	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	DLL1	16
BP	GO:0072176	nephric duct development	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	EPHA4	16
BP	GO:0072189	ureter development	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	EMX2	16
BP	GO:0072321	chaperone-mediated protein transport	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	CLU	16
BP	GO:0072578	neurotransmitter-gated ion channel clustering	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	NLGN1	16
BP	GO:0099171	presynaptic modulation of chemical synaptic transmission	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	SYT1	16
BP	GO:1900118	negative regulation of execution phase of apoptosis	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	FZD3	16
BP	GO:1900221	regulation of amyloid-beta clearance	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	CLU	16
BP	GO:1901163	regulation of trophoblast cell migration	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	GJA1	16
BP	GO:1902430	negative regulation of amyloid-beta formation	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	CLU	16
BP	GO:1904948	midbrain dopaminergic neuron differentiation	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	SFRP2	16
BP	GO:1905874	regulation of postsynaptic density organization	1	1/103	11/10965	0.09865279433065477	0.30419088321427207	0.24220882233000227	0.6158100419549126	CDH2	16
BP	GO:0045785	positive regulation of cell adhesion	5	5/103	261/10965	0.0990758014284702	0.3050709052318311	0.24290953069524052	0.6145554450666272	SOX2/SFRP2/MYO10/SOX4/TPM1	16
BP	GO:0006942	regulation of striated muscle contraction	2	2/103	57/10965	0.10005136769907258	0.30722144347485303	0.2446218743714021	0.6115047104475849	AKAP9/TNNI3	16
BP	GO:0032507	maintenance of protein location in cell	2	2/103	57/10965	0.10005136769907258	0.30722144347485303	0.2446218743714021	0.6115047104475849	GJA1/TMSB15A	16
BP	GO:0043406	positive regulation of MAP kinase activity	4	4/103	188/10965	0.10069613093143281	0.308773613105099	0.24585777327220332	0.6093160560911025	EPHA4/MAPK10/TGFBR1/MAP2K6	16
BP	GO:0010950	positive regulation of endopeptidase activity	3	3/103	119/10965	0.10134962337602695	0.31034822517217087	0.24711154172956848	0.607106969723769	EPHA4/SFRP2/NLRP1	16
BP	GO:0051223	regulation of protein transport	7	7/103	422/10965	0.10186102376960805	0.31056468841605284	0.24728389833284461	0.6068041614100619	VSNL1/ZIC1/TFDP2/SOX4/GJA1/LMAN1/NNAT	16
BP	GO:0001942	hair follicle development	2	2/103	58/10965	0.10301392606615421	0.31056468841605284	0.24728389833284461	0.6068041614100619	IGFBP5/FZD3	16
BP	GO:0042475	odontogenesis of dentin-containing tooth	2	2/103	58/10965	0.10301392606615421	0.31056468841605284	0.24728389833284461	0.6068041614100619	CA2/FGF8	16
BP	GO:0043502	regulation of muscle adaptation	2	2/103	58/10965	0.10301392606615421	0.31056468841605284	0.24728389833284461	0.6068041614100619	IGFBP5/TNNT1	16
BP	GO:0072655	establishment of protein localization to mitochondrion	3	3/103	120/10965	0.10327314847654041	0.31056468841605284	0.24728389833284461	0.6068041614100619	TFDP2/IMMP1L/LMAN1	16
BP	GO:0048813	dendrite morphogenesis	3	3/103	121/10965	0.10521123856304576	0.31056468841605284	0.24728389833284461	0.6068041614100619	EPHA4/NLGN1/MAP6	16
BP	GO:0051017	actin filament bundle assembly	3	3/103	121/10965	0.10521123856304576	0.31056468841605284	0.24728389833284461	0.6068041614100619	DPYSL3/TGFBR1/TPM1	16
BP	GO:0061572	actin filament bundle organization	3	3/103	121/10965	0.10521123856304576	0.31056468841605284	0.24728389833284461	0.6068041614100619	DPYSL3/TGFBR1/TPM1	16
BP	GO:1904018	positive regulation of vasculature development	3	3/103	121/10965	0.10521123856304576	0.31056468841605284	0.24728389833284461	0.6068041614100619	SFRP2/DLL1/BTG1	16
BP	GO:0031571	mitotic G1 DNA damage checkpoint	2	2/103	59/10965	0.10600054423901878	0.31056468841605284	0.24728389833284461	0.6068041614100619	TFDP2/SOX4	16
BP	GO:0042982	amyloid precursor protein metabolic process	2	2/103	59/10965	0.10600054423901878	0.31056468841605284	0.24728389833284461	0.6068041614100619	EPHA4/CLU	16
BP	GO:0044819	mitotic G1/S transition checkpoint	2	2/103	59/10965	0.10600054423901878	0.31056468841605284	0.24728389833284461	0.6068041614100619	TFDP2/SOX4	16
BP	GO:0052547	regulation of peptidase activity	5	5/103	267/10965	0.10646218319524461	0.31056468841605284	0.24728389833284461	0.6068041614100619	EPHA4/SOX2/SFRP2/SERPINF1/NLRP1	16
BP	GO:0003128	heart field specification	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	LRP2	16
BP	GO:0003222	ventricular trabecula myocardium morphogenesis	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	TGFBR1	16
BP	GO:0010460	positive regulation of heart rate	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	TPM1	16
BP	GO:0034143	regulation of toll-like receptor 4 signaling pathway	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	WDFY1	16
BP	GO:0042745	circadian sleep/wake cycle	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	NLGN1	16
BP	GO:0043567	regulation of insulin-like growth factor receptor signaling pathway	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	IGFBP5	16
BP	GO:0043576	regulation of respiratory gaseous exchange	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	NLGN1	16
BP	GO:0045663	positive regulation of myoblast differentiation	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	BTG1	16
BP	GO:0045672	positive regulation of osteoclast differentiation	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	CA2	16
BP	GO:0045683	negative regulation of epidermis development	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	DLL1	16
BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	FGF8	16
BP	GO:0045907	positive regulation of vasoconstriction	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	GJA1	16
BP	GO:0048681	negative regulation of axon regeneration	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	EPHA4	16
BP	GO:0050774	negative regulation of dendrite morphogenesis	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	NLGN1	16
BP	GO:0051350	negative regulation of lyase activity	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	AKAP9	16
BP	GO:0060572	morphogenesis of an epithelial bud	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	SULF1	16
BP	GO:0060602	branch elongation of an epithelium	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	SPRY1	16
BP	GO:0061548	ganglion development	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	FZD3	16
BP	GO:0070986	left/right axis specification	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	DLL1	16
BP	GO:0071474	cellular hyperosmotic response	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	MAPK10	16
BP	GO:1900029	positive regulation of ruffle assembly	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	NLGN1	16
BP	GO:1904424	regulation of GTP binding	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	EPHA4	16
BP	GO:2000052	positive regulation of non-canonical Wnt signaling pathway	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	RSPO3	16
BP	GO:2000191	regulation of fatty acid transport	1	1/103	12/10965	0.10712812409000683	0.31056468841605284	0.24728389833284461	0.6068041614100619	MAP2K6	16
BP	GO:0030010	establishment of cell polarity	3	3/103	122/10965	0.1071637287497882	0.31056468841605284	0.24728389833284461	0.6068041614100619	SPRY1/GJA1/PAX6	16
BP	GO:0048167	regulation of synaptic plasticity	3	3/103	122/10965	0.1071637287497882	0.31056468841605284	0.24728389833284461	0.6068041614100619	EPHA4/NLGN1/NPTN	16
BP	GO:0070585	protein localization to mitochondrion	3	3/103	122/10965	0.1071637287497882	0.31056468841605284	0.24728389833284461	0.6068041614100619	TFDP2/IMMP1L/LMAN1	16
BP	GO:0071248	cellular response to metal ion	3	3/103	122/10965	0.1071637287497882	0.31056468841605284	0.24728389833284461	0.6068041614100619	NLGN1/SYT1/SERPINF1	16
BP	GO:0045930	negative regulation of mitotic cell cycle	5	5/103	268/10965	0.10771925788806833	0.31176709495802546	0.24824130201771413	0.6051259595572065	TFDP2/SOX4/FZD3/CDKN1C/BTG1	16
BP	GO:0022404	molting cycle process	2	2/103	60/10965	0.10901052000703995	0.31299122276901525	0.2492160010367916	0.6034240770253425	IGFBP5/FZD3	16
BP	GO:0022405	hair cycle process	2	2/103	60/10965	0.10901052000703995	0.31299122276901525	0.2492160010367916	0.6034240770253425	IGFBP5/FZD3	16
BP	GO:0035019	somatic stem cell population maintenance	2	2/103	60/10965	0.10901052000703995	0.31299122276901525	0.2492160010367916	0.6034240770253425	SOX2/SOX4	16
BP	GO:0036465	synaptic vesicle recycling	2	2/103	60/10965	0.10901052000703995	0.31299122276901525	0.2492160010367916	0.6034240770253425	NLGN1/SYT1	16
BP	GO:0043407	negative regulation of MAP kinase activity	2	2/103	60/10965	0.10901052000703995	0.31299122276901525	0.2492160010367916	0.6034240770253425	SPRY1/SFRP2	16
BP	GO:0044783	G1 DNA damage checkpoint	2	2/103	60/10965	0.10901052000703995	0.31299122276901525	0.2492160010367916	0.6034240770253425	TFDP2/SOX4	16
BP	GO:0007626	locomotory behavior	3	3/103	123/10965	0.10913045340570536	0.31299122276901525	0.2492160010367916	0.6034240770253425	EPHA4/ZIC1/FEZF2	16
BP	GO:0050708	regulation of protein secretion	4	4/103	194/10965	0.10968165278620308	0.3141656643759848	0.2501511379334456	0.6017975171775651	VSNL1/SOX4/GJA1/NNAT	16
BP	GO:0021766	hippocampus development	2	2/103	61/10965	0.11204316199502881	0.31815885315936143	0.2533306729094552	0.5963122232815422	FEZF2/EMX2	16
BP	GO:0048661	positive regulation of smooth muscle cell proliferation	2	2/103	61/10965	0.11204316199502881	0.31815885315936143	0.2533306729094552	0.5963122232815422	IGFBP5/GJA1	16
BP	GO:0090263	positive regulation of canonical Wnt signaling pathway	3	3/103	125/10965	0.11310594017710948	0.31815885315936143	0.2533306729094552	0.5963122232815422	SFRP2/SOX4/RSPO3	16
BP	GO:0008544	epidermis development	4	4/103	197/10965	0.11430617159424716	0.31815885315936143	0.2533306729094552	0.5963122232815422	IGFBP5/DLL1/FZD3/PAX6	16
BP	GO:1903747	regulation of establishment of protein localization to mitochondrion	2	2/103	62/10965	0.1150977895249426	0.31815885315936143	0.2533306729094552	0.5963122232815422	TFDP2/LMAN1	16
BP	GO:0009954	proximal/distal pattern formation	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	DLL1	16
BP	GO:0021692	cerebellar Purkinje cell layer morphogenesis	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	DLL1	16
BP	GO:0032098	regulation of appetite	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	GALP	16
BP	GO:0032331	negative regulation of chondrocyte differentiation	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	TGFBR1	16
BP	GO:0032495	response to muramyl dipeptide	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	NLRP1	16
BP	GO:0035437	maintenance of protein localization in endoplasmic reticulum	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	GJA1	16
BP	GO:0042438	melanin biosynthetic process	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	PMEL	16
BP	GO:0043217	myelin maintenance	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	CLU	16
BP	GO:0045780	positive regulation of bone resorption	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	CA2	16
BP	GO:0046852	positive regulation of bone remodeling	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	CA2	16
BP	GO:0055057	neuroblast division	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	SOX5	16
BP	GO:0060253	negative regulation of glial cell proliferation	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	SOX11	16
BP	GO:0060307	regulation of ventricular cardiac muscle cell membrane repolarization	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	AKAP9	16
BP	GO:0061844	antimicrobial humoral immune response mediated by antimicrobial peptide	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	GALP	16
BP	GO:0070571	negative regulation of neuron projection regeneration	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	EPHA4	16
BP	GO:0070633	transepithelial transport	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	CXADR	16
BP	GO:0090179	planar cell polarity pathway involved in neural tube closure	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	SFRP2	16
BP	GO:0098962	regulation of postsynaptic neurotransmitter receptor activity	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	AKAP9	16
BP	GO:0099625	ventricular cardiac muscle cell membrane repolarization	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	AKAP9	16
BP	GO:1900543	negative regulation of purine nucleotide metabolic process	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	DDIT4	16
BP	GO:1900746	regulation of vascular endothelial growth factor signaling pathway	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	DLL1	16
BP	GO:1901018	positive regulation of potassium ion transmembrane transporter activity	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	AKAP9	16
BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	CLU	16
BP	GO:1905244	regulation of modification of synaptic structure	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	EPHA4	16
BP	GO:1905331	negative regulation of morphogenesis of an epithelium	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	SULF1	16
BP	GO:2000726	negative regulation of cardiac muscle cell differentiation	1	1/103	13/10965	0.11552452719588902	0.31815885315936143	0.2533306729094552	0.5963122232815422	DLL1	16
BP	GO:0030512	negative regulation of transforming growth factor beta receptor signaling pathway	2	2/103	63/10965	0.11817373247919641	0.32319442514950997	0.25734019465647184	0.589492374869474	SPRY1/TGFBR1	16
BP	GO:0140029	exocytic process	2	2/103	63/10965	0.11817373247919641	0.32319442514950997	0.25734019465647184	0.589492374869474	NLGN1/SYT1	16
BP	GO:0007005	mitochondrion organization	7	7/103	439/10965	0.11869784572666532	0.32319442514950997	0.25734019465647184	0.589492374869474	MLLT11/CHCHD6/TFDP2/CLU/IMMP1L/LMAN1/CXADR	16
BP	GO:0030307	positive regulation of cell growth	3	3/103	128/10965	0.11917175075726513	0.32319442514950997	0.25734019465647184	0.589492374869474	SFRP2/TGFBR1/SYT1	16
BP	GO:0048639	positive regulation of developmental growth	3	3/103	128/10965	0.11917175075726513	0.32319442514950997	0.25734019465647184	0.589492374869474	DLL1/FGF8/SYT1	16
BP	GO:0051606	detection of stimulus	3	3/103	128/10965	0.11917175075726513	0.32319442514950997	0.25734019465647184	0.589492374869474	COL11A1/SOX4/SYT1	16
BP	GO:0001656	metanephros development	2	2/103	64/10965	0.12127033116555834	0.32319442514950997	0.25734019465647184	0.589492374869474	SPRY1/FGF8	16
BP	GO:1903845	negative regulation of cellular response to transforming growth factor beta stimulus	2	2/103	64/10965	0.12127033116555834	0.32319442514950997	0.25734019465647184	0.589492374869474	SPRY1/TGFBR1	16
BP	GO:0001738	morphogenesis of a polarized epithelium	3	3/103	130/10965	0.12328204452425506	0.32319442514950997	0.25734019465647184	0.589492374869474	SFRP2/RSPO3/FZD3	16
BP	GO:1902850	microtubule cytoskeleton organization involved in mitosis	3	3/103	130/10965	0.12328204452425506	0.32319442514950997	0.25734019465647184	0.589492374869474	SPRY1/GJA1/PAX6	16
BP	GO:0003209	cardiac atrium morphogenesis	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	SOX4	16
BP	GO:0006474	N-terminal protein amino acid acetylation	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	SOX4	16
BP	GO:0006582	melanin metabolic process	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	PMEL	16
BP	GO:0007158	neuron cell-cell adhesion	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	NLGN1	16
BP	GO:0007617	mating behavior	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	DMRTA1	16
BP	GO:0009593	detection of chemical stimulus	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	SYT1	16
BP	GO:0021513	spinal cord dorsal/ventral patterning	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	PAX6	16
BP	GO:0021544	subpallium development	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	FGF8	16
BP	GO:0021895	cerebral cortex neuron differentiation	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	FEZF2	16
BP	GO:0032332	positive regulation of chondrocyte differentiation	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	SOX5	16
BP	GO:0042481	regulation of odontogenesis	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	FGF8	16
BP	GO:0043584	nose development	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	GNG8	16
BP	GO:0044550	secondary metabolite biosynthetic process	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	PMEL	16
BP	GO:0045980	negative regulation of nucleotide metabolic process	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	DDIT4	16
BP	GO:0048791	calcium ion-regulated exocytosis of neurotransmitter	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	SYT1	16
BP	GO:0050901	leukocyte tethering or rolling	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	GCNT1	16
BP	GO:0050974	detection of mechanical stimulus involved in sensory perception	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	COL11A1	16
BP	GO:0051900	regulation of mitochondrial depolarization	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	MLLT11	16
BP	GO:0051954	positive regulation of amine transport	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	SYT1	16
BP	GO:0055083	monovalent inorganic anion homeostasis	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	CKB	16
BP	GO:0060026	convergent extension	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	SFRP2	16
BP	GO:0061684	chaperone-mediated autophagy	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	CLU	16
BP	GO:0062009	secondary palate development	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	SOX11	16
BP	GO:0071599	otic vesicle development	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	FGF8	16
BP	GO:0090178	regulation of establishment of planar polarity involved in neural tube closure	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	SFRP2	16
BP	GO:0098877	neurotransmitter receptor transport to plasma membrane	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	MAPK10	16
BP	GO:0098969	neurotransmitter receptor transport to postsynaptic membrane	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	MAPK10	16
BP	GO:0099623	regulation of cardiac muscle cell membrane repolarization	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	AKAP9	16
BP	GO:1903358	regulation of Golgi organization	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	AKAP9	16
BP	GO:1903540	establishment of protein localization to postsynaptic membrane	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	MAPK10	16
BP	GO:1904754	positive regulation of vascular associated smooth muscle cell migration	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	IGFBP5	16
BP	GO:1905809	negative regulation of synapse organization	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	NLGN1	16
BP	GO:2000269	regulation of fibroblast apoptotic process	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	BTG1	16
BP	GO:2000738	positive regulation of stem cell differentiation	1	1/103	14/10965	0.12384273151462766	0.32319442514950997	0.25734019465647184	0.589492374869474	SOX5	16
BP	GO:0070201	regulation of establishment of protein localization	7	7/103	444/10965	0.123913063318486	0.32319442514950997	0.25734019465647184	0.589492374869474	VSNL1/ZIC1/TFDP2/SOX4/GJA1/LMAN1/NNAT	16
BP	GO:0014812	muscle cell migration	2	2/103	65/10965	0.1243869361836115	0.3232893757550606	0.25741579808714316	0.5893648031521848	IGFBP5/TPM1	16
BP	GO:0043462	regulation of ATPase activity	2	2/103	65/10965	0.1243869361836115	0.3232893757550606	0.25741579808714316	0.5893648031521848	TPM1/TNNI3	16
BP	GO:0043506	regulation of JUN kinase activity	2	2/103	65/10965	0.1243869361836115	0.3232893757550606	0.25741579808714316	0.5893648031521848	EPHA4/SFRP2	16
BP	GO:0034248	regulation of cellular amide metabolic process	6	6/103	362/10965	0.12512151076950948	0.3248177861545697	0.2586327789479445	0.587316433770922	IGFBP5/EPHA4/SOX4/CLU/ZNF706/CIRBP	16
BP	GO:0016358	dendrite development	4	4/103	205/10965	0.12705152787025756	0.3260902304851491	0.259645949492484	0.585618448061354	EPHA4/NLGN1/FEZF2/MAP6	16
BP	GO:0031099	regeneration	3	3/103	132/10965	0.12744389175823992	0.3260902304851491	0.259645949492484	0.585618448061354	EPHA4/SOX2/NREP	16
BP	GO:0046928	regulation of neurotransmitter secretion	2	2/103	66/10965	0.12752290829276758	0.3260902304851491	0.259645949492484	0.585618448061354	NLGN1/SYT1	16
BP	GO:0051963	regulation of synapse assembly	2	2/103	66/10965	0.12752290829276758	0.3260902304851491	0.259645949492484	0.585618448061354	NLGN1/TPBG	16
BP	GO:0060998	regulation of dendritic spine development	2	2/103	66/10965	0.12752290829276758	0.3260902304851491	0.259645949492484	0.585618448061354	EPHA4/NLGN1	16
BP	GO:0072080	nephron tubule development	2	2/103	66/10965	0.12752290829276758	0.3260902304851491	0.259645949492484	0.585618448061354	DLL1/FGF8	16
BP	GO:0072401	signal transduction involved in DNA integrity checkpoint	2	2/103	66/10965	0.12752290829276758	0.3260902304851491	0.259645949492484	0.585618448061354	TFDP2/SOX4	16
BP	GO:0072422	signal transduction involved in DNA damage checkpoint	2	2/103	66/10965	0.12752290829276758	0.3260902304851491	0.259645949492484	0.585618448061354	TFDP2/SOX4	16
BP	GO:0110053	regulation of actin filament organization	4	4/103	206/10965	0.12868575093483137	0.3260902304851491	0.259645949492484	0.585618448061354	TGFBR1/TPM1/COTL1/TMSB15A	16
BP	GO:0010770	positive regulation of cell morphogenesis involved in differentiation	3	3/103	133/10965	0.12954372230360664	0.3260902304851491	0.259645949492484	0.585618448061354	EPHA4/TUBB2B/MAP6	16
BP	GO:0033138	positive regulation of peptidyl-serine phosphorylation	2	2/103	67/10965	0.13067761828181096	0.3260902304851491	0.259645949492484	0.585618448061354	SFRP2/AKAP9	16
BP	GO:0051492	regulation of stress fiber assembly	2	2/103	67/10965	0.13067761828181096	0.3260902304851491	0.259645949492484	0.585618448061354	TGFBR1/TPM1	16
BP	GO:0061326	renal tubule development	2	2/103	67/10965	0.13067761828181096	0.3260902304851491	0.259645949492484	0.585618448061354	DLL1/FGF8	16
BP	GO:0072332	intrinsic apoptotic signaling pathway by p53 class mediator	2	2/103	67/10965	0.13067761828181096	0.3260902304851491	0.259645949492484	0.585618448061354	ZNF385B/DDIT4	16
BP	GO:1900006	positive regulation of dendrite development	2	2/103	67/10965	0.13067761828181096	0.3260902304851491	0.259645949492484	0.585618448061354	EPHA4/NLGN1	16
BP	GO:0016049	cell growth	6	6/103	367/10965	0.1311066215073908	0.3260902304851491	0.259645949492484	0.585618448061354	IGFBP5/SFRP2/GJA1/TGFBR1/SYT1/BTG1	16
BP	GO:0043269	regulation of ion transport	6	6/103	367/10965	0.1311066215073908	0.3260902304851491	0.259645949492484	0.585618448061354	NLGN1/GJA1/AKAP9/CA2/SYT1/MAP2K6	16
BP	GO:0034249	negative regulation of cellular amide metabolic process	3	3/103	134/10965	0.13165592993262218	0.3260902304851491	0.259645949492484	0.585618448061354	IGFBP5/CLU/CIRBP	16
BP	GO:0035567	non-canonical Wnt signaling pathway	3	3/103	134/10965	0.13165592993262218	0.3260902304851491	0.259645949492484	0.585618448061354	SFRP2/RSPO3/FZD3	16
BP	GO:0002791	regulation of peptide secretion	4	4/103	208/10965	0.13198080023656905	0.3260902304851491	0.259645949492484	0.585618448061354	VSNL1/SOX4/GJA1/NNAT	16
BP	GO:0007398	ectoderm development	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	ETS2	16
BP	GO:0009620	response to fungus	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	COTL1	16
BP	GO:0010575	positive regulation of vascular endothelial growth factor production	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	SULF1	16
BP	GO:0014046	dopamine secretion	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	SYT1	16
BP	GO:0014059	regulation of dopamine secretion	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	SYT1	16
BP	GO:0022010	central nervous system myelination	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	CLU	16
BP	GO:0032291	axon ensheathment in central nervous system	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	CLU	16
BP	GO:0032309	icosanoid secretion	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	MAP2K6	16
BP	GO:0032780	negative regulation of ATPase activity	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	TNNI3	16
BP	GO:0034123	positive regulation of toll-like receptor signaling pathway	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	WDFY1	16
BP	GO:0034349	glial cell apoptotic process	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	DLL1	16
BP	GO:0035116	embryonic hindlimb morphogenesis	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	FGF8	16
BP	GO:0042407	cristae formation	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	CHCHD6	16
BP	GO:0048532	anatomical structure arrangement	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	DLL1	16
BP	GO:0048643	positive regulation of skeletal muscle tissue development	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	DLL1	16
BP	GO:0051882	mitochondrial depolarization	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	MLLT11	16
BP	GO:0071498	cellular response to fluid shear stress	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	CA2	16
BP	GO:0090083	regulation of inclusion body assembly	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	CLU	16
BP	GO:0090177	establishment of planar polarity involved in neural tube closure	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	SFRP2	16
BP	GO:1902547	regulation of cellular response to vascular endothelial growth factor stimulus	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	DLL1	16
BP	GO:1902683	regulation of receptor localization to synapse	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	NPTN	16
BP	GO:1905146	lysosomal protein catabolic process	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	LRP2	16
BP	GO:1990000	amyloid fibril formation	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	CLU	16
BP	GO:2000679	positive regulation of transcription regulatory region DNA binding	1	1/103	15/10965	0.13208345826597379	0.3260902304851491	0.259645949492484	0.585618448061354	PAX6	16
BP	GO:0099504	synaptic vesicle cycle	3	3/103	135/10965	0.13378034372872202	0.32753470269778723	0.2607960954462831	0.5836989150061733	NLGN1/SYT1/CDH2	16
BP	GO:0006029	proteoglycan metabolic process	2	2/103	68/10965	0.13385044683996175	0.32753470269778723	0.2607960954462831	0.5836989150061733	COL11A1/SULF1	16
BP	GO:0008589	regulation of smoothened signaling pathway	2	2/103	68/10965	0.13385044683996175	0.32753470269778723	0.2607960954462831	0.5836989150061733	ZIC1/OTX2	16
BP	GO:0009791	post-embryonic development	2	2/103	68/10965	0.13385044683996175	0.32753470269778723	0.2607960954462831	0.5836989150061733	TGFBR1/PLEKHA1	16
BP	GO:0016525	negative regulation of angiogenesis	2	2/103	68/10965	0.13385044683996175	0.32753470269778723	0.2607960954462831	0.5836989150061733	SULF1/SERPINF1	16
BP	GO:0042303	molting cycle	2	2/103	68/10965	0.13385044683996175	0.32753470269778723	0.2607960954462831	0.5836989150061733	IGFBP5/FZD3	16
BP	GO:0042633	hair cycle	2	2/103	68/10965	0.13385044683996175	0.32753470269778723	0.2607960954462831	0.5836989150061733	IGFBP5/FZD3	16
BP	GO:2001021	negative regulation of response to DNA damage stimulus	2	2/103	68/10965	0.13385044683996175	0.32753470269778723	0.2607960954462831	0.5836989150061733	SFRP2/CLU	16
BP	GO:0097190	apoptotic signaling pathway	7	7/103	455/10965	0.13579622838825772	0.32867852545517967	0.2617068524028851	0.5821849058591642	MLLT11/ZNF385B/TFDP2/SFRP2/CLU/TGFBR1/DDIT4	16
BP	GO:0006836	neurotransmitter transport	3	3/103	136/10965	0.13591679261016404	0.32867852545517967	0.2617068524028851	0.5821849058591642	NLGN1/SYT1/SLC6A8	16
BP	GO:0030308	negative regulation of cell growth	3	3/103	136/10965	0.13591679261016404	0.32867852545517967	0.2617068524028851	0.5821849058591642	SFRP2/GJA1/BTG1	16
BP	GO:0010035	response to inorganic substance	6	6/103	371/10965	0.1359934050220934	0.32867852545517967	0.2617068524028851	0.5821849058591642	NLGN1/MAPK10/CA2/PLEKHA1/SYT1/SERPINF1	16
BP	GO:0006959	humoral immune response	2	2/103	69/10965	0.1370407844294368	0.32867852545517967	0.2617068524028851	0.5821849058591642	CLU/GALP	16
BP	GO:0097061	dendritic spine organization	2	2/103	69/10965	0.1370407844294368	0.32867852545517967	0.2617068524028851	0.5821849058591642	EPHA4/NLGN1	16
BP	GO:1901655	cellular response to ketone	2	2/103	69/10965	0.1370407844294368	0.32867852545517967	0.2617068524028851	0.5821849058591642	DDIT4/SERPINF1	16
BP	GO:0051099	positive regulation of binding	3	3/103	137/10965	0.1380651053681005	0.32867852545517967	0.2617068524028851	0.5821849058591642	EPHA4/LFNG/PAX6	16
BP	GO:0099173	postsynapse organization	3	3/103	137/10965	0.1380651053681005	0.32867852545517967	0.2617068524028851	0.5821849058591642	EPHA4/NLGN1/CDH2	16
BP	GO:0010952	positive regulation of peptidase activity	3	3/103	138/10965	0.14022511070378602	0.32867852545517967	0.2617068524028851	0.5821849058591642	EPHA4/SFRP2/NLRP1	16
BP	GO:0002320	lymphoid progenitor cell differentiation	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	SOX4	16
BP	GO:0003044	regulation of systemic arterial blood pressure mediated by a chemical signal	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	TPM1	16
BP	GO:0003323	type B pancreatic cell development	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	DLL1	16
BP	GO:0007530	sex determination	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	SOX3	16
BP	GO:0008209	androgen metabolic process	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	PLEKHA1	16
BP	GO:0008210	estrogen metabolic process	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	PLEKHA1	16
BP	GO:0010667	negative regulation of cardiac muscle cell apoptotic process	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	SFRP2	16
BP	GO:0021511	spinal cord patterning	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	PAX6	16
BP	GO:0030449	regulation of complement activation	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	CLU	16
BP	GO:0031069	hair follicle morphogenesis	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	IGFBP5	16
BP	GO:0032892	positive regulation of organic acid transport	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	MAP2K6	16
BP	GO:0035330	regulation of hippo signaling	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	SOX11	16
BP	GO:0042249	establishment of planar polarity of embryonic epithelium	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	SFRP2	16
BP	GO:0044321	response to leptin	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	LRP2	16
BP	GO:0044331	cell-cell adhesion mediated by cadherin	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	CDH2	16
BP	GO:0044342	type B pancreatic cell proliferation	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	IGFBP5	16
BP	GO:0045761	regulation of adenylate cyclase activity	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	AKAP9	16
BP	GO:0045932	negative regulation of muscle contraction	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	TNNT1	16
BP	GO:0071786	endoplasmic reticulum tubular network organization	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	RTN3	16
BP	GO:0098698	postsynaptic specialization assembly	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	NLGN1	16
BP	GO:1900242	regulation of synaptic vesicle endocytosis	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	NLGN1	16
BP	GO:1903319	positive regulation of protein maturation	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	SOX4	16
BP	GO:1903859	regulation of dendrite extension	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	SYT1	16
BP	GO:1903861	positive regulation of dendrite extension	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	SYT1	16
BP	GO:1905208	negative regulation of cardiocyte differentiation	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	DLL1	16
BP	GO:2000311	regulation of AMPA receptor activity	1	1/103	16/10965	0.14024742208319774	0.32867852545517967	0.2617068524028851	0.5821849058591642	NLGN1	16
BP	GO:0010927	cellular component assembly involved in morphogenesis	2	2/103	70/10965	0.1402480311594948	0.32867852545517967	0.2617068524028851	0.5821849058591642	TPM1/TNNT1	16
BP	GO:0032092	positive regulation of protein binding	2	2/103	70/10965	0.1402480311594948	0.32867852545517967	0.2617068524028851	0.5821849058591642	EPHA4/LFNG	16
BP	GO:1901890	positive regulation of cell junction assembly	2	2/103	70/10965	0.1402480311594948	0.32867852545517967	0.2617068524028851	0.5821849058591642	NLGN1/TPBG	16
BP	GO:2000181	negative regulation of blood vessel morphogenesis	2	2/103	70/10965	0.1402480311594948	0.32867852545517967	0.2617068524028851	0.5821849058591642	SULF1/SERPINF1	16
BP	GO:0007219	Notch signaling pathway	3	3/103	139/10965	0.14239663726493898	0.33336150455794056	0.2654356257359003	0.5760407882456264	DLL1/LFNG/DLK1	16
BP	GO:0003014	renal system process	2	2/103	71/10965	0.14347159666194872	0.3344653310194956	0.26631453605854005	0.5746051281246249	GJA1/SULF1	16
BP	GO:0043500	muscle adaptation	2	2/103	71/10965	0.14347159666194872	0.3344653310194956	0.26631453605854005	0.5746051281246249	IGFBP5/TNNT1	16
BP	GO:0046683	response to organophosphorus	2	2/103	71/10965	0.14347159666194872	0.3344653310194956	0.26631453605854005	0.5746051281246249	IGFBP5/AKAP9	16
BP	GO:0071158	positive regulation of cell cycle arrest	2	2/103	71/10965	0.14347159666194872	0.3344653310194956	0.26631453605854005	0.5746051281246249	TFDP2/SOX4	16
BP	GO:0110020	regulation of actomyosin structure organization	2	2/103	72/10965	0.146710899968129	0.3355708459061722	0.26719479077209635	0.5731720131163522	TGFBR1/TPM1	16
BP	GO:1901216	positive regulation of neuron death	2	2/103	72/10965	0.146710899968129	0.3355708459061722	0.26719479077209635	0.5731720131163522	CLU/DDIT4	16
BP	GO:0017157	regulation of exocytosis	3	3/103	141/10965	0.14677356859917629	0.3355708459061722	0.26719479077209635	0.5731720131163522	VSNL1/NLGN1/SYT1	16
BP	GO:0032970	regulation of actin filament-based process	5	5/103	297/10965	0.1472412944042602	0.3355708459061722	0.26719479077209635	0.5731720131163522	AKAP9/TGFBR1/TPM1/COTL1/TMSB15A	16
BP	GO:0007039	protein catabolic process in the vacuole	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	LRP2	16
BP	GO:0010573	vascular endothelial growth factor production	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	SULF1	16
BP	GO:0010574	regulation of vascular endothelial growth factor production	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	SULF1	16
BP	GO:0010801	negative regulation of peptidyl-threonine phosphorylation	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	DDIT4	16
BP	GO:0031629	synaptic vesicle fusion to presynaptic active zone membrane	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	SYT1	16
BP	GO:0034138	toll-like receptor 3 signaling pathway	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	WDFY1	16
BP	GO:0042462	eye photoreceptor cell development	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	PAX6	16
BP	GO:0044346	fibroblast apoptotic process	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	BTG1	16
BP	GO:0045056	transcytosis	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	LRP2	16
BP	GO:0048169	regulation of long-term neuronal synaptic plasticity	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	NPTN	16
BP	GO:0060445	branching involved in salivary gland morphogenesis	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	FGF8	16
BP	GO:0060512	prostate gland morphogenesis	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	SULF1	16
BP	GO:0060713	labyrinthine layer morphogenesis	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	RSPO3	16
BP	GO:0060740	prostate gland epithelium morphogenesis	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	SULF1	16
BP	GO:0061037	negative regulation of cartilage development	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	TGFBR1	16
BP	GO:0070050	neuron cellular homeostasis	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	NELL2	16
BP	GO:0071715	icosanoid transport	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	MAP2K6	16
BP	GO:0090201	negative regulation of release of cytochrome c from mitochondria	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	CLU	16
BP	GO:0098801	regulation of renal system process	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	GJA1	16
BP	GO:0099500	vesicle fusion to plasma membrane	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	SYT1	16
BP	GO:0140353	lipid export from cell	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	MAP2K6	16
BP	GO:1900273	positive regulation of long-term synaptic potentiation	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	NPTN	16
BP	GO:1901571	fatty acid derivative transport	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	MAP2K6	16
BP	GO:1904385	cellular response to angiotensin	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	CA2	16
BP	GO:1905276	regulation of epithelial tube formation	1	1/103	17/10965	0.14833533107264263	0.3355708459061722	0.26719479077209635	0.5731720131163522	SFRP2	16
BP	GO:2001235	positive regulation of apoptotic signaling pathway	3	3/103	142/10965	0.1489786307156631	0.33668259357454144	0.2680800082731553	0.5717355717701229	MLLT11/TFDP2/TGFBR1	16
BP	GO:0060627	regulation of vesicle-mediated transport	6	6/103	382/10965	0.14987188617825992	0.33787929261341976	0.269032867418135	0.570194659527823	VSNL1/NLGN1/DLL1/CLU/SYT1/CDH2	16
BP	GO:0021549	cerebellum development	2	2/103	73/10965	0.1499653693872824	0.33787929261341976	0.269032867418135	0.570194659527823	DLL1/CKB	16
BP	GO:0055007	cardiac muscle cell differentiation	2	2/103	73/10965	0.1499653693872824	0.33787929261341976	0.269032867418135	0.570194659527823	DLL1/CXADR	16
BP	GO:0051651	maintenance of location in cell	3	3/103	143/10965	0.1511945288114264	0.33886664321295934	0.26981903504884874	0.5689274152087052	GJA1/AKAP9/TMSB15A	16
BP	GO:1901888	regulation of cell junction assembly	3	3/103	143/10965	0.1511945288114264	0.33886664321295934	0.26981903504884874	0.5689274152087052	NLGN1/TPBG/GJA1	16
BP	GO:0001657	ureteric bud development	2	2/103	74/10965	0.1532344423863898	0.33886664321295934	0.26981903504884874	0.5689274152087052	SPRY1/FGF8	16
BP	GO:0032231	regulation of actin filament bundle assembly	2	2/103	74/10965	0.1532344423863898	0.33886664321295934	0.26981903504884874	0.5689274152087052	TGFBR1/TPM1	16
BP	GO:0043270	positive regulation of ion transport	3	3/103	144/10965	0.15342109178318797	0.33886664321295934	0.26981903504884874	0.5689274152087052	AKAP9/SYT1/MAP2K6	16
BP	GO:0071241	cellular response to inorganic substance	3	3/103	144/10965	0.15342109178318797	0.33886664321295934	0.26981903504884874	0.5689274152087052	NLGN1/SYT1/SERPINF1	16
BP	GO:0045787	positive regulation of cell cycle	5	5/103	303/10965	0.15611297925025344	0.33886664321295934	0.26981903504884874	0.5689274152087052	TFDP2/SOX4/LFNG/FGF8/FOXG1	16
BP	GO:0002089	lens morphogenesis in camera-type eye	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	SOX11	16
BP	GO:0002455	humoral immune response mediated by circulating immunoglobulin	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	CLU	16
BP	GO:0003171	atrioventricular valve development	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	SOX4	16
BP	GO:0003181	atrioventricular valve morphogenesis	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	SOX4	16
BP	GO:0003230	cardiac atrium development	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	SOX4	16
BP	GO:0010453	regulation of cell fate commitment	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	SFRP2	16
BP	GO:0019098	reproductive behavior	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	DMRTA1	16
BP	GO:0021697	cerebellar cortex formation	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	DLL1	16
BP	GO:0021801	cerebral cortex radial glia guided migration	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	FOXG1	16
BP	GO:0022030	telencephalon glial cell migration	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	FOXG1	16
BP	GO:0032653	regulation of interleukin-10 production	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	DLL1	16
BP	GO:0034142	toll-like receptor 4 signaling pathway	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	WDFY1	16
BP	GO:0044060	regulation of endocrine process	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	GJA1	16
BP	GO:0045662	negative regulation of myoblast differentiation	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	DLL1	16
BP	GO:0046697	decidualization	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	GJA1	16
BP	GO:0048026	positive regulation of mRNA splicing, via spliceosome	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	CIRBP	16
BP	GO:0048566	embryonic digestive tract development	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	SOX11	16
BP	GO:0048730	epidermis morphogenesis	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	IGFBP5	16
BP	GO:0050829	defense response to Gram-negative bacterium	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	GALP	16
BP	GO:0051446	positive regulation of meiotic cell cycle	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	LFNG	16
BP	GO:0051968	positive regulation of synaptic transmission, glutamatergic	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	NLGN1	16
BP	GO:0060571	morphogenesis of an epithelial fold	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	SULF1	16
BP	GO:0060972	left/right pattern formation	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	DLL1	16
BP	GO:0071425	hematopoietic stem cell proliferation	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	SFRP2	16
BP	GO:1990776	response to angiotensin	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	CA2	16
BP	GO:2000810	regulation of bicellular tight junction assembly	1	1/103	18/10965	0.1563478868727448	0.33886664321295934	0.26981903504884874	0.5689274152087052	GJA1	16
BP	GO:0030183	B cell differentiation	2	2/103	75/10965	0.15651756547138942	0.33886664321295934	0.26981903504884874	0.5689274152087052	DLL1/LFNG	16
BP	GO:0042742	defense response to bacterium	2	2/103	75/10965	0.15651756547138942	0.33886664321295934	0.26981903504884874	0.5689274152087052	NLRP1/GALP	16
BP	GO:0050772	positive regulation of axonogenesis	2	2/103	75/10965	0.15651756547138942	0.33886664321295934	0.26981903504884874	0.5689274152087052	TUBB2B/MAP6	16
BP	GO:0051668	localization within membrane	2	2/103	75/10965	0.15651756547138942	0.33886664321295934	0.26981903504884874	0.5689274152087052	NLGN1/CDH2	16
BP	GO:0072163	mesonephric epithelium development	2	2/103	75/10965	0.15651756547138942	0.33886664321295934	0.26981903504884874	0.5689274152087052	SPRY1/FGF8	16
BP	GO:0072164	mesonephric tubule development	2	2/103	75/10965	0.15651756547138942	0.33886664321295934	0.26981903504884874	0.5689274152087052	SPRY1/FGF8	16
BP	GO:0106027	neuron projection organization	2	2/103	75/10965	0.15651756547138942	0.33886664321295934	0.26981903504884874	0.5689274152087052	EPHA4/NLGN1	16
BP	GO:1901215	negative regulation of neuron death	3	3/103	146/10965	0.15790552871029104	0.34153810453728317	0.2719461583026014	0.5655170719463133	FGF8/TOX3/SERPINF1	16
BP	GO:0001823	mesonephros development	2	2/103	76/10965	0.15981419406978686	0.3439884157793373	0.2738971931068294	0.562412418364737	SPRY1/FGF8	16
BP	GO:0007368	determination of left/right symmetry	2	2/103	76/10965	0.15981419406978686	0.3439884157793373	0.2738971931068294	0.562412418364737	DLL1/FGF8	16
BP	GO:0045446	endothelial cell differentiation	2	2/103	76/10965	0.15981419406978686	0.3439884157793373	0.2738971931068294	0.562412418364737	DLL1/BTG1	16
BP	GO:0051588	regulation of neurotransmitter transport	2	2/103	76/10965	0.15981419406978686	0.3439884157793373	0.2738971931068294	0.562412418364737	NLGN1/SYT1	16
BP	GO:0072009	nephron epithelium development	2	2/103	76/10965	0.15981419406978686	0.3439884157793373	0.2738971931068294	0.562412418364737	DLL1/FGF8	16
BP	GO:0031032	actomyosin structure organization	3	3/103	147/10965	0.16016306131943553	0.3444049533900956	0.2742288568407712	0.5618868467481675	TGFBR1/TPM1/TNNT1	16
BP	GO:0006897	endocytosis	6	6/103	390/10965	0.16035620800078157	0.3444861561412139	0.2742935136855474	0.5617844621872363	LRP2/NLGN1/PDLIM7/DLL1/CLU/SYT1	16
BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	3	3/103	148/10965	0.1624305761715703	0.3468776997215947	0.27619775535128765	0.5587798552378755	EPHA4/SFRP2/FGF8	16
BP	GO:0048814	regulation of dendrite morphogenesis	2	2/103	77/10965	0.1631237924146401	0.3468776997215947	0.27619775535128765	0.5587798552378755	EPHA4/NLGN1	16
BP	GO:0001774	microglial cell activation	1	1/103	19/10965	0.16428578471252797	0.3468776997215947	0.27619775535128765	0.5587798552378755	CLU	16
BP	GO:0002269	leukocyte activation involved in inflammatory response	1	1/103	19/10965	0.16428578471252797	0.3468776997215947	0.27619775535128765	0.5587798552378755	CLU	16
BP	GO:0006775	fat-soluble vitamin metabolic process	1	1/103	19/10965	0.16428578471252797	0.3468776997215947	0.27619775535128765	0.5587798552378755	LRP2	16
BP	GO:0007618	mating	1	1/103	19/10965	0.16428578471252797	0.3468776997215947	0.27619775535128765	0.5587798552378755	DMRTA1	16
BP	GO:0010664	negative regulation of striated muscle cell apoptotic process	1	1/103	19/10965	0.16428578471252797	0.3468776997215947	0.27619775535128765	0.5587798552378755	SFRP2	16
BP	GO:0034105	positive regulation of tissue remodeling	1	1/103	19/10965	0.16428578471252797	0.3468776997215947	0.27619775535128765	0.5587798552378755	CA2	16
BP	GO:0048710	regulation of astrocyte differentiation	1	1/103	19/10965	0.16428578471252797	0.3468776997215947	0.27619775535128765	0.5587798552378755	EPHA4	16
BP	GO:0060306	regulation of membrane repolarization	1	1/103	19/10965	0.16428578471252797	0.3468776997215947	0.27619775535128765	0.5587798552378755	AKAP9	16
BP	GO:0060384	innervation	1	1/103	19/10965	0.16428578471252797	0.3468776997215947	0.27619775535128765	0.5587798552378755	SULF1	16
BP	GO:0060390	regulation of SMAD protein signal transduction	1	1/103	19/10965	0.16428578471252797	0.3468776997215947	0.27619775535128765	0.5587798552378755	TGFBR1	16
BP	GO:0060441	epithelial tube branching involved in lung morphogenesis	1	1/103	19/10965	0.16428578471252797	0.3468776997215947	0.27619775535128765	0.5587798552378755	SPRY1	16
BP	GO:0060986	endocrine hormone secretion	1	1/103	19/10965	0.16428578471252797	0.3468776997215947	0.27619775535128765	0.5587798552378755	GJA1	16
BP	GO:0086064	cell communication by electrical coupling involved in cardiac conduction	1	1/103	19/10965	0.16428578471252797	0.3468776997215947	0.27619775535128765	0.5587798552378755	GJA1	16
BP	GO:0099622	cardiac muscle cell membrane repolarization	1	1/103	19/10965	0.16428578471252797	0.3468776997215947	0.27619775535128765	0.5587798552378755	AKAP9	16
BP	GO:2000178	negative regulation of neural precursor cell proliferation	1	1/103	19/10965	0.16428578471252797	0.3468776997215947	0.27619775535128765	0.5587798552378755	PAX6	16
BP	GO:2000678	negative regulation of transcription regulatory region DNA binding	1	1/103	19/10965	0.16428578471252797	0.3468776997215947	0.27619775535128765	0.5587798552378755	SOX11	16
BP	GO:0018108	peptidyl-tyrosine phosphorylation	4	4/103	227/10965	0.16494565482915577	0.3479395972942325	0.2770432802328551	0.5574523793181299	EPHA4/SFRP2/FGF8/MAP2K6	16
BP	GO:0014074	response to purine-containing compound	2	2/103	78/10965	0.16644583342990135	0.3501047558957223	0.2787672652171622	0.5547582254457	IGFBP5/AKAP9	16
BP	GO:0016079	synaptic vesicle exocytosis	2	2/103	78/10965	0.16644583342990135	0.3501047558957223	0.2787672652171622	0.5547582254457	NLGN1/SYT1	16
BP	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	2	2/103	78/10965	0.16644583342990135	0.3501047558957223	0.2787672652171622	0.5547582254457	SFRP2/TGFBR1	16
BP	GO:0034329	cell junction assembly	5	5/103	311/10965	0.1682802018461433	0.35326497622040676	0.2812835577340751	0.5508556535228983	NLGN1/TPBG/GJA1/NPTN/CDH2	16
BP	GO:0043434	response to peptide hormone	5	5/103	311/10965	0.1682802018461433	0.35326497622040676	0.2812835577340751	0.5508556535228983	IGFBP5/GJA1/CA2/GCNT1/GALP	16
BP	GO:0007276	gamete generation	6	6/103	396/10965	0.1684262877153676	0.35326497622040676	0.2812835577340751	0.5508556535228983	CCNI/GJA1/DMRTA1/TGFBR1/PLEKHA1/CXADR	16
BP	GO:0022409	positive regulation of cell-cell adhesion	3	3/103	151/10965	0.16929131503718167	0.3547437102433193	0.2824609842974367	0.5490415318251314	SOX2/MYO10/SOX4	16
BP	GO:0022037	metencephalon development	2	2/103	79/10965	0.16977979861710477	0.355096050503888	0.28274153155996495	0.5486103938361204	DLL1/CKB	16
BP	GO:1901343	negative regulation of vasculature development	2	2/103	79/10965	0.16977979861710477	0.355096050503888	0.28274153155996495	0.5486103938361204	SULF1/SERPINF1	16
BP	GO:0018212	peptidyl-tyrosine modification	4	4/103	230/10965	0.17040552395275715	0.3560223085466808	0.28347905487870456	0.5474790238491678	EPHA4/SFRP2/FGF8/MAP2K6	16
BP	GO:0001933	negative regulation of protein phosphorylation	5	5/103	313/10965	0.17138009575354085	0.3560223085466808	0.28347905487870456	0.5474790238491678	SPRY1/SFRP2/DDIT4/CDKN1C/PAX6	16
BP	GO:0006956	complement activation	1	1/103	20/10965	0.1721497134695723	0.3560223085466808	0.28347905487870456	0.5474790238491678	CLU	16
BP	GO:0006972	hyperosmotic response	1	1/103	20/10965	0.1721497134695723	0.3560223085466808	0.28347905487870456	0.5474790238491678	MAPK10	16
BP	GO:0014741	negative regulation of muscle hypertrophy	1	1/103	20/10965	0.1721497134695723	0.3560223085466808	0.28347905487870456	0.5474790238491678	IGFBP5	16
BP	GO:0015867	ATP transport	1	1/103	20/10965	0.1721497134695723	0.3560223085466808	0.28347905487870456	0.5474790238491678	GJA1	16
BP	GO:0035137	hindlimb morphogenesis	1	1/103	20/10965	0.1721497134695723	0.3560223085466808	0.28347905487870456	0.5474790238491678	FGF8	16
BP	GO:0051131	chaperone-mediated protein complex assembly	1	1/103	20/10965	0.1721497134695723	0.3560223085466808	0.28347905487870456	0.5474790238491678	CLU	16
BP	GO:0070723	response to cholesterol	1	1/103	20/10965	0.1721497134695723	0.3560223085466808	0.28347905487870456	0.5474790238491678	TGFBR1	16
BP	GO:1901381	positive regulation of potassium ion transmembrane transport	1	1/103	20/10965	0.1721497134695723	0.3560223085466808	0.28347905487870456	0.5474790238491678	AKAP9	16
BP	GO:1903579	negative regulation of ATP metabolic process	1	1/103	20/10965	0.1721497134695723	0.3560223085466808	0.28347905487870456	0.5474790238491678	DDIT4	16
BP	GO:2000171	negative regulation of dendrite development	1	1/103	20/10965	0.1721497134695723	0.3560223085466808	0.28347905487870456	0.5474790238491678	NLGN1	16
BP	GO:2001233	regulation of apoptotic signaling pathway	5	5/103	314/10965	0.17293851029283425	0.35732029573086066	0.284512563654371	0.5458985510429261	MLLT11/TFDP2/SFRP2/CLU/TGFBR1	16
BP	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	3	3/103	153/10965	0.1739119426778456	0.35899699899141874	0.28584762116117524	0.5438654176560187	SOX2/SFRP2/NLRP1	16
BP	GO:0072331	signal transduction by p53 class mediator	4	4/103	232/10965	0.17408094018381737	0.3590115761744401	0.28585922809132114	0.5438477833536783	ZNF385B/TFDP2/SOX4/DDIT4	16
BP	GO:0048871	multicellular organismal homeostasis	5	5/103	316/10965	0.17607204740693894	0.3627804173802822	0.28886012864550636	0.539312399672746	GJA1/DLL1/CA2/MAP2K6/CXADR	16
BP	GO:2001243	negative regulation of intrinsic apoptotic signaling pathway	2	2/103	81/10965	0.1764814697307833	0.3629916002254686	0.28902828078632137	0.5390596603973243	SFRP2/CLU	16
BP	GO:0002064	epithelial cell development	3	3/103	155/10965	0.17856843795340238	0.3629916002254686	0.28902828078632137	0.5390596603973243	DLL1/PAX6/WNT5B	16
BP	GO:0050821	protein stabilization	3	3/103	155/10965	0.17856843795340238	0.3629916002254686	0.28902828078632137	0.5390596603973243	EPHA4/SOX4/CLU	16
BP	GO:0006626	protein targeting to mitochondrion	2	2/103	82/10965	0.17984818054692253	0.3629916002254686	0.28902828078632137	0.5390596603973243	IMMP1L/LMAN1	16
BP	GO:0030038	contractile actin filament bundle assembly	2	2/103	82/10965	0.17984818054692253	0.3629916002254686	0.28902828078632137	0.5390596603973243	TGFBR1/TPM1	16
BP	GO:0030326	embryonic limb morphogenesis	2	2/103	82/10965	0.17984818054692253	0.3629916002254686	0.28902828078632137	0.5390596603973243	SFRP2/FGF8	16
BP	GO:0035113	embryonic appendage morphogenesis	2	2/103	82/10965	0.17984818054692253	0.3629916002254686	0.28902828078632137	0.5390596603973243	SFRP2/FGF8	16
BP	GO:0043149	stress fiber assembly	2	2/103	82/10965	0.17984818054692253	0.3629916002254686	0.28902828078632137	0.5390596603973243	TGFBR1/TPM1	16
BP	GO:0045185	maintenance of protein location	2	2/103	82/10965	0.17984818054692253	0.3629916002254686	0.28902828078632137	0.5390596603973243	GJA1/TMSB15A	16
BP	GO:0048565	digestive tract development	2	2/103	82/10965	0.17984818054692253	0.3629916002254686	0.28902828078632137	0.5390596603973243	SOX11/SFRP2	16
BP	GO:0010644	cell communication by electrical coupling	1	1/103	21/10965	0.17994035572746503	0.3629916002254686	0.28902828078632137	0.5390596603973243	GJA1	16
BP	GO:0010882	regulation of cardiac muscle contraction by calcium ion signaling	1	1/103	21/10965	0.17994035572746503	0.3629916002254686	0.28902828078632137	0.5390596603973243	TNNI3	16
BP	GO:0015872	dopamine transport	1	1/103	21/10965	0.17994035572746503	0.3629916002254686	0.28902828078632137	0.5390596603973243	SYT1	16
BP	GO:0021680	cerebellar Purkinje cell layer development	1	1/103	21/10965	0.17994035572746503	0.3629916002254686	0.28902828078632137	0.5390596603973243	DLL1	16
BP	GO:0021772	olfactory bulb development	1	1/103	21/10965	0.17994035572746503	0.3629916002254686	0.28902828078632137	0.5390596603973243	FEZF1	16
BP	GO:0032613	interleukin-10 production	1	1/103	21/10965	0.17994035572746503	0.3629916002254686	0.28902828078632137	0.5390596603973243	DLL1	16
BP	GO:0032731	positive regulation of interleukin-1 beta production	1	1/103	21/10965	0.17994035572746503	0.3629916002254686	0.28902828078632137	0.5390596603973243	NLRP1	16
BP	GO:0045429	positive regulation of nitric oxide biosynthetic process	1	1/103	21/10965	0.17994035572746503	0.3629916002254686	0.28902828078632137	0.5390596603973243	CLU	16
BP	GO:0045823	positive regulation of heart contraction	1	1/103	21/10965	0.17994035572746503	0.3629916002254686	0.28902828078632137	0.5390596603973243	TPM1	16
BP	GO:0050433	regulation of catecholamine secretion	1	1/103	21/10965	0.17994035572746503	0.3629916002254686	0.28902828078632137	0.5390596603973243	SYT1	16
BP	GO:0060669	embryonic placenta morphogenesis	1	1/103	21/10965	0.17994035572746503	0.3629916002254686	0.28902828078632137	0.5390596603973243	RSPO3	16
BP	GO:0070841	inclusion body assembly	1	1/103	21/10965	0.17994035572746503	0.3629916002254686	0.28902828078632137	0.5390596603973243	CLU	16
BP	GO:0086091	regulation of heart rate by cardiac conduction	1	1/103	21/10965	0.17994035572746503	0.3629916002254686	0.28902828078632137	0.5390596603973243	AKAP9	16
BP	GO:0001894	tissue homeostasis	3	3/103	156/10965	0.1809097164819784	0.36398355329927184	0.28981811308922867	0.537874475424958	GJA1/CA2/CXADR	16
BP	GO:0030100	regulation of endocytosis	3	3/103	156/10965	0.1809097164819784	0.36398355329927184	0.28981811308922867	0.537874475424958	NLGN1/DLL1/CLU	16
BP	GO:0051301	cell division	7	7/103	493/10965	0.18092461693089654	0.36398355329927184	0.28981811308922867	0.537874475424958	CCNG2/SFRP2/DLL1/FGF8/PAX6/SOX5/TUBA1A	16
BP	GO:0010038	response to metal ion	4	4/103	236/10965	0.18151411235049264	0.3648384289039367	0.29049879888512303	0.5368556589316249	NLGN1/CA2/SYT1/SERPINF1	16
BP	GO:0007605	sensory perception of sound	2	2/103	83/10965	0.18322482509687554	0.3673473975011979	0.292496538997464	0.533879268396146	COL11A1/LRP2	16
BP	GO:0009855	determination of bilateral symmetry	2	2/103	83/10965	0.18322482509687554	0.3673473975011979	0.292496538997464	0.533879268396146	DLL1/FGF8	16
BP	GO:0140056	organelle localization by membrane tethering	3	3/103	157/10965	0.18325945946609148	0.3673473975011979	0.292496538997464	0.533879268396146	AKAP9/SYT1/TUBA1A	16
BP	GO:0006865	amino acid transport	2	2/103	84/10965	0.18661092611637362	0.3694836996671162	0.2941975473455138	0.5313609522024704	GJA1/SYT1	16
BP	GO:0009799	specification of symmetry	2	2/103	84/10965	0.18661092611637362	0.3694836996671162	0.2941975473455138	0.5313609522024704	DLL1/FGF8	16
BP	GO:1903531	negative regulation of secretion by cell	2	2/103	84/10965	0.18661092611637362	0.3694836996671162	0.2941975473455138	0.5313609522024704	VSNL1/GJA1	16
BP	GO:0006622	protein targeting to lysosome	1	1/103	22/10965	0.1876583878327347	0.3694836996671162	0.2941975473455138	0.5313609522024704	CLU	16
BP	GO:0021952	central nervous system projection neuron axonogenesis	1	1/103	22/10965	0.1876583878327347	0.3694836996671162	0.2941975473455138	0.5313609522024704	EPHA4	16
BP	GO:0031338	regulation of vesicle fusion	1	1/103	22/10965	0.1876583878327347	0.3694836996671162	0.2941975473455138	0.5313609522024704	SYT1	16
BP	GO:0033137	negative regulation of peptidyl-serine phosphorylation	1	1/103	22/10965	0.1876583878327347	0.3694836996671162	0.2941975473455138	0.5313609522024704	DDIT4	16
BP	GO:0035774	positive regulation of insulin secretion involved in cellular response to glucose stimulus	1	1/103	22/10965	0.1876583878327347	0.3694836996671162	0.2941975473455138	0.5313609522024704	VSNL1	16
BP	GO:0045601	regulation of endothelial cell differentiation	1	1/103	22/10965	0.1876583878327347	0.3694836996671162	0.2941975473455138	0.5313609522024704	BTG1	16
BP	GO:0045736	negative regulation of cyclin-dependent protein serine/threonine kinase activity	1	1/103	22/10965	0.1876583878327347	0.3694836996671162	0.2941975473455138	0.5313609522024704	CDKN1C	16
BP	GO:0046189	phenol-containing compound biosynthetic process	1	1/103	22/10965	0.1876583878327347	0.3694836996671162	0.2941975473455138	0.5313609522024704	PMEL	16
BP	GO:0048679	regulation of axon regeneration	1	1/103	22/10965	0.1876583878327347	0.3694836996671162	0.2941975473455138	0.5313609522024704	EPHA4	16
BP	GO:0050982	detection of mechanical stimulus	1	1/103	22/10965	0.1876583878327347	0.3694836996671162	0.2941975473455138	0.5313609522024704	COL11A1	16
BP	GO:0060914	heart formation	1	1/103	22/10965	0.1876583878327347	0.3694836996671162	0.2941975473455138	0.5313609522024704	LRP2	16
BP	GO:0061036	positive regulation of cartilage development	1	1/103	22/10965	0.1876583878327347	0.3694836996671162	0.2941975473455138	0.5313609522024704	SOX5	16
BP	GO:0099560	synaptic membrane adhesion	1	1/103	22/10965	0.1876583878327347	0.3694836996671162	0.2941975473455138	0.5313609522024704	NLGN1	16
BP	GO:1903421	regulation of synaptic vesicle recycling	1	1/103	22/10965	0.1876583878327347	0.3694836996671162	0.2941975473455138	0.5313609522024704	NLGN1	16
BP	GO:1904407	positive regulation of nitric oxide metabolic process	1	1/103	22/10965	0.1876583878327347	0.3694836996671162	0.2941975473455138	0.5313609522024704	CLU	16
BP	GO:2000310	regulation of NMDA receptor activity	1	1/103	22/10965	0.1876583878327347	0.3694836996671162	0.2941975473455138	0.5313609522024704	NLGN1	16
BP	GO:2000463	positive regulation of excitatory postsynaptic potential	1	1/103	22/10965	0.1876583878327347	0.3694836996671162	0.2941975473455138	0.5313609522024704	NLGN1	16
BP	GO:0002040	sprouting angiogenesis	2	2/103	85/10965	0.19000601426624458	0.37344267165626266	0.29734983755551714	0.5267322944230249	RSPO3/DLL1	16
BP	GO:0006903	vesicle targeting	2	2/103	85/10965	0.19000601426624458	0.37344267165626266	0.29734983755551714	0.5267322944230249	NLGN1/LMAN1	16
BP	GO:0007254	JNK cascade	3	3/103	160/10965	0.19035781282521333	0.3738027201359592	0.2976365224072377	0.5263137784127064	EPHA4/MAPK10/SFRP2	16
BP	GO:0002920	regulation of humoral immune response	1	1/103	23/10965	0.19530447995127898	0.3771690174668863	0.3003169015938886	0.5224202253687675	CLU	16
BP	GO:0010665	regulation of cardiac muscle cell apoptotic process	1	1/103	23/10965	0.19530447995127898	0.3771690174668863	0.3003169015938886	0.5224202253687675	SFRP2	16
BP	GO:0010862	positive regulation of pathway-restricted SMAD protein phosphorylation	1	1/103	23/10965	0.19530447995127898	0.3771690174668863	0.3003169015938886	0.5224202253687675	TGFBR1	16
BP	GO:0021799	cerebral cortex radially oriented cell migration	1	1/103	23/10965	0.19530447995127898	0.3771690174668863	0.3003169015938886	0.5224202253687675	FOXG1	16
BP	GO:0021988	olfactory lobe development	1	1/103	23/10965	0.19530447995127898	0.3771690174668863	0.3003169015938886	0.5224202253687675	FEZF1	16
BP	GO:0030511	positive regulation of transforming growth factor beta receptor signaling pathway	1	1/103	23/10965	0.19530447995127898	0.3771690174668863	0.3003169015938886	0.5224202253687675	CDKN1C	16
BP	GO:0031365	N-terminal protein amino acid modification	1	1/103	23/10965	0.19530447995127898	0.3771690174668863	0.3003169015938886	0.5224202253687675	SOX4	16
BP	GO:0034063	stress granule assembly	1	1/103	23/10965	0.19530447995127898	0.3771690174668863	0.3003169015938886	0.5224202253687675	CIRBP	16
BP	GO:0036314	response to sterol	1	1/103	23/10965	0.19530447995127898	0.3771690174668863	0.3003169015938886	0.5224202253687675	TGFBR1	16
BP	GO:0046676	negative regulation of insulin secretion	1	1/103	23/10965	0.19530447995127898	0.3771690174668863	0.3003169015938886	0.5224202253687675	VSNL1	16
BP	GO:0046949	fatty-acyl-CoA biosynthetic process	1	1/103	23/10965	0.19530447995127898	0.3771690174668863	0.3003169015938886	0.5224202253687675	SCD5	16
BP	GO:0048009	insulin-like growth factor receptor signaling pathway	1	1/103	23/10965	0.19530447995127898	0.3771690174668863	0.3003169015938886	0.5224202253687675	IGFBP5	16
BP	GO:0050432	catecholamine secretion	1	1/103	23/10965	0.19530447995127898	0.3771690174668863	0.3003169015938886	0.5224202253687675	SYT1	16
BP	GO:0051154	negative regulation of striated muscle cell differentiation	1	1/103	23/10965	0.19530447995127898	0.3771690174668863	0.3003169015938886	0.5224202253687675	DLL1	16
BP	GO:0051180	vitamin transport	1	1/103	23/10965	0.19530447995127898	0.3771690174668863	0.3003169015938886	0.5224202253687675	LRP2	16
BP	GO:0062208	positive regulation of pattern recognition receptor signaling pathway	1	1/103	23/10965	0.19530447995127898	0.3771690174668863	0.3003169015938886	0.5224202253687675	WDFY1	16
BP	GO:0110111	negative regulation of animal organ morphogenesis	1	1/103	23/10965	0.19530447995127898	0.3771690174668863	0.3003169015938886	0.5224202253687675	SULF1	16
BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	1	1/103	23/10965	0.19530447995127898	0.3771690174668863	0.3003169015938886	0.5224202253687675	CDKN1C	16
BP	GO:1904030	negative regulation of cyclin-dependent protein kinase activity	1	1/103	23/10965	0.19530447995127898	0.3771690174668863	0.3003169015938886	0.5224202253687675	CDKN1C	16
BP	GO:0060996	dendritic spine development	2	2/103	87/10965	0.19682131360124663	0.3794372628295337	0.30212296833802343	0.5198162570395757	EPHA4/NLGN1	16
BP	GO:2000134	negative regulation of G1/S transition of mitotic cell cycle	2	2/103	87/10965	0.19682131360124663	0.3794372628295337	0.30212296833802343	0.5198162570395757	TFDP2/SOX4	16
BP	GO:2000116	regulation of cysteine-type endopeptidase activity	3	3/103	163/10965	0.19752638462747243	0.38046567742754683	0.3029418327498023	0.5186407515005289	SOX2/SFRP2/NLRP1	16
BP	GO:0007015	actin filament organization	5	5/103	330/10965	0.19860112278993033	0.38220372328582947	0.3043257336611049	0.5166613223231171	DPYSL3/TGFBR1/TPM1/COTL1/TMSB15A	16
BP	GO:0051384	response to glucocorticoid	2	2/103	88/10965	0.20024062480082733	0.38312044251067906	0.3050556617954128	0.5156209101448375	DDIT4/SERPINF1	16
BP	GO:0071156	regulation of cell cycle arrest	2	2/103	88/10965	0.20024062480082733	0.38312044251067906	0.3050556617954128	0.5156209101448375	TFDP2/SOX4	16
BP	GO:1902807	negative regulation of cell cycle G1/S phase transition	2	2/103	88/10965	0.20024062480082733	0.38312044251067906	0.3050556617954128	0.5156209101448375	TFDP2/SOX4	16
BP	GO:0022406	membrane docking	3	3/103	165/10965	0.20234225818318446	0.38312044251067906	0.3050556617954128	0.5156209101448375	AKAP9/SYT1/TUBA1A	16
BP	GO:0015865	purine nucleotide transport	1	1/103	24/10965	0.2028792961242838	0.38312044251067906	0.3050556617954128	0.5156209101448375	GJA1	16
BP	GO:0015868	purine ribonucleotide transport	1	1/103	24/10965	0.2028792961242838	0.38312044251067906	0.3050556617954128	0.5156209101448375	GJA1	16
BP	GO:0021696	cerebellar cortex morphogenesis	1	1/103	24/10965	0.2028792961242838	0.38312044251067906	0.3050556617954128	0.5156209101448375	DLL1	16
BP	GO:0032438	melanosome organization	1	1/103	24/10965	0.2028792961242838	0.38312044251067906	0.3050556617954128	0.5156209101448375	PMEL	16
BP	GO:0032732	positive regulation of interleukin-1 production	1	1/103	24/10965	0.2028792961242838	0.38312044251067906	0.3050556617954128	0.5156209101448375	NLRP1	16
BP	GO:0035633	maintenance of blood-brain barrier	1	1/103	24/10965	0.2028792961242838	0.38312044251067906	0.3050556617954128	0.5156209101448375	GJA1	16
BP	GO:0051503	adenine nucleotide transport	1	1/103	24/10965	0.2028792961242838	0.38312044251067906	0.3050556617954128	0.5156209101448375	GJA1	16
BP	GO:0051788	response to misfolded protein	1	1/103	24/10965	0.2028792961242838	0.38312044251067906	0.3050556617954128	0.5156209101448375	CLU	16
BP	GO:0060251	regulation of glial cell proliferation	1	1/103	24/10965	0.2028792961242838	0.38312044251067906	0.3050556617954128	0.5156209101448375	SOX11	16
BP	GO:0061756	leukocyte adhesion to vascular endothelial cell	1	1/103	24/10965	0.2028792961242838	0.38312044251067906	0.3050556617954128	0.5156209101448375	GCNT1	16
BP	GO:0061900	glial cell activation	1	1/103	24/10965	0.2028792961242838	0.38312044251067906	0.3050556617954128	0.5156209101448375	CLU	16
BP	GO:0070570	regulation of neuron projection regeneration	1	1/103	24/10965	0.2028792961242838	0.38312044251067906	0.3050556617954128	0.5156209101448375	EPHA4	16
BP	GO:0090200	positive regulation of release of cytochrome c from mitochondria	1	1/103	24/10965	0.2028792961242838	0.38312044251067906	0.3050556617954128	0.5156209101448375	MLLT11	16
BP	GO:0090278	negative regulation of peptide hormone secretion	1	1/103	24/10965	0.2028792961242838	0.38312044251067906	0.3050556617954128	0.5156209101448375	VSNL1	16
BP	GO:0099563	modification of synaptic structure	1	1/103	24/10965	0.2028792961242838	0.38312044251067906	0.3050556617954128	0.5156209101448375	EPHA4	16
BP	GO:1900739	regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	1	1/103	24/10965	0.2028792961242838	0.38312044251067906	0.3050556617954128	0.5156209101448375	TFDP2	16
BP	GO:1900740	positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	1	1/103	24/10965	0.2028792961242838	0.38312044251067906	0.3050556617954128	0.5156209101448375	TFDP2	16
BP	GO:1905606	regulation of presynapse assembly	1	1/103	24/10965	0.2028792961242838	0.38312044251067906	0.3050556617954128	0.5156209101448375	NLGN1	16
BP	GO:0022898	regulation of transmembrane transporter activity	3	3/103	166/10965	0.20476075532999094	0.38634433580135313	0.307622653248282	0.5119816863658059	NLGN1/GJA1/AKAP9	16
BP	GO:0015718	monocarboxylic acid transport	2	2/103	90/10965	0.2071003768162055	0.38768031290079513	0.3086864110982757	0.5104824884801041	MAP2K6/SLC6A8	16
BP	GO:0051224	negative regulation of protein transport	2	2/103	90/10965	0.2071003768162055	0.38768031290079513	0.3086864110982757	0.5104824884801041	VSNL1/LMAN1	16
BP	GO:0071902	positive regulation of protein serine/threonine kinase activity	4	4/103	250/10965	0.2083270949375144	0.38768031290079513	0.3086864110982757	0.5104824884801041	EPHA4/MAPK10/TGFBR1/MAP2K6	16
BP	GO:0070372	regulation of ERK1 and ERK2 cascade	3	3/103	168/10965	0.20961806474012748	0.38768031290079513	0.3086864110982757	0.5104824884801041	SPRY1/FGF8/NPTN	16
BP	GO:0042326	negative regulation of phosphorylation	5	5/103	337/10965	0.21022892848243754	0.38768031290079513	0.3086864110982757	0.5104824884801041	SPRY1/SFRP2/DDIT4/CDKN1C/PAX6	16
BP	GO:0001662	behavioral fear response	1	1/103	25/10965	0.2103834943236439	0.38768031290079513	0.3086864110982757	0.5104824884801041	GJA1	16
BP	GO:0003016	respiratory system process	1	1/103	25/10965	0.2103834943236439	0.38768031290079513	0.3086864110982757	0.5104824884801041	NLGN1	16
BP	GO:0010662	regulation of striated muscle cell apoptotic process	1	1/103	25/10965	0.2103834943236439	0.38768031290079513	0.3086864110982757	0.5104824884801041	SFRP2	16
BP	GO:0014002	astrocyte development	1	1/103	25/10965	0.2103834943236439	0.38768031290079513	0.3086864110982757	0.5104824884801041	DLL1	16
BP	GO:0019229	regulation of vasoconstriction	1	1/103	25/10965	0.2103834943236439	0.38768031290079513	0.3086864110982757	0.5104824884801041	GJA1	16
BP	GO:0031279	regulation of cyclase activity	1	1/103	25/10965	0.2103834943236439	0.38768031290079513	0.3086864110982757	0.5104824884801041	AKAP9	16
BP	GO:0032760	positive regulation of tumor necrosis factor production	1	1/103	25/10965	0.2103834943236439	0.38768031290079513	0.3086864110982757	0.5104824884801041	CLU	16
BP	GO:0042461	photoreceptor cell development	1	1/103	25/10965	0.2103834943236439	0.38768031290079513	0.3086864110982757	0.5104824884801041	PAX6	16
BP	GO:0042491	inner ear auditory receptor cell differentiation	1	1/103	25/10965	0.2103834943236439	0.38768031290079513	0.3086864110982757	0.5104824884801041	DLL1	16
BP	GO:0042596	fear response	1	1/103	25/10965	0.2103834943236439	0.38768031290079513	0.3086864110982757	0.5104824884801041	GJA1	16
BP	GO:0043268	positive regulation of potassium ion transport	1	1/103	25/10965	0.2103834943236439	0.38768031290079513	0.3086864110982757	0.5104824884801041	AKAP9	16
BP	GO:0045124	regulation of bone resorption	1	1/103	25/10965	0.2103834943236439	0.38768031290079513	0.3086864110982757	0.5104824884801041	CA2	16
BP	GO:0048286	lung alveolus development	1	1/103	25/10965	0.2103834943236439	0.38768031290079513	0.3086864110982757	0.5104824884801041	IGFBP5	16
BP	GO:0048753	pigment granule organization	1	1/103	25/10965	0.2103834943236439	0.38768031290079513	0.3086864110982757	0.5104824884801041	PMEL	16
BP	GO:0060325	face morphogenesis	1	1/103	25/10965	0.2103834943236439	0.38768031290079513	0.3086864110982757	0.5104824884801041	PLEKHA1	16
BP	GO:0099174	regulation of presynapse organization	1	1/103	25/10965	0.2103834943236439	0.38768031290079513	0.3086864110982757	0.5104824884801041	NLGN1	16
BP	GO:1900027	regulation of ruffle assembly	1	1/103	25/10965	0.2103834943236439	0.38768031290079513	0.3086864110982757	0.5104824884801041	NLGN1	16
BP	GO:1900117	regulation of execution phase of apoptosis	1	1/103	25/10965	0.2103834943236439	0.38768031290079513	0.3086864110982757	0.5104824884801041	FZD3	16
BP	GO:0030534	adult behavior	2	2/103	91/10965	0.21053996244138806	0.38768031290079513	0.3086864110982757	0.5104824884801041	EPHA4/ZIC1	16
BP	GO:0031644	regulation of nervous system process	2	2/103	91/10965	0.21053996244138806	0.38768031290079513	0.3086864110982757	0.5104824884801041	NLGN1/AKAP9	16
BP	GO:0044773	mitotic DNA damage checkpoint	2	2/103	91/10965	0.21053996244138806	0.38768031290079513	0.3086864110982757	0.5104824884801041	TFDP2/SOX4	16
BP	GO:0055123	digestive system development	2	2/103	91/10965	0.21053996244138806	0.38768031290079513	0.3086864110982757	0.5104824884801041	SOX11/SFRP2	16
BP	GO:0097711	ciliary basal body-plasma membrane docking	2	2/103	91/10965	0.21053996244138806	0.38768031290079513	0.3086864110982757	0.5104824884801041	AKAP9/TUBA1A	16
BP	GO:1905039	carboxylic acid transmembrane transport	2	2/103	91/10965	0.21053996244138806	0.38768031290079513	0.3086864110982757	0.5104824884801041	LRP2/SLC6A8	16
BP	GO:0030330	DNA damage response, signal transduction by p53 class mediator	2	2/103	92/10965	0.2139854631163401	0.39337128667406795	0.3132177896884894	0.5041535794872183	TFDP2/SOX4	16
BP	GO:1903825	organic acid transmembrane transport	2	2/103	92/10965	0.2139854631163401	0.39337128667406795	0.3132177896884894	0.5041535794872183	LRP2/SLC6A8	16
BP	GO:0007600	sensory perception	4	4/103	253/10965	0.21421952128838623	0.3934752930375744	0.31330060367210893	0.504038768312635	COL11A1/LRP2/PAX6/RAX	16
BP	GO:0097191	extrinsic apoptotic signaling pathway	3	3/103	170/10965	0.21450139491949763	0.39366688123884624	0.3134531537818034	0.5038273561866624	MLLT11/SFRP2/TGFBR1	16
BP	GO:0071417	cellular response to organonitrogen compound	6	6/103	430/10965	0.21718869097809212	0.39452769580536423	0.31413856841421356	0.5028787397518244	IGFBP5/EPHA4/GJA1/AKAP9/COL1A2/CA2	16
BP	GO:0045598	regulation of fat cell differentiation	2	2/103	93/10965	0.2174364692489756	0.39452769580536423	0.31413856841421356	0.5028787397518244	SFRP2/WNT5B	16
BP	GO:0001754	eye photoreceptor cell differentiation	1	1/103	26/10965	0.2178177265068858	0.39452769580536423	0.31413856841421356	0.5028787397518244	PAX6	16
BP	GO:0002209	behavioral defense response	1	1/103	26/10965	0.2178177265068858	0.39452769580536423	0.31413856841421356	0.5028787397518244	GJA1	16
BP	GO:0003254	regulation of membrane depolarization	1	1/103	26/10965	0.2178177265068858	0.39452769580536423	0.31413856841421356	0.5028787397518244	MLLT11	16
BP	GO:0010659	cardiac muscle cell apoptotic process	1	1/103	26/10965	0.2178177265068858	0.39452769580536423	0.31413856841421356	0.5028787397518244	SFRP2	16
BP	GO:0030201	heparan sulfate proteoglycan metabolic process	1	1/103	26/10965	0.2178177265068858	0.39452769580536423	0.31413856841421356	0.5028787397518244	SULF1	16
BP	GO:0051339	regulation of lyase activity	1	1/103	26/10965	0.2178177265068858	0.39452769580536423	0.31413856841421356	0.5028787397518244	AKAP9	16
BP	GO:0051642	centrosome localization	1	1/103	26/10965	0.2178177265068858	0.39452769580536423	0.31413856841421356	0.5028787397518244	AKAP9	16
BP	GO:0060416	response to growth hormone	1	1/103	26/10965	0.2178177265068858	0.39452769580536423	0.31413856841421356	0.5028787397518244	IGFBP5	16
BP	GO:0061384	heart trabecula morphogenesis	1	1/103	26/10965	0.2178177265068858	0.39452769580536423	0.31413856841421356	0.5028787397518244	TGFBR1	16
BP	GO:0086009	membrane repolarization	1	1/103	26/10965	0.2178177265068858	0.39452769580536423	0.31413856841421356	0.5028787397518244	AKAP9	16
BP	GO:0097484	dendrite extension	1	1/103	26/10965	0.2178177265068858	0.39452769580536423	0.31413856841421356	0.5028787397518244	SYT1	16
BP	GO:1903557	positive regulation of tumor necrosis factor superfamily cytokine production	1	1/103	26/10965	0.2178177265068858	0.39452769580536423	0.31413856841421356	0.5028787397518244	CLU	16
BP	GO:1905332	positive regulation of morphogenesis of an epithelium	1	1/103	26/10965	0.2178177265068858	0.39452769580536423	0.31413856841421356	0.5028787397518244	GJA1	16
BP	GO:2000036	regulation of stem cell population maintenance	1	1/103	26/10965	0.2178177265068858	0.39452769580536423	0.31413856841421356	0.5028787397518244	ZNF706	16
BP	GO:0051493	regulation of cytoskeleton organization	6	6/103	432/10965	0.2202018767463589	0.39814540328398035	0.31701913031229256	0.49891452977472617	AKAP9/TGFBR1/MAP6/TPM1/COTL1/TMSB15A	16
BP	GO:0042752	regulation of circadian rhythm	2	2/103	94/10965	0.2208925782766332	0.39814540328398035	0.31701913031229256	0.49891452977472617	NLGN1/MAPK10	16
BP	GO:0050954	sensory perception of mechanical stimulus	2	2/103	94/10965	0.2208925782766332	0.39814540328398035	0.31701913031229256	0.49891452977472617	COL11A1/LRP2	16
BP	GO:0051048	negative regulation of secretion	2	2/103	94/10965	0.2208925782766332	0.39814540328398035	0.31701913031229256	0.49891452977472617	VSNL1/GJA1	16
BP	GO:1902107	positive regulation of leukocyte differentiation	2	2/103	94/10965	0.2208925782766332	0.39814540328398035	0.31701913031229256	0.49891452977472617	SOX4/CA2	16
BP	GO:1904950	negative regulation of establishment of protein localization	2	2/103	94/10965	0.2208925782766332	0.39814540328398035	0.31701913031229256	0.49891452977472617	VSNL1/LMAN1	16
BP	GO:0032409	regulation of transporter activity	3	3/103	174/10965	0.22434105310868852	0.40131021698949604	0.319539080260848	0.49547601918407913	NLGN1/GJA1/AKAP9	16
BP	GO:0002285	lymphocyte activation involved in immune response	2	2/103	95/10965	0.22435339457235146	0.40131021698949604	0.319539080260848	0.49547601918407913	DLL1/LFNG	16
BP	GO:0006862	nucleotide transport	1	1/103	27/10965	0.22518263867159816	0.40131021698949604	0.319539080260848	0.49547601918407913	GJA1	16
BP	GO:0010043	response to zinc ion	1	1/103	27/10965	0.22518263867159816	0.40131021698949604	0.319539080260848	0.49547601918407913	CA2	16
BP	GO:0010656	negative regulation of muscle cell apoptotic process	1	1/103	27/10965	0.22518263867159816	0.40131021698949604	0.319539080260848	0.49547601918407913	SFRP2	16
BP	GO:0019748	secondary metabolic process	1	1/103	27/10965	0.22518263867159816	0.40131021698949604	0.319539080260848	0.49547601918407913	PMEL	16
BP	GO:0031116	positive regulation of microtubule polymerization	1	1/103	27/10965	0.22518263867159816	0.40131021698949604	0.319539080260848	0.49547601918407913	AKAP9	16
BP	GO:0032924	activin receptor signaling pathway	1	1/103	27/10965	0.22518263867159816	0.40131021698949604	0.319539080260848	0.49547601918407913	TGFBR1	16
BP	GO:0050853	B cell receptor signaling pathway	1	1/103	27/10965	0.22518263867159816	0.40131021698949604	0.319539080260848	0.49547601918407913	PLEKHA1	16
BP	GO:0061842	microtubule organizing center localization	1	1/103	27/10965	0.22518263867159816	0.40131021698949604	0.319539080260848	0.49547601918407913	AKAP9	16
BP	GO:0070423	nucleotide-binding oligomerization domain containing signaling pathway	1	1/103	27/10965	0.22518263867159816	0.40131021698949604	0.319539080260848	0.49547601918407913	MAP2K6	16
BP	GO:1903793	positive regulation of anion transport	1	1/103	27/10965	0.22518263867159816	0.40131021698949604	0.319539080260848	0.49547601918407913	MAP2K6	16
BP	GO:2000725	regulation of cardiac muscle cell differentiation	1	1/103	27/10965	0.22518263867159816	0.40131021698949604	0.319539080260848	0.49547601918407913	DLL1	16
BP	GO:2000826	regulation of heart morphogenesis	1	1/103	27/10965	0.22518263867159816	0.40131021698949604	0.319539080260848	0.49547601918407913	TGFBR1	16
BP	GO:0120031	plasma membrane bounded cell projection assembly	6	6/103	436/10965	0.2262712867826999	0.40292646007810895	0.3208259969854895	0.4937304474642599	NLGN1/MYO10/DPYSL3/AKAP9/TGFBR1/TUBA1A	16
BP	GO:0030705	cytoskeleton-dependent intracellular transport	3	3/103	175/10965	0.22681526230371352	0.403570976346174	0.32133918635070335	0.4930363103085448	MYO10/MAP6/TUBA1A	16
BP	GO:0007519	skeletal muscle tissue development	2	2/103	96/10965	0.22781852935226077	0.40438244961886477	0.3219853134918388	0.4921639370461398	SOX11/DLL1	16
BP	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	2	2/103	96/10965	0.22781852935226077	0.40438244961886477	0.3219853134918388	0.4921639370461398	EPHA4/FGF8	16
BP	GO:0051592	response to calcium ion	2	2/103	96/10965	0.22781852935226077	0.40438244961886477	0.3219853134918388	0.4921639370461398	NLGN1/SYT1	16
BP	GO:0051495	positive regulation of cytoskeleton organization	3	3/103	176/10965	0.22929487940346502	0.4051931264198816	0.3226308064506998	0.49129416629369616	AKAP9/TGFBR1/TPM1	16
BP	GO:0098656	anion transmembrane transport	3	3/103	176/10965	0.22929487940346502	0.4051931264198816	0.3226308064506998	0.49129416629369616	LRP2/GJA1/SLC6A8	16
BP	GO:0018107	peptidyl-threonine phosphorylation	2	2/103	97/10965	0.23128760058407527	0.4051931264198816	0.3226308064506998	0.49129416629369616	TGFBR1/DDIT4	16
BP	GO:0031960	response to corticosteroid	2	2/103	97/10965	0.23128760058407527	0.4051931264198816	0.3226308064506998	0.49129416629369616	DDIT4/SERPINF1	16
BP	GO:0051101	regulation of DNA binding	2	2/103	97/10965	0.23128760058407527	0.4051931264198816	0.3226308064506998	0.49129416629369616	SOX11/PAX6	16
BP	GO:0106106	cold-induced thermogenesis	2	2/103	97/10965	0.23128760058407527	0.4051931264198816	0.3226308064506998	0.49129416629369616	GJA1/MAP2K6	16
BP	GO:0120161	regulation of cold-induced thermogenesis	2	2/103	97/10965	0.23128760058407527	0.4051931264198816	0.3226308064506998	0.49129416629369616	GJA1/MAP2K6	16
BP	GO:1903305	regulation of regulated secretory pathway	2	2/103	97/10965	0.23128760058407527	0.4051931264198816	0.3226308064506998	0.49129416629369616	NLGN1/SYT1	16
BP	GO:0001844	protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	1	1/103	28/10965	0.23247887090937724	0.4051931264198816	0.3226308064506998	0.49129416629369616	TFDP2	16
BP	GO:0001893	maternal placenta development	1	1/103	28/10965	0.23247887090937724	0.4051931264198816	0.3226308064506998	0.49129416629369616	GJA1	16
BP	GO:0007007	inner mitochondrial membrane organization	1	1/103	28/10965	0.23247887090937724	0.4051931264198816	0.3226308064506998	0.49129416629369616	CHCHD6	16
BP	GO:0007020	microtubule nucleation	1	1/103	28/10965	0.23247887090937724	0.4051931264198816	0.3226308064506998	0.49129416629369616	AKAP9	16
BP	GO:0010658	striated muscle cell apoptotic process	1	1/103	28/10965	0.23247887090937724	0.4051931264198816	0.3226308064506998	0.49129416629369616	SFRP2	16
BP	GO:0010677	negative regulation of cellular carbohydrate metabolic process	1	1/103	28/10965	0.23247887090937724	0.4051931264198816	0.3226308064506998	0.49129416629369616	DDIT4	16
BP	GO:0018279	protein N-linked glycosylation via asparagine	1	1/103	28/10965	0.23247887090937724	0.4051931264198816	0.3226308064506998	0.49129416629369616	LMAN1	16
BP	GO:0035872	nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway	1	1/103	28/10965	0.23247887090937724	0.4051931264198816	0.3226308064506998	0.49129416629369616	MAP2K6	16
BP	GO:0038084	vascular endothelial growth factor signaling pathway	1	1/103	28/10965	0.23247887090937724	0.4051931264198816	0.3226308064506998	0.49129416629369616	DLL1	16
BP	GO:0050685	positive regulation of mRNA processing	1	1/103	28/10965	0.23247887090937724	0.4051931264198816	0.3226308064506998	0.49129416629369616	CIRBP	16
BP	GO:0086004	regulation of cardiac muscle cell contraction	1	1/103	28/10965	0.23247887090937724	0.4051931264198816	0.3226308064506998	0.49129416629369616	AKAP9	16
BP	GO:1903428	positive regulation of reactive oxygen species biosynthetic process	1	1/103	28/10965	0.23247887090937724	0.4051931264198816	0.3226308064506998	0.49129416629369616	CLU	16
BP	GO:1903672	positive regulation of sprouting angiogenesis	1	1/103	28/10965	0.23247887090937724	0.4051931264198816	0.3226308064506998	0.49129416629369616	DLL1	16
BP	GO:2000279	negative regulation of DNA biosynthetic process	1	1/103	28/10965	0.23247887090937724	0.4051931264198816	0.3226308064506998	0.49129416629369616	GJA1	16
BP	GO:2000758	positive regulation of peptidyl-lysine acetylation	1	1/103	28/10965	0.23247887090937724	0.4051931264198816	0.3226308064506998	0.49129416629369616	SOX4	16
BP	GO:0009306	protein secretion	4	4/103	263/10965	0.23418747546983595	0.4073537081967274	0.324351147186056	0.48898456169030524	VSNL1/SOX4/GJA1/NNAT	16
BP	GO:0035592	establishment of protein localization to extracellular region	4	4/103	263/10965	0.23418747546983595	0.4073537081967274	0.324351147186056	0.48898456169030524	VSNL1/SOX4/GJA1/NNAT	16
BP	GO:0051402	neuron apoptotic process	3	3/103	178/10965	0.23426972392910575	0.4073537081967274	0.324351147186056	0.48898456169030524	FGF8/TOX3/NLRP1	16
BP	GO:0044774	mitotic DNA integrity checkpoint	2	2/103	98/10965	0.234760232896671	0.4078867055892787	0.32477554080821425	0.4884166853791687	TFDP2/SOX4	16
BP	GO:0070371	ERK1 and ERK2 cascade	3	3/103	179/10965	0.23676464675473105	0.41072552570832455	0.3270359217590676	0.48540454163658664	SPRY1/FGF8/NPTN	16
BP	GO:2001234	negative regulation of apoptotic signaling pathway	3	3/103	179/10965	0.23676464675473105	0.41072552570832455	0.3270359217590676	0.48540454163658664	SFRP2/CLU/TGFBR1	16
BP	GO:0050801	ion homeostasis	6	6/103	443/10965	0.23702517683332167	0.41085599455783745	0.3271398062215386	0.4852666079063789	MLLT11/GJA1/CA2/CKB/NPTN/TNNI3	16
BP	GO:0010469	regulation of signaling receptor activity	2	2/103	99/10965	0.2382360574907421	0.41132395231209995	0.3275124127091573	0.48477223561437777	NLGN1/AKAP9	16
BP	GO:0032271	regulation of protein polymerization	3	3/103	180/10965	0.2392643683080519	0.41132395231209995	0.3275124127091573	0.48477223561437777	AKAP9/COTL1/TMSB15A	16
BP	GO:0051656	establishment of organelle localization	5	5/103	354/10965	0.23934993125297754	0.41132395231209995	0.3275124127091573	0.48477223561437777	NLGN1/SPRY1/GJA1/PAX6/LMAN1	16
BP	GO:0000083	regulation of transcription involved in G1/S transition of mitotic cell cycle	1	1/103	29/10965	0.23970705745928422	0.41132395231209995	0.3275124127091573	0.48477223561437777	TFDP2	16
BP	GO:0010165	response to X-ray	1	1/103	29/10965	0.23970705745928422	0.41132395231209995	0.3275124127091573	0.48477223561437777	SFRP2	16
BP	GO:0017158	regulation of calcium ion-dependent exocytosis	1	1/103	29/10965	0.23970705745928422	0.41132395231209995	0.3275124127091573	0.48477223561437777	SYT1	16
BP	GO:0018196	peptidyl-asparagine modification	1	1/103	29/10965	0.23970705745928422	0.41132395231209995	0.3275124127091573	0.48477223561437777	LMAN1	16
BP	GO:0032890	regulation of organic acid transport	1	1/103	29/10965	0.23970705745928422	0.41132395231209995	0.3275124127091573	0.48477223561437777	MAP2K6	16
BP	GO:0045668	negative regulation of osteoblast differentiation	1	1/103	29/10965	0.23970705745928422	0.41132395231209995	0.3275124127091573	0.48477223561437777	IGFBP5	16
BP	GO:0048512	circadian behavior	1	1/103	29/10965	0.23970705745928422	0.41132395231209995	0.3275124127091573	0.48477223561437777	NLGN1	16
BP	GO:0060323	head morphogenesis	1	1/103	29/10965	0.23970705745928422	0.41132395231209995	0.3275124127091573	0.48477223561437777	PLEKHA1	16
BP	GO:0097009	energy homeostasis	1	1/103	29/10965	0.23970705745928422	0.41132395231209995	0.3275124127091573	0.48477223561437777	DLL1	16
BP	GO:0150076	neuroinflammatory response	1	1/103	29/10965	0.23970705745928422	0.41132395231209995	0.3275124127091573	0.48477223561437777	CLU	16
BP	GO:0032956	regulation of actin cytoskeleton organization	4	4/103	266/10965	0.24026737639264104	0.41196656880315946	0.32802408939671845	0.4840942614471375	TGFBR1/TPM1/COTL1/TMSB15A	16
BP	GO:0030031	cell projection assembly	6	6/103	446/10965	0.24168318363956579	0.41380812093899944	0.3294904061034124	0.482157226402315	NLGN1/MYO10/DPYSL3/AKAP9/TGFBR1/TUBA1A	16
BP	GO:0001101	response to acid chemical	2	2/103	100/10965	0.24171471205052064	0.41380812093899944	0.3294904061034124	0.482157226402315	MAPK10/COL1A2	16
BP	GO:0071692	protein localization to extracellular region	4	4/103	267/10965	0.24230243636522486	0.4144942140599564	0.3300367006046801	0.4814377632013598	VSNL1/SOX4/GJA1/NNAT	16
BP	GO:0006469	negative regulation of protein kinase activity	3	3/103	182/10965	0.24427760785895564	0.4171539420188703	0.3321544812884389	0.4786598838645749	SPRY1/SFRP2/CDKN1C	16
BP	GO:1990845	adaptive thermogenesis	2	2/103	101/10965	0.24519584065654923	0.4171539420188703	0.3321544812884389	0.4786598838645749	GJA1/MAP2K6	16
BP	GO:0007622	rhythmic behavior	1	1/103	30/10965	0.24686782676082897	0.4171539420188703	0.3321544812884389	0.4786598838645749	NLGN1	16
BP	GO:0014911	positive regulation of smooth muscle cell migration	1	1/103	30/10965	0.24686782676082897	0.4171539420188703	0.3321544812884389	0.4786598838645749	IGFBP5	16
BP	GO:0021587	cerebellum morphogenesis	1	1/103	30/10965	0.24686782676082897	0.4171539420188703	0.3321544812884389	0.4786598838645749	DLL1	16
BP	GO:0033120	positive regulation of RNA splicing	1	1/103	30/10965	0.24686782676082897	0.4171539420188703	0.3321544812884389	0.4786598838645749	CIRBP	16
BP	GO:0033628	regulation of cell adhesion mediated by integrin	1	1/103	30/10965	0.24686782676082897	0.4171539420188703	0.3321544812884389	0.4786598838645749	SFRP2	16
BP	GO:0035315	hair cell differentiation	1	1/103	30/10965	0.24686782676082897	0.4171539420188703	0.3321544812884389	0.4786598838645749	DLL1	16
BP	GO:0035337	fatty-acyl-CoA metabolic process	1	1/103	30/10965	0.24686782676082897	0.4171539420188703	0.3321544812884389	0.4786598838645749	SCD5	16
BP	GO:0046329	negative regulation of JNK cascade	1	1/103	30/10965	0.24686782676082897	0.4171539420188703	0.3321544812884389	0.4786598838645749	SFRP2	16
BP	GO:0046622	positive regulation of organ growth	1	1/103	30/10965	0.24686782676082897	0.4171539420188703	0.3321544812884389	0.4786598838645749	FGF8	16
BP	GO:0046685	response to arsenic-containing substance	1	1/103	30/10965	0.24686782676082897	0.4171539420188703	0.3321544812884389	0.4786598838645749	SERPINF1	16
BP	GO:0051937	catecholamine transport	1	1/103	30/10965	0.24686782676082897	0.4171539420188703	0.3321544812884389	0.4786598838645749	SYT1	16
BP	GO:0086002	cardiac muscle cell action potential involved in contraction	1	1/103	30/10965	0.24686782676082897	0.4171539420188703	0.3321544812884389	0.4786598838645749	GJA1	16
BP	GO:1902042	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	1	1/103	30/10965	0.24686782676082897	0.4171539420188703	0.3321544812884389	0.4786598838645749	SFRP2	16
BP	GO:1903115	regulation of actin filament-based movement	1	1/103	30/10965	0.24686782676082897	0.4171539420188703	0.3321544812884389	0.4786598838645749	AKAP9	16
BP	GO:0010822	positive regulation of mitochondrion organization	2	2/103	102/10965	0.2486790936994943	0.41957500055690933	0.33408222393178877	0.47614663197550877	MLLT11/TFDP2	16
BP	GO:0043524	negative regulation of neuron apoptotic process	2	2/103	102/10965	0.2486790936994943	0.41957500055690933	0.33408222393178877	0.47614663197550877	FGF8/TOX3	16
BP	GO:0006873	cellular ion homeostasis	5	5/103	360/10965	0.24989186956512077	0.421300589221196	0.33545620593212533	0.4743641692758258	GJA1/CA2/CKB/NPTN/TNNI3	16
BP	GO:0060538	skeletal muscle organ development	2	2/103	103/10965	0.25216412779498765	0.4242903646871545	0.33783678350561835	0.47129306641742197	SOX11/DLL1	16
BP	GO:0006099	tricarboxylic acid cycle	1	1/103	31/10965	0.2539618015064745	0.4242903646871545	0.33783678350561835	0.47129306641742197	ME3	16
BP	GO:0014014	negative regulation of gliogenesis	1	1/103	31/10965	0.2539618015064745	0.4242903646871545	0.33783678350561835	0.47129306641742197	SOX11	16
BP	GO:0021795	cerebral cortex cell migration	1	1/103	31/10965	0.2539618015064745	0.4242903646871545	0.33783678350561835	0.47129306641742197	FOXG1	16
BP	GO:0021955	central nervous system neuron axonogenesis	1	1/103	31/10965	0.2539618015064745	0.4242903646871545	0.33783678350561835	0.47129306641742197	EPHA4	16
BP	GO:0031112	positive regulation of microtubule polymerization or depolymerization	1	1/103	31/10965	0.2539618015064745	0.4242903646871545	0.33783678350561835	0.47129306641742197	AKAP9	16
BP	GO:0035176	social behavior	1	1/103	31/10965	0.2539618015064745	0.4242903646871545	0.33783678350561835	0.47129306641742197	GNG8	16
BP	GO:0046850	regulation of bone remodeling	1	1/103	31/10965	0.2539618015064745	0.4242903646871545	0.33783678350561835	0.47129306641742197	CA2	16
BP	GO:0048641	regulation of skeletal muscle tissue development	1	1/103	31/10965	0.2539618015064745	0.4242903646871545	0.33783678350561835	0.47129306641742197	DLL1	16
BP	GO:0050906	detection of stimulus involved in sensory perception	1	1/103	31/10965	0.2539618015064745	0.4242903646871545	0.33783678350561835	0.47129306641742197	COL11A1	16
BP	GO:0051703	intraspecies interaction between organisms	1	1/103	31/10965	0.2539618015064745	0.4242903646871545	0.33783678350561835	0.47129306641742197	GNG8	16
BP	GO:0085029	extracellular matrix assembly	1	1/103	31/10965	0.2539618015064745	0.4242903646871545	0.33783678350561835	0.47129306641742197	COL1A2	16
BP	GO:0007163	establishment or maintenance of cell polarity	3	3/103	186/10965	0.2543551243069111	0.4246274929129683	0.3381052183439204	0.4709481262455292	SPRY1/GJA1/PAX6	16
BP	GO:0007006	mitochondrial membrane organization	2	2/103	104/10965	0.25565060569948744	0.4258282440539171	0.33906130393296724	0.4697217721426675	CHCHD6/TFDP2	16
BP	GO:0018210	peptidyl-threonine modification	2	2/103	104/10965	0.25565060569948744	0.4258282440539171	0.33906130393296724	0.4697217721426675	TGFBR1/DDIT4	16
BP	GO:0070374	positive regulation of ERK1 and ERK2 cascade	2	2/103	104/10965	0.25565060569948744	0.4258282440539171	0.33906130393296724	0.4697217721426675	FGF8/NPTN	16
BP	GO:0045732	positive regulation of protein catabolic process	3	3/103	187/10965	0.25688428251072726	0.4275619026473591	0.3404417115303379	0.4679572347870219	LRP2/GJA1/CLU	16
BP	GO:0045862	positive regulation of proteolysis	4	4/103	275/10965	0.2587230425269057	0.43029931379006	0.3426213466400449	0.46518558229528506	EPHA4/SFRP2/CLU/NLRP1	16
BP	GO:0030902	hindbrain development	2	2/103	105/10965	0.259138196227145	0.4306667024254726	0.3429138760142999	0.46481494079782065	DLL1/CKB	16
BP	GO:0008542	visual learning	1	1/103	32/10965	0.26098959869367355	0.43083688779141793	0.3430493843392958	0.46464335575248494	NPTN	16
BP	GO:0010596	negative regulation of endothelial cell migration	1	1/103	32/10965	0.26098959869367355	0.43083688779141793	0.3430493843392958	0.46464335575248494	SERPINF1	16
BP	GO:0015844	monoamine transport	1	1/103	32/10965	0.26098959869367355	0.43083688779141793	0.3430493843392958	0.46464335575248494	SYT1	16
BP	GO:0021575	hindbrain morphogenesis	1	1/103	32/10965	0.26098959869367355	0.43083688779141793	0.3430493843392958	0.46464335575248494	DLL1	16
BP	GO:0042307	positive regulation of protein import into nucleus	1	1/103	32/10965	0.26098959869367355	0.43083688779141793	0.3430493843392958	0.46464335575248494	ZIC1	16
BP	GO:0048255	mRNA stabilization	1	1/103	32/10965	0.26098959869367355	0.43083688779141793	0.3430493843392958	0.46464335575248494	CIRBP	16
BP	GO:0060443	mammary gland morphogenesis	1	1/103	32/10965	0.26098959869367355	0.43083688779141793	0.3430493843392958	0.46464335575248494	IGFBP5	16
BP	GO:0097755	positive regulation of blood vessel diameter	1	1/103	32/10965	0.26098959869367355	0.43083688779141793	0.3430493843392958	0.46464335575248494	GJA1	16
BP	GO:1901030	positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	1	1/103	32/10965	0.26098959869367355	0.43083688779141793	0.3430493843392958	0.46464335575248494	TFDP2	16
BP	GO:0060560	developmental growth involved in morphogenesis	3	3/103	189/10965	0.2619533239550178	0.43210604107758516	0.3440599344240013	0.46336589777039827	SPRY1/SFRP2/SYT1	16
BP	GO:0002763	positive regulation of myeloid leukocyte differentiation	1	1/103	33/10965	0.2679518296764367	0.43808938524532465	0.34882410989550094	0.45739350529707146	CA2	16
BP	GO:0007223	Wnt signaling pathway, calcium modulating pathway	1	1/103	33/10965	0.2679518296764367	0.43808938524532465	0.34882410989550094	0.45739350529707146	FZD3	16
BP	GO:0016266	O-glycan processing	1	1/103	33/10965	0.2679518296764367	0.43808938524532465	0.34882410989550094	0.45739350529707146	GCNT1	16
BP	GO:0030593	neutrophil chemotaxis	1	1/103	33/10965	0.2679518296764367	0.43808938524532465	0.34882410989550094	0.45739350529707146	CXADR	16
BP	GO:0045912	negative regulation of carbohydrate metabolic process	1	1/103	33/10965	0.2679518296764367	0.43808938524532465	0.34882410989550094	0.45739350529707146	DDIT4	16
BP	GO:0050886	endocrine process	1	1/103	33/10965	0.2679518296764367	0.43808938524532465	0.34882410989550094	0.45739350529707146	GJA1	16
BP	GO:0060393	regulation of pathway-restricted SMAD protein phosphorylation	1	1/103	33/10965	0.2679518296764367	0.43808938524532465	0.34882410989550094	0.45739350529707146	TGFBR1	16
BP	GO:0071470	cellular response to osmotic stress	1	1/103	33/10965	0.2679518296764367	0.43808938524532465	0.34882410989550094	0.45739350529707146	MAPK10	16
BP	GO:0098815	modulation of excitatory postsynaptic potential	1	1/103	33/10965	0.2679518296764367	0.43808938524532465	0.34882410989550094	0.45739350529707146	NLGN1	16
BP	GO:0120163	negative regulation of cold-induced thermogenesis	1	1/103	33/10965	0.2679518296764367	0.43808938524532465	0.34882410989550094	0.45739350529707146	MAP2K6	16
BP	GO:1903539	protein localization to postsynaptic membrane	1	1/103	33/10965	0.2679518296764367	0.43808938524532465	0.34882410989550094	0.45739350529707146	MAPK10	16
BP	GO:1905207	regulation of cardiocyte differentiation	1	1/103	33/10965	0.2679518296764367	0.43808938524532465	0.34882410989550094	0.45739350529707146	DLL1	16
BP	GO:0000187	activation of MAPK activity	2	2/103	108/10965	0.2696044208379451	0.4401421215005334	0.3504585797575645	0.4553633033626878	MAPK10/MAP2K6	16
BP	GO:1903034	regulation of response to wounding	2	2/103	108/10965	0.2696044208379451	0.4401421215005334	0.3504585797575645	0.4553633033626878	EPHA4/GJA1	16
BP	GO:0051648	vesicle localization	3	3/103	193/10965	0.2721303402959643	0.4439388995115179	0.35348172470185674	0.4516330346713431	NLGN1/CDH2/LMAN1	16
BP	GO:0031333	negative regulation of protein-containing complex assembly	2	2/103	109/10965	0.2730932682993593	0.4447344716380501	0.3541151907209885	0.4508554426155231	CLU/TMSB15A	16
BP	GO:0030155	regulation of cell adhesion	6	6/103	466/10965	0.2734110065957706	0.4447344716380501	0.3541151907209885	0.4508554426155231	SOX2/SFRP2/MYO10/SOX4/DLL1/TPM1	16
BP	GO:0033673	negative regulation of kinase activity	3	3/103	194/10965	0.2746818903615626	0.4447344716380501	0.3541151907209885	0.4508554426155231	SPRY1/SFRP2/CDKN1C	16
BP	GO:0006940	regulation of smooth muscle contraction	1	1/103	34/10965	0.27484910021644104	0.4447344716380501	0.3541151907209885	0.4508554426155231	TNNI3	16
BP	GO:0021762	substantia nigra development	1	1/103	34/10965	0.27484910021644104	0.4447344716380501	0.3541151907209885	0.4508554426155231	CKB	16
BP	GO:0042310	vasoconstriction	1	1/103	34/10965	0.27484910021644104	0.4447344716380501	0.3541151907209885	0.4508554426155231	GJA1	16
BP	GO:0048538	thymus development	1	1/103	34/10965	0.27484910021644104	0.4447344716380501	0.3541151907209885	0.4508554426155231	TGFBR1	16
BP	GO:0061098	positive regulation of protein tyrosine kinase activity	1	1/103	34/10965	0.27484910021644104	0.4447344716380501	0.3541151907209885	0.4508554426155231	EPHA4	16
BP	GO:0090317	negative regulation of intracellular protein transport	1	1/103	34/10965	0.27484910021644104	0.4447344716380501	0.3541151907209885	0.4508554426155231	LMAN1	16
BP	GO:1901016	regulation of potassium ion transmembrane transporter activity	1	1/103	34/10965	0.27484910021644104	0.4447344716380501	0.3541151907209885	0.4508554426155231	AKAP9	16
BP	GO:1904591	positive regulation of protein import	1	1/103	34/10965	0.27484910021644104	0.4447344716380501	0.3541151907209885	0.4508554426155231	ZIC1	16
BP	GO:0019953	sexual reproduction	6	6/103	467/10965	0.2750252415948429	0.4447344716380501	0.3541151907209885	0.4508554426155231	CCNI/GJA1/DMRTA1/TGFBR1/PLEKHA1/CXADR	16
BP	GO:0002790	peptide secretion	4	4/103	283/10965	0.2753639768824328	0.4449576798457387	0.3542929179314407	0.4506375288241362	VSNL1/SOX4/GJA1/NNAT	16
BP	GO:0001659	temperature homeostasis	2	2/103	110/10965	0.2765816604794634	0.44589547469648605	0.3550396273133477	0.449723170992648	GJA1/MAP2K6	16
BP	GO:0051147	regulation of muscle cell differentiation	2	2/103	110/10965	0.2765816604794634	0.44589547469648605	0.3550396273133477	0.449723170992648	DLL1/CDH2	16
BP	GO:1901699	cellular response to nitrogen compound	6	6/103	468/10965	0.27664186995102547	0.44589547469648605	0.3550396273133477	0.449723170992648	IGFBP5/EPHA4/GJA1/AKAP9/COL1A2/CA2	16
BP	GO:0006605	protein targeting	5	5/103	375/10965	0.2767488377006607	0.44589547469648605	0.3550396273133477	0.449723170992648	NLGN1/CLU/IMMP1L/SRP14/LMAN1	16
BP	GO:0031400	negative regulation of protein modification process	6	6/103	469/10965	0.27826085633533043	0.4470214870101372	0.35593620288963285	0.44862783690321495	SPRY1/SFRP2/SOX4/DDIT4/CDKN1C/PAX6	16
BP	GO:0045860	positive regulation of protein kinase activity	5	5/103	376/10965	0.27856185569394637	0.4470214870101372	0.35593620288963285	0.44862783690321495	EPHA4/MAPK10/CLU/TGFBR1/MAP2K6	16
BP	GO:0000075	cell cycle checkpoint	3	3/103	196/10965	0.2797927828661662	0.4470214870101372	0.35593620288963285	0.44862783690321495	SOX11/TFDP2/SOX4	16
BP	GO:0019722	calcium-mediated signaling	2	2/103	111/10965	0.2800693008477305	0.4470214870101372	0.35593620288963285	0.44862783690321495	NCALD/TNNI3	16
BP	GO:0006636	unsaturated fatty acid biosynthetic process	1	1/103	35/10965	0.2816820105336769	0.4470214870101372	0.35593620288963285	0.44862783690321495	SCD5	16
BP	GO:0007632	visual behavior	1	1/103	35/10965	0.2816820105336769	0.4470214870101372	0.35593620288963285	0.44862783690321495	NPTN	16
BP	GO:0009409	response to cold	1	1/103	35/10965	0.2816820105336769	0.4470214870101372	0.35593620288963285	0.44862783690321495	CIRBP	16
BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	1	1/103	35/10965	0.2816820105336769	0.4470214870101372	0.35593620288963285	0.44862783690321495	TGFBR1	16
BP	GO:0032007	negative regulation of TOR signaling	1	1/103	35/10965	0.2816820105336769	0.4470214870101372	0.35593620288963285	0.44862783690321495	DDIT4	16
BP	GO:0032651	regulation of interleukin-1 beta production	1	1/103	35/10965	0.2816820105336769	0.4470214870101372	0.35593620288963285	0.44862783690321495	NLRP1	16
BP	GO:0034113	heterotypic cell-cell adhesion	1	1/103	35/10965	0.2816820105336769	0.4470214870101372	0.35593620288963285	0.44862783690321495	CXADR	16
BP	GO:0043900	regulation of multi-organism process	1	1/103	35/10965	0.2816820105336769	0.4470214870101372	0.35593620288963285	0.44862783690321495	GJA1	16
BP	GO:0045428	regulation of nitric oxide biosynthetic process	1	1/103	35/10965	0.2816820105336769	0.4470214870101372	0.35593620288963285	0.44862783690321495	CLU	16
BP	GO:0046530	photoreceptor cell differentiation	1	1/103	35/10965	0.2816820105336769	0.4470214870101372	0.35593620288963285	0.44862783690321495	PAX6	16
BP	GO:0048260	positive regulation of receptor-mediated endocytosis	1	1/103	35/10965	0.2816820105336769	0.4470214870101372	0.35593620288963285	0.44862783690321495	CLU	16
BP	GO:0048747	muscle fiber development	1	1/103	35/10965	0.2816820105336769	0.4470214870101372	0.35593620288963285	0.44862783690321495	CXADR	16
BP	GO:0050775	positive regulation of dendrite morphogenesis	1	1/103	35/10965	0.2816820105336769	0.4470214870101372	0.35593620288963285	0.44862783690321495	EPHA4	16
BP	GO:0051898	negative regulation of protein kinase B signaling	1	1/103	35/10965	0.2816820105336769	0.4470214870101372	0.35593620288963285	0.44862783690321495	PLEKHA1	16
BP	GO:0099637	neurotransmitter receptor transport	1	1/103	35/10965	0.2816820105336769	0.4470214870101372	0.35593620288963285	0.44862783690321495	MAPK10	16
BP	GO:0140115	export across plasma membrane	1	1/103	35/10965	0.2816820105336769	0.4470214870101372	0.35593620288963285	0.44862783690321495	GJA1	16
BP	GO:1901985	positive regulation of protein acetylation	1	1/103	35/10965	0.2816820105336769	0.4470214870101372	0.35593620288963285	0.44862783690321495	SOX4	16
BP	GO:0071407	cellular response to organic cyclic compound	5	5/103	378/10965	0.2821954471213626	0.44744393188338466	0.3562725702198021	0.44821761312681085	IGFBP5/AKAP9/CLU/DDIT4/SERPINF1	16
BP	GO:0051604	protein maturation	3	3/103	197/10965	0.2823518541744949	0.44744393188338466	0.3562725702198021	0.44821761312681085	SOX4/IMMP1L/NNAT	16
BP	GO:0007269	neurotransmitter secretion	2	2/103	112/10965	0.2835558983766494	0.44871051156390557	0.35728107109781815	0.44698999229330805	NLGN1/SYT1	16
BP	GO:0099643	signal release from synapse	2	2/103	112/10965	0.2835558983766494	0.44871051156390557	0.35728107109781815	0.44698999229330805	NLGN1/SYT1	16
BP	GO:0051346	negative regulation of hydrolase activity	4	4/103	289/10965	0.2879651723165413	0.45226040412000035	0.3601076360701947	0.4435676693313315	SPRY1/SFRP2/SERPINF1/TNNI3	16
BP	GO:0021695	cerebellar cortex development	1	1/103	36/10965	0.28845115535664434	0.45226040412000035	0.3601076360701947	0.4435676693313315	DLL1	16
BP	GO:0042398	cellular modified amino acid biosynthetic process	1	1/103	36/10965	0.28845115535664434	0.45226040412000035	0.3601076360701947	0.4435676693313315	CKB	16
BP	GO:0048168	regulation of neuronal synaptic plasticity	1	1/103	36/10965	0.28845115535664434	0.45226040412000035	0.3601076360701947	0.4435676693313315	NPTN	16
BP	GO:0050918	positive chemotaxis	1	1/103	36/10965	0.28845115535664434	0.45226040412000035	0.3601076360701947	0.4435676693313315	FGF8	16
BP	GO:0051445	regulation of meiotic cell cycle	1	1/103	36/10965	0.28845115535664434	0.45226040412000035	0.3601076360701947	0.4435676693313315	LFNG	16
BP	GO:0055081	anion homeostasis	1	1/103	36/10965	0.28845115535664434	0.45226040412000035	0.3601076360701947	0.4435676693313315	CKB	16
BP	GO:0060042	retina morphogenesis in camera-type eye	1	1/103	36/10965	0.28845115535664434	0.45226040412000035	0.3601076360701947	0.4435676693313315	DLL1	16
BP	GO:0060389	pathway-restricted SMAD protein phosphorylation	1	1/103	36/10965	0.28845115535664434	0.45226040412000035	0.3601076360701947	0.4435676693313315	TGFBR1	16
BP	GO:0062237	protein localization to postsynapse	1	1/103	36/10965	0.28845115535664434	0.45226040412000035	0.3601076360701947	0.4435676693313315	MAPK10	16
BP	GO:0072348	sulfur compound transport	1	1/103	36/10965	0.28845115535664434	0.45226040412000035	0.3601076360701947	0.4435676693313315	GJA1	16
BP	GO:0099054	presynapse assembly	1	1/103	36/10965	0.28845115535664434	0.45226040412000035	0.3601076360701947	0.4435676693313315	NLGN1	16
BP	GO:1903214	regulation of protein targeting to mitochondrion	1	1/103	36/10965	0.28845115535664434	0.45226040412000035	0.3601076360701947	0.4435676693313315	LMAN1	16
BP	GO:0001890	placenta development	2	2/103	114/10965	0.29052482786952905	0.454547313610971	0.3619285639321028	0.4413771403829192	GJA1/RSPO3	16
BP	GO:0006575	cellular modified amino acid metabolic process	2	2/103	114/10965	0.29052482786952905	0.454547313610971	0.3619285639321028	0.4413771403829192	CKB/SLC6A8	16
BP	GO:0042770	signal transduction in response to DNA damage	2	2/103	114/10965	0.29052482786952905	0.454547313610971	0.3619285639321028	0.4413771403829192	TFDP2/SOX4	16
BP	GO:0050776	regulation of immune response	6	6/103	478/10965	0.2929320153256226	0.4563527976507356	0.3633661617929794	0.4396555184997253	MAPK10/MYO10/COL1A2/CLU/PLEKHA1/CXADR	16
BP	GO:0006090	pyruvate metabolic process	2	2/103	115/10965	0.29400660461880335	0.4563527976507356	0.3633661617929794	0.4396555184997253	DDIT4/ME3	16
BP	GO:0045727	positive regulation of translation	2	2/103	115/10965	0.29400660461880335	0.4563527976507356	0.3633661617929794	0.4396555184997253	SOX4/CIRBP	16
BP	GO:1902904	negative regulation of supramolecular fiber organization	2	2/103	115/10965	0.29400660461880335	0.4563527976507356	0.3633661617929794	0.4396555184997253	CLU/TMSB15A	16
BP	GO:0007218	neuropeptide signaling pathway	1	1/103	37/10965	0.2951571239720955	0.4563527976507356	0.3633661617929794	0.4396555184997253	GALP	16
BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	1	1/103	37/10965	0.2951571239720955	0.4563527976507356	0.3633661617929794	0.4396555184997253	DDIT4	16
BP	GO:0032945	negative regulation of mononuclear cell proliferation	1	1/103	37/10965	0.2951571239720955	0.4563527976507356	0.3633661617929794	0.4396555184997253	SOX11	16
BP	GO:0034121	regulation of toll-like receptor signaling pathway	1	1/103	37/10965	0.2951571239720955	0.4563527976507356	0.3633661617929794	0.4396555184997253	WDFY1	16
BP	GO:0042769	DNA damage response, detection of DNA damage	1	1/103	37/10965	0.2951571239720955	0.4563527976507356	0.3633661617929794	0.4396555184997253	SOX4	16
BP	GO:0048489	synaptic vesicle transport	1	1/103	37/10965	0.2951571239720955	0.4563527976507356	0.3633661617929794	0.4396555184997253	NLGN1	16
BP	GO:0050672	negative regulation of lymphocyte proliferation	1	1/103	37/10965	0.2951571239720955	0.4563527976507356	0.3633661617929794	0.4396555184997253	SOX11	16
BP	GO:0051148	negative regulation of muscle cell differentiation	1	1/103	37/10965	0.2951571239720955	0.4563527976507356	0.3633661617929794	0.4396555184997253	DLL1	16
BP	GO:0060688	regulation of morphogenesis of a branching structure	1	1/103	37/10965	0.2951571239720955	0.4563527976507356	0.3633661617929794	0.4396555184997253	SULF1	16
BP	GO:0070317	negative regulation of G0 to G1 transition	1	1/103	37/10965	0.2951571239720955	0.4563527976507356	0.3633661617929794	0.4396555184997253	TFDP2	16
BP	GO:0097756	negative regulation of blood vessel diameter	1	1/103	37/10965	0.2951571239720955	0.4563527976507356	0.3633661617929794	0.4396555184997253	GJA1	16
BP	GO:0099172	presynapse organization	1	1/103	37/10965	0.2951571239720955	0.4563527976507356	0.3633661617929794	0.4396555184997253	NLGN1	16
BP	GO:0022412	cellular process involved in reproduction in multicellular organism	3	3/103	202/10965	0.29517812892699813	0.4563527976507356	0.3633661617929794	0.4396555184997253	DMRTA1/TGFBR1/CXADR	16
BP	GO:0001817	regulation of cytokine production	5	5/103	386/10965	0.2968232532797187	0.45857641290671525	0.36513669227954393	0.4375445229696169	DLL1/SULF1/CLU/NPTN/NLRP1	16
BP	GO:0046649	lymphocyte activation	5	5/103	388/10965	0.3005015838798336	0.4611245410807722	0.3671656127970254	0.4351379997796577	SOX11/SOX4/DLL1/LFNG/CXADR	16
BP	GO:0007030	Golgi organization	2	2/103	117/10965	0.3009634332453497	0.4611245410807722	0.3671656127970254	0.4351379997796577	AKAP9/LMAN1	16
BP	GO:0034764	positive regulation of transmembrane transport	2	2/103	117/10965	0.3009634332453497	0.4611245410807722	0.3671656127970254	0.4351379997796577	AKAP9/CA2	16
BP	GO:0007566	embryo implantation	1	1/103	38/10965	0.3018005002743349	0.4611245410807722	0.3671656127970254	0.4351379997796577	GJA1	16
BP	GO:0032611	interleukin-1 beta production	1	1/103	38/10965	0.3018005002743349	0.4611245410807722	0.3671656127970254	0.4351379997796577	NLRP1	16
BP	GO:0032873	negative regulation of stress-activated MAPK cascade	1	1/103	38/10965	0.3018005002743349	0.4611245410807722	0.3671656127970254	0.4351379997796577	SFRP2	16
BP	GO:0042059	negative regulation of epidermal growth factor receptor signaling pathway	1	1/103	38/10965	0.3018005002743349	0.4611245410807722	0.3671656127970254	0.4351379997796577	SPRY1	16
BP	GO:0043489	RNA stabilization	1	1/103	38/10965	0.3018005002743349	0.4611245410807722	0.3671656127970254	0.4351379997796577	CIRBP	16
BP	GO:0045453	bone resorption	1	1/103	38/10965	0.3018005002743349	0.4611245410807722	0.3671656127970254	0.4351379997796577	CA2	16
BP	GO:0045670	regulation of osteoclast differentiation	1	1/103	38/10965	0.3018005002743349	0.4611245410807722	0.3671656127970254	0.4351379997796577	CA2	16
BP	GO:0060999	positive regulation of dendritic spine development	1	1/103	38/10965	0.3018005002743349	0.4611245410807722	0.3671656127970254	0.4351379997796577	NLGN1	16
BP	GO:0061383	trabecula morphogenesis	1	1/103	38/10965	0.3018005002743349	0.4611245410807722	0.3671656127970254	0.4351379997796577	TGFBR1	16
BP	GO:0061462	protein localization to lysosome	1	1/103	38/10965	0.3018005002743349	0.4611245410807722	0.3671656127970254	0.4351379997796577	CLU	16
BP	GO:0070303	negative regulation of stress-activated protein kinase signaling cascade	1	1/103	38/10965	0.3018005002743349	0.4611245410807722	0.3671656127970254	0.4351379997796577	SFRP2	16
BP	GO:0097178	ruffle assembly	1	1/103	38/10965	0.3018005002743349	0.4611245410807722	0.3671656127970254	0.4351379997796577	NLGN1	16
BP	GO:1902373	negative regulation of mRNA catabolic process	1	1/103	38/10965	0.3018005002743349	0.4611245410807722	0.3671656127970254	0.4351379997796577	CIRBP	16
BP	GO:0030098	lymphocyte differentiation	3	3/103	205/10965	0.30289392961838324	0.46247647518178764	0.36824207624331495	0.43386658944345224	SOX4/DLL1/LFNG	16
BP	GO:1902532	negative regulation of intracellular signal transduction	5	5/103	390/10965	0.30418767832355387	0.4641321974145347	0.36956042782526155	0.4323145387972283	SPRY1/SFRP2/CLU/DDIT4/PLEKHA1	16
BP	GO:0017148	negative regulation of translation	2	2/103	119/10965	0.3079095564469946	0.4669963045483642	0.3718409432982489	0.4296427918919593	IGFBP5/CIRBP	16
BP	GO:2001236	regulation of extrinsic apoptotic signaling pathway	2	2/103	119/10965	0.3079095564469946	0.4669963045483642	0.3718409432982489	0.4296427918919593	SFRP2/TGFBR1	16
BP	GO:0000186	activation of MAPKK activity	1	1/103	39/10965	0.3083818628140754	0.4669963045483642	0.3718409432982489	0.4296427918919593	TGFBR1	16
BP	GO:0006623	protein targeting to vacuole	1	1/103	39/10965	0.3083818628140754	0.4669963045483642	0.3718409432982489	0.4296427918919593	CLU	16
BP	GO:0015837	amine transport	1	1/103	39/10965	0.3083818628140754	0.4669963045483642	0.3718409432982489	0.4296427918919593	SYT1	16
BP	GO:0045123	cellular extravasation	1	1/103	39/10965	0.3083818628140754	0.4669963045483642	0.3718409432982489	0.4296427918919593	GCNT1	16
BP	GO:0045604	regulation of epidermal cell differentiation	1	1/103	39/10965	0.3083818628140754	0.4669963045483642	0.3718409432982489	0.4296427918919593	DLL1	16
BP	GO:0051952	regulation of amine transport	1	1/103	39/10965	0.3083818628140754	0.4669963045483642	0.3718409432982489	0.4296427918919593	SYT1	16
BP	GO:0060711	labyrinthine layer development	1	1/103	39/10965	0.3083818628140754	0.4669963045483642	0.3718409432982489	0.4296427918919593	RSPO3	16
BP	GO:0072595	maintenance of protein localization in organelle	1	1/103	39/10965	0.3083818628140754	0.4669963045483642	0.3718409432982489	0.4296427918919593	GJA1	16
BP	GO:0090102	cochlea development	1	1/103	39/10965	0.3083818628140754	0.4669963045483642	0.3718409432982489	0.4296427918919593	EPHA4	16
BP	GO:0007186	G protein-coupled receptor signaling pathway	5	5/103	393/10965	0.3097305216901508	0.4687184754860507	0.3732122039693788	0.4280441633448807	FZD3/CA2/FGF8/GALP/GNG8	16
BP	GO:0007568	aging	3	3/103	208/10965	0.31062055149804796	0.4697447221495037	0.3740293421858451	0.42709432654405594	IGFBP5/FOXG1/SERPINF1	16
BP	GO:0007565	female pregnancy	2	2/103	120/10965	0.3113779701414089	0.4705691614202478	0.37468579336787766	0.4263327733564404	IGFBP5/GJA1	16
BP	GO:0072594	establishment of protein localization to organelle	6	6/103	490/10965	0.31274175179915836	0.4717143628415386	0.3755976480712486	0.4252771358757791	ZIC1/TFDP2/CLU/IMMP1L/SRP14/LMAN1	16
BP	GO:0051403	stress-activated MAPK cascade	3	3/103	209/10965	0.3131979165588576	0.4717143628415386	0.3755976480712486	0.4252771358757791	EPHA4/MAPK10/SFRP2	16
BP	GO:0001667	ameboidal-type cell migration	4	4/103	301/10965	0.3134060831180908	0.4717143628415386	0.3755976480712486	0.4252771358757791	GJA1/TGFBR1/FGF8/SERPINF1	16
BP	GO:0003179	heart valve morphogenesis	1	1/103	40/10965	0.3149017848468548	0.4717143628415386	0.3755976480712486	0.4252771358757791	SOX4	16
BP	GO:0032370	positive regulation of lipid transport	1	1/103	40/10965	0.3149017848468548	0.4717143628415386	0.3755976480712486	0.4252771358757791	MAP2K6	16
BP	GO:0033627	cell adhesion mediated by integrin	1	1/103	40/10965	0.3149017848468548	0.4717143628415386	0.3755976480712486	0.4252771358757791	SFRP2	16
BP	GO:0034260	negative regulation of GTPase activity	1	1/103	40/10965	0.3149017848468548	0.4717143628415386	0.3755976480712486	0.4252771358757791	SPRY1	16
BP	GO:0042771	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	1	1/103	40/10965	0.3149017848468548	0.4717143628415386	0.3755976480712486	0.4252771358757791	DDIT4	16
BP	GO:0045023	G0 to G1 transition	1	1/103	40/10965	0.3149017848468548	0.4717143628415386	0.3755976480712486	0.4252771358757791	TFDP2	16
BP	GO:0045840	positive regulation of mitotic nuclear division	1	1/103	40/10965	0.3149017848468548	0.4717143628415386	0.3755976480712486	0.4252771358757791	FGF8	16
BP	GO:0070316	regulation of G0 to G1 transition	1	1/103	40/10965	0.3149017848468548	0.4717143628415386	0.3755976480712486	0.4252771358757791	TFDP2	16
BP	GO:0070664	negative regulation of leukocyte proliferation	1	1/103	40/10965	0.3149017848468548	0.4717143628415386	0.3755976480712486	0.4252771358757791	SOX11	16
BP	GO:1900449	regulation of glutamate receptor signaling pathway	1	1/103	40/10965	0.3149017848468548	0.4717143628415386	0.3755976480712486	0.4252771358757791	NLGN1	16
BP	GO:0045861	negative regulation of proteolysis	3	3/103	210/10965	0.31577599006479856	0.47270450369592065	0.3763860374133176	0.4243664957304927	EPHA4/SFRP2/SERPINF1	16
BP	GO:0009913	epidermal cell differentiation	2	2/103	122/10965	0.3183042777013758	0.4756012547003586	0.3786925452282607	0.4217132441215732	DLL1/PAX6	16
BP	GO:0006839	mitochondrial transport	3	3/103	211/10965	0.31835465131950025	0.4756012547003586	0.3786925452282607	0.4217132441215732	TFDP2/IMMP1L/LMAN1	16
BP	GO:0033157	regulation of intracellular protein transport	3	3/103	211/10965	0.31835465131950025	0.4756012547003586	0.3786925452282607	0.4217132441215732	ZIC1/TFDP2/LMAN1	16
BP	GO:0001658	branching involved in ureteric bud morphogenesis	1	1/103	41/10965	0.32136083438102225	0.47560545382024455	0.3786958887337322	0.42170940971927334	FGF8	16
BP	GO:0009880	embryonic pattern specification	1	1/103	41/10965	0.32136083438102225	0.47560545382024455	0.3786958887337322	0.42170940971927334	DLL1	16
BP	GO:0010171	body morphogenesis	1	1/103	41/10965	0.32136083438102225	0.47560545382024455	0.3786958887337322	0.42170940971927334	PLEKHA1	16
BP	GO:0014743	regulation of muscle hypertrophy	1	1/103	41/10965	0.32136083438102225	0.47560545382024455	0.3786958887337322	0.42170940971927334	IGFBP5	16
BP	GO:0032652	regulation of interleukin-1 production	1	1/103	41/10965	0.32136083438102225	0.47560545382024455	0.3786958887337322	0.42170940971927334	NLRP1	16
BP	GO:0033555	multicellular organismal response to stress	1	1/103	41/10965	0.32136083438102225	0.47560545382024455	0.3786958887337322	0.42170940971927334	GJA1	16
BP	GO:0035384	thioester biosynthetic process	1	1/103	41/10965	0.32136083438102225	0.47560545382024455	0.3786958887337322	0.42170940971927334	SCD5	16
BP	GO:0043388	positive regulation of DNA binding	1	1/103	41/10965	0.32136083438102225	0.47560545382024455	0.3786958887337322	0.42170940971927334	PAX6	16
BP	GO:0050732	negative regulation of peptidyl-tyrosine phosphorylation	1	1/103	41/10965	0.32136083438102225	0.47560545382024455	0.3786958887337322	0.42170940971927334	SFRP2	16
BP	GO:0051204	protein insertion into mitochondrial membrane	1	1/103	41/10965	0.32136083438102225	0.47560545382024455	0.3786958887337322	0.42170940971927334	TFDP2	16
BP	GO:0060113	inner ear receptor cell differentiation	1	1/103	41/10965	0.32136083438102225	0.47560545382024455	0.3786958887337322	0.42170940971927334	DLL1	16
BP	GO:0071616	acyl-CoA biosynthetic process	1	1/103	41/10965	0.32136083438102225	0.47560545382024455	0.3786958887337322	0.42170940971927334	SCD5	16
BP	GO:0072583	clathrin-dependent endocytosis	1	1/103	41/10965	0.32136083438102225	0.47560545382024455	0.3786958887337322	0.42170940971927334	DLL1	16
BP	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	1	1/103	41/10965	0.32136083438102225	0.47560545382024455	0.3786958887337322	0.42170940971927334	TFDP2	16
BP	GO:0002221	pattern recognition receptor signaling pathway	2	2/103	123/10965	0.32176169628477536	0.4758810411363222	0.37891532226366226	0.42145783272971804	WDFY1/MAP2K6	16
BP	GO:0098771	inorganic ion homeostasis	5	5/103	400/10965	0.32272097224171203	0.4769815969732504	0.37979162838550956	0.4204546124953895	GJA1/CA2/CKB/NPTN/TNNI3	16
BP	GO:0008360	regulation of cell shape	2	2/103	124/10965	0.3252149823516557	0.47970832726122464	0.3819627589758915	0.41797897834404896	MYO10/TPM1	16
BP	GO:0051100	negative regulation of binding	2	2/103	124/10965	0.3252149823516557	0.47970832726122464	0.3819627589758915	0.41797897834404896	SOX11/CRMP1	16
BP	GO:1903708	positive regulation of hemopoiesis	2	2/103	124/10965	0.3252149823516557	0.47970832726122464	0.3819627589758915	0.41797897834404896	SOX4/CA2	16
BP	GO:0035329	hippo signaling	1	1/103	42/10965	0.32775957422528734	0.48153941421965674	0.383420742894079	0.41632439568134116	SOX11	16
BP	GO:0046580	negative regulation of Ras protein signal transduction	1	1/103	42/10965	0.32775957422528734	0.48153941421965674	0.383420742894079	0.41632439568134116	SPRY1	16
BP	GO:0048857	neural nucleus development	1	1/103	42/10965	0.32775957422528734	0.48153941421965674	0.383420742894079	0.41632439568134116	CKB	16
BP	GO:0061178	regulation of insulin secretion involved in cellular response to glucose stimulus	1	1/103	42/10965	0.32775957422528734	0.48153941421965674	0.383420742894079	0.41632439568134116	VSNL1	16
BP	GO:1901185	negative regulation of ERBB signaling pathway	1	1/103	42/10965	0.32775957422528734	0.48153941421965674	0.383420742894079	0.41632439568134116	SPRY1	16
BP	GO:1903317	regulation of protein maturation	1	1/103	42/10965	0.32775957422528734	0.48153941421965674	0.383420742894079	0.41632439568134116	SOX4	16
BP	GO:0044772	mitotic cell cycle phase transition	6	6/103	500/10965	0.32942664761977997	0.4836681309755313	0.3851157114383904	0.4144087632474117	TFDP2/CCNG2/CCNI/SOX4/AKAP9/TUBA1A	16
BP	GO:0002521	leukocyte differentiation	4	4/103	310/10965	0.3326327709772277	0.48762114024587483	0.3882632538956542	0.4108737101119624	SOX4/DLL1/LFNG/CA2	16
BP	GO:0060249	anatomical structure homeostasis	4	4/103	310/10965	0.3326327709772277	0.48762114024587483	0.3882632538956542	0.4108737101119624	GJA1/CA2/NELL2/CXADR	16
BP	GO:0007585	respiratory gaseous exchange by respiratory system	1	1/103	43/10965	0.334098562035852	0.48762114024587483	0.3882632538956542	0.4108737101119624	NLGN1	16
BP	GO:0010660	regulation of muscle cell apoptotic process	1	1/103	43/10965	0.334098562035852	0.48762114024587483	0.3882632538956542	0.4108737101119624	SFRP2	16
BP	GO:0031646	positive regulation of nervous system process	1	1/103	43/10965	0.334098562035852	0.48762114024587483	0.3882632538956542	0.4108737101119624	NLGN1	16
BP	GO:0032835	glomerulus development	1	1/103	43/10965	0.334098562035852	0.48762114024587483	0.3882632538956542	0.4108737101119624	SULF1	16
BP	GO:0042733	embryonic digit morphogenesis	1	1/103	43/10965	0.334098562035852	0.48762114024587483	0.3882632538956542	0.4108737101119624	SFRP2	16
BP	GO:0061045	negative regulation of wound healing	1	1/103	43/10965	0.334098562035852	0.48762114024587483	0.3882632538956542	0.4108737101119624	GJA1	16
BP	GO:1990266	neutrophil migration	1	1/103	43/10965	0.334098562035852	0.48762114024587483	0.3882632538956542	0.4108737101119624	CXADR	16
BP	GO:0009100	glycoprotein metabolic process	4	4/103	311/10965	0.3347741725294242	0.48828575032745625	0.3887924427505848	0.41028218537029293	COL11A1/SULF1/GCNT1/LMAN1	16
BP	GO:0015850	organic hydroxy compound transport	2	2/103	127/10965	0.3355478076641003	0.4884500916554894	0.3889232978212643	0.4101360403646135	CLU/SYT1	16
BP	GO:0050773	regulation of dendrite development	2	2/103	127/10965	0.3355478076641003	0.4884500916554894	0.3889232978212643	0.4101360403646135	EPHA4/NLGN1	16
BP	GO:1903364	positive regulation of cellular protein catabolic process	2	2/103	127/10965	0.3355478076641003	0.4884500916554894	0.3889232978212643	0.4101360403646135	LRP2/CLU	16
BP	GO:0090132	epithelium migration	3	3/103	218/10965	0.3364118187937779	0.48938648442638166	0.38966889081169054	0.409304264692585	TGFBR1/FGF8/SERPINF1	16
BP	GO:0010951	negative regulation of endopeptidase activity	2	2/103	128/10965	0.33898234824992335	0.49096864200065937	0.3909286673005749	0.40790248102861115	SFRP2/SERPINF1	16
BP	GO:0050679	positive regulation of epithelial cell proliferation	2	2/103	128/10965	0.33898234824992335	0.49096864200065937	0.3909286673005749	0.40790248102861115	SOX11/TGFBR1	16
BP	GO:2000045	regulation of G1/S transition of mitotic cell cycle	2	2/103	128/10965	0.33898234824992335	0.49096864200065937	0.3909286673005749	0.40790248102861115	TFDP2/SOX4	16
BP	GO:0051235	maintenance of location	3	3/103	219/10965	0.33899096288234765	0.49096864200065937	0.3909286673005749	0.40790248102861115	GJA1/AKAP9/TMSB15A	16
BP	GO:0051348	negative regulation of transferase activity	3	3/103	219/10965	0.33899096288234765	0.49096864200065937	0.3909286673005749	0.40790248102861115	SPRY1/SFRP2/CDKN1C	16
BP	GO:0002011	morphogenesis of an epithelial sheet	1	1/103	44/10965	0.34037835036310937	0.49096864200065937	0.3909286673005749	0.40790248102861115	SOX11	16
BP	GO:0017156	calcium-ion regulated exocytosis	1	1/103	44/10965	0.34037835036310937	0.49096864200065937	0.3909286673005749	0.40790248102861115	SYT1	16
BP	GO:0032387	negative regulation of intracellular transport	1	1/103	44/10965	0.34037835036310937	0.49096864200065937	0.3909286673005749	0.40790248102861115	LMAN1	16
BP	GO:0035924	cellular response to vascular endothelial growth factor stimulus	1	1/103	44/10965	0.34037835036310937	0.49096864200065937	0.3909286673005749	0.40790248102861115	DLL1	16
BP	GO:0051452	intracellular pH reduction	1	1/103	44/10965	0.34037835036310937	0.49096864200065937	0.3909286673005749	0.40790248102861115	CA2	16
BP	GO:0060135	maternal process involved in female pregnancy	1	1/103	44/10965	0.34037835036310937	0.49096864200065937	0.3909286673005749	0.40790248102861115	GJA1	16
BP	GO:1903573	negative regulation of response to endoplasmic reticulum stress	1	1/103	44/10965	0.34037835036310937	0.49096864200065937	0.3909286673005749	0.40790248102861115	CLU	16
BP	GO:2000243	positive regulation of reproductive process	1	1/103	44/10965	0.34037835036310937	0.49096864200065937	0.3909286673005749	0.40790248102861115	LFNG	16
BP	GO:0031098	stress-activated protein kinase signaling cascade	3	3/103	220/10965	0.341569655708466	0.4923666623573921	0.3920418264479484	0.40666759617722925	EPHA4/MAPK10/SFRP2	16
BP	GO:0034614	cellular response to reactive oxygen species	2	2/103	129/10965	0.34241167076586065	0.4926195159558164	0.39224315849198976	0.4064446226424628	PLEKHA1/TPM1	16
BP	GO:0043409	negative regulation of MAPK cascade	2	2/103	129/10965	0.34241167076586065	0.4926195159558164	0.39224315849198976	0.4064446226424628	SPRY1/SFRP2	16
BP	GO:1901654	response to ketone	2	2/103	129/10965	0.34241167076586065	0.4926195159558164	0.39224315849198976	0.4064446226424628	DDIT4/SERPINF1	16
BP	GO:0006417	regulation of translation	4	4/103	315/10965	0.3433467502252599	0.4936444521721149	0.39305925327855884	0.40554197524244706	IGFBP5/SOX4/ZNF706/CIRBP	16
BP	GO:0032102	negative regulation of response to external stimulus	3	3/103	221/10965	0.3441477870900289	0.4941550238002028	0.39346579061934817	0.4050930208426212	EPHA4/GJA1/SERPINF1	16
BP	GO:0090130	tissue migration	3	3/103	221/10965	0.3441477870900289	0.4941550238002028	0.39346579061934817	0.4050930208426212	TGFBR1/FGF8/SERPINF1	16
BP	GO:0009612	response to mechanical stimulus	2	2/103	130/10965	0.3458355711758857	0.4941550238002028	0.39346579061934817	0.4050930208426212	COL11A1/GJA1	16
BP	GO:0006809	nitric oxide biosynthetic process	1	1/103	45/10965	0.34659948669793206	0.4941550238002028	0.39346579061934817	0.4050930208426212	CLU	16
BP	GO:0030279	negative regulation of ossification	1	1/103	45/10965	0.34659948669793206	0.4941550238002028	0.39346579061934817	0.4050930208426212	IGFBP5	16
BP	GO:0031113	regulation of microtubule polymerization	1	1/103	45/10965	0.34659948669793206	0.4941550238002028	0.39346579061934817	0.4050930208426212	AKAP9	16
BP	GO:0032612	interleukin-1 production	1	1/103	45/10965	0.34659948669793206	0.4941550238002028	0.39346579061934817	0.4050930208426212	NLRP1	16
BP	GO:0042246	tissue regeneration	1	1/103	45/10965	0.34659948669793206	0.4941550238002028	0.39346579061934817	0.4050930208426212	SOX2	16
BP	GO:0042490	mechanoreceptor differentiation	1	1/103	45/10965	0.34659948669793206	0.4941550238002028	0.39346579061934817	0.4050930208426212	DLL1	16
BP	GO:0045844	positive regulation of striated muscle tissue development	1	1/103	45/10965	0.34659948669793206	0.4941550238002028	0.39346579061934817	0.4050930208426212	DLL1	16
BP	GO:0046148	pigment biosynthetic process	1	1/103	45/10965	0.34659948669793206	0.4941550238002028	0.39346579061934817	0.4050930208426212	PMEL	16
BP	GO:0048636	positive regulation of muscle organ development	1	1/103	45/10965	0.34659948669793206	0.4941550238002028	0.39346579061934817	0.4050930208426212	DLL1	16
BP	GO:0090151	establishment of protein localization to mitochondrial membrane	1	1/103	45/10965	0.34659948669793206	0.4941550238002028	0.39346579061934817	0.4050930208426212	TFDP2	16
BP	GO:0044706	multi-multicellular organism process	2	2/103	131/10965	0.349253849659094	0.4956112119571515	0.3946252652717723	0.40381511316173907	IGFBP5/GJA1	16
BP	GO:2001242	regulation of intrinsic apoptotic signaling pathway	2	2/103	131/10965	0.349253849659094	0.4956112119571515	0.3946252652717723	0.40381511316173907	SFRP2/CLU	16
BP	GO:0006874	cellular calcium ion homeostasis	3	3/103	223/10965	0.3493019300567295	0.4956112119571515	0.3946252652717723	0.40381511316173907	GJA1/NPTN/TNNI3	16
BP	GO:1903362	regulation of cellular protein catabolic process	3	3/103	223/10965	0.3493019300567295	0.4956112119571515	0.3946252652717723	0.40381511316173907	LRP2/EPHA4/CLU	16
BP	GO:0034762	regulation of transmembrane transport	4	4/103	319/10965	0.35192723325840874	0.4956112119571515	0.3946252652717723	0.40381511316173907	NLGN1/GJA1/AKAP9/CA2	16
BP	GO:0030833	regulation of actin filament polymerization	2	2/103	132/10965	0.35266631054987596	0.4956112119571515	0.3946252652717723	0.40381511316173907	COTL1/TMSB15A	16
BP	GO:0003170	heart valve development	1	1/103	46/10965	0.3527625135175395	0.4956112119571515	0.3946252652717723	0.40381511316173907	SOX4	16
BP	GO:0014015	positive regulation of gliogenesis	1	1/103	46/10965	0.3527625135175395	0.4956112119571515	0.3946252652717723	0.40381511316173907	LRP2	16
BP	GO:0032418	lysosome localization	1	1/103	46/10965	0.3527625135175395	0.4956112119571515	0.3946252652717723	0.40381511316173907	MAP6	16
BP	GO:0032781	positive regulation of ATPase activity	1	1/103	46/10965	0.3527625135175395	0.4956112119571515	0.3946252652717723	0.40381511316173907	TPM1	16
BP	GO:0035914	skeletal muscle cell differentiation	1	1/103	46/10965	0.3527625135175395	0.4956112119571515	0.3946252652717723	0.40381511316173907	SOX11	16
BP	GO:0042116	macrophage activation	1	1/103	46/10965	0.3527625135175395	0.4956112119571515	0.3946252652717723	0.40381511316173907	CLU	16
BP	GO:0042306	regulation of protein import into nucleus	1	1/103	46/10965	0.3527625135175395	0.4956112119571515	0.3946252652717723	0.40381511316173907	ZIC1	16
BP	GO:0043392	negative regulation of DNA binding	1	1/103	46/10965	0.3527625135175395	0.4956112119571515	0.3946252652717723	0.40381511316173907	SOX11	16
BP	GO:0045851	pH reduction	1	1/103	46/10965	0.3527625135175395	0.4956112119571515	0.3946252652717723	0.40381511316173907	CA2	16
BP	GO:0055013	cardiac muscle cell development	1	1/103	46/10965	0.3527625135175395	0.4956112119571515	0.3946252652717723	0.40381511316173907	CXADR	16
BP	GO:0060395	SMAD protein signal transduction	1	1/103	46/10965	0.3527625135175395	0.4956112119571515	0.3946252652717723	0.40381511316173907	TGFBR1	16
BP	GO:0060675	ureteric bud morphogenesis	1	1/103	46/10965	0.3527625135175395	0.4956112119571515	0.3946252652717723	0.40381511316173907	FGF8	16
BP	GO:0071621	granulocyte chemotaxis	1	1/103	46/10965	0.3527625135175395	0.4956112119571515	0.3946252652717723	0.40381511316173907	CXADR	16
BP	GO:0072171	mesonephric tubule morphogenesis	1	1/103	46/10965	0.3527625135175395	0.4956112119571515	0.3946252652717723	0.40381511316173907	FGF8	16
BP	GO:1901863	positive regulation of muscle tissue development	1	1/103	46/10965	0.3527625135175395	0.4956112119571515	0.3946252652717723	0.40381511316173907	DLL1	16
BP	GO:1902041	regulation of extrinsic apoptotic signaling pathway via death domain receptors	1	1/103	46/10965	0.3527625135175395	0.4956112119571515	0.3946252652717723	0.40381511316173907	SFRP2	16
BP	GO:1903779	regulation of cardiac conduction	1	1/103	46/10965	0.3527625135175395	0.4956112119571515	0.3946252652717723	0.40381511316173907	CXADR	16
BP	GO:0010466	negative regulation of peptidase activity	2	2/103	133/10965	0.3560727622788271	0.4999451006790118	0.3980760790250945	0.40003391902362495	SFRP2/SERPINF1	16
BP	GO:0010657	muscle cell apoptotic process	1	1/103	47/10965	0.358867968330956	0.5019623254193877	0.39968227321335764	0.3982851132268705	SFRP2	16
BP	GO:0034103	regulation of tissue remodeling	1	1/103	47/10965	0.358867968330956	0.5019623254193877	0.39968227321335764	0.3982851132268705	CA2	16
BP	GO:0035773	insulin secretion involved in cellular response to glucose stimulus	1	1/103	47/10965	0.358867968330956	0.5019623254193877	0.39968227321335764	0.3982851132268705	VSNL1	16
BP	GO:0045685	regulation of glial cell differentiation	1	1/103	47/10965	0.358867968330956	0.5019623254193877	0.39968227321335764	0.3982851132268705	EPHA4	16
BP	GO:0050709	negative regulation of protein secretion	1	1/103	47/10965	0.358867968330956	0.5019623254193877	0.39968227321335764	0.3982851132268705	VSNL1	16
BP	GO:1902369	negative regulation of RNA catabolic process	1	1/103	47/10965	0.358867968330956	0.5019623254193877	0.39968227321335764	0.3982851132268705	CIRBP	16
BP	GO:0070972	protein localization to endoplasmic reticulum	2	2/103	134/10965	0.35947301731437553	0.5020342715216906	0.3997395595479311	0.3982228703958225	GJA1/SRP14	16
BP	GO:0009416	response to light stimulus	3	3/103	227/10965	0.3595987474859922	0.5020342715216906	0.3997395595479311	0.3982228703958225	MAPK10/NPTN/CIRBP	16
BP	GO:0048545	response to steroid hormone	3	3/103	227/10965	0.3595987474859922	0.5020342715216906	0.3997395595479311	0.3982228703958225	CA2/DDIT4/SERPINF1	16
BP	GO:0000077	DNA damage checkpoint	2	2/103	135/10965	0.362866892105137	0.5062780993059086	0.4031186632177237	0.3945670948143454	TFDP2/SOX4	16
BP	GO:0010633	negative regulation of epithelial cell migration	1	1/103	48/10965	0.36491638372406	0.5072223339913736	0.40387050025094773	0.3937578676671373	SERPINF1	16
BP	GO:0030837	negative regulation of actin filament polymerization	1	1/103	48/10965	0.36491638372406	0.5072223339913736	0.40387050025094773	0.3937578676671373	TMSB15A	16
BP	GO:0033059	cellular pigmentation	1	1/103	48/10965	0.36491638372406	0.5072223339913736	0.40387050025094773	0.3937578676671373	PMEL	16
BP	GO:0046209	nitric oxide metabolic process	1	1/103	48/10965	0.36491638372406	0.5072223339913736	0.40387050025094773	0.3937578676671373	CLU	16
BP	GO:0051058	negative regulation of small GTPase mediated signal transduction	1	1/103	48/10965	0.36491638372406	0.5072223339913736	0.40387050025094773	0.3937578676671373	SPRY1	16
BP	GO:0072666	establishment of protein localization to vacuole	1	1/103	48/10965	0.36491638372406	0.5072223339913736	0.40387050025094773	0.3937578676671373	CLU	16
BP	GO:0050900	leukocyte migration	3	3/103	230/10965	0.3673080453410872	0.5099072864879087	0.40600836571005056	0.3914650177915708	COL1A2/GCNT1/CXADR	16
BP	GO:0055074	calcium ion homeostasis	3	3/103	230/10965	0.3673080453410872	0.5099072864879087	0.40600836571005056	0.3914650177915708	GJA1/NPTN/TNNI3	16
BP	GO:0001816	cytokine production	5	5/103	425/10965	0.3695476710945937	0.5113828813278481	0.4071832927316674	0.39021004998195963	DLL1/SULF1/CLU/NPTN/NLRP1	16
BP	GO:0046328	regulation of JNK cascade	2	2/103	137/10965	0.3696347863067485	0.5113828813278481	0.4071832927316674	0.39021004998195963	EPHA4/SFRP2	16
BP	GO:0002792	negative regulation of peptide secretion	1	1/103	49/10965	0.3709082874042309	0.5113828813278481	0.4071832927316674	0.39021004998195963	VSNL1	16
BP	GO:0045582	positive regulation of T cell differentiation	1	1/103	49/10965	0.3709082874042309	0.5113828813278481	0.4071832927316674	0.39021004998195963	SOX4	16
BP	GO:0048008	platelet-derived growth factor receptor signaling pathway	1	1/103	49/10965	0.3709082874042309	0.5113828813278481	0.4071832927316674	0.39021004998195963	PLEKHA1	16
BP	GO:0051781	positive regulation of cell division	1	1/103	49/10965	0.3709082874042309	0.5113828813278481	0.4071832927316674	0.39021004998195963	FGF8	16
BP	GO:0097345	mitochondrial outer membrane permeabilization	1	1/103	49/10965	0.3709082874042309	0.5113828813278481	0.4071832927316674	0.39021004998195963	TFDP2	16
BP	GO:1901379	regulation of potassium ion transmembrane transport	1	1/103	49/10965	0.3709082874042309	0.5113828813278481	0.4071832927316674	0.39021004998195963	AKAP9	16
BP	GO:1903670	regulation of sprouting angiogenesis	1	1/103	49/10965	0.3709082874042309	0.5113828813278481	0.4071832927316674	0.39021004998195963	DLL1	16
BP	GO:1904589	regulation of protein import	1	1/103	49/10965	0.3709082874042309	0.5113828813278481	0.4071832927316674	0.39021004998195963	ZIC1	16
BP	GO:2001057	reactive nitrogen species metabolic process	1	1/103	49/10965	0.3709082874042309	0.5113828813278481	0.4071832927316674	0.39021004998195963	CLU	16
BP	GO:0045936	negative regulation of phosphate metabolic process	5	5/103	426/10965	0.3714282051954081	0.5117814362450092	0.40750063793313884	0.3898717070451698	SPRY1/SFRP2/DDIT4/CDKN1C/PAX6	16
BP	GO:0001818	negative regulation of cytokine production	2	2/103	138/10965	0.37300845800679217	0.5128843323070378	0.4083788074348467	0.388936803443385	DLL1/NPTN	16
BP	GO:1902806	regulation of cell cycle G1/S phase transition	2	2/103	138/10965	0.37300845800679217	0.5128843323070378	0.4083788074348467	0.388936803443385	TFDP2/SOX4	16
BP	GO:0010563	negative regulation of phosphorus metabolic process	5	5/103	427/10965	0.3733089118122783	0.5128843323070378	0.4083788074348467	0.388936803443385	SPRY1/SFRP2/DDIT4/CDKN1C/PAX6	16
BP	GO:0032787	monocarboxylic acid metabolic process	5	5/103	427/10965	0.3733089118122783	0.5128843323070378	0.4083788074348467	0.388936803443385	SCD5/DDIT4/ME3/CKB/SLC6A8	16
BP	GO:0009314	response to radiation	4	4/103	329/10965	0.3733853461179788	0.5128843323070378	0.4083788074348467	0.388936803443385	MAPK10/SFRP2/NPTN/CIRBP	16
BP	GO:0051258	protein polymerization	3	3/103	233/10965	0.3750029003170434	0.5144067225007858	0.4095909947695167	0.38764960028637463	AKAP9/COTL1/TMSB15A	16
BP	GO:0090068	positive regulation of cell cycle process	3	3/103	233/10965	0.3750029003170434	0.5144067225007858	0.4095909947695167	0.38764960028637463	TFDP2/SOX4/FGF8	16
BP	GO:0033674	positive regulation of kinase activity	5	5/103	428/10965	0.3751897475344026	0.5144067225007858	0.4095909947695167	0.38764960028637463	EPHA4/MAPK10/CLU/TGFBR1/MAP2K6	16
BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	2	2/103	139/10965	0.3763750539300307	0.515082365213475	0.41012896824205186	0.38707955452777687	GJA1/NPTN	16
BP	GO:0050920	regulation of chemotaxis	2	2/103	139/10965	0.3763750539300307	0.515082365213475	0.41012896824205186	0.38707955452777687	FEZF2/TUBB2B	16
BP	GO:0002753	cytoplasmic pattern recognition receptor signaling pathway	1	1/103	50/10965	0.37684420224459014	0.515082365213475	0.41012896824205186	0.38707955452777687	MAP2K6	16
BP	GO:0006821	chloride transport	1	1/103	50/10965	0.37684420224459014	0.515082365213475	0.41012896824205186	0.38707955452777687	CA2	16
BP	GO:0043627	response to estrogen	1	1/103	50/10965	0.37684420224459014	0.515082365213475	0.41012896824205186	0.38707955452777687	CA2	16
BP	GO:0032147	activation of protein kinase activity	3	3/103	234/10965	0.3775641845241797	0.515748488656874	0.41065936209556664	0.3865182718014873	MAPK10/TGFBR1/MAP2K6	16
BP	GO:0042176	regulation of protein catabolic process	4	4/103	332/10965	0.37981764472672164	0.5185072157383879	0.41285596979952827	0.3842014312273315	LRP2/EPHA4/GJA1/CLU	16
BP	GO:0001819	positive regulation of cytokine production	3	3/103	236/10965	0.3826806770163875	0.518816413733346	0.4131021654824306	0.38394252844484855	SULF1/CLU/NLRP1	16
BP	GO:0071214	cellular response to abiotic stimulus	3	3/103	236/10965	0.3826806770163875	0.518816413733346	0.4131021654824306	0.38394252844484855	MAPK10/SFRP2/GJA1	16
BP	GO:0104004	cellular response to environmental stimulus	3	3/103	236/10965	0.3826806770163875	0.518816413733346	0.4131021654824306	0.38394252844484855	MAPK10/SFRP2/GJA1	16
BP	GO:0001523	retinoid metabolic process	1	1/103	51/10965	0.3827246463278522	0.518816413733346	0.4131021654824306	0.38394252844484855	LRP2	16
BP	GO:0008306	associative learning	1	1/103	51/10965	0.3827246463278522	0.518816413733346	0.4131021654824306	0.38394252844484855	NPTN	16
BP	GO:0015908	fatty acid transport	1	1/103	51/10965	0.3827246463278522	0.518816413733346	0.4131021654824306	0.38394252844484855	MAP2K6	16
BP	GO:0061077	chaperone-mediated protein folding	1	1/103	51/10965	0.3827246463278522	0.518816413733346	0.4131021654824306	0.38394252844484855	CLU	16
BP	GO:0070830	bicellular tight junction assembly	1	1/103	51/10965	0.3827246463278522	0.518816413733346	0.4131021654824306	0.38394252844484855	GJA1	16
BP	GO:1902110	positive regulation of mitochondrial membrane permeability involved in apoptotic process	1	1/103	51/10965	0.3827246463278522	0.518816413733346	0.4131021654824306	0.38394252844484855	TFDP2	16
BP	GO:1903749	positive regulation of establishment of protein localization to mitochondrion	1	1/103	51/10965	0.3827246463278522	0.518816413733346	0.4131021654824306	0.38394252844484855	TFDP2	16
BP	GO:2000756	regulation of peptidyl-lysine acetylation	1	1/103	51/10965	0.3827246463278522	0.518816413733346	0.4131021654824306	0.38394252844484855	SOX4	16
BP	GO:0038093	Fc receptor signaling pathway	2	2/103	141/10965	0.3830863641323804	0.518816413733346	0.4131021654824306	0.38394252844484855	MAPK10/MYO10	16
BP	GO:0042113	B cell activation	2	2/103	141/10965	0.3830863641323804	0.518816413733346	0.4131021654824306	0.38394252844484855	DLL1/LFNG	16
BP	GO:0009895	negative regulation of catabolic process	3	3/103	237/10965	0.3852356973373411	0.5214087551873536	0.41516629036355057	0.3817779164877013	EPHA4/DDIT4/CIRBP	16
BP	GO:0030217	T cell differentiation	2	2/103	142/10965	0.38643076032404755	0.5227071358379582	0.41620011243275923	0.3806978068035838	SOX4/LFNG	16
BP	GO:0042440	pigment metabolic process	1	1/103	52/10965	0.3885501329897757	0.5236569269533937	0.41695637371547195	0.37990938302576116	PMEL	16
BP	GO:0051205	protein insertion into membrane	1	1/103	52/10965	0.3885501329897757	0.5236569269533937	0.41695637371547195	0.37990938302576116	TFDP2	16
BP	GO:0051785	positive regulation of nuclear division	1	1/103	52/10965	0.3885501329897757	0.5236569269533937	0.41695637371547195	0.37990938302576116	FGF8	16
BP	GO:0051899	membrane depolarization	1	1/103	52/10965	0.3885501329897757	0.5236569269533937	0.41695637371547195	0.37990938302576116	MLLT11	16
BP	GO:0071260	cellular response to mechanical stimulus	1	1/103	52/10965	0.3885501329897757	0.5236569269533937	0.41695637371547195	0.37990938302576116	GJA1	16
BP	GO:0072078	nephron tubule morphogenesis	1	1/103	52/10965	0.3885501329897757	0.5236569269533937	0.41695637371547195	0.37990938302576116	FGF8	16
BP	GO:0032680	regulation of tumor necrosis factor production	1	1/103	53/10965	0.3943211708622264	0.5298242641221551	0.4218670516975781	0.3748243921926638	CLU	16
BP	GO:0051881	regulation of mitochondrial membrane potential	1	1/103	53/10965	0.3943211708622264	0.5298242641221551	0.4218670516975781	0.3748243921926638	MLLT11	16
BP	GO:0072088	nephron epithelium morphogenesis	1	1/103	53/10965	0.3943211708622264	0.5298242641221551	0.4218670516975781	0.3748243921926638	FGF8	16
BP	GO:0120192	tight junction assembly	1	1/103	53/10965	0.3943211708622264	0.5298242641221551	0.4218670516975781	0.3748243921926638	GJA1	16
BP	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	1	1/103	53/10965	0.3943211708622264	0.5298242641221551	0.4218670516975781	0.3748243921926638	TFDP2	16
BP	GO:0008064	regulation of actin polymerization or depolymerization	2	2/103	145/10965	0.3964170791619509	0.5316737232317272	0.42333966424974795	0.3733110389727481	COTL1/TMSB15A	16
BP	GO:0030832	regulation of actin filament length	2	2/103	145/10965	0.3964170791619509	0.5316737232317272	0.42333966424974795	0.3733110389727481	COTL1/TMSB15A	16
BP	GO:0031570	DNA integrity checkpoint	2	2/103	145/10965	0.3964170791619509	0.5316737232317272	0.42333966424974795	0.3733110389727481	TFDP2/SOX4	16
BP	GO:0006954	inflammatory response	4	4/103	340/10965	0.39693994359295737	0.531705534233483	0.42336499342855494	0.37328505512468363	GJA1/CLU/SERPINF1/NLRP1	16
BP	GO:0072503	cellular divalent inorganic cation homeostasis	3	3/103	242/10965	0.39797487288319433	0.531705534233483	0.42336499342855494	0.37328505512468363	GJA1/NPTN/TNNI3	16
BP	GO:0018958	phenol-containing compound metabolic process	1	1/103	54/10965	0.4000382639158546	0.531705534233483	0.42336499342855494	0.37328505512468363	PMEL	16
BP	GO:0033866	nucleoside bisphosphate biosynthetic process	1	1/103	54/10965	0.4000382639158546	0.531705534233483	0.42336499342855494	0.37328505512468363	SCD5	16
BP	GO:0034030	ribonucleoside bisphosphate biosynthetic process	1	1/103	54/10965	0.4000382639158546	0.531705534233483	0.42336499342855494	0.37328505512468363	SCD5	16
BP	GO:0034033	purine nucleoside bisphosphate biosynthetic process	1	1/103	54/10965	0.4000382639158546	0.531705534233483	0.42336499342855494	0.37328505512468363	SCD5	16
BP	GO:0043507	positive regulation of JUN kinase activity	1	1/103	54/10965	0.4000382639158546	0.531705534233483	0.42336499342855494	0.37328505512468363	EPHA4	16
BP	GO:0061333	renal tubule morphogenesis	1	1/103	54/10965	0.4000382639158546	0.531705534233483	0.42336499342855494	0.37328505512468363	FGF8	16
BP	GO:0062207	regulation of pattern recognition receptor signaling pathway	1	1/103	54/10965	0.4000382639158546	0.531705534233483	0.42336499342855494	0.37328505512468363	WDFY1	16
BP	GO:0070373	negative regulation of ERK1 and ERK2 cascade	1	1/103	54/10965	0.4000382639158546	0.531705534233483	0.42336499342855494	0.37328505512468363	SPRY1	16
BP	GO:0071806	protein transmembrane transport	1	1/103	54/10965	0.4000382639158546	0.531705534233483	0.42336499342855494	0.37328505512468363	CLU	16
BP	GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels	1	1/103	54/10965	0.4000382639158546	0.531705534233483	0.42336499342855494	0.37328505512468363	MAPK10	16
BP	GO:1902108	regulation of mitochondrial membrane permeability involved in apoptotic process	1	1/103	54/10965	0.4000382639158546	0.531705534233483	0.42336499342855494	0.37328505512468363	TFDP2	16
BP	GO:1903555	regulation of tumor necrosis factor superfamily cytokine production	1	1/103	54/10965	0.4000382639158546	0.531705534233483	0.42336499342855494	0.37328505512468363	CLU	16
BP	GO:1905954	positive regulation of lipid localization	1	1/103	54/10965	0.4000382639158546	0.531705534233483	0.42336499342855494	0.37328505512468363	MAP2K6	16
BP	GO:0043254	regulation of protein-containing complex assembly	4	4/103	342/10965	0.4012110278547163	0.532944786551172	0.42435173517855584	0.372274017649149	AKAP9/CLU/COTL1/TMSB15A	16
BP	GO:0030041	actin filament polymerization	2	2/103	147/10965	0.403034107560966	0.5344058710901086	0.4255151085241375	0.37108501505724845	COTL1/TMSB15A	16
BP	GO:0071383	cellular response to steroid hormone stimulus	2	2/103	147/10965	0.403034107560966	0.5344058710901086	0.4255151085241375	0.37108501505724845	DDIT4/SERPINF1	16
BP	GO:0090316	positive regulation of intracellular protein transport	2	2/103	147/10965	0.403034107560966	0.5344058710901086	0.4255151085241375	0.37108501505724845	ZIC1/TFDP2	16
BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	3	3/103	245/10965	0.4055864382907186	0.5353816296433297	0.4262920461087121	0.3702927704805286	MAPK10/MYO10/PLEKHA1	16
BP	GO:0016101	diterpenoid metabolic process	1	1/103	55/10965	0.4057019115023879	0.5353816296433297	0.4262920461087121	0.3702927704805286	LRP2	16
BP	GO:0021675	nerve development	1	1/103	55/10965	0.4057019115023879	0.5353816296433297	0.4262920461087121	0.3702927704805286	SULF1	16
BP	GO:0030865	cortical cytoskeleton organization	1	1/103	55/10965	0.4057019115023879	0.5353816296433297	0.4262920461087121	0.3702927704805286	NLGN1	16
BP	GO:0035794	positive regulation of mitochondrial membrane permeability	1	1/103	55/10965	0.4057019115023879	0.5353816296433297	0.4262920461087121	0.3702927704805286	TFDP2	16
BP	GO:0043266	regulation of potassium ion transport	1	1/103	55/10965	0.4057019115023879	0.5353816296433297	0.4262920461087121	0.3702927704805286	AKAP9	16
BP	GO:0045682	regulation of epidermis development	1	1/103	55/10965	0.4057019115023879	0.5353816296433297	0.4262920461087121	0.3702927704805286	DLL1	16
BP	GO:0072028	nephron morphogenesis	1	1/103	55/10965	0.4057019115023879	0.5353816296433297	0.4262920461087121	0.3702927704805286	FGF8	16
BP	GO:0001505	regulation of neurotransmitter levels	2	2/103	148/10965	0.406330046347122	0.5358915602329384	0.4266980730292893	0.36987931841239197	NLGN1/SYT1	16
BP	GO:0007093	mitotic cell cycle checkpoint	2	2/103	149/10965	0.40961742244433497	0.5379823320443309	0.4283628283067886	0.36818822262463213	TFDP2/SOX4	16
BP	GO:0002764	immune response-regulating signaling pathway	3	3/103	247/10965	0.41064607229578	0.5379823320443309	0.4283628283067886	0.36818822262463213	MAPK10/MYO10/PLEKHA1	16
BP	GO:0031647	regulation of protein stability	3	3/103	247/10965	0.41064607229578	0.5379823320443309	0.4283628283067886	0.36818822262463213	EPHA4/SOX4/CLU	16
BP	GO:0014897	striated muscle hypertrophy	1	1/103	56/10965	0.41131260839654527	0.5379823320443309	0.4283628283067886	0.36818822262463213	IGFBP5	16
BP	GO:0030301	cholesterol transport	1	1/103	56/10965	0.41131260839654527	0.5379823320443309	0.4283628283067886	0.36818822262463213	CLU	16
BP	GO:0034109	homotypic cell-cell adhesion	1	1/103	56/10965	0.41131260839654527	0.5379823320443309	0.4283628283067886	0.36818822262463213	CXADR	16
BP	GO:0045638	negative regulation of myeloid cell differentiation	1	1/103	56/10965	0.41131260839654527	0.5379823320443309	0.4283628283067886	0.36818822262463213	DLL1	16
BP	GO:0046824	positive regulation of nucleocytoplasmic transport	1	1/103	56/10965	0.41131260839654527	0.5379823320443309	0.4283628283067886	0.36818822262463213	ZIC1	16
BP	GO:0048278	vesicle docking	1	1/103	56/10965	0.41131260839654527	0.5379823320443309	0.4283628283067886	0.36818822262463213	SYT1	16
BP	GO:0071230	cellular response to amino acid stimulus	1	1/103	56/10965	0.41131260839654527	0.5379823320443309	0.4283628283067886	0.36818822262463213	COL1A2	16
BP	GO:0097530	granulocyte migration	1	1/103	56/10965	0.41131260839654527	0.5379823320443309	0.4283628283067886	0.36818822262463213	CXADR	16
BP	GO:1901570	fatty acid derivative biosynthetic process	1	1/103	56/10965	0.41131260839654527	0.5379823320443309	0.4283628283067886	0.36818822262463213	SCD5	16
BP	GO:1903426	regulation of reactive oxygen species biosynthetic process	1	1/103	56/10965	0.41131260839654527	0.5379823320443309	0.4283628283067886	0.36818822262463213	CLU	16
BP	GO:1905710	positive regulation of membrane permeability	1	1/103	56/10965	0.41131260839654527	0.5379823320443309	0.4283628283067886	0.36818822262463213	TFDP2	16
BP	GO:0043542	endothelial cell migration	2	2/103	150/10965	0.41289610554979705	0.5394170100199766	0.4295051757013985	0.367031598386839	TGFBR1/SERPINF1	16
BP	GO:0070661	leukocyte proliferation	2	2/103	150/10965	0.41289610554979705	0.5394170100199766	0.4295051757013985	0.367031598386839	SOX11/CLU	16
BP	GO:1903827	regulation of cellular protein localization	5	5/103	450/10965	0.4165153782326415	0.5438248489645267	0.4330148715492777	0.3634971878940269	ZIC1/TFDP2/NPTN/CDH2/LMAN1	16
BP	GO:0014896	muscle hypertrophy	1	1/103	57/10965	0.4168708448375714	0.5439686068304272	0.4331293372526299	0.3633823991022362	IGFBP5	16
BP	GO:0071396	cellular response to lipid	4	4/103	350/10965	0.4182437514150905	0.5454390569925034	0.4343001678780847	0.36221000276185167	CLU/DDIT4/WNT5B/SERPINF1	16
BP	GO:0043523	regulation of neuron apoptotic process	2	2/103	152/10965	0.41942688727259914	0.5463392532804655	0.43501693979599776	0.3614938310529846	FGF8/TOX3	16
BP	GO:1905475	regulation of protein localization to membrane	2	2/103	152/10965	0.41942688727259914	0.5463392532804655	0.43501693979599776	0.3614938310529846	TFDP2/CDH2	16
BP	GO:0001570	vasculogenesis	1	1/103	58/10965	0.4223771065704033	0.5492141027956505	0.4373060087782475	0.35921455521561085	TNNI3	16
BP	GO:0007215	glutamate receptor signaling pathway	1	1/103	58/10965	0.4223771065704033	0.5492141027956505	0.4373060087782475	0.35921455521561085	NLGN1	16
BP	GO:0032640	tumor necrosis factor production	1	1/103	58/10965	0.4223771065704033	0.5492141027956505	0.4373060087782475	0.35921455521561085	CLU	16
BP	GO:0051259	protein complex oligomerization	2	2/103	153/10965	0.4226787408433905	0.5492841550116042	0.437361787125542	0.35915916452079855	COL1A2/SYT1	16
BP	GO:0022407	regulation of cell-cell adhesion	3	3/103	253/10965	0.4257469858201448	0.5514553875716777	0.4390906084361054	0.35744585177740357	SOX2/MYO10/SOX4	16
BP	GO:0031503	protein-containing complex localization	3	3/103	253/10965	0.4257469858201448	0.5514553875716777	0.4390906084361054	0.35744585177740357	NLGN1/MAPK10/NPTN	16
BP	GO:0072507	divalent inorganic cation homeostasis	3	3/103	253/10965	0.4257469858201448	0.5514553875716777	0.4390906084361054	0.35744585177740357	GJA1/NPTN/TNNI3	16
BP	GO:0016064	immunoglobulin mediated immune response	1	1/103	59/10965	0.4278318748864617	0.5514553875716777	0.4390906084361054	0.35744585177740357	CLU	16
BP	GO:0019724	B cell mediated immunity	1	1/103	59/10965	0.4278318748864617	0.5514553875716777	0.4390906084361054	0.35744585177740357	CLU	16
BP	GO:0032963	collagen metabolic process	1	1/103	59/10965	0.4278318748864617	0.5514553875716777	0.4390906084361054	0.35744585177740357	COL1A2	16
BP	GO:0043297	apical junction assembly	1	1/103	59/10965	0.4278318748864617	0.5514553875716777	0.4390906084361054	0.35744585177740357	GJA1	16
BP	GO:0048207	vesicle targeting, rough ER to cis-Golgi	1	1/103	59/10965	0.4278318748864617	0.5514553875716777	0.4390906084361054	0.35744585177740357	LMAN1	16
BP	GO:0048208	COPII vesicle coating	1	1/103	59/10965	0.4278318748864617	0.5514553875716777	0.4390906084361054	0.35744585177740357	LMAN1	16
BP	GO:0060079	excitatory postsynaptic potential	1	1/103	59/10965	0.4278318748864617	0.5514553875716777	0.4390906084361054	0.35744585177740357	NLGN1	16
BP	GO:0060349	bone morphogenesis	1	1/103	59/10965	0.4278318748864617	0.5514553875716777	0.4390906084361054	0.35744585177740357	SFRP2	16
BP	GO:0071229	cellular response to acid chemical	1	1/103	59/10965	0.4278318748864617	0.5514553875716777	0.4390906084361054	0.35744585177740357	COL1A2	16
BP	GO:0071706	tumor necrosis factor superfamily cytokine production	1	1/103	59/10965	0.4278318748864617	0.5514553875716777	0.4390906084361054	0.35744585177740357	CLU	16
BP	GO:1901983	regulation of protein acetylation	1	1/103	59/10965	0.4278318748864617	0.5514553875716777	0.4390906084361054	0.35744585177740357	SOX4	16
BP	GO:0030003	cellular cation homeostasis	4	4/103	355/10965	0.4288384164363185	0.5524315916556177	0.4398679007698744	0.35667772937834763	GJA1/CA2/NPTN/TNNI3	16
BP	GO:0001578	microtubule bundle formation	1	1/103	60/10965	0.4332356266640789	0.5551927076961057	0.44206641065753594	0.3545124826518574	NAV1	16
BP	GO:0006110	regulation of glycolytic process	1	1/103	60/10965	0.4332356266640789	0.5551927076961057	0.44206641065753594	0.3545124826518574	DDIT4	16
BP	GO:0006970	response to osmotic stress	1	1/103	60/10965	0.4332356266640789	0.5551927076961057	0.44206641065753594	0.3545124826518574	MAPK10	16
BP	GO:0030282	bone mineralization	1	1/103	60/10965	0.4332356266640789	0.5551927076961057	0.44206641065753594	0.3545124826518574	COL1A2	16
BP	GO:0045621	positive regulation of lymphocyte differentiation	1	1/103	60/10965	0.4332356266640789	0.5551927076961057	0.44206641065753594	0.3545124826518574	SOX4	16
BP	GO:0045639	positive regulation of myeloid cell differentiation	1	1/103	60/10965	0.4332356266640789	0.5551927076961057	0.44206641065753594	0.3545124826518574	CA2	16
BP	GO:0051149	positive regulation of muscle cell differentiation	1	1/103	60/10965	0.4332356266640789	0.5551927076961057	0.44206641065753594	0.3545124826518574	CDH2	16
BP	GO:0051453	regulation of intracellular pH	1	1/103	60/10965	0.4332356266640789	0.5551927076961057	0.44206641065753594	0.3545124826518574	CA2	16
BP	GO:0061097	regulation of protein tyrosine kinase activity	1	1/103	60/10965	0.4332356266640789	0.5551927076961057	0.44206641065753594	0.3545124826518574	EPHA4	16
BP	GO:0006721	terpenoid metabolic process	1	1/103	61/10965	0.43858883440856333	0.5594106816674361	0.44542492849810805	0.35122548104644835	LRP2	16
BP	GO:0030316	osteoclast differentiation	1	1/103	61/10965	0.43858883440856333	0.5594106816674361	0.44542492849810805	0.35122548104644835	CA2	16
BP	GO:0032272	negative regulation of protein polymerization	1	1/103	61/10965	0.43858883440856333	0.5594106816674361	0.44542492849810805	0.35122548104644835	TMSB15A	16
BP	GO:0032368	regulation of lipid transport	1	1/103	61/10965	0.43858883440856333	0.5594106816674361	0.44542492849810805	0.35122548104644835	MAP2K6	16
BP	GO:0033559	unsaturated fatty acid metabolic process	1	1/103	61/10965	0.43858883440856333	0.5594106816674361	0.44542492849810805	0.35122548104644835	SCD5	16
BP	GO:0051865	protein autoubiquitination	1	1/103	61/10965	0.43858883440856333	0.5594106816674361	0.44542492849810805	0.35122548104644835	UBE3D	16
BP	GO:0072665	protein localization to vacuole	1	1/103	61/10965	0.43858883440856333	0.5594106816674361	0.44542492849810805	0.35122548104644835	CLU	16
BP	GO:1903533	regulation of protein targeting	1	1/103	61/10965	0.43858883440856333	0.5594106816674361	0.44542492849810805	0.35122548104644835	LMAN1	16
BP	GO:0051480	regulation of cytosolic calcium ion concentration	2	2/103	158/10965	0.43879800424883686	0.5594106816674361	0.44542492849810805	0.35122548104644835	GJA1/NPTN	16
BP	GO:0002433	immune response-regulating cell surface receptor signaling pathway involved in phagocytosis	1	1/103	62/10965	0.4438919662919011	0.5639590196384784	0.4490464952324042	0.34770868889102374	MYO10	16
BP	GO:0014032	neural crest cell development	1	1/103	62/10965	0.4438919662919011	0.5639590196384784	0.4490464952324042	0.34770868889102374	SOX11	16
BP	GO:0032414	positive regulation of ion transmembrane transporter activity	1	1/103	62/10965	0.4438919662919011	0.5639590196384784	0.4490464952324042	0.34770868889102374	AKAP9	16
BP	GO:0038094	Fc-gamma receptor signaling pathway	1	1/103	62/10965	0.4438919662919011	0.5639590196384784	0.4490464952324042	0.34770868889102374	MYO10	16
BP	GO:0038096	Fc-gamma receptor signaling pathway involved in phagocytosis	1	1/103	62/10965	0.4438919662919011	0.5639590196384784	0.4490464952324042	0.34770868889102374	MYO10	16
BP	GO:2000379	positive regulation of reactive oxygen species metabolic process	1	1/103	62/10965	0.4438919662919011	0.5639590196384784	0.4490464952324042	0.34770868889102374	CLU	16
BP	GO:0017038	protein import	2	2/103	160/10965	0.44517834795583744	0.5649458485507107	0.44983224747503353	0.34694941417726466	ZIC1/CLU	16
BP	GO:0032412	regulation of ion transmembrane transporter activity	2	2/103	160/10965	0.44517834795583744	0.5649458485507107	0.44983224747503353	0.34694941417726466	NLGN1/AKAP9	16
BP	GO:0010256	endomembrane system organization	4	4/103	363/10965	0.44568968065380066	0.5652711796392883	0.4500912889656893	0.34669939228423163	AKAP9/CLU/RTN3/LMAN1	16
BP	GO:0007623	circadian rhythm	2	2/103	161/10965	0.448353676182099	0.5673820757196004	0.4517720679827031	0.3450806240043674	NLGN1/MAPK10	16
BP	GO:0045444	fat cell differentiation	2	2/103	161/10965	0.448353676182099	0.5673820757196004	0.4517720679827031	0.3450806240043674	SFRP2/WNT5B	16
BP	GO:0006513	protein monoubiquitination	1	1/103	63/10965	0.4491454861921059	0.5673820757196004	0.4517720679827031	0.3450806240043674	UBE3D	16
BP	GO:0006901	vesicle coating	1	1/103	63/10965	0.4491454861921059	0.5673820757196004	0.4517720679827031	0.3450806240043674	LMAN1	16
BP	GO:0097194	execution phase of apoptosis	1	1/103	63/10965	0.4491454861921059	0.5673820757196004	0.4517720679827031	0.3450806240043674	FZD3	16
BP	GO:0120162	positive regulation of cold-induced thermogenesis	1	1/103	63/10965	0.4491454861921059	0.5673820757196004	0.4517720679827031	0.3450806240043674	GJA1	16
BP	GO:1903051	negative regulation of proteolysis involved in cellular protein catabolic process	1	1/103	63/10965	0.4491454861921059	0.5673820757196004	0.4517720679827031	0.3450806240043674	EPHA4	16
BP	GO:0002253	activation of immune response	3	3/103	263/10965	0.4506182921518411	0.5689184246586741	0.45299536982294547	0.3439062369951631	MYO10/CLU/PLEKHA1	16
BP	GO:0009617	response to bacterium	3	3/103	264/10965	0.45308275740214565	0.5710281324967741	0.45467520271447437	0.3422987309014144	GJA1/NLRP1/GALP	16
BP	GO:1901990	regulation of mitotic cell cycle phase transition	4	4/103	367/10965	0.4540623516714942	0.5710281324967741	0.45467520271447437	0.3422987309014144	TFDP2/SOX4/AKAP9/TUBA1A	16
BP	GO:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process	1	1/103	64/10965	0.45434985373220993	0.5710281324967741	0.45467520271447437	0.3422987309014144	NLRP1	16
BP	GO:0009581	detection of external stimulus	1	1/103	64/10965	0.45434985373220993	0.5710281324967741	0.45467520271447437	0.3422987309014144	COL11A1	16
BP	GO:0043154	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	1	1/103	64/10965	0.45434985373220993	0.5710281324967741	0.45467520271447437	0.3422987309014144	SFRP2	16
BP	GO:0048864	stem cell development	1	1/103	64/10965	0.45434985373220993	0.5710281324967741	0.45467520271447437	0.3422987309014144	SOX11	16
BP	GO:0051153	regulation of striated muscle cell differentiation	1	1/103	64/10965	0.45434985373220993	0.5710281324967741	0.45467520271447437	0.3422987309014144	DLL1	16
BP	GO:0071479	cellular response to ionizing radiation	1	1/103	64/10965	0.45434985373220993	0.5710281324967741	0.45467520271447437	0.3422987309014144	SFRP2	16
BP	GO:0045637	regulation of myeloid cell differentiation	2	2/103	163/10965	0.45467416800459015	0.5711119719355107	0.4547419589943031	0.3422349716383725	DLL1/CA2	16
BP	GO:0070507	regulation of microtubule cytoskeleton organization	2	2/103	164/10965	0.4578191485065075	0.5745762816779562	0.45750037954273554	0.33960854130628193	AKAP9/MAP6	16
BP	GO:0042110	T cell activation	3	3/103	266/10965	0.4579984428594006	0.5745762816779562	0.45750037954273554	0.33960854130628193	SOX4/LFNG/CXADR	16
BP	GO:0002431	Fc receptor mediated stimulatory signaling pathway	1	1/103	65/10965	0.4595055243189068	0.5745762816779562	0.45750037954273554	0.33960854130628193	MYO10	16
BP	GO:0009582	detection of abiotic stimulus	1	1/103	65/10965	0.4595055243189068	0.5745762816779562	0.45750037954273554	0.33960854130628193	COL11A1	16
BP	GO:0043648	dicarboxylic acid metabolic process	1	1/103	65/10965	0.4595055243189068	0.5745762816779562	0.45750037954273554	0.33960854130628193	ME3	16
BP	GO:0046902	regulation of mitochondrial membrane permeability	1	1/103	65/10965	0.4595055243189068	0.5745762816779562	0.45750037954273554	0.33960854130628193	TFDP2	16
BP	GO:0099565	chemical synaptic transmission, postsynaptic	1	1/103	65/10965	0.4595055243189068	0.5745762816779562	0.45750037954273554	0.33960854130628193	NLGN1	16
BP	GO:1901264	carbohydrate derivative transport	1	1/103	65/10965	0.4595055243189068	0.5745762816779562	0.45750037954273554	0.33960854130628193	GJA1	16
BP	GO:0001938	positive regulation of endothelial cell proliferation	1	1/103	66/10965	0.4646129491808474	0.5790033211545467	0.4610253636142606	0.3362751809558994	TGFBR1	16
BP	GO:0006493	protein O-linked glycosylation	1	1/103	66/10965	0.4646129491808474	0.5790033211545467	0.4610253636142606	0.3362751809558994	GCNT1	16
BP	GO:0014031	mesenchymal cell development	1	1/103	66/10965	0.4646129491808474	0.5790033211545467	0.4610253636142606	0.3362751809558994	SOX11	16
BP	GO:0015918	sterol transport	1	1/103	66/10965	0.4646129491808474	0.5790033211545467	0.4610253636142606	0.3362751809558994	CLU	16
BP	GO:0042058	regulation of epidermal growth factor receptor signaling pathway	1	1/103	66/10965	0.4646129491808474	0.5790033211545467	0.4610253636142606	0.3362751809558994	SPRY1	16
BP	GO:0090114	COPII-coated vesicle budding	1	1/103	66/10965	0.4646129491808474	0.5790033211545467	0.4610253636142606	0.3362751809558994	LMAN1	16
BP	GO:0030641	regulation of cellular pH	1	1/103	67/10965	0.4696725754065907	0.5843232882583679	0.465261332008301	0.3323030402955515	CA2	16
BP	GO:0048199	vesicle targeting, to, from or within Golgi	1	1/103	67/10965	0.4696725754065907	0.5843232882583679	0.465261332008301	0.3323030402955515	LMAN1	16
BP	GO:1900182	positive regulation of protein localization to nucleus	1	1/103	67/10965	0.4696725754065907	0.5843232882583679	0.465261332008301	0.3323030402955515	ZIC1	16
BP	GO:0040017	positive regulation of locomotion	4	4/103	376/10965	0.47275268290698236	0.5862820632549102	0.4668209861968446	0.33084962823803	IGFBP5/TUBB2B/TGFBR1/WNT5B	16
BP	GO:0001892	embryonic placenta development	1	1/103	68/10965	0.47468484598221183	0.5862820632549102	0.4668209861968446	0.33084962823803	RSPO3	16
BP	GO:0006487	protein N-linked glycosylation	1	1/103	68/10965	0.47468484598221183	0.5862820632549102	0.4668209861968446	0.33084962823803	LMAN1	16
BP	GO:0014033	neural crest cell differentiation	1	1/103	68/10965	0.47468484598221183	0.5862820632549102	0.4668209861968446	0.33084962823803	SOX11	16
BP	GO:0031397	negative regulation of protein ubiquitination	1	1/103	68/10965	0.47468484598221183	0.5862820632549102	0.4668209861968446	0.33084962823803	SOX4	16
BP	GO:0032411	positive regulation of transporter activity	1	1/103	68/10965	0.47468484598221183	0.5862820632549102	0.4668209861968446	0.33084962823803	AKAP9	16
BP	GO:0035150	regulation of tube size	1	1/103	68/10965	0.47468484598221183	0.5862820632549102	0.4668209861968446	0.33084962823803	GJA1	16
BP	GO:0035296	regulation of tube diameter	1	1/103	68/10965	0.47468484598221183	0.5862820632549102	0.4668209861968446	0.33084962823803	GJA1	16
BP	GO:0043470	regulation of carbohydrate catabolic process	1	1/103	68/10965	0.47468484598221183	0.5862820632549102	0.4668209861968446	0.33084962823803	DDIT4	16
BP	GO:0046785	microtubule polymerization	1	1/103	68/10965	0.47468484598221183	0.5862820632549102	0.4668209861968446	0.33084962823803	AKAP9	16
BP	GO:0097746	regulation of blood vessel diameter	1	1/103	68/10965	0.47468484598221183	0.5862820632549102	0.4668209861968446	0.33084962823803	GJA1	16
BP	GO:1903312	negative regulation of mRNA metabolic process	1	1/103	68/10965	0.47468484598221183	0.5862820632549102	0.4668209861968446	0.33084962823803	CIRBP	16
BP	GO:2000117	negative regulation of cysteine-type endopeptidase activity	1	1/103	68/10965	0.47468484598221183	0.5862820632549102	0.4668209861968446	0.33084962823803	SFRP2	16
BP	GO:0032872	regulation of stress-activated MAPK cascade	2	2/103	170/10965	0.47646994583661684	0.5875049332145604	0.4677946836648946	0.3299447181149801	EPHA4/SFRP2	16
BP	GO:0050727	regulation of inflammatory response	2	2/103	170/10965	0.47646994583661684	0.5875049332145604	0.4677946836648946	0.3299447181149801	SERPINF1/NLRP1	16
BP	GO:1902105	regulation of leukocyte differentiation	2	2/103	170/10965	0.47646994583661684	0.5875049332145604	0.4677946836648946	0.3299447181149801	SOX4/CA2	16
BP	GO:0008154	actin polymerization or depolymerization	2	2/103	171/10965	0.4795411591514678	0.5897515551212436	0.46958353295744626	0.328287141043035	COTL1/TMSB15A	16
BP	GO:0072593	reactive oxygen species metabolic process	2	2/103	171/10965	0.4795411591514678	0.5897515551212436	0.46958353295744626	0.328287141043035	CLU/DDIT4	16
BP	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	1	1/103	69/10965	0.47965019982857604	0.5897515551212436	0.46958353295744626	0.328287141043035	SFRP2	16
BP	GO:0034754	cellular hormone metabolic process	1	1/103	69/10965	0.47965019982857604	0.5897515551212436	0.46958353295744626	0.328287141043035	PLEKHA1	16
BP	GO:1903409	reactive oxygen species biosynthetic process	1	1/103	69/10965	0.47965019982857604	0.5897515551212436	0.46958353295744626	0.328287141043035	CLU	16
BP	GO:1903829	positive regulation of cellular protein localization	3	3/103	275/10965	0.47988804936342955	0.5897515551212436	0.46958353295744626	0.328287141043035	ZIC1/TFDP2/NPTN	16
BP	GO:0000302	response to reactive oxygen species	2	2/103	172/10965	0.4826015318856912	0.5927576710197104	0.47197712143012344	0.3260790528012227	PLEKHA1/TPM1	16
BP	GO:0051272	positive regulation of cellular component movement	4	4/103	381/10965	0.48303833801021334	0.5928750729941783	0.4720706015294433	0.3259930446674224	IGFBP5/TUBB2B/TGFBR1/WNT5B	16
BP	GO:0031110	regulation of microtubule polymerization or depolymerization	1	1/103	70/10965	0.4845690718382729	0.5928750729941783	0.4720706015294433	0.3259930446674224	AKAP9	16
BP	GO:0048010	vascular endothelial growth factor receptor signaling pathway	1	1/103	70/10965	0.4845690718382729	0.5928750729941783	0.4720706015294433	0.3259930446674224	SULF1	16
BP	GO:0050728	negative regulation of inflammatory response	1	1/103	70/10965	0.4845690718382729	0.5928750729941783	0.4720706015294433	0.3259930446674224	SERPINF1	16
BP	GO:0062014	negative regulation of small molecule metabolic process	1	1/103	70/10965	0.4845690718382729	0.5928750729941783	0.4720706015294433	0.3259930446674224	DDIT4	16
BP	GO:0070301	cellular response to hydrogen peroxide	1	1/103	70/10965	0.4845690718382729	0.5928750729941783	0.4720706015294433	0.3259930446674224	PLEKHA1	16
BP	GO:1903313	positive regulation of mRNA metabolic process	1	1/103	70/10965	0.4845690718382729	0.5928750729941783	0.4720706015294433	0.3259930446674224	CIRBP	16
BP	GO:0031396	regulation of protein ubiquitination	2	2/103	173/10965	0.4856509953440745	0.5935436916636236	0.4726029821807073	0.3255035422454633	SOX4/TGFBR1	16
BP	GO:0070302	regulation of stress-activated protein kinase signaling cascade	2	2/103	173/10965	0.4856509953440745	0.5935436916636236	0.4726029821807073	0.3255035422454633	EPHA4/SFRP2	16
BP	GO:0062197	cellular response to chemical stress	3	3/103	278/10965	0.4870955989924819	0.5946536029550288	0.4734867374857363	0.324692181217049	MAPK10/PLEKHA1/TPM1	16
BP	GO:1901653	cellular response to peptide	3	3/103	278/10965	0.4870955989924819	0.5946536029550288	0.4734867374857363	0.324692181217049	EPHA4/GJA1/CA2	16
BP	GO:0006885	regulation of pH	1	1/103	71/10965	0.4894418929122204	0.5965884127993876	0.47502730967147305	0.32328142174632485	CA2	16
BP	GO:1901184	regulation of ERBB signaling pathway	1	1/103	71/10965	0.4894418929122204	0.5965884127993876	0.47502730967147305	0.32328142174632485	SPRY1	16
BP	GO:0051051	negative regulation of transport	3	3/103	279/10965	0.48948774148943885	0.5965884127993876	0.47502730967147305	0.32328142174632485	VSNL1/GJA1/LMAN1	16
BP	GO:0060078	regulation of postsynaptic membrane potential	1	1/103	72/10965	0.4942690899959401	0.6020849299565929	0.4794038542065886	0.3192984787422378	NLGN1	16
BP	GO:0007611	learning or memory	2	2/103	176/10965	0.4947332761001151	0.6023194251037646	0.4795905685250401	0.31912936618579674	NPTN/SERPINF1	16
BP	GO:1901987	regulation of cell cycle phase transition	4	4/103	387/10965	0.49527976326695633	0.6026538063462361	0.4798568161064682	0.31888833189823795	TFDP2/SOX4/AKAP9/TUBA1A	16
BP	GO:0016050	vesicle organization	3	3/103	283/10965	0.49900304078546	0.6049186757343215	0.481660194766022	0.3172592430519136	SYT1/PMEL/LMAN1	16
BP	GO:0090150	establishment of protein localization to membrane	3	3/103	283/10965	0.49900304078546	0.6049186757343215	0.481660194766022	0.3172592430519136	TFDP2/MAPK10/SRP14	16
BP	GO:0002761	regulation of myeloid leukocyte differentiation	1	1/103	73/10965	0.49905108611550475	0.6049186757343215	0.481660194766022	0.3172592430519136	CA2	16
BP	GO:0009060	aerobic respiration	1	1/103	73/10965	0.49905108611550475	0.6049186757343215	0.481660194766022	0.3172592430519136	ME3	16
BP	GO:0048259	regulation of receptor-mediated endocytosis	1	1/103	73/10965	0.49905108611550475	0.6049186757343215	0.481660194766022	0.3172592430519136	CLU	16
BP	GO:0090559	regulation of membrane permeability	1	1/103	73/10965	0.49905108611550475	0.6049186757343215	0.481660194766022	0.3172592430519136	TFDP2	16
BP	GO:1903363	negative regulation of cellular protein catabolic process	1	1/103	73/10965	0.49905108611550475	0.6049186757343215	0.481660194766022	0.3172592430519136	EPHA4	16
BP	GO:0032386	regulation of intracellular transport	3	3/103	284/10965	0.5013682947773301	0.6070636316337198	0.48336809355921856	0.31572202014370154	ZIC1/TFDP2/LMAN1	16
BP	GO:0043687	post-translational protein modification	3	3/103	284/10965	0.5013682947773301	0.6070636316337198	0.48336809355921856	0.31572202014370154	IGFBP5/PRSS23/CDH2	16
BP	GO:0032388	positive regulation of intracellular transport	2	2/103	179/10965	0.5037151088747231	0.6080014491104977	0.48411482095686664	0.3150516214259251	ZIC1/TFDP2	16
BP	GO:0051650	establishment of vesicle localization	2	2/103	179/10965	0.5037151088747231	0.6080014491104977	0.48411482095686664	0.3150516214259251	NLGN1/LMAN1	16
BP	GO:0006637	acyl-CoA metabolic process	1	1/103	74/10965	0.5037883004131638	0.6080014491104977	0.48411482095686664	0.3150516214259251	SCD5	16
BP	GO:0032091	negative regulation of protein binding	1	1/103	74/10965	0.5037883004131638	0.6080014491104977	0.48411482095686664	0.3150516214259251	CRMP1	16
BP	GO:0035383	thioester metabolic process	1	1/103	74/10965	0.5037883004131638	0.6080014491104977	0.48411482095686664	0.3150516214259251	SCD5	16
BP	GO:0048194	Golgi vesicle budding	1	1/103	74/10965	0.5037883004131638	0.6080014491104977	0.48411482095686664	0.3150516214259251	LMAN1	16
BP	GO:0010389	regulation of G2/M transition of mitotic cell cycle	2	2/103	180/10965	0.5066864655103034	0.6111664276585106	0.48663490215954347	0.3127967460593043	AKAP9/TUBA1A	16
BP	GO:0050878	regulation of body fluid levels	3	3/103	287/10965	0.5084307063429352	0.612331724889152	0.48756275794179327	0.31196947499392935	GJA1/COL1A2/LMAN1	16
BP	GO:0043473	pigmentation	1	1/103	75/10965	0.5084811481826472	0.612331724889152	0.48756275794179327	0.31196947499392935	PMEL	16
BP	GO:1903321	negative regulation of protein modification by small protein conjugation or removal	1	1/103	75/10965	0.5084811481826472	0.612331724889152	0.48756275794179327	0.31196947499392935	SOX4	16
BP	GO:0007283	spermatogenesis	3	3/103	289/10965	0.5131107212736667	0.6172595228890425	0.49148646577163274	0.3084884369806269	CCNI/GJA1/PLEKHA1	16
BP	GO:0032436	positive regulation of proteasomal ubiquitin-dependent protein catabolic process	1	1/103	76/10965	0.5131300409041522	0.6172595228890425	0.49148646577163274	0.3084884369806269	CLU	16
BP	GO:0055080	cation homeostasis	4	4/103	396/10965	0.5134173366912854	0.6172701927573643	0.4914949615431474	0.30848092988723547	GJA1/CA2/NPTN/TNNI3	16
BP	GO:0002576	platelet degranulation	1	1/103	77/10965	0.5177353862790139	0.6217872976059448	0.49509165922900517	0.3053143901325241	CLU	16
BP	GO:0030004	cellular monovalent inorganic cation homeostasis	1	1/103	77/10965	0.5177353862790139	0.6217872976059448	0.49509165922900517	0.3053143901325241	CA2	16
BP	GO:0006720	isoprenoid metabolic process	1	1/103	78/10965	0.5222975882640675	0.6265875287778342	0.49891379330077534	0.30197448910229646	LRP2	16
BP	GO:0048013	ephrin receptor signaling pathway	1	1/103	78/10965	0.5222975882640675	0.6265875287778342	0.49891379330077534	0.30197448910229646	EPHA4	16
BP	GO:0007009	plasma membrane organization	1	1/103	79/10965	0.526817047105695	0.630304043946749	0.5018730297930812	0.29940614228717666	CLU	16
BP	GO:0010771	negative regulation of cell morphogenesis involved in differentiation	1	1/103	79/10965	0.526817047105695	0.630304043946749	0.5018730297930812	0.29940614228717666	NLGN1	16
BP	GO:0098876	vesicle-mediated transport to the plasma membrane	1	1/103	79/10965	0.526817047105695	0.630304043946749	0.5018730297930812	0.29940614228717666	MAPK10	16
BP	GO:1904064	positive regulation of cation transmembrane transport	1	1/103	79/10965	0.526817047105695	0.630304043946749	0.5018730297930812	0.29940614228717666	AKAP9	16
BP	GO:1905897	regulation of response to endoplasmic reticulum stress	1	1/103	79/10965	0.526817047105695	0.630304043946749	0.5018730297930812	0.29940614228717666	CLU	16
BP	GO:0006457	protein folding	2	2/103	188/10965	0.5300436036541736	0.6331393692356158	0.5041306280218064	0.2974569165733731	CLU/LMAN1	16
BP	GO:0032886	regulation of microtubule-based process	2	2/103	188/10965	0.5300436036541736	0.6331393692356158	0.5041306280218064	0.2974569165733731	AKAP9/MAP6	16
BP	GO:2001020	regulation of response to DNA damage stimulus	2	2/103	188/10965	0.5300436036541736	0.6331393692356158	0.5041306280218064	0.2974569165733731	SFRP2/CLU	16
BP	GO:0006766	vitamin metabolic process	1	1/103	80/10965	0.5312941593735725	0.6339500276271315	0.504776106322294	0.29690121069334435	LRP2	16
BP	GO:0032006	regulation of TOR signaling	1	1/103	80/10965	0.5312941593735725	0.6339500276271315	0.504776106322294	0.29690121069334435	DDIT4	16
BP	GO:0051250	negative regulation of lymphocyte activation	1	1/103	81/10965	0.5357293179941073	0.6382116593191487	0.5081693861682275	0.29399150185684386	SOX11	16
BP	GO:1990823	response to leukemia inhibitory factor	1	1/103	81/10965	0.5357293179941073	0.6382116593191487	0.5081693861682275	0.29399150185684386	PAX6	16
BP	GO:1990830	cellular response to leukemia inhibitory factor	1	1/103	81/10965	0.5357293179941073	0.6382116593191487	0.5081693861682275	0.29399150185684386	PAX6	16
BP	GO:0048232	male gamete generation	3	3/103	299/10965	0.5361586081124747	0.6383800398417596	0.5083034574055176	0.29387693627992206	CCNI/GJA1/PLEKHA1	16
BP	GO:0006875	cellular metal ion homeostasis	3	3/103	300/10965	0.5384301477712783	0.6402673418284641	0.5098062019544354	0.29259488550424684	GJA1/NPTN/TNNI3	16
BP	GO:0006486	protein glycosylation	2	2/103	191/10965	0.5386101003653971	0.6402673418284641	0.5098062019544354	0.29259488550424684	GCNT1/LMAN1	16
BP	GO:0043413	macromolecule glycosylation	2	2/103	191/10965	0.5386101003653971	0.6402673418284641	0.5098062019544354	0.29259488550424684	GCNT1/LMAN1	16
BP	GO:0001824	blastocyst development	1	1/103	82/10965	0.540122912283579	0.6410345270517637	0.5104170651975442	0.29207481391614526	TGFBR1	16
BP	GO:0006906	vesicle fusion	1	1/103	82/10965	0.540122912283579	0.6410345270517637	0.5104170651975442	0.29207481391614526	SYT1	16
BP	GO:0007613	memory	1	1/103	82/10965	0.540122912283579	0.6410345270517637	0.5104170651975442	0.29207481391614526	SERPINF1	16
BP	GO:0031334	positive regulation of protein-containing complex assembly	2	2/103	193/10965	0.5442619967972055	0.6448193387467028	0.5134306820873256	0.2895181818993536	AKAP9/CLU	16
BP	GO:1902749	regulation of cell cycle G2/M phase transition	2	2/103	193/10965	0.5442619967972055	0.6448193387467028	0.5134306820873256	0.2895181818993536	AKAP9/TUBA1A	16
BP	GO:1903050	regulation of proteolysis involved in cellular protein catabolic process	2	2/103	193/10965	0.5442619967972055	0.6448193387467028	0.5134306820873256	0.2895181818993536	EPHA4/CLU	16
BP	GO:0031532	actin cytoskeleton reorganization	1	1/103	83/10965	0.5444753279809778	0.6448193387467028	0.5134306820873256	0.2895181818993536	CXADR	16
BP	GO:0030216	keratinocyte differentiation	1	1/103	84/10965	0.5487869472805513	0.6485397985719522	0.5163930594711507	0.28701960345758654	PAX6	16
BP	GO:0034767	positive regulation of ion transmembrane transport	1	1/103	84/10965	0.5487869472805513	0.6485397985719522	0.5163930594711507	0.28701960345758654	AKAP9	16
BP	GO:0045580	regulation of T cell differentiation	1	1/103	84/10965	0.5487869472805513	0.6485397985719522	0.5163930594711507	0.28701960345758654	SOX4	16
BP	GO:1905952	regulation of lipid localization	1	1/103	84/10965	0.5487869472805513	0.6485397985719522	0.5163930594711507	0.28701960345758654	MAP2K6	16
BP	GO:0007596	blood coagulation	2	2/103	195/10965	0.5498663305708483	0.6494691821393558	0.5171330714563064	0.28639768753887096	COL1A2/LMAN1	16
BP	GO:0001701	in utero embryonic development	3	3/103	306/10965	0.5519280380185291	0.650121906697566	0.5176527965870514	0.2859614353975555	RSPO3/TGFBR1/TPM1	16
BP	GO:0048863	stem cell differentiation	2	2/103	196/10965	0.5526505939492471	0.650121906697566	0.5176527965870514	0.2859614353975555	SOX11/SOX5	16
BP	GO:0050817	coagulation	2	2/103	196/10965	0.5526505939492471	0.650121906697566	0.5176527965870514	0.2859614353975555	COL1A2/LMAN1	16
BP	GO:0015698	inorganic anion transport	1	1/103	85/10965	0.5530581488640548	0.650121906697566	0.5176527965870514	0.2859614353975555	CA2	16
BP	GO:0031214	biomineral tissue development	1	1/103	85/10965	0.5530581488640548	0.650121906697566	0.5176527965870514	0.2859614353975555	COL1A2	16
BP	GO:0046718	viral entry into host cell	1	1/103	85/10965	0.5530581488640548	0.650121906697566	0.5176527965870514	0.2859614353975555	CXADR	16
BP	GO:0061041	regulation of wound healing	1	1/103	85/10965	0.5530581488640548	0.650121906697566	0.5176527965870514	0.2859614353975555	GJA1	16
BP	GO:0110148	biomineralization	1	1/103	85/10965	0.5530581488640548	0.650121906697566	0.5176527965870514	0.2859614353975555	COL1A2	16
BP	GO:1900542	regulation of purine nucleotide metabolic process	1	1/103	85/10965	0.5530581488640548	0.650121906697566	0.5176527965870514	0.2859614353975555	DDIT4	16
BP	GO:0007159	leukocyte cell-cell adhesion	2	2/103	197/10965	0.5554228887161676	0.6525556673469759	0.5195906531542761	0.28433866999322027	SOX4/GCNT1	16
BP	GO:0006140	regulation of nucleotide metabolic process	1	1/103	86/10965	0.5572893079327134	0.6533635090887495	0.5202338887267446	0.2838013606990683	DDIT4	16
BP	GO:0032355	response to estradiol	1	1/103	86/10965	0.5572893079327134	0.6533635090887495	0.5202338887267446	0.2838013606990683	GJA1	16
BP	GO:0051053	negative regulation of DNA metabolic process	1	1/103	86/10965	0.5572893079327134	0.6533635090887495	0.5202338887267446	0.2838013606990683	GJA1	16
BP	GO:0098739	import across plasma membrane	1	1/103	86/10965	0.5572893079327134	0.6533635090887495	0.5202338887267446	0.2838013606990683	LRP2	16
BP	GO:0007599	hemostasis	2	2/103	198/10965	0.5581831920388018	0.6533749402059259	0.5202429906347306	0.2837937624362109	COL1A2/LMAN1	16
BP	GO:0031330	negative regulation of cellular catabolic process	2	2/103	198/10965	0.5581831920388018	0.6533749402059259	0.5202429906347306	0.2837937624362109	EPHA4/CIRBP	16
BP	GO:1901991	negative regulation of mitotic cell cycle phase transition	2	2/103	198/10965	0.5581831920388018	0.6533749402059259	0.5202429906347306	0.2837937624362109	TFDP2/SOX4	16
BP	GO:0050890	cognition	2	2/103	199/10965	0.5609314825511089	0.6548147949824439	0.5213894600031139	0.28283775243265685	NPTN/SERPINF1	16
BP	GO:1903320	regulation of protein modification by small protein conjugation or removal	2	2/103	199/10965	0.5609314825511089	0.6548147949824439	0.5213894600031139	0.28283775243265685	SOX4/TGFBR1	16
BP	GO:0006096	glycolytic process	1	1/103	87/10965	0.561480796238893	0.6548147949824439	0.5213894600031139	0.28283775243265685	DDIT4	16
BP	GO:0015748	organophosphate ester transport	1	1/103	87/10965	0.561480796238893	0.6548147949824439	0.5213894600031139	0.28283775243265685	GJA1	16
BP	GO:0050921	positive regulation of chemotaxis	1	1/103	87/10965	0.561480796238893	0.6548147949824439	0.5213894600031139	0.28283775243265685	TUBB2B	16
BP	GO:0090174	organelle membrane fusion	1	1/103	87/10965	0.561480796238893	0.6548147949824439	0.5213894600031139	0.28283775243265685	SYT1	16
BP	GO:2000060	positive regulation of ubiquitin-dependent protein catabolic process	1	1/103	87/10965	0.561480796238893	0.6548147949824439	0.5213894600031139	0.28283775243265685	CLU	16
BP	GO:0006757	ATP generation from ADP	1	1/103	88/10965	0.5656329821174917	0.658963910328155	0.524693149880263	0.2800946056865893	DDIT4	16
BP	GO:0008277	regulation of G protein-coupled receptor signaling pathway	1	1/103	88/10965	0.5656329821174917	0.658963910328155	0.524693149880263	0.2800946056865893	FGF8	16
BP	GO:0070085	glycosylation	2	2/103	201/10965	0.566391946864602	0.6595015473733313	0.5251212377774976	0.2797404169385039	GCNT1/LMAN1	16
BP	GO:0008202	steroid metabolic process	2	2/103	202/10965	0.5691040850439782	0.6620164533837943	0.5271237054932569	0.2780874525131496	LRP2/PLEKHA1	16
BP	GO:0043200	response to amino acid	1	1/103	89/10965	0.5697462305170409	0.6620164533837943	0.5271237054932569	0.2780874525131496	COL1A2	16
BP	GO:1901568	fatty acid derivative metabolic process	1	1/103	89/10965	0.5697462305170409	0.6620164533837943	0.5271237054932569	0.2780874525131496	SCD5	16
BP	GO:1903828	negative regulation of cellular protein localization	1	1/103	89/10965	0.5697462305170409	0.6620164533837943	0.5271237054932569	0.2780874525131496	LMAN1	16
BP	GO:0009615	response to virus	2	2/103	205/10965	0.5771679386855959	0.66968623236898706	0.5332306871223755	0.2730848651388647	CLU/DDIT4	16
BP	GO:0002224	toll-like receptor signaling pathway	1	1/103	91/10965	0.5778573579259685	0.66968623236898706	0.5332306871223755	0.2730848651388647	WDFY1	16
BP	GO:0002695	negative regulation of leukocyte activation	1	1/103	91/10965	0.5778573579259685	0.66968623236898706	0.5332306871223755	0.2730848651388647	SOX11	16
BP	GO:0035725	sodium ion transmembrane transport	1	1/103	91/10965	0.5778573579259685	0.66968623236898706	0.5332306871223755	0.2730848651388647	SLC6A8	16
BP	GO:0038095	Fc-epsilon receptor signaling pathway	1	1/103	91/10965	0.5778573579259685	0.66968623236898706	0.5332306871223755	0.2730848651388647	MAPK10	16
BP	GO:1904062	regulation of cation transmembrane transport	2	2/103	206/10965	0.5798316593126893	0.6716231915863283	0.5347729707239619	0.2718305516009369	NLGN1/AKAP9	16
BP	GO:1903706	regulation of hemopoiesis	3	3/103	319/10965	0.5803749836021732	0.6719014823216803	0.5349945568233307	0.2716506365836634	SOX4/DLL1/CA2	16
BP	GO:0019932	second-messenger-mediated signaling	2	2/103	207/10965	0.5824832460706267	0.6736386836403649	0.536377785278775	0.2705292172682917	NCALD/TNNI3	16
BP	GO:1901988	negative regulation of cell cycle phase transition	2	2/103	207/10965	0.5824832460706267	0.6736386836403649	0.536377785278775	0.2705292172682917	TFDP2/SOX4	16
BP	GO:0006869	lipid transport	2	2/103	208/10965	0.5851226897072537	0.6757317163453006	0.5380443407692088	0.2691819322185984	CLU/MAP2K6	16
BP	GO:0043280	positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	1	1/103	93/10965	0.5858170314910545	0.6757317163453006	0.5380443407692088	0.2691819322185984	NLRP1	16
BP	GO:0071805	potassium ion transmembrane transport	1	1/103	93/10965	0.5858170314910545	0.6757317163453006	0.5380443407692088	0.2691819322185984	AKAP9	16
BP	GO:1903578	regulation of ATP metabolic process	1	1/103	93/10965	0.5858170314910545	0.6757317163453006	0.5380443407692088	0.2691819322185984	DDIT4	16
BP	GO:1903707	negative regulation of hemopoiesis	1	1/103	93/10965	0.5858170314910545	0.6757317163453006	0.5380443407692088	0.2691819322185984	DLL1	16
BP	GO:0010639	negative regulation of organelle organization	3	3/103	323/10965	0.5889008734598437	0.6784928318163144	0.5402428502034324	0.2674109720388777	CLU/LMAN1/TMSB15A	16
BP	GO:0006614	SRP-dependent cotranslational protein targeting to membrane	1	1/103	94/10965	0.5897409503428226	0.6784928318163144	0.5402428502034324	0.2674109720388777	SRP14	16
BP	GO:0007173	epidermal growth factor receptor signaling pathway	1	1/103	94/10965	0.5897409503428226	0.6784928318163144	0.5402428502034324	0.2674109720388777	SPRY1	16
BP	GO:0014065	phosphatidylinositol 3-kinase signaling	1	1/103	94/10965	0.5897409503428226	0.6784928318163144	0.5402428502034324	0.2674109720388777	PLEKHA1	16
BP	GO:2000278	regulation of DNA biosynthetic process	1	1/103	94/10965	0.5897409503428226	0.6784928318163144	0.5402428502034324	0.2674109720388777	GJA1	16
BP	GO:0032870	cellular response to hormone stimulus	4	4/103	436/10965	0.5901886134109463	0.6786556825373796	0.5403725183938398	0.26730674590721404	GJA1/CA2/DDIT4/SERPINF1	16
BP	GO:0032868	response to insulin	2	2/103	211/10965	0.5929680877021901	0.6803881071170748	0.5417519434206178	0.2661995220656682	GCNT1/GALP	16
BP	GO:0007041	lysosomal transport	1	1/103	95/10965	0.5936280519999552	0.6803881071170748	0.5417519434206178	0.2661995220656682	CLU	16
BP	GO:0046031	ADP metabolic process	1	1/103	95/10965	0.5936280519999552	0.6803881071170748	0.5417519434206178	0.2661995220656682	DDIT4	16
BP	GO:0046822	regulation of nucleocytoplasmic transport	1	1/103	95/10965	0.5936280519999552	0.6803881071170748	0.5417519434206178	0.2661995220656682	ZIC1	16
BP	GO:0055067	monovalent inorganic cation homeostasis	1	1/103	95/10965	0.5936280519999552	0.6803881071170748	0.5417519434206178	0.2661995220656682	CA2	16
BP	GO:1901800	positive regulation of proteasomal protein catabolic process	1	1/103	95/10965	0.5936280519999552	0.6803881071170748	0.5417519434206178	0.2661995220656682	CLU	16
BP	GO:0002366	leukocyte activation involved in immune response	4	4/103	438/10965	0.5938434764418311	0.6803881071170748	0.5417519434206178	0.2661995220656682	DLL1/LFNG/SRP14/COTL1	16
BP	GO:0006900	vesicle budding from membrane	1	1/103	96/10965	0.5974786785541415	0.6831409130245135	0.5439438364513968	0.264445939968073	LMAN1	16
BP	GO:0030168	platelet activation	1	1/103	96/10965	0.5974786785541415	0.6831409130245135	0.5439438364513968	0.264445939968073	COL1A2	16
BP	GO:0044409	entry into host	1	1/103	96/10965	0.5974786785541415	0.6831409130245135	0.5439438364513968	0.264445939968073	CXADR	16
BP	GO:2000736	regulation of stem cell differentiation	1	1/103	96/10965	0.5974786785541415	0.6831409130245135	0.5439438364513968	0.264445939968073	SOX5	16
BP	GO:0002263	cell activation involved in immune response	4	4/103	441/10965	0.59929051106306	0.6848593108385587	0.5453120928121278	0.2633548713149299	DLL1/LFNG/SRP14/COTL1	16
BP	GO:0003018	vascular process in circulatory system	1	1/103	97/10965	0.6012931689496629	0.6864402448822877	0.546570895077557	0.2623534982265092	GJA1	16
BP	GO:0010675	regulation of cellular carbohydrate metabolic process	1	1/103	97/10965	0.6012931689496629	0.6864402448822877	0.546570895077557	0.2623534982265092	DDIT4	16
BP	GO:0006613	cotranslational protein targeting to membrane	1	1/103	98/10965	0.605071859012065	0.6889801291370046	0.5485932514601319	0.2607495391880197	SRP14	16
BP	GO:0006633	fatty acid biosynthetic process	1	1/103	98/10965	0.605071859012065	0.6889801291370046	0.5485932514601319	0.2607495391880197	SCD5	16
BP	GO:0007266	Rho protein signal transduction	1	1/103	98/10965	0.605071859012065	0.6889801291370046	0.5485932514601319	0.2607495391880197	COL1A2	16
BP	GO:0031109	microtubule polymerization or depolymerization	1	1/103	98/10965	0.605071859012065	0.6889801291370046	0.5485932514601319	0.2607495391880197	AKAP9	16
BP	GO:0046330	positive regulation of JNK cascade	1	1/103	98/10965	0.605071859012065	0.6889801291370046	0.5485932514601319	0.2607495391880197	EPHA4	16
BP	GO:0010631	epithelial cell migration	2	2/103	216/10965	0.6058003724446496	0.689455557345887	0.5489718062194301	0.2604499592252098	TGFBR1/SERPINF1	16
BP	GO:0000082	G1/S transition of mitotic cell cycle	2	2/103	217/10965	0.6083303076796855	0.6919796265396936	0.5509815700244837	0.25886292777349945	TFDP2/SOX4	16
BP	GO:0007612	learning	1	1/103	99/10965	0.6088150814765683	0.6921759157095138	0.5511378632314197	0.2587397518712549	NPTN	16
BP	GO:0006979	response to oxidative stress	3	3/103	334/10965	0.6117791215493777	0.6935464040132642	0.5522291002683779	0.25788071150880876	PLEKHA1/FGF8/TPM1	16
BP	GO:0007043	cell-cell junction assembly	1	1/103	100/10965	0.6125231660162253	0.6935464040132642	0.5522291002683779	0.25788071150880876	GJA1	16
BP	GO:0030879	mammary gland development	1	1/103	100/10965	0.6125231660162253	0.6935464040132642	0.5522291002683779	0.25788071150880876	IGFBP5	16
BP	GO:0031929	TOR signaling	1	1/103	100/10965	0.6125231660162253	0.6935464040132642	0.5522291002683779	0.25788071150880876	DDIT4	16
BP	GO:0033865	nucleoside bisphosphate metabolic process	1	1/103	100/10965	0.6125231660162253	0.6935464040132642	0.5522291002683779	0.25788071150880876	SCD5	16
BP	GO:0033875	ribonucleoside bisphosphate metabolic process	1	1/103	100/10965	0.6125231660162253	0.6935464040132642	0.5522291002683779	0.25788071150880876	SCD5	16
BP	GO:0034032	purine nucleoside bisphosphate metabolic process	1	1/103	100/10965	0.6125231660162253	0.6935464040132642	0.5522291002683779	0.25788071150880876	SCD5	16
BP	GO:0097529	myeloid leukocyte migration	1	1/103	100/10965	0.6125231660162253	0.6935464040132642	0.5522291002683779	0.25788071150880876	CXADR	16
BP	GO:0006661	phosphatidylinositol biosynthetic process	1	1/103	101/10965	0.6161964392698221	0.6955740864873705	0.5538436213181969	0.25661284174370874	PLEKHA1	16
BP	GO:0030595	leukocyte chemotaxis	1	1/103	101/10965	0.6161964392698221	0.6955740864873705	0.5538436213181969	0.25661284174370874	CXADR	16
BP	GO:0048024	regulation of mRNA splicing, via spliceosome	1	1/103	101/10965	0.6161964392698221	0.6955740864873705	0.5538436213181969	0.25661284174370874	CIRBP	16
BP	GO:1900180	regulation of protein localization to nucleus	1	1/103	101/10965	0.6161964392698221	0.6955740864873705	0.5538436213181969	0.25661284174370874	ZIC1	16
BP	GO:1905477	positive regulation of protein localization to membrane	1	1/103	101/10965	0.6161964392698221	0.6955740864873705	0.5538436213181969	0.25661284174370874	TFDP2	16
BP	GO:2001056	positive regulation of cysteine-type endopeptidase activity	1	1/103	101/10965	0.6161964392698221	0.6955740864873705	0.5538436213181969	0.25661284174370874	NLRP1	16
BP	GO:0006165	nucleoside diphosphate phosphorylation	1	1/103	103/10965	0.6234398434682982	0.702677240960456	0.5594994340814684	0.2522003484125208	DDIT4	16
BP	GO:0009135	purine nucleoside diphosphate metabolic process	1	1/103	103/10965	0.6234398434682982	0.702677240960456	0.5594994340814684	0.2522003484125208	DDIT4	16
BP	GO:0009179	purine ribonucleoside diphosphate metabolic process	1	1/103	103/10965	0.6234398434682982	0.702677240960456	0.5594994340814684	0.2522003484125208	DDIT4	16
BP	GO:0055065	metal ion homeostasis	3	3/103	341/10965	0.6258964153427979	0.7050875776498897	0.5614186395645444	0.2507131725251567	GJA1/NPTN/TNNI3	16
BP	GO:0042542	response to hydrogen peroxide	1	1/103	104/10965	0.6270106127670246	0.705267645106288	0.5615620164011325	0.2506022752109946	PLEKHA1	16
BP	GO:0042552	myelination	1	1/103	104/10965	0.6270106127670246	0.705267645106288	0.5615620164011325	0.2506022752109946	CLU	16
BP	GO:0045619	regulation of lymphocyte differentiation	1	1/103	104/10965	0.6270106127670246	0.705267645106288	0.5615620164011325	0.2506022752109946	SOX4	16
BP	GO:0002429	immune response-activating cell surface receptor signaling pathway	2	2/103	225/10965	0.6281320050651867	0.7058128004204354	0.5619960906417255	0.25026670546053237	MYO10/PLEKHA1	16
BP	GO:0002757	immune response-activating signal transduction	2	2/103	225/10965	0.6281320050651867	0.7058128004204354	0.5619960906417255	0.25026670546053237	MYO10/PLEKHA1	16
BP	GO:0046939	nucleotide phosphorylation	1	1/103	105/10965	0.6305478475414465	0.7074517095138598	0.5633010549366109	0.24925943542767096	DDIT4	16
BP	GO:0050670	regulation of lymphocyte proliferation	1	1/103	105/10965	0.6305478475414465	0.7074517095138598	0.5633010549366109	0.24925943542767096	SOX11	16
BP	GO:2001257	regulation of cation channel activity	1	1/103	105/10965	0.6305478475414465	0.7074517095138598	0.5633010549366109	0.24925943542767096	NLGN1	16
BP	GO:0000086	G2/M transition of mitotic cell cycle	2	2/103	227/10965	0.6329610708765435	0.7085146032690346	0.5641473730181473	0.24860742983226078	AKAP9/TUBA1A	16
BP	GO:0010959	regulation of metal ion transport	2	2/103	227/10965	0.6329610708765435	0.7085146032690346	0.5641473730181473	0.24860742983226078	GJA1/AKAP9	16
BP	GO:0007272	ensheathment of neurons	1	1/103	106/10965	0.6340518596688158	0.7085146032690346	0.5641473730181473	0.24860742983226078	CLU	16
BP	GO:0008366	axon ensheathment	1	1/103	106/10965	0.6340518596688158	0.7085146032690346	0.5641473730181473	0.24860742983226078	CLU	16
BP	GO:0009185	ribonucleoside diphosphate metabolic process	1	1/103	106/10965	0.6340518596688158	0.7085146032690346	0.5641473730181473	0.24860742983226078	DDIT4	16
BP	GO:0032273	positive regulation of protein polymerization	1	1/103	106/10965	0.6340518596688158	0.7085146032690346	0.5641473730181473	0.24860742983226078	AKAP9	16
BP	GO:0032944	regulation of mononuclear cell proliferation	1	1/103	106/10965	0.6340518596688158	0.7085146032690346	0.5641473730181473	0.24860742983226078	SOX11	16
BP	GO:0050866	negative regulation of cell activation	1	1/103	106/10965	0.6340518596688158	0.7085146032690346	0.5641473730181473	0.24860742983226078	SOX11	16
BP	GO:0006813	potassium ion transport	1	1/103	107/10965	0.637522958154322	0.7112039529085568	0.5662887396565532	0.2469620739970687	AKAP9	16
BP	GO:0045047	protein targeting to ER	1	1/103	107/10965	0.637522958154322	0.7112039529085568	0.5662887396565532	0.2469620739970687	SRP14	16
BP	GO:1903052	positive regulation of proteolysis involved in cellular protein catabolic process	1	1/103	107/10965	0.637522958154322	0.7112039529085568	0.5662887396565532	0.2469620739970687	CLU	16
BP	GO:0044843	cell cycle G1/S phase transition	2	2/103	229/10965	0.6377417493830451	0.7112039529085568	0.5662887396565532	0.2469620739970687	TFDP2/SOX4	16
BP	GO:0071496	cellular response to external stimulus	2	2/103	230/10965	0.6401139748570974	0.7134905390941101	0.5681094100898904	0.24556801706622455	SFRP2/GJA1	16
BP	GO:0042177	negative regulation of protein catabolic process	1	1/103	108/10965	0.640961449157279	0.7140761471264762	0.5685756943860127	0.24521170957637436	EPHA4	16
BP	GO:0072599	establishment of protein localization to endoplasmic reticulum	1	1/103	110/10965	0.6477418192788875	0.7212675104677516	0.5743017425418037	0.2408598659839533	SRP14	16
BP	GO:0007584	response to nutrient	1	1/103	111/10965	0.6510842967191707	0.7242618594211748	0.5766859617070532	0.23906062051101754	SFRP2	16
BP	GO:0038127	ERBB signaling pathway	1	1/103	111/10965	0.6510842967191707	0.7242618594211748	0.5766859617070532	0.23906062051101754	SPRY1	16
BP	GO:0050778	positive regulation of immune response	3	3/103	355/10965	0.653081410607744	0.726119100961569	0.5781647709387039	0.23794837453502832	MYO10/CLU/PLEKHA1	16
BP	GO:0051092	positive regulation of NF-kappaB transcription factor activity	1	1/103	112/10965	0.654395363370905	0.7272152985430057	0.5790376068450114	0.23729322916567983	CLU	16
BP	GO:0034599	cellular response to oxidative stress	2	2/103	237/10965	0.6563828287950726	0.7290584826847073	0.5805052230193739	0.23619386840036266	PLEKHA1/TPM1	16
BP	GO:0048284	organelle fusion	1	1/103	113/10965	0.6576753115486251	0.7301282752645478	0.5813570342181927	0.23555706835415033	SYT1	16
BP	GO:0090066	regulation of anatomical structure size	3	3/103	358/10965	0.6587230772142763	0.7309254565485738	0.5819917815122182	0.23508314811487835	GJA1/COTL1/TMSB15A	16
BP	GO:0009152	purine ribonucleotide biosynthetic process	1	1/103	114/10965	0.660924430873219	0.7326347316229632	0.5833527739865201	0.23406873261442285	SCD5	16
BP	GO:0070663	regulation of leukocyte proliferation	1	1/103	114/10965	0.660924430873219	0.7326347316229632	0.5833527739865201	0.23406873261442285	SOX11	16
BP	GO:0010876	lipid localization	2	2/103	240/10965	0.6631757666100874	0.7347629558093771	0.5850473503275291	0.23280898322760576	CLU/MAP2K6	16
BP	GO:0006606	protein import into nucleus	1	1/103	115/10965	0.6641430082965033	0.7350998748843474	0.5853156186316504	0.2326098869655401	ZIC1	16
BP	GO:0016571	histone methylation	1	1/103	115/10965	0.6641430082965033	0.7350998748843474	0.5853156186316504	0.2326098869655401	FEZF2	16
BP	GO:0030335	positive regulation of cell migration	3	3/103	362/10965	0.6661439852378934	0.7369467142077892	0.5867861452064015	0.23152014897231754	IGFBP5/TGFBR1/WNT5B	16
BP	GO:0032434	regulation of proteasomal ubiquitin-dependent protein catabolic process	1	1/103	116/10965	0.6673313281255779	0.7371359141317768	0.5869367936751845	0.2314086647422807	CLU	16
BP	GO:0035264	multicellular organism growth	1	1/103	116/10965	0.6673313281255779	0.7371359141317768	0.5869367936751845	0.2314086647422807	PLEKHA1	16
BP	GO:0042445	hormone metabolic process	1	1/103	116/10965	0.6673313281255779	0.7371359141317768	0.5869367936751845	0.2314086647422807	PLEKHA1	16
BP	GO:0044839	cell cycle G2/M phase transition	2	2/103	242/10965	0.6676449777070852	0.7371359141317768	0.5869367936751845	0.2314086647422807	AKAP9/TUBA1A	16
BP	GO:0002449	lymphocyte mediated immunity	1	1/103	117/10965	0.6704896720469593	0.7391723535196961	0.5885582873264157	0.23021052073776271	CLU	16
BP	GO:0032874	positive regulation of stress-activated MAPK cascade	1	1/103	117/10965	0.6704896720469593	0.7391723535196961	0.5885582873264157	0.23021052073776271	EPHA4	16
BP	GO:0052126	movement in host environment	1	1/103	117/10965	0.6704896720469593	0.7391723535196961	0.5885582873264157	0.23021052073776271	CXADR	16
BP	GO:0009896	positive regulation of catabolic process	3	3/103	366/10965	0.6734489826658243	0.7411473020132253	0.5901308194934732	0.22905170380459264	LRP2/GJA1/CLU	16
BP	GO:0010594	regulation of endothelial cell migration	1	1/103	118/10965	0.6736183191504956	0.7411473020132253	0.5901308194934732	0.22905170380459264	SERPINF1	16
BP	GO:0031348	negative regulation of defense response	1	1/103	118/10965	0.6736183191504956	0.7411473020132253	0.5901308194934732	0.22905170380459264	SERPINF1	16
BP	GO:0050870	positive regulation of T cell activation	1	1/103	118/10965	0.6736183191504956	0.7411473020132253	0.5901308194934732	0.22905170380459264	SOX4	16
BP	GO:0002683	negative regulation of immune system process	2	2/103	245/10965	0.674260118310984	0.7414854574878231	0.5904000722679199	0.2288535980251962	SOX11/DLL1	16
BP	GO:0009132	nucleoside diphosphate metabolic process	1	1/103	119/10965	0.6767175459530677	0.7432868992274737	0.5918344514894349	0.22779975756628706	DDIT4	16
BP	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	1	1/103	119/10965	0.6767175459530677	0.7432868992274737	0.5918344514894349	0.22779975756628706	EPHA4	16
BP	GO:2000147	positive regulation of cell motility	3	3/103	368/10965	0.6770579988349615	0.7432868992274737	0.5918344514894349	0.22779975756628706	IGFBP5/TGFBR1/WNT5B	16
BP	GO:0030001	metal ion transport	4	4/103	487/10965	0.6772393037616133	0.7432868992274737	0.5918344514894349	0.22779975756628706	LRP2/GJA1/AKAP9/SLC6A8	16
BP	GO:0009411	response to UV	1	1/103	120/10965	0.6797876264220732	0.7449773444279467	0.5931804508727615	0.22681317021611955	CIRBP	16
BP	GO:0048015	phosphatidylinositol-mediated signaling	1	1/103	120/10965	0.6797876264220732	0.7449773444279467	0.5931804508727615	0.22681317021611955	PLEKHA1	16
BP	GO:0061025	membrane fusion	1	1/103	120/10965	0.6797876264220732	0.7449773444279467	0.5931804508727615	0.22681317021611955	SYT1	16
BP	GO:0051249	regulation of lymphocyte activation	2	2/103	249/10965	0.6829157890910901	0.7480357235251712	0.59561565337308	0.22503389707798835	SOX11/SOX4	16
BP	GO:0048017	inositol lipid-mediated signaling	1	1/103	122/10965	0.6858414316209926	0.7508693599524646	0.5978719068633682	0.22339185297031747	PLEKHA1	16
BP	GO:0043467	regulation of generation of precursor metabolites and energy	1	1/103	123/10965	0.6888256917466995	0.7537643428442412	0.6001770068370215	0.22172064669037625	DDIT4	16
BP	GO:0051494	negative regulation of cytoskeleton organization	1	1/103	124/10965	0.6917818763759276	0.7566257621733751	0.6024553821735157	0.2200751113976735	TMSB15A	16
BP	GO:0010212	response to ionizing radiation	1	1/103	125/10965	0.6947102470735826	0.7594539535316236	0.6047073000842925	0.21845478851793954	SFRP2	16
BP	GO:0009260	ribonucleotide biosynthetic process	1	1/103	126/10965	0.6976110629916104	0.7614986344915805	0.6063353560014153	0.21728710689512082	SCD5	16
BP	GO:1903039	positive regulation of leukocyte cell-cell adhesion	1	1/103	126/10965	0.6976110629916104	0.7614986344915805	0.6063353560014153	0.21728710689512082	SOX4	16
BP	GO:2000377	regulation of reactive oxygen species metabolic process	1	1/103	126/10965	0.6976110629916104	0.7614986344915805	0.6063353560014153	0.21728710689512082	CLU	16
BP	GO:0009101	glycoprotein biosynthetic process	2	2/103	257/10965	0.6996694276276176	0.7633696461862344	0.6078251295749663	0.2162213486619105	GCNT1/LMAN1	16
BP	GO:0098657	import into cell	1	1/103	127/10965	0.7004845808910352	0.7638830869825012	0.608233951461033	0.21592934131019906	LRP2	16
BP	GO:0031347	regulation of defense response	3	3/103	382/10965	0.7015105107894424	0.7646257632351002	0.6088252996915049	0.21550730878656613	GJA1/SERPINF1/NLRP1	16
BP	GO:0045931	positive regulation of mitotic cell cycle	1	1/103	128/10965	0.7033310551637997	0.7662333903184982	0.6101053560117378	0.21459516239306972	FGF8	16
BP	GO:0034765	regulation of ion transmembrane transport	2	2/103	260/10965	0.7057627058894244	0.7677960695552841	0.6113496230772791	0.2137103512182874	NLGN1/AKAP9	16
BP	GO:0002573	myeloid leukocyte differentiation	1	1/103	129/10965	0.7061507378544087	0.7677960695552841	0.6113496230772791	0.2137103512182874	CA2	16
BP	GO:0006164	purine nucleotide biosynthetic process	1	1/103	129/10965	0.7061507378544087	0.7677960695552841	0.6113496230772791	0.2137103512182874	SCD5	16
BP	GO:0006814	sodium ion transport	1	1/103	129/10965	0.7061507378544087	0.7677960695552841	0.6113496230772791	0.2137103512182874	SLC6A8	16
BP	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	1	1/103	132/10965	0.7144515221157859	0.7764406982993614	0.6182328186729478	0.20884794429010148	CLU	16
BP	GO:0007265	Ras protein signal transduction	2	2/103	265/10965	0.7156919856437207	0.7774077080706168	0.6190027901310089	0.20830739340997895	SPRY1/COL1A2	16
BP	GO:0007034	vacuolar transport	1	1/103	133/10965	0.7171665127206115	0.7782467737159059	0.6196708874114257	0.20783890684139103	CLU	16
BP	GO:0046390	ribose phosphate biosynthetic process	1	1/103	133/10965	0.7171665127206115	0.7782467737159059	0.6196708874114257	0.20783890684139103	SCD5	16
BP	GO:1990778	protein localization to cell periphery	2	2/103	269/10965	0.7234342276305958	0.7846642283057882	0.6247807187848952	0.20427238158679467	MAPK10/CDH2	16
BP	GO:0051170	import into nucleus	1	1/103	136/10965	0.7251590409838459	0.7861504126460569	0.6259640775858497	0.20345058908011476	ZIC1	16
BP	GO:0002244	hematopoietic progenitor cell differentiation	1	1/103	137/10965	0.7277731899152953	0.7878286924034227	0.6273003903618165	0.20252444220612162	SOX4	16
BP	GO:0044272	sulfur compound biosynthetic process	1	1/103	137/10965	0.7277731899152953	0.7878286924034227	0.6273003903618165	0.20252444220612162	SCD5	16
BP	GO:0046651	lymphocyte proliferation	1	1/103	137/10965	0.7277731899152953	0.7878286924034227	0.6273003903618165	0.20252444220612162	SOX11	16
BP	GO:0032943	mononuclear cell proliferation	1	1/103	138/10965	0.7303627135058681	0.7883223640908031	0.6276934713008461	0.2022523884637739	SOX11	16
BP	GO:0046488	phosphatidylinositol metabolic process	1	1/103	138/10965	0.7303627135058681	0.7883223640908031	0.6276934713008461	0.2022523884637739	PLEKHA1	16
BP	GO:0050684	regulation of mRNA processing	1	1/103	138/10965	0.7303627135058681	0.7883223640908031	0.6276934713008461	0.2022523884637739	CIRBP	16
BP	GO:0051924	regulation of calcium ion transport	1	1/103	138/10965	0.7303627135058681	0.7883223640908031	0.6276934713008461	0.2022523884637739	GJA1	16
BP	GO:0072522	purine-containing compound biosynthetic process	1	1/103	138/10965	0.7303627135058681	0.7883223640908031	0.6276934713008461	0.2022523884637739	SCD5	16
BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	1	1/103	138/10965	0.7303627135058681	0.7883223640908031	0.6276934713008461	0.2022523884637739	CLU	16
BP	GO:0043484	regulation of RNA splicing	1	1/103	139/10965	0.7329278414738091	0.7903215099938884	0.6292852704032244	0.201152433606823	CIRBP	16
BP	GO:1990138	neuron projection extension	1	1/103	139/10965	0.7329278414738091	0.7903215099938884	0.6292852704032244	0.201152433606823	SYT1	16
BP	GO:0006479	protein methylation	1	1/103	140/10965	0.7354688014154493	0.7919059411063872	0.6305468571732362	0.20028263461724669	FEZF2	16
BP	GO:0008213	protein alkylation	1	1/103	140/10965	0.7354688014154493	0.7919059411063872	0.6305468571732362	0.20028263461724669	FEZF2	16
BP	GO:0016485	protein processing	1	1/103	140/10965	0.7354688014154493	0.7919059411063872	0.6305468571732362	0.20028263461724669	IMMP1L	16
BP	GO:0009150	purine ribonucleotide metabolic process	2	2/103	276/10965	0.7365599884976832	0.7923112540026026	0.6308695833451389	0.20006041110060446	SCD5/DDIT4	16
BP	GO:0015672	monovalent inorganic cation transport	2	2/103	276/10965	0.7365599884976832	0.7923112540026026	0.6308695833451389	0.20006041110060446	AKAP9/SLC6A8	16
BP	GO:0007088	regulation of mitotic nuclear division	1	1/103	141/10965	0.7379858188246142	0.793460019560703	0.6317842759553209	0.19943118715327582	FGF8	16
BP	GO:0002274	myeloid leukocyte activation	3	3/103	406/10965	0.7401597350998801	0.7954116009289549	0.6333382022922667	0.1983643149975663	CLU/SRP14/COTL1	16
BP	GO:0046578	regulation of Ras protein signal transduction	1	1/103	143/10965	0.742948917623492	0.798022165877559	0.6354168374411445	0.1969412813079042	SPRY1	16
BP	GO:0010948	negative regulation of cell cycle process	2	2/103	280/10965	0.7438226137604426	0.7981871900807848	0.6355482362440832	0.19685148218371143	TFDP2/SOX4	16
BP	GO:0030099	myeloid cell differentiation	2	2/103	280/10965	0.7438226137604426	0.7981871900807848	0.6355482362440832	0.19685148218371143	DLL1/CA2	16
BP	GO:0018394	peptidyl-lysine acetylation	1	1/103	144/10965	0.745395439660526	0.7983293187088821	0.6356614046838048	0.1967741567332992	SOX4	16
BP	GO:0071478	cellular response to radiation	1	1/103	144/10965	0.745395439660526	0.7983293187088821	0.6356614046838048	0.1967741567332992	SFRP2	16
BP	GO:0072330	monocarboxylic acid biosynthetic process	1	1/103	144/10965	0.745395439660526	0.7983293187088821	0.6356614046838048	0.1967741567332992	SCD5	16
BP	GO:0097305	response to alcohol	1	1/103	144/10965	0.745395439660526	0.7983293187088821	0.6356614046838048	0.1967741567332992	TGFBR1	16
BP	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	1	1/103	145/10965	0.7478189004973215	0.8005381469833711	0.6374201611903775	0.1955742041894646	GJA1	16
BP	GO:0060271	cilium assembly	2	2/103	285/10965	0.7526622031575906	0.8053340272202598	0.6412388308754721	0.19298018637353032	AKAP9/TUBA1A	16
BP	GO:0002694	regulation of leukocyte activation	2	2/103	286/10965	0.7543986822298013	0.8068026427899032	0.6424082007258114	0.19218892366456403	SOX11/SOX4	16
BP	GO:0060326	cell chemotaxis	1	1/103	148/10965	0.7549530585388271	0.8070062347061618	0.6425703086685343	0.19207934582360248	CXADR	16
BP	GO:0006109	regulation of carbohydrate metabolic process	1	1/103	149/10965	0.7572864074313574	0.8087205998436028	0.6439353540525232	0.19115773013629173	DDIT4	16
BP	GO:0016052	carbohydrate catabolic process	1	1/103	149/10965	0.7572864074313574	0.8087205998436028	0.6439353540525232	0.19115773013629173	DDIT4	16
BP	GO:0090407	organophosphate biosynthetic process	3	3/103	418/10965	0.7579674346585017	0.809058162078911	0.6442041344663646	0.19097649222951307	SCD5/PLEKHA1/CKB	16
BP	GO:0007281	germ cell development	1	1/103	150/10965	0.7595977517392876	0.8104081884533207	0.6452790789052152	0.19025241526372513	DMRTA1	16
BP	GO:0009259	ribonucleotide metabolic process	2	2/103	290/10965	0.7612411155988563	0.8117708288997906	0.6463640671675562	0.18952279496956548	SCD5/DDIT4	16
BP	GO:0006367	transcription initiation from RNA polymerase II promoter	1	1/103	152/10965	0.7641552466938526	0.814095233983792	0.6482148505048639	0.18828102356848506	NR2F1	16
BP	GO:0051607	defense response to virus	1	1/103	152/10965	0.7641552466938526	0.814095233983792	0.6482148505048639	0.18828102356848506	DDIT4	16
BP	GO:0045333	cellular respiration	1	1/103	154/10965	0.768627164688791	0.8184661018804272	0.6516951085409285	0.18595553869698234	ME3	16
BP	GO:0050851	antigen receptor-mediated signaling pathway	1	1/103	155/10965	0.7708315308008116	0.8204193489128176	0.6532503611455952	0.1849203415034369	PLEKHA1	16
BP	GO:0032535	regulation of cellular component size	2	2/103	297/10965	0.7728231452330808	0.821166492765012	0.6538452666557107	0.1845250158782238	COTL1/TMSB15A	16
BP	GO:0044782	cilium organization	2	2/103	297/10965	0.7728231452330808	0.821166492765012	0.6538452666557107	0.1845250158782238	AKAP9/TUBA1A	16
BP	GO:0051701	interaction with host	1	1/103	156/10965	0.7730150971585836	0.821166492765012	0.6538452666557107	0.1845250158782238	CXADR	16
BP	GO:0051783	regulation of nuclear division	1	1/103	156/10965	0.7730150971585836	0.821166492765012	0.6538452666557107	0.1845250158782238	FGF8	16
BP	GO:0032496	response to lipopolysaccharide	1	1/103	157/10965	0.7751780581163656	0.8230698059597618	0.6553607599622632	0.18351956576420067	GJA1	16
BP	GO:0043488	regulation of mRNA stability	1	1/103	158/10965	0.7773206062301715	0.8248904383440323	0.6568104195346687	0.18255996625628113	CIRBP	16
BP	GO:0019693	ribose phosphate metabolic process	2	2/103	300/10965	0.7776369039869317	0.8248904383440323	0.6568104195346687	0.18255996625628113	SCD5/DDIT4	16
BP	GO:0051090	regulation of DNA-binding transcription factor activity	2	2/103	301/10965	0.7792217963834729	0.8256211088638314	0.6573922083254493	0.1821754476552396	MAPK10/CLU	16
BP	GO:0051251	positive regulation of lymphocyte activation	1	1/103	159/10965	0.7794429322742441	0.8256211088638314	0.6573922083254493	0.1821754476552396	SOX4	16
BP	GO:0071897	DNA biosynthetic process	1	1/103	159/10965	0.7794429322742441	0.8256211088638314	0.6573922083254493	0.1821754476552396	GJA1	16
BP	GO:0002237	response to molecule of bacterial origin	1	1/103	161/10965	0.7836276724390993	0.8292613602851948	0.660290720603125	0.18026480604241563	GJA1	16
BP	GO:0042594	response to starvation	1	1/103	161/10965	0.7836276724390993	0.8292613602851948	0.660290720603125	0.18026480604241563	GALP	16
BP	GO:0006163	purine nucleotide metabolic process	2	2/103	305/10965	0.7854640051750061	0.8308080627256624	0.6615222663110112	0.17945553322514515	SCD5/DDIT4	16
BP	GO:0051321	meiotic cell cycle	1	1/103	163/10965	0.7877337697860641	0.8328115248525055	0.6631175021615991	0.17840950927409832	LFNG	16
BP	GO:0006473	protein acetylation	1	1/103	164/10965	0.7897577858675338	0.8345533895463881	0.6645044437809714	0.1775021104276425	SOX4	16
BP	GO:0050865	regulation of cell activation	2	2/103	309/10965	0.7915524442754522	0.835875180629153	0.6655569061629464	0.1768148057400507	SOX11/SOX4	16
BP	GO:0043487	regulation of RNA stability	1	1/103	165/10965	0.7917626880113764	0.835875180629153	0.6655569061629464	0.1768148057400507	CIRBP	16
BP	GO:0006909	phagocytosis	1	1/103	166/10965	0.7937486549683048	0.8375729500546083	0.6669087373841265	0.17593359271351794	MYO10	16
BP	GO:0061136	regulation of proteasomal protein catabolic process	1	1/103	168/10965	0.7976644900631854	0.8413045549334358	0.6698799889007772	0.1740029955478686	CLU	16
BP	GO:1901617	organic hydroxy compound biosynthetic process	1	1/103	169/10965	0.7995947074868672	0.8429393563948572	0.6711816825364649	0.17315990450636526	PMEL	16
BP	GO:0006612	protein targeting to membrane	1	1/103	170/10965	0.8015066883250344	0.84455338784059	0.6724668382634994	0.17232912740625728	SRP14	16
BP	GO:0031331	positive regulation of cellular catabolic process	2	2/103	317/10965	0.8032787915902053	0.8457450794396959	0.6734157102867175	0.1717167560631018	LRP2/CLU	16
BP	GO:0009266	response to temperature stimulus	1	1/103	171/10965	0.8034006032025258	0.8457450794396959	0.6734157102867175	0.1717167560631018	CIRBP	16
BP	GO:0002696	positive regulation of leukocyte activation	1	1/103	172/10965	0.8052766211634431	0.8469156874380235	0.6743477947124209	0.17111605840986313	SOX4	16
BP	GO:0010632	regulation of epithelial cell migration	1	1/103	172/10965	0.8052766211634431	0.8469156874380235	0.6743477947124209	0.17111605840986313	SERPINF1	16
BP	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	1	1/103	173/10965	0.8071349096856486	0.8484675650891811	0.6755834611279143	0.17032099087841626	LMAN1	16
BP	GO:0072521	purine-containing compound metabolic process	2	2/103	320/10965	0.8075247934783243	0.8484751029106374	0.6755894630397354	0.17031713260515136	SCD5/DDIT4	16
BP	GO:0009165	nucleotide biosynthetic process	1	1/103	174/10965	0.8089756346951352	0.8495968650493201	0.6764826544584716	0.16974333457197172	SCD5	16
BP	GO:0022411	cellular component disassembly	3	3/103	458/10965	0.810385778784227	0.8506748444908293	0.6773409843606204	0.16919264542840337	EPHA4/TGFBR1/DDIT4	16
BP	GO:0043312	neutrophil degranulation	2	2/103	323/10965	0.8116900080184519	0.8514669247320399	0.6779716700024362	0.16878845335811585	SRP14/COTL1	16
BP	GO:0035966	response to topologically incorrect protein	1	1/103	176/10965	0.8126050502058626	0.8514669247320399	0.6779716700024362	0.16878845335811585	CLU	16
BP	GO:1901293	nucleoside phosphate biosynthetic process	1	1/103	176/10965	0.8126050502058626	0.8514669247320399	0.6779716700024362	0.16878845335811585	SCD5	16
BP	GO:0002283	neutrophil activation involved in immune response	2	2/103	324/10965	0.8130606583932019	0.8514669247320399	0.6779716700024362	0.16878845335811585	SRP14/COTL1	16
BP	GO:0018205	peptidyl-lysine modification	2	2/103	324/10965	0.8130606583932019	0.8514669247320399	0.6779716700024362	0.16878845335811585	SOX4/NNAT	16
BP	GO:0061013	regulation of mRNA catabolic process	1	1/103	177/10965	0.8143940649272267	0.8524606430328903	0.6787629078489932	0.16828189846491823	CIRBP	16
BP	GO:0002443	leukocyte mediated immunity	3	3/103	462/10965	0.8150682545199979	0.8527637188630651	0.679004228821955	0.1681275209355204	CLU/SRP14/COTL1	16
BP	GO:0050867	positive regulation of cell activation	1	1/103	178/10965	0.8161661646039504	0.8535096164749802	0.6795981420262288	0.1677478171320964	SOX4	16
BP	GO:0046474	glycerophospholipid biosynthetic process	1	1/103	179/10965	0.8179215076136651	0.8541365908523295	0.6800973638436753	0.1674289085391519	PLEKHA1	16
BP	GO:0048588	developmental cell growth	1	1/103	179/10965	0.8179215076136651	0.8541365908523295	0.6800973638436753	0.1674289085391519	SYT1	16
BP	GO:1903037	regulation of leukocyte cell-cell adhesion	1	1/103	179/10965	0.8179215076136651	0.8541365908523295	0.6800973638436753	0.1674289085391519	SOX4	16
BP	GO:0042119	neutrophil activation	2	2/103	328/10965	0.8184556202750752	0.8542919539311873	0.6802210700769656	0.167349919776957	SRP14/COTL1	16
BP	GO:0031667	response to nutrient levels	2	2/103	330/10965	0.8211011116931323	0.8566499598229056	0.6820986077074342	0.16615283694531519	SFRP2/GALP	16
BP	GO:0002446	neutrophil mediated immunity	2	2/103	331/10965	0.8224110084417056	0.8571100676999774	0.6824649638121038	0.16591963939876891	SRP14/COTL1	16
BP	GO:0036230	granulocyte activation	2	2/103	331/10965	0.8224110084417056	0.8571100676999774	0.6824649638121038	0.16591963939876891	SRP14/COTL1	16
BP	GO:0048872	homeostasis of number of cells	1	1/103	182/10965	0.8230885584723735	0.8571100676999774	0.6824649638121038	0.16591963939876891	CDH2	16
BP	GO:0051091	positive regulation of DNA-binding transcription factor activity	1	1/103	182/10965	0.8230885584723735	0.8571100676999774	0.6824649638121038	0.16591963939876891	CLU	16
BP	GO:0031668	cellular response to extracellular stimulus	1	1/103	184/10965	0.8264523138401776	0.8602088167998467	0.6849323105065371	0.1643523462098466	SFRP2	16
BP	GO:0098655	cation transmembrane transport	3	3/103	473/10965	0.8274492153816115	0.8608422855471763	0.6854367033984354	0.16403264391457842	NLGN1/AKAP9/SLC6A8	16
BP	GO:0002250	adaptive immune response	1	1/103	186/10965	0.8297527207412639	0.8620252023820909	0.6863785886070634	0.1634362726460035	CLU	16
BP	GO:0046777	protein autophosphorylation	1	1/103	186/10965	0.8297527207412639	0.8620252023820909	0.6863785886070634	0.1634362726460035	EPHA4	16
BP	GO:0050863	regulation of T cell activation	1	1/103	186/10965	0.8297527207412639	0.8620252023820909	0.6863785886070634	0.1634362726460035	SOX4	16
BP	GO:0030522	intracellular receptor signaling pathway	1	1/103	187/10965	0.8313795386059684	0.8633107433674154	0.6874021872265297	0.16278909032666478	MAP2K6	16
BP	GO:0006352	DNA-templated transcription, initiation	1	1/103	188/10965	0.8329909607180102	0.8645791010823167	0.6884121038459013	0.16215150239550477	NR2F1	16
BP	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	1	1/103	190/10965	0.8361681934894433	0.8674706995629835	0.69071450901746	0.16070142119084235	GJA1	16
BP	GO:0043299	leukocyte degranulation	2	2/103	348/10965	0.8434116927637061	0.8745761098489879	0.6963721179482719	0.1571586259286625	SRP14/COTL1	16
BP	GO:0031349	positive regulation of defense response	1	1/103	196/10965	0.845345126743044	0.8761607418648865	0.6976338646855231	0.15637244595237101	GJA1	16
BP	GO:1901615	organic hydroxy compound metabolic process	2	2/103	350/10965	0.8457302605281267	0.8761607418648865	0.6976338646855231	0.15637244595237101	LRP2/PMEL	16
BP	GO:0009991	response to extracellular stimulus	2	2/103	351/10965	0.8468779522120127	0.8769399439766614	0.6982542962509134	0.15598638347182028	SFRP2/GALP	16
BP	GO:0002275	myeloid cell activation involved in immune response	2	2/103	353/10965	0.8491503570261694	0.8788825123842287	0.6998010461117923	0.15502541263870928	SRP14/COTL1	16
BP	GO:1901137	carbohydrate derivative biosynthetic process	3	3/103	495/10965	0.8501201197644253	0.8794756441986611	0.7002733211410178	0.15473241899250006	SCD5/GCNT1/LMAN1	16
BP	GO:0002697	regulation of immune effector process	1	1/103	201/10965	0.8526022935587563	0.8812211118040852	0.7016631315411774	0.15387134260882143	CLU	16
BP	GO:0043543	protein acylation	1	1/103	201/10965	0.8526022935587563	0.8812211118040852	0.7016631315411774	0.15387134260882143	SOX4	16
BP	GO:0045017	glycerolipid biosynthetic process	1	1/103	203/10965	0.855409804651079	0.883710874609246	0.7036455792416048	0.15264603650850544	PLEKHA1	16
BP	GO:0044262	cellular carbohydrate metabolic process	1	1/103	204/10965	0.856793635734608	0.8847282209704825	0.7044556306851361	0.1521463552237904	DDIT4	16
BP	GO:0002444	myeloid leukocyte mediated immunity	2	2/103	361/10965	0.8579395920021677	0.8854991040357569	0.7050694382964008	0.15176810969806073	SRP14/COTL1	16
BP	GO:0043087	regulation of GTPase activity	2	2/103	363/10965	0.8600634279636454	0.887278092040671	0.7064859389655083	0.15089647739710504	EPHA4/SPRY1	16
BP	GO:0007249	I-kappaB kinase/NF-kappaB signaling	1	1/103	211/10965	0.8661199959920867	0.8928436576169195	0.7109174625850837	0.14818081787023288	GJA1	16
BP	GO:0009117	nucleotide metabolic process	2	2/103	369/10965	0.8662637381750086	0.8928436576169195	0.7109174625850837	0.14818081787023288	SCD5/DDIT4	16
BP	GO:0008654	phospholipid biosynthetic process	1	1/103	212/10965	0.8674022761123039	0.8936016943034284	0.7115210414010632	0.14781225224975575	PLEKHA1	16
BP	GO:0015980	energy derivation by oxidation of organic compounds	1	1/103	213/10965	0.8686723928760379	0.8944945169559574	0.7122319421385658	0.1473785530102028	ME3	16
BP	GO:0006753	nucleoside phosphate metabolic process	2	2/103	373/10965	0.8702577814200255	0.8957110034392742	0.7132005568300751	0.14678832642190093	SCD5/DDIT4	16
BP	GO:0046034	ATP metabolic process	1	1/103	221/10965	0.8784089363463077	0.903681026394322	0.7195466045928725	0.1429410718287913	DDIT4	16
BP	GO:0006091	generation of precursor metabolites and energy	2	2/103	384/10965	0.880688458987043	0.9039706590540537	0.7197772215813918	0.1428019013591821	DDIT4/ME3	16
BP	GO:0015931	nucleobase-containing compound transport	1	1/103	223/10965	0.8807291942069265	0.9039706590540537	0.7197772215813918	0.1428019013591821	GJA1	16
BP	GO:0034504	protein localization to nucleus	1	1/103	223/10965	0.8807291942069265	0.9039706590540537	0.7197772215813918	0.1428019013591821	ZIC1	16
BP	GO:0046394	carboxylic acid biosynthetic process	1	1/103	223/10965	0.8807291942069265	0.9039706590540537	0.7197772215813918	0.1428019013591821	SCD5	16
BP	GO:0072659	protein localization to plasma membrane	1	1/103	223/10965	0.8807291942069265	0.9039706590540537	0.7197772215813918	0.1428019013591821	CDH2	16
BP	GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process	2	2/103	385/10965	0.8815977128985258	0.9043071486118675	0.7200451478869508	0.14264027181393893	UBE3D/CLU	16
BP	GO:0016053	organic acid biosynthetic process	1	1/103	224/10965	0.8818728260256461	0.9043071486118675	0.7200451478869508	0.14264027181393893	SCD5	16
BP	GO:0016579	protein deubiquitination	1	1/103	226/10965	0.8841276109046418	0.9062001448800697	0.7215524264482003	0.14173210852061396	TGFBR1	16
BP	GO:0006816	calcium ion transport	1	1/103	230/10965	0.8885100922021827	0.9102711988965985	0.7247939608050689	0.13978543398461063	GJA1	16
BP	GO:0007264	small GTPase mediated signal transduction	2	2/103	401/10965	0.895309267153489	0.9168132310758824	0.7300029857865084	0.13667536356727988	SPRY1/COL1A2	16
BP	GO:0071375	cellular response to peptide hormone stimulus	1	1/103	237/10965	0.8957879938001667	0.9168799548730239	0.7300561139149924	0.13664375765071204	CA2	16
BP	GO:0043414	macromolecule methylation	1	1/103	238/10965	0.8967885378567088	0.9174804745862128	0.730534271481651	0.13635940523791387	FEZF2	16
BP	GO:0034976	response to endoplasmic reticulum stress	1	1/103	243/10965	0.9016503290383869	0.9216038632909652	0.7338174767889034	0.134411949185961	CLU	16
BP	GO:0070646	protein modification by small protein removal	1	1/103	243/10965	0.9016503290383869	0.9216038632909652	0.7338174767889034	0.134411949185961	TGFBR1	16
BP	GO:0098662	inorganic cation transmembrane transport	2	2/103	410/10965	0.9023651214058432	0.9219094350952787	0.7340607851552748	0.1342679760996047	AKAP9/SLC6A8	16
BP	GO:0006631	fatty acid metabolic process	1	1/103	246/10965	0.9044578112515402	0.9236218183070773	0.7354242524516148	0.13346205228570976	SCD5	16
BP	GO:0019058	viral life cycle	1	1/103	250/10965	0.9080780173956001	0.9264652391008033	0.737688296641762	0.13212710652971935	CXADR	16
BP	GO:0140014	mitotic nuclear division	1	1/103	250/10965	0.9080780173956001	0.9264652391008033	0.737688296641762	0.13212710652971935	FGF8	16
BP	GO:0006650	glycerophospholipid metabolic process	1	1/103	252/10965	0.9098368406334516	0.9274061037629251	0.7384374503290011	0.13168628590035655	PLEKHA1	16
BP	GO:0051056	regulation of small GTPase mediated signal transduction	1	1/103	252/10965	0.9098368406334516	0.9274061037629251	0.7384374503290011	0.13168628590035655	SPRY1	16
BP	GO:0055086	nucleobase-containing small molecule metabolic process	2	2/103	431/10965	0.9171551194142886	0.9344360752488409	0.7440349919010071	0.12840663914207662	SCD5/DDIT4	16
BP	GO:0006790	sulfur compound metabolic process	1	1/103	263/10965	0.9189310532160624	0.935117753474798	0.7445777710881164	0.12808993351901501	SCD5	16
BP	GO:0070838	divalent metal ion transport	1	1/103	263/10965	0.9189310532160624	0.935117753474798	0.7445777710881164	0.12808993351901501	GJA1	16
BP	GO:0010498	proteasomal protein catabolic process	2	2/103	434/10965	0.9190895736678326	0.935117753474798	0.7445777710881164	0.12808993351901501	UBE3D/CLU	16
BP	GO:0001666	response to hypoxia	1	1/103	266/10965	0.9212495246103484	0.9364558441362413	0.745643211839839	0.1274689315019861	DDIT4	16
BP	GO:0072511	divalent inorganic cation transport	1	1/103	266/10965	0.9212495246103484	0.9364558441362413	0.745643211839839	0.1274689315019861	GJA1	16
BP	GO:0019221	cytokine-mediated signaling pathway	2	2/103	442/10965	0.9240446163379332	0.938436515996884	0.7472203011783466	0.12655133729996393	SOX2/COL1A2	16
BP	GO:0045087	innate immune response	2	2/103	442/10965	0.9240446163379332	0.938436515996884	0.7472203011783466	0.12655133729996393	CLU/NLRP1	16
BP	GO:0032259	methylation	1	1/103	273/10965	0.9264070470864688	0.9404049557649731	0.7487876508405669	0.12564132668451178	FEZF2	16
BP	GO:0098660	inorganic ion transmembrane transport	2	2/103	448/10965	0.9275736878881233	0.9411582910974688	0.7493874862523825	0.12529356330642366	AKAP9/SLC6A8	16
BP	GO:0036293	response to decreased oxygen levels	1	1/103	276/10965	0.9285136639298981	0.941681058066141	0.7498037340060861	0.12505240113212523	DDIT4	16
BP	GO:0032103	positive regulation of response to external stimulus	1	1/103	280/10965	0.9312298587481106	0.944003930884573	0.7516532972928941	0.12398243306917626	TUBB2B	16
BP	GO:0051052	regulation of DNA metabolic process	1	1/103	282/10965	0.9325493743958918	0.9449094895044298	0.7523743389117244	0.1235660252682386	GJA1	16
BP	GO:0032984	protein-containing complex disassembly	1	1/103	284/10965	0.9338438131852409	0.94578882313005	0.7530744991520517	0.12316205836739398	DDIT4	16
BP	GO:0070482	response to oxygen levels	1	1/103	296/10965	0.9411096565952752	0.9527123783889156	0.7585873079116927	0.11999442784734311	DDIT4	16
BP	GO:0046486	glycerolipid metabolic process	1	1/103	299/10965	0.9427990067753085	0.9535517326737495	0.7592556350183406	0.11961197616532546	PLEKHA1	16
BP	GO:1903311	regulation of mRNA metabolic process	1	1/103	299/10965	0.9427990067753085	0.9535517326737495	0.7592556350183406	0.11961197616532546	CIRBP	16
BP	GO:0000209	protein polyubiquitination	1	1/103	302/10965	0.9444403527310488	0.9543410492273178	0.7598841201026574	0.11925263118902624	UBE3D	16
BP	GO:0006913	nucleocytoplasmic transport	1	1/103	302/10965	0.9444403527310488	0.9543410492273178	0.7598841201026574	0.11925263118902624	ZIC1	16
BP	GO:0051169	nuclear transport	1	1/103	305/10965	0.9460350455444623	0.9555169457731538	0.7608204154792296	0.11871784227067349	ZIC1	16
BP	GO:0006644	phospholipid metabolic process	1	1/103	317/10965	0.9519730105356924	0.9610765775763342	0.765247214393805	0.11619824262001173	PLEKHA1	16
BP	GO:0000377	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	1	1/103	325/10965	0.955567317148498	0.9638010838793964	0.7674165741593657	0.11496882542930448	CIRBP	16
BP	GO:0000398	mRNA splicing, via spliceosome	1	1/103	325/10965	0.955567317148498	0.9638010838793964	0.7674165741593657	0.11496882542930448	CIRBP	16
BP	GO:0048193	Golgi vesicle transport	1	1/103	326/10965	0.9559974455633198	0.9638010838793964	0.7674165741593657	0.11496882542930448	LMAN1	16
BP	GO:0000375	RNA splicing, via transesterification reactions	1	1/103	328/10965	0.9568453701481965	0.9638010838793964	0.7674165741593657	0.11496882542930448	CIRBP	16
BP	GO:0062012	regulation of small molecule metabolic process	1	1/103	328/10965	0.9568453701481965	0.9638010838793964	0.7674165741593657	0.11496882542930448	DDIT4	16
BP	GO:0006402	mRNA catabolic process	1	1/103	331/10965	0.95808700819962	0.9645841683642619	0.7680400970238906	0.11461610619030455	CIRBP	16
BP	GO:0000280	nuclear division	1	1/103	332/10965	0.9584929737963324	0.9645841683642619	0.7680400970238906	0.11461610619030455	FGF8	16
BP	GO:0006401	RNA catabolic process	1	1/103	361/10965	0.968713045930728	0.9744268706118075	0.7758772461676526	0.11020698432050831	CIRBP	16
BP	GO:0048285	organelle fission	1	1/103	369/10965	0.9710639299892485	0.9763486316490538	0.7774074283766415	0.1093513138622368	FGF8	16
BP	GO:0016570	histone modification	1	1/103	389/10965	0.9762032595039065	0.9810710001451318	0.7811675651038084	0.10725579737198658	FEZF2	16
BP	GO:0016569	covalent chromatin modification	1	1/103	398/10965	0.9782103687611396	0.9826426767301526	0.7824189962141661	0.10656061393257278	FEZF2	16
BP	GO:0008380	RNA splicing	1	1/103	410/10965	0.980627956153888	0.9846250809751674	0.7839974649456857	0.10568534160367382	CIRBP	16
BP	GO:0005975	carbohydrate metabolic process	1	1/103	439/10965	0.9854284999845322	0.9889972768065677	0.7874787803359751	0.10376114002363912	DDIT4	16
BP	GO:0006914	autophagy	1	1/103	450/10965	0.9869230966398934	0.989601313998482	0.787959738658431	0.10349597251701947	CLU	16
BP	GO:0061919	process utilizing autophagic mechanism	1	1/103	450/10965	0.9869230966398934	0.989601313998482	0.787959738658431	0.10349597251701947	CLU	16
BP	GO:0006397	mRNA processing	1	1/103	459/10965	0.9880322050637147	0.9902655509160289	0.7884886303853857	0.1032045646007577	CIRBP	16
BP	GO:0034655	nucleobase-containing compound catabolic process	1	1/103	463/10965	0.9884947385832774	0.9902814439399577	0.7885012850401485	0.10319759455398671	CIRBP	16
BP	GO:0046700	heterocycle catabolic process	1	1/103	483/10965	0.9905548283379354	0.9916108303451379	0.7895597951184846	0.10261497432364834	CIRBP	16
BP	GO:0044270	cellular nitrogen compound catabolic process	1	1/103	485/10965	0.9907395485880263	0.9916108303451379	0.7895597951184846	0.10261497432364834	CIRBP	16
BP	GO:0019439	aromatic compound catabolic process	1	1/103	490/10965	0.9911858443928478	0.9916108303451379	0.7895597951184846	0.10261497432364834	CIRBP	16
BP	GO:0044283	small molecule biosynthetic process	1	1/103	495/10965	0.9916108303451379	0.9916108303451379	0.7895597951184846	0.10261497432364834	SCD5	16
MF	GO:0030165	PDZ domain binding	5	5/100	67/11258	3.122718004549107e-4	0.04347929340968326	0.03960664379424589	1.4022319574794235	NLGN1/GJA1/FZD3/PLEKHA1/CXADR	16
MF	GO:0005539	glycosaminoglycan binding	6	6/100	105/11258	3.344561031514097e-4	0.04347929340968326	0.03960664379424589	1.4022319574794235	COL11A1/DPYSL3/RSPO3/SULF1/NELL2/SMOC1	16
MF	GO:0005509	calcium ion binding	11	11/100	396/11258	7.560487544321705e-4	0.04884531666878269	0.04449472166184658	1.3516915056279983	VSNL1/LRP2/DLL1/SULF1/NCALD/SYT1/NELL2/SMOC1/DLK1/CDH2/PCDH19	16
MF	GO:0001228	DNA-binding transcription activator activity, RNA polymerase II-specific	10	10/100	341/11258	8.786119751993067e-4	0.04884531666878269	0.04449472166184658	1.3516915056279983	SOX11/ZIC1/SOX2/FEZF2/TFDP2/SOX4/PAX6/OTX2/ZNF521/RAX	16
MF	GO:0001216	DNA-binding transcription activator activity	10	10/100	344/11258	9.393330128612056e-4	0.04884531666878269	0.04449472166184658	1.3516915056279983	SOX11/ZIC1/SOX2/FEZF2/TFDP2/SOX4/PAX6/OTX2/ZNF521/RAX	16
MF	GO:0031994	insulin-like growth factor I binding	2	2/100	10/11258	0.003355722533121203	0.13957458863818845	0.12714284390118383	0.8957080786002448	LRP2/IGFBP5	16
MF	GO:0005104	fibroblast growth factor receptor binding	2	2/100	11/11258	0.004077759664864637	0.13957458863818845	0.12714284390118383	0.8957080786002448	FGF8/NPTN	16
MF	GO:0016538	cyclin-dependent protein serine/threonine kinase regulator activity	3	3/100	38/11258	0.0045791350756519515	0.13957458863818845	0.12714284390118383	0.8957080786002448	CCNG2/CCNI/CDKN1C	16
MF	GO:0008201	heparin binding	4	4/100	77/11258	0.004831428068244985	0.13957458863818845	0.12714284390118383	0.8957080786002448	COL11A1/RSPO3/NELL2/SMOC1	16
MF	GO:0072349	modified amino acid transmembrane transporter activity	2	2/100	13/11258	0.005716490204409911	0.1486287453146577	0.13539055747286632	0.8684116235417767	GJA1/SLC6A8	16
MF	GO:0019838	growth factor binding	4	4/100	87/11258	0.00743008510463234	0.16481586789489877	0.150135912050009	0.823515413421634	LRP2/IGFBP5/COL1A2/TGFBR1	16
MF	GO:0050750	low-density lipoprotein particle receptor binding	2	2/100	15/11258	0.007606886210533789	0.16481586789489877	0.150135912050009	0.823515413421634	CLU/SYT1	16
MF	GO:0004708	MAP kinase kinase activity	2	2/100	16/11258	0.008643563293123407	0.1666174487385042	0.15177702820309089	0.8187939549200097	MAPK10/MAP2K6	16
MF	GO:0005520	insulin-like growth factor binding	2	2/100	17/11258	0.009739712676590536	0.1666174487385042	0.15177702820309089	0.8187939549200097	LRP2/IGFBP5	16
MF	GO:0001540	amyloid-beta binding	3	3/100	51/11258	0.010403747974739374	0.1666174487385042	0.15177702820309089	0.8187939549200097	EPHA4/NLGN1/CLU	16
MF	GO:1901681	sulfur compound binding	5	5/100	149/11258	0.010455211202181647	0.1666174487385042	0.15177702820309089	0.8187939549200097	COL11A1/DPYSL3/RSPO3/NELL2/SMOC1	16
MF	GO:0070325	lipoprotein particle receptor binding	2	2/100	18/11258	0.010894217802132967	0.1666174487385042	0.15177702820309089	0.8187939549200097	CLU/SYT1	16
MF	GO:0001968	fibronectin binding	2	2/100	19/11258	0.012105976908048235	0.17486411089403006	0.15928916984273994	0.7978137511130465	IGFBP5/SFRP2	16
MF	GO:0017147	Wnt-protein binding	2	2/100	23/11258	0.017504026303721488	0.23952878099829406	0.21819423370289942	0.6611567308517197	SFRP2/FZD3	16
MF	GO:0005109	frizzled binding	2	2/100	25/11258	0.02051898832872216	0.24218144486923104	0.22061062791731573	0.6563735692545626	RSPO3/WNT5B	16
MF	GO:0030020	extracellular matrix structural constituent conferring tensile strength	2	2/100	25/11258	0.02051898832872216	0.24218144486923104	0.22061062791731573	0.6563735692545626	COL11A1/COL1A2	16
MF	GO:0005200	structural constituent of cytoskeleton	3	3/100	66/11258	0.020784571387391447	0.24218144486923104	0.22061062791731573	0.6563735692545626	TUBB2B/TUBA1A/TPM1	16
MF	GO:0046332	SMAD binding	3	3/100	67/11258	0.0216216314855547	0.24218144486923104	0.22061062791731573	0.6563735692545626	COL1A2/TGFBR1/PAX6	16
MF	GO:0003779	actin binding	7	7/100	321/11258	0.024044391014369924	0.24218144486923104	0.22061062791731573	0.6563735692545626	MYO10/PDLIM7/NCALD/TPM1/COTL1/TNNI3/TMSB15A	16
MF	GO:0001227	DNA-binding transcription repressor activity, RNA polymerase II-specific	6	6/100	253/11258	0.025065171545321924	0.24218144486923104	0.22061062791731573	0.6563735692545626	FEZF2/NR2F1/FEZF1/EMX2/PAX6/ETS2	16
MF	GO:0035198	miRNA binding	2	2/100	28/11258	0.02541355553701083	0.24218144486923104	0.22061062791731573	0.6563735692545626	SOX2/SOX4	16
MF	GO:0001217	DNA-binding transcription repressor activity	6	6/100	254/11258	0.025492664573115102	0.24218144486923104	0.22061062791731573	0.6563735692545626	FEZF2/NR2F1/FEZF1/EMX2/PAX6/ETS2	16
MF	GO:0008013	beta-catenin binding	3	3/100	72/11258	0.02608107867822488	0.24218144486923104	0.22061062791731573	0.6563735692545626	GJA1/CDH2/CXADR	16
MF	GO:0016504	peptidase activator activity	2	2/100	30/11258	0.028913294842228678	0.2592226434130847	0.2361339869147533	0.6268415001417241	SFRP2/NLRP1	16
MF	GO:0061980	regulatory RNA binding	2	2/100	34/11258	0.03644698828887159	0.3158738985035538	0.28773938122793363	0.5410006946632684	SOX2/SOX4	16
MF	GO:0005516	calmodulin binding	4	4/100	143/11258	0.03838784956877232	0.3219626092864775	0.29328577769011116	0.5327089967550935	MYO10/MAP6/SYT1/PNCK	16
MF	GO:0050840	extracellular matrix binding	2	2/100	36/11258	0.0404664528304583	0.3252773331969465	0.29630526303365573	0.5282606344255343	COL11A1/SMOC1	16
MF	GO:0051015	actin filament binding	4	4/100	147/11258	0.04179724216740315	0.3252773331969465	0.29630526303365573	0.5282606344255343	MYO10/TPM1/COTL1/TNNI3	16
MF	GO:0008375	acetylglucosaminyltransferase activity	2	2/100	37/11258	0.042536266648831464	0.3252773331969465	0.29630526303365573	0.5282606344255343	LFNG/GCNT1	16
MF	GO:0098632	cell-cell adhesion mediator activity	2	2/100	39/11258	0.04679180211221621	0.34759624426217756	0.31663625489469616	0.49943935984872745	NPTN/CXADR	16
MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	2	2/100	43/11258	0.05574340582696109	0.3773039974955653	0.34369797342713443	0.46382302861927016	MAPK10/MAP2K6	16
MF	GO:0016836	hydro-lyase activity	2	2/100	43/11258	0.05574340582696109	0.3773039974955653	0.34369797342713443	0.46382302861927016	CA2/CA4	16
MF	GO:0098631	cell adhesion mediator activity	2	2/100	46/11258	0.06281747717790027	0.3773039974955653	0.34369797342713443	0.46382302861927016	NPTN/CXADR	16
MF	GO:0042277	peptide binding	4	4/100	169/11258	0.0635192961593274	0.3773039974955653	0.34369797342713443	0.46382302861927016	EPHA4/NLGN1/CLU/SRP14	16
MF	GO:0048018	receptor ligand activity	4	4/100	172/11258	0.06686625436405873	0.3773039974955653	0.34369797342713443	0.46382302861927016	SFRP2/FGF8/WNT5B/GALP	16
MF	GO:0097110	scaffold protein binding	2	2/100	48/11258	0.06769362979064159	0.3773039974955653	0.34369797342713443	0.46382302861927016	NLGN1/DLL1	16
MF	GO:0030546	signaling receptor activator activity	4	4/100	176/11258	0.07146959130222724	0.3773039974955653	0.34369797342713443	0.46382302861927016	SFRP2/FGF8/WNT5B/GALP	16
MF	GO:0030276	clathrin binding	2	2/100	51/11258	0.07523332047432356	0.3773039974955653	0.34369797342713443	0.46382302861927016	NCALD/SYT1	16
MF	GO:0048306	calcium-dependent protein binding	2	2/100	51/11258	0.07523332047432356	0.3773039974955653	0.34369797342713443	0.46382302861927016	SYT1/TNNI3	16
MF	GO:0061134	peptidase regulator activity	3	3/100	111/11258	0.0759967246982477	0.3773039974955653	0.34369797342713443	0.46382302861927016	SFRP2/SERPINF1/NLRP1	16
MF	GO:0017124	SH3 domain binding	3	3/100	114/11258	0.0808684694256789	0.3773039974955653	0.34369797342713443	0.46382302861927016	LRP2/DPYSL3/GJA1	16
MF	GO:0001162	RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding	1	1/100	10/11258	0.08539080998615245	0.3773039974955653	0.34369797342713443	0.46382302861927016	EMX2	16
MF	GO:0005024	transforming growth factor beta-activated receptor activity	1	1/100	10/11258	0.08539080998615245	0.3773039974955653	0.34369797342713443	0.46382302861927016	TGFBR1	16
MF	GO:0008656	cysteine-type endopeptidase activator activity involved in apoptotic process	1	1/100	10/11258	0.08539080998615245	0.3773039974955653	0.34369797342713443	0.46382302861927016	NLRP1	16
MF	GO:0030957	Tat protein binding	1	1/100	10/11258	0.08539080998615245	0.3773039974955653	0.34369797342713443	0.46382302861927016	DLL1	16
MF	GO:0042043	neurexin family protein binding	1	1/100	10/11258	0.08539080998615245	0.3773039974955653	0.34369797342713443	0.46382302861927016	NLGN1	16
MF	GO:0048407	platelet-derived growth factor binding	1	1/100	10/11258	0.08539080998615245	0.3773039974955653	0.34369797342713443	0.46382302861927016	COL1A2	16
MF	GO:0051371	muscle alpha-actinin binding	1	1/100	10/11258	0.08539080998615245	0.3773039974955653	0.34369797342713443	0.46382302861927016	PDLIM7	16
MF	GO:0070181	small ribosomal subunit rRNA binding	1	1/100	10/11258	0.08539080998615245	0.3773039974955653	0.34369797342713443	0.46382302861927016	CIRBP	16
MF	GO:0070410	co-SMAD binding	1	1/100	10/11258	0.08539080998615245	0.3773039974955653	0.34369797342713443	0.46382302861927016	PAX6	16
MF	GO:0071837	HMG box domain binding	1	1/100	10/11258	0.08539080998615245	0.3773039974955653	0.34369797342713443	0.46382302861927016	PAX6	16
MF	GO:0016835	carbon-oxygen lyase activity	2	2/100	57/11258	0.09105514007901427	0.3773039974955653	0.34369797342713443	0.46382302861927016	CA2/CA4	16
MF	GO:0019199	transmembrane receptor protein kinase activity	2	2/100	57/11258	0.09105514007901427	0.3773039974955653	0.34369797342713443	0.46382302861927016	EPHA4/TGFBR1	16
MF	GO:0030545	receptor regulator activity	4	4/100	193/11258	0.0927807447687622	0.3773039974955653	0.34369797342713443	0.46382302861927016	SFRP2/FGF8/WNT5B/GALP	16
MF	GO:0005523	tropomyosin binding	1	1/100	11/11258	0.09352211501828167	0.3773039974955653	0.34369797342713443	0.46382302861927016	TNNT1	16
MF	GO:0022829	wide pore channel activity	1	1/100	11/11258	0.09352211501828167	0.3773039974955653	0.34369797342713443	0.46382302861927016	GJA1	16
MF	GO:0035091	phosphatidylinositol binding	4	4/100	195/11258	0.0954682533877775	0.3773039974955653	0.34369797342713443	0.46382302861927016	WDFY1/MYO10/PLEKHA1/SYT1	16
MF	GO:1901981	phosphatidylinositol phosphate binding	3	3/100	124/11258	0.09804631606247646	0.3773039974955653	0.34369797342713443	0.46382302861927016	MYO10/PLEKHA1/SYT1	16
MF	GO:0001161	intronic transcription regulatory region sequence-specific DNA binding	1	1/100	12/11258	0.10158184547957527	0.3773039974955653	0.34369797342713443	0.46382302861927016	EMX2	16
MF	GO:0005005	transmembrane-ephrin receptor activity	1	1/100	12/11258	0.10158184547957527	0.3773039974955653	0.34369797342713443	0.46382302861927016	EPHA4	16
MF	GO:0005545	1-phosphatidylinositol binding	1	1/100	12/11258	0.10158184547957527	0.3773039974955653	0.34369797342713443	0.46382302861927016	WDFY1	16
MF	GO:0008484	sulfuric ester hydrolase activity	1	1/100	12/11258	0.10158184547957527	0.3773039974955653	0.34369797342713443	0.46382302861927016	SULF1	16
MF	GO:0016505	peptidase activator activity involved in apoptotic process	1	1/100	12/11258	0.10158184547957527	0.3773039974955653	0.34369797342713443	0.46382302861927016	NLRP1	16
MF	GO:0048185	activin binding	1	1/100	12/11258	0.10158184547957527	0.3773039974955653	0.34369797342713443	0.46382302861927016	TGFBR1	16
MF	GO:0086080	protein binding involved in heterotypic cell-cell adhesion	1	1/100	12/11258	0.10158184547957527	0.3773039974955653	0.34369797342713443	0.46382302861927016	CXADR	16
MF	GO:0005003	ephrin receptor activity	1	1/100	13/11258	0.10957062508583926	0.37984483363090943	0.34601250027107133	0.4609082113208498	EPHA4	16
MF	GO:0005343	organic acid:sodium symporter activity	1	1/100	13/11258	0.10957062508583926	0.37984483363090943	0.34601250027107133	0.4609082113208498	SLC6A8	16
MF	GO:0035259	glucocorticoid receptor binding	1	1/100	13/11258	0.10957062508583926	0.37984483363090943	0.34601250027107133	0.4609082113208498	ETS2	16
MF	GO:0042813	Wnt-activated receptor activity	1	1/100	13/11258	0.10957062508583926	0.37984483363090943	0.34601250027107133	0.4609082113208498	FZD3	16
MF	GO:0070411	I-SMAD binding	1	1/100	13/11258	0.10957062508583926	0.37984483363090943	0.34601250027107133	0.4609082113208498	TGFBR1	16
MF	GO:0005112	Notch binding	1	1/100	14/11258	0.11748907217267046	0.3949536645659945	0.35977560537388165	0.443968287379245	DLL1	16
MF	GO:0050431	transforming growth factor beta binding	1	1/100	14/11258	0.11748907217267046	0.3949536645659945	0.35977560537388165	0.443968287379245	TGFBR1	16
MF	GO:0016829	lyase activity	3	3/100	135/11258	0.11848609936979836	0.3949536645659945	0.35977560537388165	0.443968287379245	CA2/ME3/CA4	16
MF	GO:0004675	transmembrane receptor protein serine/threonine kinase activity	1	1/100	15/11258	0.12533779974139458	0.3974125357653975	0.3620154678024876	0.44127287300894824	TGFBR1	16
MF	GO:0031681	G-protein beta-subunit binding	1	1/100	15/11258	0.12533779974139458	0.3974125357653975	0.3620154678024876	0.44127287300894824	GNG8	16
MF	GO:0042056	chemoattractant activity	1	1/100	15/11258	0.12533779974139458	0.3974125357653975	0.3620154678024876	0.44127287300894824	FGF8	16
MF	GO:0051393	alpha-actinin binding	1	1/100	15/11258	0.12533779974139458	0.3974125357653975	0.3620154678024876	0.44127287300894824	PDLIM7	16
MF	GO:0019887	protein kinase regulator activity	3	3/100	142/11258	0.1322534272785906	0.4023672055181828	0.3665288309376159	0.435891858336223	CCNG2/CCNI/CDKN1C	16
MF	GO:0004707	MAP kinase activity	1	1/100	16/11258	0.13311741550461242	0.4023672055181828	0.3665288309376159	0.435891858336223	MAPK10	16
MF	GO:0033218	amide binding	4	4/100	223/11258	0.13676364866957455	0.4023672055181828	0.3665288309376159	0.435891858336223	EPHA4/NLGN1/CLU/SRP14	16
MF	GO:0099106	ion channel regulator activity	2	2/100	74/11258	0.14018665346348214	0.4023672055181828	0.3665288309376159	0.435891858336223	AKAP9/TNNI3	16
MF	GO:0000146	microfilament motor activity	1	1/100	17/11258	0.14082852193136397	0.4023672055181828	0.3665288309376159	0.435891858336223	MYO10	16
MF	GO:0005160	transforming growth factor beta receptor binding	1	1/100	17/11258	0.14082852193136397	0.4023672055181828	0.3665288309376159	0.435891858336223	TGFBR1	16
MF	GO:0017075	syntaxin-1 binding	1	1/100	17/11258	0.14082852193136397	0.4023672055181828	0.3665288309376159	0.435891858336223	SYT1	16
MF	GO:0030898	actin-dependent ATPase activity	1	1/100	17/11258	0.14082852193136397	0.4023672055181828	0.3665288309376159	0.435891858336223	MYO10	16
MF	GO:0140103	catalytic activity, acting on a glycoprotein	1	1/100	17/11258	0.14082852193136397	0.4023672055181828	0.3665288309376159	0.435891858336223	GCNT1	16
MF	GO:0043325	phosphatidylinositol-3,4-bisphosphate binding	1	1/100	18/11258	0.14847171629190647	0.4175911130269914	0.38039676287883833	0.41976318750181507	PLEKHA1	16
MF	GO:1902936	phosphatidylinositol bisphosphate binding	2	2/100	77/11258	0.14936912889042384	0.4175911130269914	0.38039676287883833	0.41976318750181507	PLEKHA1/SYT1	16
MF	GO:0008236	serine-type peptidase activity	2	2/100	78/11258	0.15245689627951692	0.4216892875816426	0.38412991783752864	0.4155218666287518	PRSS23/IMMP1L	16
MF	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	1	1/100	19/11258	0.15604759070212126	0.4226288914849118	0.3849858323243123	0.4145552524566601	PAX6	16
MF	GO:0070412	R-SMAD binding	1	1/100	19/11258	0.15604759070212126	0.4226288914849118	0.3849858323243123	0.4145552524566601	PAX6	16
MF	GO:0017171	serine hydrolase activity	2	2/100	81/11258	0.16179445563919678	0.43315004916726224	0.3945698828446721	0.4038760671161087	PRSS23/IMMP1L	16
MF	GO:0030507	spectrin binding	1	1/100	20/11258	0.1635567321675352	0.43315004916726224	0.3945698828446721	0.4038760671161087	MYO10	16
MF	GO:0070851	growth factor receptor binding	2	2/100	82/11258	0.16493021102907293	0.43315004916726224	0.3945698828446721	0.4038760671161087	FGF8/NPTN	16
MF	GO:0003785	actin monomer binding	1	1/100	21/11258	0.1709997226269806	0.43454057577891814	0.3958365568836299	0.40248409967057597	TMSB15A	16
MF	GO:0034237	protein kinase A regulatory subunit binding	1	1/100	21/11258	0.1709997226269806	0.43454057577891814	0.3958365568836299	0.40248409967057597	AKAP9	16
MF	GO:0042805	actinin binding	1	1/100	21/11258	0.1709997226269806	0.43454057577891814	0.3958365568836299	0.40248409967057597	PDLIM7	16
MF	GO:0061135	endopeptidase regulator activity	2	2/100	86/11258	0.17757769023796663	0.43454057577891814	0.3958365568836299	0.40248409967057597	SFRP2/SERPINF1	16
MF	GO:0019207	kinase regulator activity	3	3/100	164/11258	0.17876000889605734	0.43454057577891814	0.3958365568836299	0.40248409967057597	CCNG2/CCNI/CDKN1C	16
MF	GO:0005178	integrin binding	2	2/100	87/11258	0.18076355260417495	0.43454057577891814	0.3958365568836299	0.40248409967057597	SFRP2/CXADR	16
MF	GO:0008194	UDP-glycosyltransferase activity	2	2/100	88/11258	0.18395818623438978	0.43454057577891814	0.3958365568836299	0.40248409967057597	LFNG/GCNT1	16
MF	GO:0004683	calmodulin-dependent protein kinase activity	1	1/100	23/11258	0.1856895532091576	0.43454057577891814	0.3958365568836299	0.40248409967057597	PNCK	16
MF	GO:0030371	translation repressor activity	1	1/100	23/11258	0.1856895532091576	0.43454057577891814	0.3958365568836299	0.40248409967057597	CIRBP	16
MF	GO:0051787	misfolded protein binding	1	1/100	23/11258	0.1856895532091576	0.43454057577891814	0.3958365568836299	0.40248409967057597	CLU	16
MF	GO:0005201	extracellular matrix structural constituent	2	2/100	90/11258	0.19037216711802635	0.43454057577891814	0.3958365568836299	0.40248409967057597	COL11A1/COL1A2	16
MF	GO:0015370	solute:sodium symporter activity	1	1/100	24/11258	0.19293753226381616	0.43454057577891814	0.3958365568836299	0.40248409967057597	SLC6A8	16
MF	GO:0051087	chaperone binding	2	2/100	91/11258	0.19359072997756605	0.43454057577891814	0.3958365568836299	0.40248409967057597	LRP2/CLU	16
MF	GO:0046982	protein heterodimerization activity	3	3/100	172/11258	0.19667685903500973	0.43454057577891814	0.3958365568836299	0.40248409967057597	TUBB2B/SYT1/TPM1	16
MF	GO:0016247	channel regulator activity	2	2/100	92/11258	0.1968164951573063	0.43454057577891814	0.3958365568836299	0.40248409967057597	AKAP9/TNNI3	16
MF	GO:0044325	ion channel binding	2	2/100	92/11258	0.1968164951573063	0.43454057577891814	0.3958365568836299	0.40248409967057597	AKAP9/NPTN	16
MF	GO:0008200	ion channel inhibitor activity	1	1/100	25/11258	0.20012163826111173	0.43454057577891814	0.3958365568836299	0.40248409967057597	TNNI3	16
MF	GO:0030291	protein serine/threonine kinase inhibitor activity	1	1/100	25/11258	0.20012163826111173	0.43454057577891814	0.3958365568836299	0.40248409967057597	CDKN1C	16
MF	GO:0035035	histone acetyltransferase binding	1	1/100	25/11258	0.20012163826111173	0.43454057577891814	0.3958365568836299	0.40248409967057597	PAX6	16
MF	GO:1904680	peptide transmembrane transporter activity	1	1/100	25/11258	0.20012163826111173	0.43454057577891814	0.3958365568836299	0.40248409967057597	GJA1	16
MF	GO:0016248	channel inhibitor activity	1	1/100	26/11258	0.20724242844840712	0.43454057577891814	0.3958365568836299	0.40248409967057597	TNNI3	16
MF	GO:0016831	carboxy-lyase activity	1	1/100	26/11258	0.20724242844840712	0.43454057577891814	0.3958365568836299	0.40248409967057597	ME3	16
MF	GO:0031624	ubiquitin conjugating enzyme binding	1	1/100	26/11258	0.20724242844840712	0.43454057577891814	0.3958365568836299	0.40248409967057597	UBE3D	16
MF	GO:0046875	ephrin receptor binding	1	1/100	26/11258	0.20724242844840712	0.43454057577891814	0.3958365568836299	0.40248409967057597	EPHA4	16
MF	GO:0071889	14-3-3 protein binding	1	1/100	26/11258	0.20724242844840712	0.43454057577891814	0.3958365568836299	0.40248409967057597	DDIT4	16
MF	GO:0008307	structural constituent of muscle	1	1/100	27/11258	0.21430045526065378	0.4363228324845441	0.3974600700770139	0.40070649522453217	TPM1	16
MF	GO:0030332	cyclin binding	1	1/100	27/11258	0.21430045526065378	0.4363228324845441	0.3974600700770139	0.40070649522453217	UBE3D	16
MF	GO:0031369	translation initiation factor binding	1	1/100	27/11258	0.21430045526065378	0.4363228324845441	0.3974600700770139	0.40070649522453217	OTX2	16
MF	GO:0004713	protein tyrosine kinase activity	2	2/100	99/11258	0.21956760696578348	0.4363228324845441	0.3974600700770139	0.40070649522453217	EPHA4/MAP2K6	16
MF	GO:0051082	unfolded protein binding	2	2/100	99/11258	0.21956760696578348	0.4363228324845441	0.3974600700770139	0.40070649522453217	CLU/LMAN1	16
MF	GO:0004879	nuclear receptor activity	1	1/100	29/11258	0.22823040468422306	0.4363228324845441	0.3974600700770139	0.40070649522453217	NR2F1	16
MF	GO:0005246	calcium channel regulator activity	1	1/100	29/11258	0.22823040468422306	0.4363228324845441	0.3974600700770139	0.40070649522453217	TNNI3	16
MF	GO:0005544	calcium-dependent phospholipid binding	1	1/100	29/11258	0.22823040468422306	0.4363228324845441	0.3974600700770139	0.40070649522453217	SYT1	16
MF	GO:0005547	phosphatidylinositol-3,4,5-trisphosphate binding	1	1/100	29/11258	0.22823040468422306	0.4363228324845441	0.3974600700770139	0.40070649522453217	MYO10	16
MF	GO:0008028	monocarboxylic acid transmembrane transporter activity	1	1/100	29/11258	0.22823040468422306	0.4363228324845441	0.3974600700770139	0.40070649522453217	SLC6A8	16
MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	1	1/100	29/11258	0.22823040468422306	0.4363228324845441	0.3974600700770139	0.40070649522453217	NLRP1	16
MF	GO:0098531	ligand-activated transcription factor activity	1	1/100	29/11258	0.22823040468422306	0.4363228324845441	0.3974600700770139	0.40070649522453217	NR2F1	16
MF	GO:0097718	disordered domain specific binding	1	1/100	30/11258	0.23510340847187794	0.4429484507441178	0.40349555229727335	0.39416124811265996	GJA1	16
MF	GO:1901682	sulfur compound transmembrane transporter activity	1	1/100	30/11258	0.23510340847187794	0.4429484507441178	0.40349555229727335	0.39416124811265996	GJA1	16
MF	GO:0015459	potassium channel regulator activity	1	1/100	32/11258	0.24866814220468247	0.4585369998100528	0.4176956476002506	0.3791400500713459	AKAP9	16
MF	GO:0043014	alpha-tubulin binding	1	1/100	32/11258	0.24866814220468247	0.4585369998100528	0.4176956476002506	0.3791400500713459	NCALD	16
MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	1	1/100	32/11258	0.24866814220468247	0.4585369998100528	0.4176956476002506	0.3791400500713459	UBE3D	16
MF	GO:0001786	phosphatidylserine binding	1	1/100	34/11258	0.26199468121953184	0.47635396585369427	0.43392567739708987	0.3625846498894221	SYT1	16
MF	GO:0004867	serine-type endopeptidase inhibitor activity	1	1/100	34/11258	0.26199468121953184	0.47635396585369427	0.43392567739708987	0.3625846498894221	SERPINF1	16
MF	GO:0042887	amide transmembrane transporter activity	1	1/100	36/11258	0.27508716666665667	0.496685162037019	0.4524459978070011	0.34443324906429196	GJA1	16
MF	GO:0005179	hormone activity	1	1/100	37/11258	0.28154691388937436	0.5048427421464644	0.45987699183382386	0.33735831812669814	GALP	16
MF	GO:0005048	signal sequence binding	1	1/100	39/11258	0.2942959280617742	0.5155995746295811	0.46967572587714884	0.328201884760386	SRP14	16
MF	GO:0016830	carbon-carbon lyase activity	1	1/100	39/11258	0.2942959280617742	0.5155995746295811	0.46967572587714884	0.328201884760386	ME3	16
MF	GO:0050661	NADP binding	1	1/100	39/11258	0.2942959280617742	0.5155995746295811	0.46967572587714884	0.328201884760386	ME3	16
MF	GO:0001046	core promoter sequence-specific DNA binding	1	1/100	40/11258	0.3005861863017085	0.5155995746295811	0.46967572587714884	0.328201884760386	PAX6	16
MF	GO:0001618	virus receptor activity	1	1/100	40/11258	0.3005861863017085	0.5155995746295811	0.46967572587714884	0.328201884760386	CXADR	16
MF	GO:0140272	exogenous protein binding	1	1/100	40/11258	0.3005861863017085	0.5155995746295811	0.46967572587714884	0.328201884760386	CXADR	16
MF	GO:0008514	organic anion transmembrane transporter activity	2	2/100	124/11258	0.3018471152509766	0.5155995746295811	0.46967572587714884	0.328201884760386	GJA1/SLC6A8	16
MF	GO:0050839	cell adhesion molecule binding	5	5/100	412/11258	0.3034105189166381	0.5155995746295811	0.46967572587714884	0.328201884760386	NLGN1/SFRP2/NPTN/CDH2/CXADR	16
MF	GO:0051018	protein kinase A binding	1	1/100	41/11258	0.3068209323678369	0.5178857720334905	0.4717582943624914	0.32628045541487166	AKAP9	16
MF	GO:0005543	phospholipid binding	4	4/100	316/11258	0.30873959486611935	0.5178857720334905	0.4717582943624914	0.32628045541487166	WDFY1/MYO10/PLEKHA1/SYT1	16
MF	GO:0004714	transmembrane receptor protein tyrosine kinase activity	1	1/100	42/11258	0.3130006512555268	0.5183450275569234	0.47217664453565894	0.32589549840964	EPHA4	16
MF	GO:0048029	monosaccharide binding	1	1/100	42/11258	0.3130006512555268	0.5183450275569234	0.47217664453565894	0.32589549840964	LMAN1	16
MF	GO:0015294	solute:cation symporter activity	1	1/100	43/11258	0.31912582376573073	0.5251437606271518	0.47836982243364035	0.3202362252653137	SLC6A8	16
MF	GO:0005080	protein kinase C binding	1	1/100	44/11258	0.32519692654089094	0.5284450056289478	0.48137702941908206	0.3175146374397896	NELL2	16
MF	GO:0048156	tau protein binding	1	1/100	44/11258	0.32519692654089094	0.5284450056289478	0.48137702941908206	0.3175146374397896	CLU	16
MF	GO:0003713	transcription coactivator activity	3	3/100	228/11258	0.33021653460626466	0.5332689378734708	0.48577129968231153	0.31356814773962427	SOX11/NR2F1/SOX4	16
MF	GO:0051287	NAD binding	1	1/100	46/11258	0.33717880887659923	0.541151174740221	0.4929514749657884	0.30719582959052744	ME3	16
MF	GO:0003924	GTPase activity	3	3/100	234/11258	0.34484978154280943	0.5500671362032543	0.5010733022094422	0.3000987363754691	TUBB2B/TUBA1A/GNG8	16
MF	GO:0042054	histone methyltransferase activity	1	1/100	48/11258	0.3489500295772623	0.5525097865678029	0.5032983885739095	0.2981744600947728	FEZF2	16
MF	GO:0016758	transferase activity, transferring hexosyl groups	2	2/100	139/11258	0.3507474726152704	0.5525097865678029	0.5032983885739095	0.2981744600947728	LFNG/GCNT1	16
MF	GO:0004672	protein kinase activity	5	5/100	440/11258	0.35275624834713576	0.5525097865678029	0.5032983885739095	0.2981744600947728	EPHA4/MAPK10/TGFBR1/MAP2K6/PNCK	16
MF	GO:0001664	G protein-coupled receptor binding	2	2/100	142/11258	0.3604042498344957	0.5579387290108859	0.5082437814876491	0.293927926378308	RSPO3/WNT5B	16
MF	GO:0005546	phosphatidylinositol-4,5-bisphosphate binding	1	1/100	50/11258	0.3605142556685724	0.5579387290108859	0.5082437814876491	0.293927926378308	SYT1	16
MF	GO:0060090	molecular adaptor activity	3	3/100	244/11258	0.369179608588872	0.5666926539381555	0.5162180045995345	0.28716685224882416	COL11A1/AKAP9/COL1A2	16
MF	GO:0005198	structural molecule activity	5	5/100	450/11258	0.3705298121903325	0.5666926539381555	0.5162180045995345	0.28716685224882416	COL11A1/TUBB2B/COL1A2/TUBA1A/TPM1	16
MF	GO:0004860	protein kinase inhibitor activity	1	1/100	54/11258	0.38303607724147937	0.5823940355718399	0.530520882605927	0.2752975165279063	CDKN1C	16
MF	GO:0004674	protein serine/threonine kinase activity	4	4/100	354/11258	0.38570447045241973	0.5830416413815647	0.5311108069265267	0.2748148615618334	MAPK10/TGFBR1/MAP2K6/PNCK	16
MF	GO:0019905	syntaxin binding	1	1/100	55/11258	0.38854271703761034	0.583937031386004	0.53192644559453806	0.2741484174811275	SYT1	16
MF	GO:0019210	kinase inhibitor activity	1	1/100	56/11258	0.3940006951056493	0.5887366708475219	0.5362985868044228	0.27059334744090296	CDKN1C	16
MF	GO:0019843	rRNA binding	1	1/100	58/11258	0.4047723652271932	0.5979591759038081	0.544699654163388	0.2638429004657699	CIRBP	16
MF	GO:0072341	modified amino acid binding	1	1/100	58/11258	0.4047723652271932	0.5979591759038081	0.544699654163388	0.2638429004657699	SYT1	16
MF	GO:0019955	cytokine binding	1	1/100	59/11258	0.41008689768052176	0.6023875333160207	0.5487335829801808	0.26063845978448413	TGFBR1	16
MF	GO:0002039	p53 binding	1	1/100	60/11258	0.4153544492683373	0.6033081386020542	0.5495721910342599	0.2599752511776274	ZNF385B	16
MF	GO:0005125	cytokine activity	1	1/100	60/11258	0.4153544492683373	0.6033081386020542	0.5495721910342599	0.2599752511776274	WNT5B	16
MF	GO:0031625	ubiquitin protein ligase binding	3	3/100	265/11258	0.419694069524441	0.604891066866023	0.5510141297362559	0.25883726432823884	CLU/PAX6/CKB	16
MF	GO:0008144	drug binding	1	1/100	62/11258	0.425750250909547	0.604891066866023	0.5510141297362559	0.25883726432823884	LRP2	16
MF	GO:0015081	sodium ion transmembrane transporter activity	1	1/100	62/11258	0.425750250909547	0.604891066866023	0.5510141297362559	0.25883726432823884	SLC6A8	16
MF	GO:0035258	steroid hormone receptor binding	1	1/100	62/11258	0.425750250909547	0.604891066866023	0.5510141297362559	0.25883726432823884	ETS2	16
MF	GO:0004252	serine-type endopeptidase activity	1	1/100	64/11258	0.43596301683945726	0.612704780423021	0.5581318850007276	0.25326316636647156	PRSS23	16
MF	GO:0015293	symporter activity	1	1/100	64/11258	0.43596301683945726	0.612704780423021	0.5581318850007276	0.25326316636647156	SLC6A8	16
MF	GO:0008276	protein methyltransferase activity	1	1/100	66/11258	0.4459959377280781	0.6234351817704318	0.5679065420985715	0.24572312835660987	FEZF2	16
MF	GO:0008083	growth factor activity	1	1/100	68/11258	0.4558521491835502	0.6324565742269553	0.5761244097209106	0.23948372383176714	FGF8	16
MF	GO:0044389	ubiquitin-like protein ligase binding	3	3/100	281/11258	0.4573147536717984	0.6324565742269553	0.5761244097209106	0.23948372383176714	CLU/PAX6/CKB	16
MF	GO:0051219	phosphoprotein binding	1	1/100	69/11258	0.4607149539272182	0.6337877673072843	0.577337034996514	0.23857058250010216	TOX3	16
MF	GO:0038023	signaling receptor activity	4	4/100	397/11258	0.4715564450057359	0.6419092968664468	0.584735189453241	0.23304076946782926	EPHA4/NLGN1/FZD3/TGFBR1	16
MF	GO:0060089	molecular transducer activity	4	4/100	397/11258	0.4715564450057359	0.6419092968664468	0.584735189453241	0.23304076946782926	EPHA4/NLGN1/FZD3/TGFBR1	16
MF	GO:0005506	iron ion binding	1	1/100	73/11258	0.4797396656201811	0.6431930432510639	0.5859045940546128	0.23217309669337777	SCD5	16
MF	GO:1990782	protein tyrosine kinase binding	1	1/100	73/11258	0.4797396656201811	0.6431930432510639	0.5859045940546128	0.23217309669337777	EPHA4	16
MF	GO:0008509	anion transmembrane transporter activity	2	2/100	182/11258	0.4829045187042973	0.6431930432510639	0.5859045940546128	0.23217309669337777	GJA1/SLC6A8	16
MF	GO:0052689	carboxylic ester hydrolase activity	1	1/100	74/11258	0.48439107674561555	0.6431930432510639	0.5859045940546128	0.23217309669337777	CA2	16
MF	GO:0015631	tubulin binding	3	3/100	293/11258	0.48486860183541736	0.6431930432510639	0.5859045940546128	0.23217309669337777	GJA1/NCALD/MAP6	16
MF	GO:0004888	transmembrane signaling receptor activity	3	3/100	296/11258	0.49165631069196425	0.6488865014208665	0.5910909425898583	0.22834569538530697	EPHA4/FZD3/TGFBR1	16
MF	GO:0031490	chromatin DNA binding	1	1/100	77/11258	0.4980997064404047	0.6523256021750539	0.5942237266776806	0.22605001130134317	TOX3	16
MF	GO:0016922	nuclear receptor binding	1	1/100	78/11258	0.5025885741048319	0.6523256021750539	0.5942237266776806	0.22605001130134317	ETS2	16
MF	GO:0004866	endopeptidase inhibitor activity	1	1/100	79/11258	0.5070376924044306	0.6523256021750539	0.5942237266776806	0.22605001130134317	SERPINF1	16
MF	GO:0003712	transcription coregulator activity	4	4/100	416/11258	0.5081946732187221	0.6523256021750539	0.5942237266776806	0.22605001130134317	SOX11/NR2F1/SOX4/BTG1	16
MF	GO:0016616	oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	1	1/100	80/11258	0.5114474097995069	0.6523256021750539	0.5942237266776806	0.22605001130134317	ME3	16
MF	GO:0046943	carboxylic acid transmembrane transporter activity	1	1/100	80/11258	0.5114474097995069	0.6523256021750539	0.5942237266776806	0.22605001130134317	SLC6A8	16
MF	GO:0005342	organic acid transmembrane transporter activity	1	1/100	81/11258	0.5158180717265108	0.6523256021750539	0.5942237266776806	0.22605001130134317	SLC6A8	16
MF	GO:0030414	peptidase inhibitor activity	1	1/100	81/11258	0.5158180717265108	0.6523256021750539	0.5942237266776806	0.22605001130134317	SERPINF1	16
MF	GO:0016757	transferase activity, transferring glycosyl groups	2	2/100	194/11258	0.5168425924925426	0.6523256021750539	0.5942237266776806	0.22605001130134317	LFNG/GCNT1	16
MF	GO:0003730	mRNA 3'-UTR binding	1	1/100	82/11258	0.52015002062401	0.6533285283200125	0.5951373233684324	0.22538281259074147	CIRBP	16
MF	GO:0000149	SNARE binding	1	1/100	85/11258	0.5329169690961624	0.6649777719623712	0.6057489825568159	0.21770730665035154	SYT1	16
MF	GO:0030674	protein-macromolecule adaptor activity	2	2/100	201/11258	0.535958652304559	0.6649777719623712	0.6057489825568159	0.21770730665035154	COL11A1/COL1A2	16
MF	GO:0016705	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	1	1/100	86/11258	0.5370974312003767	0.6649777719623712	0.6057489825568159	0.21770730665035154	SCD5	16
MF	GO:0016614	oxidoreductase activity, acting on CH-OH group of donors	1	1/100	87/11258	0.5412408483933556	0.6669318511008174	0.6075290141606636	0.21643297634861516	ME3	16
MF	GO:0002020	protease binding	1	1/100	93/11258	0.5653414113461999	0.6900881077465351	0.6286227702144549	0.2016098918526638	COL1A2	16
MF	GO:0003774	motor activity	1	1/100	93/11258	0.5653414113461999	0.6900881077465351	0.6286227702144549	0.2016098918526638	MYO10	16
MF	GO:0061629	RNA polymerase II-specific DNA-binding transcription factor binding	2	2/100	221/11258	0.5877039532998236	0.7140328404577295	0.6504347736963124	0.18679624843993736	DLL1/ETS2	16
MF	GO:0003682	chromatin binding	4	4/100	463/11258	0.5935853503099089	0.71782414456082	0.6538883907942693	0.1844963730803377	FEZF2/PAX6/TOX3/TSHZ2	16
MF	GO:0004857	enzyme inhibitor activity	2	2/100	230/11258	0.6095768672260866	0.7337499327721413	0.668395687747902	0.17496636068369112	CDKN1C/SERPINF1	16
MF	GO:0004930	G protein-coupled receptor activity	1	1/100	106/11258	0.6133430632453911	0.7348810896027728	0.669426093767708	0.17429736314875166	FZD3	16
MF	GO:0005126	cytokine receptor binding	1	1/100	111/11258	0.6303737052256293	0.7518218502690991	0.6848579607714467	0.1643994916457422	TGFBR1	16
MF	GO:0008289	lipid binding	4	4/100	487/11258	0.633748330916226	0.7523952787133276	0.6853803146174038	0.16406837346292114	WDFY1/MYO10/PLEKHA1/SYT1	16
MF	GO:0030246	carbohydrate binding	1	1/100	116/11258	0.646661390615781	0.7610652330628923	0.6932780463123513	0.15909255216869056	LMAN1	16
MF	GO:0019903	protein phosphatase binding	1	1/100	117/11258	0.6498326220767773	0.7610652330628923	0.6932780463123513	0.15909255216869056	CDH2	16
MF	GO:0035257	nuclear hormone receptor binding	1	1/100	117/11258	0.6498326220767773	0.7610652330628923	0.6932780463123513	0.15909255216869056	ETS2	16
MF	GO:0015291	secondary active transmembrane transporter activity	1	1/100	119/11258	0.6560907932952513	0.7615339565034168	0.6937050211063512	0.15882516202217817	SLC6A8	16
MF	GO:0022853	active ion transmembrane transporter activity	1	1/100	119/11258	0.6560907932952513	0.7615339565034168	0.6937050211063512	0.15882516202217817	SLC6A8	16
MF	GO:0045182	translation regulator activity	1	1/100	121/11258	0.6622382174797815	0.7652530513099697	0.6970928605050333	0.15670936520373915	CIRBP	16
MF	GO:0005525	GTP binding	2	2/100	267/11258	0.6903168768632544	0.7910715659335914	0.7206117503443646	0.14229866052026136	TUBB2B/TUBA1A	16
MF	GO:0051427	hormone receptor binding	1	1/100	133/11258	0.6969034119681834	0.7910715659335914	0.7206117503443646	0.14229866052026136	ETS2	16
MF	GO:0032550	purine ribonucleoside binding	2	2/100	271/11258	0.6981799551292907	0.7910715659335914	0.7206117503443646	0.14229866052026136	TUBB2B/TUBA1A	16
MF	GO:0001883	purine nucleoside binding	2	2/100	273/11258	0.7020499695542384	0.7910715659335914	0.7206117503443646	0.14229866052026136	TUBB2B/TUBA1A	16
MF	GO:0032549	ribonucleoside binding	2	2/100	274/11258	0.703969685827146	0.7910715659335914	0.7206117503443646	0.14229866052026136	TUBB2B/TUBA1A	16
MF	GO:0019001	guanyl nucleotide binding	2	2/100	275/11258	0.7058792434484354	0.7910715659335914	0.7206117503443646	0.14229866052026136	TUBB2B/TUBA1A	16
MF	GO:0032561	guanyl ribonucleotide binding	2	2/100	275/11258	0.7058792434484354	0.7910715659335914	0.7206117503443646	0.14229866052026136	TUBB2B/TUBA1A	16
MF	GO:0001882	nucleoside binding	2	2/100	279/11258	0.7134164302467716	0.7926849224964129	0.7220814071323599	0.14141383750603695	TUBB2B/TUBA1A	16
MF	GO:0140297	DNA-binding transcription factor binding	2	2/100	279/11258	0.7134164302467716	0.7926849224964129	0.7220814071323599	0.14141383750603695	DLL1/ETS2	16
MF	GO:0019902	phosphatase binding	1	1/100	155/11258	0.7515563649329163	0.8315091697130138	0.7574476242325024	0.12064739225565858	CDH2	16
MF	GO:0008022	protein C-terminus binding	1	1/100	160/11258	0.7625467135621173	0.8365491372411413	0.7620386877702705	0.11802297950208868	SYT1	16
MF	GO:0015077	monovalent inorganic cation transmembrane transporter activity	1	1/100	160/11258	0.7625467135621173	0.8365491372411413	0.7620386877702705	0.11802297950208868	SLC6A8	16
MF	GO:0008168	methyltransferase activity	1	1/100	164/11258	0.7709912749802724	0.8422593760288689	0.7672403222935044	0.115068580903355	FEZF2	16
MF	GO:0016741	transferase activity, transferring one-carbon groups	1	1/100	172/11258	0.7869985190614323	0.8561490165521857	0.7798928288430843	0.10796507300169574	FEZF2	16
MF	GO:0015267	channel activity	1	1/100	185/11258	0.8106801492302147	0.8745926921155843	0.7966937478785687	0.0987085909836632	GJA1	16
MF	GO:0022803	passive transmembrane transporter activity	1	1/100	185/11258	0.8106801492302147	0.8745926921155843	0.7966937478785687	0.0987085909836632	GJA1	16
MF	GO:0022804	active transmembrane transporter activity	1	1/100	189/11258	0.8174279359091651	0.8782283608941442	0.8000055919076214	0.09690697735038672	SLC6A8	16
MF	GO:0008233	peptidase activity	2	2/100	353/11258	0.8260932190021255	0.883885748726554	0.8051590828480756	0.09411830351117122	PRSS23/IMMP1L	16
MF	GO:0046873	metal ion transmembrane transporter activity	1	1/100	200/11258	0.8347810798243227	0.8895208227636227	0.8102922474567412	0.09135831622415218	SLC6A8	16
MF	GO:0008017	microtubule binding	1	1/100	213/11258	0.8531942591835204	0.9054306423988381	0.8247849981365933	0.0836592469555626	MAP6	16
MF	GO:0061630	ubiquitin protein ligase activity	1	1/100	221/11258	0.8634997833159838	0.9116587840170245	0.830458406493241	0.08068211430569248	UBE3D	16
MF	GO:0004175	endopeptidase activity	1	1/100	228/11258	0.8719274757334216	0.9116587840170245	0.830458406493241	0.08068211430569248	PRSS23	16
MF	GO:0008047	enzyme activator activity	2	2/100	397/11258	0.8726771504189597	0.9116587840170245	0.830458406493241	0.08068211430569248	SFRP2/NLRP1	16
MF	GO:0061659	ubiquitin-like protein ligase activity	1	1/100	229/11258	0.8730886046932272	0.9116587840170245	0.830458406493241	0.08068211430569248	UBE3D	16
MF	GO:0015075	ion transmembrane transporter activity	2	2/100	432/11258	0.901294827554445	0.9340199665340158	0.8508279047374638	0.0701582749108636	GJA1/SLC6A8	16
MF	GO:0003729	mRNA binding	1	1/100	257/11258	0.9016885061539922	0.9340199665340158	0.8508279047374638	0.0701582749108636	CIRBP	16
MF	GO:0042803	protein homodimerization activity	2	2/100	447/11258	0.9116406657221854	0.9405816392371755	0.8568051369569412	0.06711793836508324	TPM1/TOX3	16
MF	GO:0022890	inorganic cation transmembrane transporter activity	1	1/100	275/11258	0.9166003982308455	0.9419608835573907	0.8580615336049107	0.0664815667587169	SLC6A8	16
MF	GO:0045296	cadherin binding	1	1/100	284/11258	0.9231931949627759	0.945000908229613	0.860830786848838	0.06508220924335799	CDH2	16
MF	GO:0008324	cation transmembrane transporter activity	1	1/100	304/11258	0.9360533312708825	0.952555161344498	0.867712191508146	0.06162430059185167	SLC6A8	16
MF	GO:0016491	oxidoreductase activity	2	2/100	494/11258	0.9379004665545827	0.952555161344498	0.867712191508146	0.06162430059185167	SCD5/ME3	16
MF	GO:0016887	ATPase activity	1	1/100	332/11258	0.9505509586920091	0.9616468842798536	0.875994125356142	0.05749880631361516	MYO10	16
MF	GO:0004842	ubiquitin-protein transferase activity	1	1/100	343/11258	0.9553097523100051	0.9627152542658967	0.8769673368818898	0.05701658186329287	UBE3D	16
MF	GO:0019787	ubiquitin-like protein transferase activity	1	1/100	362/11258	0.9624851970573826	0.9662013561193802	0.8801429357362776	0.055446792439998185	UBE3D	16
MF	GO:0015318	inorganic molecular entity transmembrane transporter activity	1	1/100	386/11258	0.969939280150999	0.969939280150999	0.8835479272630558	0.05376988760448993	SLC6A8	16
CC	GO:0062023	collagen-containing extracellular matrix	10	10/106	225/11368	4.5791891476821775e-5	0.008273461462439832	0.006433927066387152	2.191523866474946	COL11A1/SFRP2/COL1A2/SULF1/CLU/WNT5B/SMOC1/SERPINF1/CDH2/LMAN1	16
CC	GO:0009986	cell surface	13	13/106	391/11368	6.753846091787619e-5	0.008273461462439832	0.006433927066387152	2.191523866474946	LRP2/EPHA4/NLGN1/TPBG/FZD3/SULF1/CLU/TGFBR1/FGF8/WNT5B/NPTN/CA4/CDH2	16
CC	GO:0005865	striated muscle thin filament	3	3/106	16/11368	4.0398236332722296e-4	0.016788103720892313	0.013055410412380274	1.8842094710619914	TPM1/TNNT1/TNNI3	16
CC	GO:0032433	filopodium tip	3	3/106	16/11368	4.0398236332722296e-4	0.016788103720892313	0.013055410412380274	1.8842094710619914	NLGN1/MYO10/FZD3	16
CC	GO:0030424	axon	13	13/106	470/11368	4.1489694163692506e-4	0.016788103720892313	0.013055410412380274	1.8842094710619914	NAV1/LRP2/EPHA4/CRMP1/DPYSL3/FZD3/CA2/MAP6/SYT1/OTX2/NPTN/SERPINF1/CXADR	16
CC	GO:0031012	extracellular matrix	10	10/106	295/11368	4.203489005569487e-4	0.016788103720892313	0.013055410412380274	1.8842094710619914	COL11A1/SFRP2/COL1A2/SULF1/CLU/WNT5B/SMOC1/SERPINF1/CDH2/LMAN1	16
CC	GO:0099634	postsynaptic specialization membrane	5	5/106	70/11368	4.79660106311209e-4	0.016788103720892313	0.013055410412380274	1.8842094710619914	EPHA4/NLGN1/AKAP9/NPTN/CDH2	16
CC	GO:0036379	myofilament	3	3/106	18/11368	5.807267369202306e-4	0.017784756318182063	0.013830465708231808	1.8591631958046453	TPM1/TNNT1/TNNI3	16
CC	GO:0030175	filopodium	5	5/106	84/11368	0.0011038125593530637	0.030048230782388954	0.023367260028409886	1.6313922086306485	EPHA4/NLGN1/MYO10/FZD3/CXADR	16
CC	GO:0099055	integral component of postsynaptic membrane	4	4/106	54/11368	0.0015787647711110442	0.03867973689222058	0.030079623533799893	1.5217276035264213	EPHA4/NLGN1/NPTN/CDH2	16
CC	GO:0098936	intrinsic component of postsynaptic membrane	4	4/106	56/11368	0.0018076406490503032	0.04026108718339312	0.03130937392134975	1.5043256166763321	EPHA4/NLGN1/NPTN/CDH2	16
CC	GO:0005788	endoplasmic reticulum lumen	7	7/106	196/11368	0.002353734132391327	0.0480554052029896	0.03737069104937107	1.4274688712123453	COL11A1/IGFBP5/COL1A2/CLU/PRSS23/WNT5B/CDH2	16
CC	GO:0099056	integral component of presynaptic membrane	3	3/106	31/11368	0.002929711764150556	0.05521379863206817	0.04293747605759114	1.367163487763686	EPHA4/NPTN/CDH2	16
CC	GO:0098858	actin-based cell projection	6	6/106	157/11368	0.00345804826119945	0.05674236323546184	0.04412617720996173	1.3553036952251827	EPHA4/NLGN1/MYO10/FZD3/CA2/CXADR	16
CC	GO:0099059	integral component of presynaptic active zone membrane	2	2/106	10/11368	0.0036912339693873026	0.05674236323546184	0.04412617720996173	1.3553036952251827	NPTN/CDH2	16
CC	GO:0098889	intrinsic component of presynaptic membrane	3	3/106	34/11368	0.0038221126845617804	0.05674236323546184	0.04412617720996173	1.3553036952251827	EPHA4/NPTN/CDH2	16
CC	GO:0099699	integral component of synaptic membrane	4	4/106	72/11368	0.004519470508390183	0.05674236323546184	0.04412617720996173	1.3553036952251827	EPHA4/NLGN1/NPTN/CDH2	16
CC	GO:0045121	membrane raft	7	7/106	222/11368	0.004685298266563213	0.05674236323546184	0.04412617720996173	1.3553036952251827	GJA1/DLL1/SULF1/TGFBR1/TUBA1A/CDH2/CXADR	16
CC	GO:0044297	cell body	10	10/106	409/11368	0.0047842864785509415	0.05674236323546184	0.04412617720996173	1.3553036952251827	EPHA4/CRMP1/MAPK10/MYO10/DPYSL3/AKAP9/FZD3/CKB/SERPINF1/CXADR	16
CC	GO:0098857	membrane microdomain	7	7/106	223/11368	0.004800795007961637	0.05674236323546184	0.04412617720996173	1.3553036952251827	GJA1/DLL1/SULF1/TGFBR1/TUBA1A/CDH2/CXADR	16
CC	GO:0014704	intercalated disc	3	3/106	37/11368	0.004863631134468158	0.05674236323546184	0.04412617720996173	1.3553036952251827	GJA1/CDH2/CXADR	16
CC	GO:0098945	intrinsic component of presynaptic active zone membrane	2	2/106	12/11368	0.005348355925366996	0.05820714720112311	0.04526527881161453	1.3442348002471423	NPTN/CDH2	16
CC	GO:0099060	integral component of postsynaptic specialization membrane	3	3/106	39/11368	0.005644120052483129	0.05820714720112311	0.04526527881161453	1.3442348002471423	NLGN1/NPTN/CDH2	16
CC	GO:0099240	intrinsic component of synaptic membrane	4	4/106	77/11368	0.0057381415366357736	0.05820714720112311	0.04526527881161453	1.3442348002471423	EPHA4/NLGN1/NPTN/CDH2	16
CC	GO:0098589	membrane region	7	7/106	232/11368	0.005939504816441133	0.05820714720112311	0.04526527881161453	1.3442348002471423	GJA1/DLL1/SULF1/TGFBR1/TUBA1A/CDH2/CXADR	16
CC	GO:0098948	intrinsic component of postsynaptic specialization membrane	3	3/106	41/11368	0.006495575974706103	0.061208312069345974	0.04759915997659128	1.3224007115809813	NLGN1/NPTN/CDH2	16
CC	GO:0045177	apical part of cell	7	7/106	239/11368	0.006956583206584331	0.06312455131900596	0.04908933958642355	1.3090128105544658	LRP2/GJA1/DLL1/FZD3/CA2/CA4/CDH2	16
CC	GO:0098644	complex of collagen trimers	2	2/106	14/11368	0.007285219694616325	0.06374567232789284	0.049572359576148674	1.3047604087827198	COL11A1/COL1A2	16
CC	GO:0030017	sarcomere	5	5/106	131/11368	0.007545436847403877	0.06374593198668793	0.04957256150200007	1.3047586397504374	PDLIM7/TPM1/LMAN1/TNNT1/TNNI3	16
CC	GO:0016324	apical plasma membrane	6	6/106	190/11368	0.008644374905063909	0.06954576378841443	0.05408284960559833	1.2669404336458792	LRP2/GJA1/DLL1/FZD3/CA4/CDH2	16
CC	GO:0005912	adherens junction	5	5/106	136/11368	0.008799668071187131	0.06954576378841443	0.05408284960559833	1.2669404336458792	EPHA4/PDLIM7/DLL1/CDH2/CXADR	16
CC	GO:0042734	presynaptic membrane	4	4/106	88/11368	0.009148336391417005	0.07004195049678644	0.05446871338310782	1.263852883166669	EPHA4/SYT1/NPTN/CDH2	16
CC	GO:0030658	transport vesicle membrane	5	5/106	140/11368	0.009901784661808565	0.07351324976191206	0.05716819852591228	1.2428454929804522	NCALD/MAP6/SYT1/CA4/LMAN1	16
CC	GO:0005884	actin filament	4	4/106	91/11368	0.010265799226252832	0.07397414148329247	0.0575266148591877	1.2401311811844722	DPYSL3/PDLIM7/TPM1/COTL1	16
CC	GO:0030016	myofibril	5	5/106	146/11368	0.011727681217966579	0.08209376852576605	0.063840911291788	1.1949009223125553	PDLIM7/TPM1/LMAN1/TNNT1/TNNI3	16
CC	GO:0044291	cell-cell contact zone	3	3/106	53/11368	0.013171672093613628	0.0896405461926483	0.06970972657731189	1.1567066206948162	GJA1/CDH2/CXADR	16
CC	GO:0043292	contractile fiber	5	5/106	153/11368	0.014133215889831316	0.09112279203986523	0.07086240755839145	1.1495840965475486	PDLIM7/TPM1/LMAN1/TNNT1/TNNI3	16
CC	GO:0045211	postsynaptic membrane	5	5/106	154/11368	0.014501991200470797	0.09112279203986523	0.07086240755839145	1.1495840965475486	EPHA4/NLGN1/AKAP9/NPTN/CDH2	16
CC	GO:0048786	presynaptic active zone	3	3/106	55/11368	0.014555324881417512	0.09112279203986523	0.07086240755839145	1.1495840965475486	FZD3/NPTN/CDH2	16
CC	GO:0030426	growth cone	5	5/106	155/11368	0.014877190537120855	0.09112279203986523	0.07086240755839145	1.1495840965475486	EPHA4/CRMP1/DPYSL3/OTX2/CXADR	16
CC	GO:0048787	presynaptic active zone membrane	2	2/106	21/11368	0.016114536075615384	0.0934330536498297	0.07265900197902976	1.1387105717633805	NPTN/CDH2	16
CC	GO:0030427	site of polarized growth	5	5/106	159/11368	0.01644313781815587	0.0934330536498297	0.07265900197902976	1.1387105717633805	EPHA4/CRMP1/DPYSL3/OTX2/CXADR	16
CC	GO:0098685	Schaffer collateral - CA1 synapse	3	3/106	58/11368	0.01677981371670411	0.0934330536498297	0.07265900197902976	1.1387105717633805	EPHA4/TUBB2B/NPTN	16
CC	GO:0098839	postsynaptic density membrane	3	3/106	58/11368	0.01677981371670411	0.0934330536498297	0.07265900197902976	1.1387105717633805	EPHA4/AKAP9/NPTN	16
CC	GO:0043025	neuronal cell body	8	8/106	359/11368	0.018879313319528218	0.10118924593099457	0.07869067030509137	1.1040767552547	EPHA4/CRMP1/MAPK10/MYO10/AKAP9/FZD3/CKB/SERPINF1	16
CC	GO:0097060	synaptic membrane	6	6/106	226/11368	0.018998797195207143	0.10118924593099457	0.07869067030509137	1.1040767552547	EPHA4/NLGN1/AKAP9/SYT1/NPTN/CDH2	16
CC	GO:0030425	dendrite	9	9/106	443/11368	0.022397535643755292	0.11236115435473286	0.0873785990900393	1.0585949224593953	LRP2/EPHA4/NLGN1/AKAP9/FZD3/CLU/MAP6/CKB/NPTN	16
CC	GO:0097447	dendritic tree	9	9/106	443/11368	0.022397535643755292	0.11236115435473286	0.0873785990900393	1.0585949224593953	LRP2/EPHA4/NLGN1/AKAP9/FZD3/CLU/MAP6/CKB/NPTN	16
CC	GO:0031526	brush border membrane	2	2/106	25/11368	0.02247223087094657	0.11236115435473286	0.0873785990900393	1.0585949224593953	LRP2/CA4	16
CC	GO:0031941	filamentous actin	2	2/106	26/11368	0.024198850351648045	0.11752212823534929	0.09139207394456808	1.0390914671917564	DPYSL3/PDLIM7	16
CC	GO:0015629	actin cytoskeleton	8	8/106	377/11368	0.024463789959195157	0.11752212823534929	0.09139207394456808	1.0390914671917564	MYO10/DPYSL3/PDLIM7/TPM1/COTL1/CDH2/TNNT1/TNNI3	16
CC	GO:1902554	serine/threonine protein kinase complex	3	3/106	76/11368	0.0339225098043506	0.15351789143202677	0.11938448270331621	0.9230521180497737	CCNG2/CCNI/TGFBR1	16
CC	GO:0009897	external side of plasma membrane	4	4/106	131/11368	0.034004681497214306	0.15351789143202677	0.11938448270331621	0.9230521180497737	LRP2/NLGN1/FGF8/CA4	16
CC	GO:0030665	clathrin-coated vesicle membrane	3	3/106	77/11368	0.03506511932871736	0.15351789143202677	0.11938448270331621	0.9230521180497737	LRP2/NCALD/SYT1	16
CC	GO:0043198	dendritic shaft	2	2/106	32/11368	0.035624807427915746	0.15351789143202677	0.11938448270331621	0.9230521180497737	EPHA4/NLGN1	16
CC	GO:0060076	excitatory synapse	2	2/106	32/11368	0.035624807427915746	0.15351789143202677	0.11938448270331621	0.9230521180497737	NLGN1/SYT1	16
CC	GO:0098978	glutamatergic synapse	6	6/106	262/11368	0.0357164073943899	0.15351789143202677	0.11938448270331621	0.9230521180497737	EPHA4/NLGN1/MAPK10/AKAP9/SYT1/NPTN	16
CC	GO:0030662	coated vesicle membrane	4	4/106	134/11368	0.036497061939822814	0.1541686237113205	0.11989053014714936	0.9212151193803784	LRP2/NCALD/SYT1/LMAN1	16
CC	GO:0005798	Golgi-associated vesicle	4	4/106	140/11368	0.04179155682330191	0.17354121053744012	0.1349557856381382	0.8698084922348668	GJA1/NCALD/MAP6/LMAN1	16
CC	GO:0030660	Golgi-associated vesicle membrane	3	3/106	84/11368	0.0436130843138691	0.1780867609482988	0.1384906712422861	0.8585794797724393	GJA1/NCALD/LMAN1	16
CC	GO:0098984	neuron to neuron synapse	6	6/106	278/11368	0.04548622438566562	0.18269057335226355	0.14207086477662603	0.8474949760069975	EPHA4/NLGN1/AKAP9/SYT1/NPTN/CDH2	16
CC	GO:0043209	myelin sheath	2	2/106	37/11368	0.04642641112576845	0.18345920525505274	0.14266859785677574	0.8456716069714572	CA2/TUBA1A	16
CC	GO:1902911	protein kinase complex	3	3/106	87/11368	0.04756674967958961	0.18498180430951516	0.14385265984971962	0.8420821035520607	CCNG2/CCNI/TGFBR1	16
CC	GO:0000307	cyclin-dependent protein kinase holoenzyme complex	2	2/106	38/11368	0.04871426122707526	0.1864842812598975	0.14502107371876025	0.8385688837321756	CCNG2/CCNI	16
CC	GO:0005911	cell-cell junction	7	7/106	360/11368	0.05103518008590093	0.1922397723621177	0.14949687990351582	0.825367871251433	EPHA4/PDLIM7/GJA1/DLL1/TGFBR1/CDH2/CXADR	16
CC	GO:0031253	cell projection membrane	5	5/106	217/11368	0.05218289801677404	0.1922397723621177	0.14949687990351582	0.825367871251433	LRP2/MYO10/PLEKHA1/TPM1/CA4	16
CC	GO:0001726	ruffle	4	4/106	151/11368	0.052571692850048514	0.1922397723621177	0.14949687990351582	0.825367871251433	MYO10/PDLIM7/PLEKHA1/TPM1	16
CC	GO:0005771	multivesicular body	2	2/106	40/11368	0.053409824429236516	0.19243245566416098	0.14964672169801563	0.8249327927834069	GJA1/PMEL	16
CC	GO:0005581	collagen trimer	2	2/106	41/11368	0.055815683324340656	0.1981861219487458	0.15412110879795055	0.8121378751904456	COL11A1/COL1A2	16
CC	GO:0030133	transport vesicle	6	6/106	296/11368	0.058306905569181264	0.20407416949213442	0.1586999986168693	0.799423077030193	DPYSL3/NCALD/MAP6/SYT1/CA4/LMAN1	16
CC	GO:0150034	distal axon	5	5/106	225/11368	0.05916498823785944	0.2041608749052896	0.1587674258124916	0.7992385966257425	EPHA4/CRMP1/DPYSL3/OTX2/CXADR	16
CC	GO:0005801	cis-Golgi network	2	2/106	43/11368	0.06073902134428231	0.20668139207429395	0.1607275272414488	0.7939097367695408	AKAP9/MAP6	16
CC	GO:0070160	tight junction	3	3/106	102/11368	0.06983602450370563	0.23438117812887507	0.18226849942567727	0.7392883818535605	GJA1/TGFBR1/CXADR	16
CC	GO:0043204	perikaryon	3	3/106	104/11368	0.07310679301183014	0.24204276064727548	0.1882265936719951	0.7253190170985828	EPHA4/CRMP1/MAPK10	16
CC	GO:0098797	plasma membrane protein complex	6	6/106	316/11368	0.07486936212641283	0.24457324961294857	0.19019444975271188	0.7208021607789455	NLGN1/GJA1/AKAP9/TGFBR1/CDH2/GNG8	16
CC	GO:0099513	polymeric cytoskeletal fiber	8	8/106	477/11368	0.07701697555464371	0.24827840803799617	0.19307579744308184	0.7142721627596161	NAV1/DPYSL3/PDLIM7/TUBB2B/MAP6/TUBA1A/TPM1/COTL1	16
CC	GO:0001725	stress fiber	2	2/106	52/11368	0.08456522054469312	0.2656215260698694	0.20656281941416266	0.6849478472714166	PDLIM7/TPM1	16
CC	GO:0097517	contractile actin filament bundle	2	2/106	52/11368	0.08456522054469312	0.2656215260698694	0.20656281941416266	0.6849478472714166	PDLIM7/TPM1	16
CC	GO:0031680	G-protein beta/gamma-subunit complex	1	1/106	10/11368	0.08946133808637369	0.27025280921309236	0.21016437580051436	0.6774408977484738	GNG8	16
CC	GO:0033643	host cell part	1	1/106	10/11368	0.08946133808637369	0.27025280921309236	0.21016437580051436	0.6774408977484738	LMAN1	16
CC	GO:0089717	spanning component of membrane	1	1/106	10/11368	0.08946133808637369	0.27025280921309236	0.21016437580051436	0.6774408977484738	NLGN1	16
CC	GO:0005795	Golgi stack	3	3/106	114/11368	0.09045196063458602	0.27025280921309236	0.21016437580051436	0.6774408977484738	AKAP9/SULF1/GCNT1	16
CC	GO:0031252	cell leading edge	6	6/106	338/11368	0.09589888170668102	0.27434381064440905	0.21334577755805817	0.6709159480771419	MYO10/DPYSL3/PDLIM7/PLEKHA1/TPM1/CDH2	16
CC	GO:0001401	SAM complex	1	1/106	11/11368	0.09795905759357959	0.27434381064440905	0.21334577755805817	0.6709159480771419	CHCHD6	16
CC	GO:0005921	gap junction	1	1/106	11/11368	0.09795905759357959	0.27434381064440905	0.21334577755805817	0.6709159480771419	GJA1	16
CC	GO:0030130	clathrin coat of trans-Golgi network vesicle	1	1/106	11/11368	0.09795905759357959	0.27434381064440905	0.21334577755805817	0.6709159480771419	NCALD	16
CC	GO:0014069	postsynaptic density	5	5/106	262/11368	0.09803515426484505	0.27434381064440905	0.21334577755805817	0.6709159480771419	EPHA4/NLGN1/AKAP9/NPTN/CDH2	16
CC	GO:0032432	actin filament bundle	2	2/106	57/11368	0.09883267705793967	0.27434381064440905	0.21334577755805817	0.6709159480771419	PDLIM7/TPM1	16
CC	GO:0032279	asymmetric synapse	5	5/106	267/11368	0.1040929165405929	0.27434381064440905	0.21334577755805817	0.6709159480771419	EPHA4/NLGN1/AKAP9/NPTN/CDH2	16
CC	GO:0005903	brush border	2	2/106	59/11368	0.10471758793333236	0.27434381064440905	0.21334577755805817	0.6709159480771419	LRP2/CA4	16
CC	GO:0098793	presynapse	6	6/106	347/11368	0.10533379599217327	0.27434381064440905	0.21334577755805817	0.6709159480771419	EPHA4/NLGN1/FZD3/SYT1/NPTN/CDH2	16
CC	GO:0019897	extrinsic component of plasma membrane	3	3/106	122/11368	0.10544584429292843	0.27434381064440905	0.21334577755805817	0.6709159480771419	AKAP9/CDH2/GNG8	16
CC	GO:0012510	trans-Golgi network transport vesicle membrane	1	1/106	12/11368	0.10637821229068922	0.27434381064440905	0.21334577755805817	0.6709159480771419	NCALD	16
CC	GO:0043083	synaptic cleft	1	1/106	12/11368	0.10637821229068922	0.27434381064440905	0.21334577755805817	0.6709159480771419	NLGN1	16
CC	GO:0099243	extrinsic component of synaptic membrane	1	1/106	12/11368	0.10637821229068922	0.27434381064440905	0.21334577755805817	0.6709159480771419	AKAP9	16
CC	GO:0099572	postsynaptic specialization	5	5/106	272/11368	0.11033375692184859	0.27555179228585486	0.21428517466698058	0.6690078746093318	EPHA4/NLGN1/AKAP9/NPTN/CDH2	16
CC	GO:0031594	neuromuscular junction	2	2/106	62/11368	0.11371803290300185	0.27555179228585486	0.21428517466698058	0.6690078746093318	EPHA4/TUBA1A	16
CC	GO:0042641	actomyosin	2	2/106	62/11368	0.11371803290300185	0.27555179228585486	0.21428517466698058	0.6690078746093318	PDLIM7/TPM1	16
CC	GO:0031233	intrinsic component of external side of plasma membrane	1	1/106	13/11368	0.11471952168635591	0.27555179228585486	0.21428517466698058	0.6690078746093318	CA4	16
CC	GO:0034358	plasma lipoprotein particle	1	1/106	13/11368	0.11471952168635591	0.27555179228585486	0.21428517466698058	0.6690078746093318	CLU	16
CC	GO:0043194	axon initial segment	1	1/106	13/11368	0.11471952168635591	0.27555179228585486	0.21428517466698058	0.6690078746093318	NAV1	16
CC	GO:1990777	lipoprotein particle	1	1/106	13/11368	0.11471952168635591	0.27555179228585486	0.21428517466698058	0.6690078746093318	CLU	16
CC	GO:0030864	cortical actin cytoskeleton	2	2/106	64/11368	0.11982589278048135	0.27899079811895977	0.21695954655008257	0.6636212354964873	COTL1/CDH2	16
CC	GO:0043235	receptor complex	4	4/106	202/11368	0.11988914588481255	0.27899079811895977	0.21695954655008257	0.6636212354964873	LRP2/EPHA4/NLGN1/TGFBR1	16
CC	GO:0031045	dense core granule	1	1/106	14/11368	0.12298369876264348	0.27899079811895977	0.21695954655008257	0.6636212354964873	SYT1	16
CC	GO:0031527	filopodium membrane	1	1/106	14/11368	0.12298369876264348	0.27899079811895977	0.21695954655008257	0.6636212354964873	MYO10	16
CC	GO:0060077	inhibitory synapse	1	1/106	14/11368	0.12298369876264348	0.27899079811895977	0.21695954655008257	0.6636212354964873	NPTN	16
CC	GO:0097440	apical dendrite	1	1/106	14/11368	0.12298369876264348	0.27899079811895977	0.21695954655008257	0.6636212354964873	CLU	16
CC	GO:0098552	side of membrane	5	5/106	284/11368	0.12603671964518184	0.2832935441566014	0.22030561328612183	0.6569744370837738	LRP2/NLGN1/FGF8/CA4/GNG8	16
CC	GO:0030136	clathrin-coated vesicle	3	3/106	137/11368	0.1359357941167949	0.3027660868964977	0.23544860033626674	0.6281038869500446	LRP2/NCALD/SYT1	16
CC	GO:0016327	apicolateral plasma membrane	1	1/106	16/11368	0.13928347560368293	0.3046826028830564	0.2369389951528817	0.6253634576983486	CXADR	16
CC	GO:0032994	protein-lipid complex	1	1/106	16/11368	0.13928347560368293	0.3046826028830564	0.2369389951528817	0.6253634576983486	CLU	16
CC	GO:0005604	basement membrane	2	2/106	72/11368	0.1450081748579031	0.3143982552228873	0.24449445411532797	0.6117309875605113	SMOC1/SERPINF1	16
CC	GO:0005741	mitochondrial outer membrane	3	3/106	143/11368	0.1488991352957237	0.32000252760923076	0.24885266379063703	0.604057706081771	EPHA4/CHCHD6/GJA1	16
CC	GO:0031904	endosome lumen	1	1/106	18/11368	0.15528311835362274	0.3279686551434274	0.2550475900363495	0.5933787757942718	LRP2	16
CC	GO:0097038	perinuclear endoplasmic reticulum	1	1/106	18/11368	0.15528311835362274	0.3279686551434274	0.2550475900363495	0.5933787757942718	CLU	16
CC	GO:0032587	ruffle membrane	2	2/106	76/11368	0.15798353623848607	0.3289645927247682	0.25582208929401956	0.5920619585113185	PLEKHA1/TPM1	16
CC	GO:0030135	coated vesicle	4	4/106	225/11368	0.15844008955723532	0.3289645927247682	0.25582208929401956	0.5920619585113185	LRP2/NCALD/SYT1/LMAN1	16
CC	GO:0016342	catenin complex	1	1/106	19/11368	0.16317210420864625	0.3331430460926527	0.25907149878741204	0.5865803623912307	CDH2	16
CC	GO:0098799	outer mitochondrial membrane protein complex	1	1/106	19/11368	0.16317210420864625	0.3331430460926527	0.25907149878741204	0.5865803623912307	CHCHD6	16
CC	GO:0016323	basolateral plasma membrane	3	3/106	151/11368	0.16677515972500767	0.33768524076551143	0.2626037747736093	0.5806990354759132	CA2/CDH2/CXADR	16
CC	GO:0098686	hippocampal mossy fiber to CA3 synapse	1	1/106	20/11368	0.1709881018255186	0.3433777454692791	0.26703059905452003	0.573438969949632	SYT1	16
CC	GO:0030863	cortical cytoskeleton	2	2/106	83/11368	0.1811740291284759	0.36087509867054146	0.28063756330555534	0.5518541991505187	COTL1/CDH2	16
CC	GO:0030285	integral component of synaptic vesicle membrane	1	1/106	22/11368	0.18640380190802786	0.36829783441505504	0.28640991634425333	0.5430119495658745	SYT1	16
CC	GO:0031968	organelle outer membrane	3	3/106	161/11368	0.18995120184333408	0.3723043556129348	0.289525621335945	0.5383129976966179	EPHA4/CHCHD6/GJA1	16
CC	GO:0019867	outer membrane	3	3/106	162/11368	0.19231386918146431	0.37394363451951396	0.29080042039970794	0.5364049699686346	EPHA4/CHCHD6/GJA1	16
CC	GO:0044306	neuron projection terminus	2	2/106	89/11368	0.20143280914993822	0.3855549862635536	0.2998300859879837	0.5231247906905772	EPHA4/SYT1	16
CC	GO:0098862	cluster of actin-based cell projections	2	2/106	89/11368	0.20143280914993822	0.3855549862635536	0.2998300859879837	0.5231247906905772	LRP2/CA4	16
CC	GO:0042470	melanosome	2	2/106	90/11368	0.2048360304589573	0.38603713432649644	0.3002050324945042	0.5225820317254125	PMEL/SERPINF1	16
CC	GO:0048770	pigment granule	2	2/106	90/11368	0.2048360304589573	0.38603713432649644	0.3002050324945042	0.5225820317254125	PMEL/SERPINF1	16
CC	GO:0098800	inner mitochondrial membrane protein complex	2	2/106	91/11368	0.2082457548120563	0.3894672513660595	0.3028724919323599	0.5187401692042395	CHCHD6/IMMP1L	16
CC	GO:0030027	lamellipodium	3	3/106	172/11368	0.21632931251377888	0.39563545522407295	0.30766924767156695	0.5119159104278208	MYO10/DPYSL3/CDH2	16
CC	GO:0001772	immunological synapse	1	1/106	26/11368	0.21638837142867662	0.39563545522407295	0.30766924767156695	0.5119159104278208	NPTN	16
CC	GO:0030125	clathrin vesicle coat	1	1/106	26/11368	0.21638837142867662	0.39563545522407295	0.30766924767156695	0.5119159104278208	NCALD	16
CC	GO:0005834	heterotrimeric G-protein complex	1	1/106	27/11368	0.2237118445928944	0.3971695791685444	0.30886227209240186	0.5102351380655555	GNG8	16
CC	GO:0030140	trans-Golgi network transport vesicle	1	1/106	27/11368	0.2237118445928944	0.3971695791685444	0.30886227209240186	0.5102351380655555	NCALD	16
CC	GO:0044295	axonal growth cone	1	1/106	27/11368	0.2237118445928944	0.3971695791685444	0.30886227209240186	0.5102351380655555	EPHA4	16
CC	GO:1905360	GTPase complex	1	1/106	27/11368	0.2237118445928944	0.3971695791685444	0.30886227209240186	0.5102351380655555	GNG8	16
CC	GO:0005923	bicellular tight junction	2	2/106	97/11368	0.22881806799184734	0.40331242200001866	0.3136393056154818	0.5035695163248498	TGFBR1/CXADR	16
CC	GO:0046658	anchored component of plasma membrane	1	1/106	28/11368	0.23096751379959157	0.40357609015518286	0.3138443493795407	0.5032856862115388	CA4	16
CC	GO:0098802	plasma membrane signaling receptor complex	2	2/106	98/11368	0.23226215800767666	0.40357609015518286	0.3138443493795407	0.5032856862115388	NLGN1/TGFBR1	16
CC	GO:0008328	ionotropic glutamate receptor complex	1	1/106	30/11368	0.24527792203280896	0.41731313123637637	0.32452707520422824	0.48874906428342635	NLGN1	16
CC	GO:0098878	neurotransmitter receptor complex	1	1/106	30/11368	0.24527792203280896	0.41731313123637637	0.32452707520422824	0.48874906428342635	NLGN1	16
CC	GO:0099061	integral component of postsynaptic density membrane	1	1/106	30/11368	0.24527792203280896	0.41731313123637637	0.32452707520422824	0.48874906428342635	NPTN	16
CC	GO:0034703	cation channel complex	2	2/106	104/11368	0.2529856781157162	0.42745855957483087	0.3324167530957868	0.47831709682020673	NLGN1/AKAP9	16
CC	GO:0008076	voltage-gated potassium channel complex	1	1/106	32/11368	0.2593245033319377	0.43009214479037167	0.33446478284449954	0.4756496041188488	AKAP9	16
CC	GO:0099146	intrinsic component of postsynaptic density membrane	1	1/106	32/11368	0.2593245033319377	0.43009214479037167	0.33446478284449954	0.4756496041188488	NPTN	16
CC	GO:0098791	Golgi apparatus subcompartment	4	4/106	279/11368	0.2627923857986766	0.43009214479037167	0.33446478284449954	0.4756496041188488	AKAP9/SULF1/GCNT1/CA4	16
CC	GO:0005793	endoplasmic reticulum-Golgi intermediate compartment	2	2/106	107/11368	0.26337003670891557	0.43009214479037167	0.33446478284449954	0.4756496041188488	CA4/LMAN1	16
CC	GO:0098563	intrinsic component of synaptic vesicle membrane	1	1/106	33/11368	0.2662503680678948	0.43009214479037167	0.33446478284449954	0.4756496041188488	SYT1	16
CC	GO:0101002	ficolin-1-rich granule	2	2/106	108/11368	0.26683267758423057	0.43009214479037167	0.33446478284449954	0.4756496041188488	SRP14/COTL1	16
CC	GO:1904813	ficolin-1-rich granule lumen	2	2/106	108/11368	0.26683267758423057	0.43009214479037167	0.33446478284449954	0.4756496041188488	SRP14/COTL1	16
CC	GO:0034705	potassium channel complex	1	1/106	34/11368	0.2731120761388969	0.4373363310720898	0.3400982853879624	0.46839555756573015	AKAP9	16
CC	GO:0016459	myosin complex	1	1/106	35/11368	0.27991021624206225	0.4453117076578263	0.34630040423659103	0.46054700149813255	MYO10	16
CC	GO:0043296	apical junction complex	2	2/106	114/11368	0.2875999118568735	0.45459340906409035	0.35351839759656434	0.4515879799809155	TGFBR1/CXADR	16
CC	GO:0031093	platelet alpha granule lumen	1	1/106	38/11368	0.2999290357486344	0.47104239588727836	0.3663100908940811	0.4361511174827273	CLU	16
CC	GO:0031984	organelle subcompartment	4	4/106	299/11368	0.30449440660205496	0.47506692706730413	0.3694398015002451	0.4324563177729669	AKAP9/SULF1/GCNT1/CA4	16
CC	GO:0098982	GABA-ergic synapse	1	1/106	39/11368	0.30647868466396055	0.47506692706730413	0.3694398015002451	0.4324563177729669	NPTN	16
CC	GO:0031256	leading edge membrane	2	2/106	120/11368	0.30830874042327083	0.47506692706730413	0.3694398015002451	0.4324563177729669	PLEKHA1/TPM1	16
CC	GO:0061695	transferase complex, transferring phosphorus-containing groups	3	3/106	212/11368	0.3169148937848734	0.4800743863356286	0.3733338944221215	0.42790257934167336	CCNG2/CCNI/TGFBR1	16
CC	GO:0030118	clathrin coat	1	1/106	41/11368	0.31939642846003047	0.4800743863356286	0.3733338944221215	0.42790257934167336	NCALD	16
CC	GO:0031304	intrinsic component of mitochondrial inner membrane	1	1/106	41/11368	0.31939642846003047	0.4800743863356286	0.3733338944221215	0.42790257934167336	CHCHD6	16
CC	GO:0031305	integral component of mitochondrial inner membrane	1	1/106	41/11368	0.31939642846003047	0.4800743863356286	0.3733338944221215	0.42790257934167336	CHCHD6	16
CC	GO:0034774	secretory granule lumen	3	3/106	215/11368	0.324593355638217	0.4849108056790437	0.37709497670421877	0.42354925280829975	CLU/SRP14/COTL1	16
CC	GO:0060205	cytoplasmic vesicle lumen	3	3/106	217/11368	0.32971339006307143	0.4874669420478464	0.37908277770423293	0.4212659457711868	CLU/SRP14/COTL1	16
CC	GO:0044304	main axon	1	1/106	43/11368	0.33207579030820433	0.4874669420478464	0.37908277770423293	0.4212659457711868	NAV1	16
CC	GO:0031983	vesicle lumen	3	3/106	218/11368	0.33227338498771575	0.4874669420478464	0.37908277770423293	0.4212659457711868	CLU/SRP14/COTL1	16
CC	GO:0019898	extrinsic component of membrane	3	3/106	219/11368	0.3348332162189458	0.4882984403192959	0.37972939934604755	0.4205257776837812	AKAP9/CDH2/GNG8	16
CC	GO:0072562	blood microparticle	1	1/106	44/11368	0.33832744295520933	0.4904746954084396	0.3814217824658542	0.41859450862983033	CLU	16
CC	GO:0043197	dendritic spine	2	2/106	131/11368	0.3459441069944712	0.49856650713909084	0.3877144480866829	0.41148801481067515	EPHA4/NLGN1	16
CC	GO:0012507	ER to Golgi transport vesicle membrane	1	1/106	46/11368	0.350657378288477	0.5024038460858297	0.39069858707426486	0.4081581593586803	LMAN1	16
CC	GO:0044309	neuron spine	2	2/106	133/11368	0.35272271557154256	0.5024247983431857	0.39071488077386296	0.40814004791290304	EPHA4/NLGN1	16
CC	GO:0034702	ion channel complex	2	2/106	139/11368	0.3729105007181308	0.5253960771980892	0.40857868946446474	0.388724288925662	NLGN1/AKAP9	16
CC	GO:0005938	cell cortex	3	3/106	234/11368	0.3731384384998675	0.5253960771980892	0.40857868946446474	0.388724288925662	MYO10/COTL1/CDH2	16
CC	GO:0005796	Golgi lumen	1	1/106	52/11368	0.38629795416651047	0.5317022402853655	0.4134827303615517	0.3835426246006878	WNT5B	16
CC	GO:0030120	vesicle coat	1	1/106	52/11368	0.38629795416651047	0.5317022402853655	0.4134827303615517	0.3835426246006878	NCALD	16
CC	GO:0030173	integral component of Golgi membrane	1	1/106	52/11368	0.38629795416651047	0.5317022402853655	0.4134827303615517	0.3835426246006878	LFNG	16
CC	GO:0031091	platelet alpha granule	1	1/106	52/11368	0.38629795416651047	0.5317022402853655	0.4134827303615517	0.3835426246006878	CLU	16
CC	GO:0016328	lateral plasma membrane	1	1/106	53/11368	0.39204666544773625	0.5366001845513708	0.4172916580184667	0.3795602970825875	FZD3	16
CC	GO:0005874	microtubule	4	4/106	344/11368	0.4000572494833209	0.5445223673522979	0.4234524102718192	0.3731953908059674	NAV1/TUBB2B/MAP6/TUBA1A	16
CC	GO:0031228	intrinsic component of Golgi membrane	1	1/106	55/11368	0.4033845391338228	0.5460177463413624	0.42461530435139233	0.37200435667125364	LFNG	16
CC	GO:0098794	postsynapse	5	5/106	450/11368	0.41028967164708197	0.5489495530644407	0.42689524856998395	0.3696786789541249	EPHA4/NLGN1/AKAP9/NPTN/CDH2	16
CC	GO:1902495	transmembrane transporter complex	2	2/106	151/11368	0.41250128211432713	0.5489495530644407	0.42689524856998395	0.3696786789541249	NLGN1/AKAP9	16
CC	GO:0018995	host cellular component	1	1/106	57/11368	0.4145129278241695	0.5489495530644407	0.42689524856998395	0.3696786789541249	LMAN1	16
CC	GO:0043657	host cell	1	1/106	57/11368	0.4145129278241695	0.5489495530644407	0.42689524856998395	0.3696786789541249	LMAN1	16
CC	GO:0005881	cytoplasmic microtubule	1	1/106	59/11368	0.42543566589558113	0.5594677851303921	0.43507484042363465	0.36143603043081984	TUBA1A	16
CC	GO:0001669	acrosomal vesicle	1	1/106	60/11368	0.4308210951479523	0.5594677851303921	0.43507484042363465	0.36143603043081984	CXADR	16
CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	1	1/106	60/11368	0.4308210951479523	0.5594677851303921	0.43507484042363465	0.36143603043081984	LMAN1	16
CC	GO:0070382	exocytic vesicle	2	2/106	158/11368	0.435034211307779	0.5594677851303921	0.43507484042363465	0.36143603043081984	DPYSL3/SYT1	16
CC	GO:1990351	transporter complex	2	2/106	158/11368	0.435034211307779	0.5594677851303921	0.43507484042363465	0.36143603043081984	NLGN1/AKAP9	16
CC	GO:0005905	clathrin-coated pit	1	1/106	61/11368	0.4361565182036934	0.5594677851303921	0.43507484042363465	0.36143603043081984	LRP2	16
CC	GO:0005902	microvillus	1	1/106	62/11368	0.44144239501190163	0.563298889468312	0.43805413101509977	0.3584722197502642	CA2	16
CC	GO:0005791	rough endoplasmic reticulum	1	1/106	64/11368	0.45186732876876	0.573613966571742	0.44607573769918496	0.35059139762794883	CA4	16
CC	GO:0016234	inclusion body	1	1/106	66/11368	0.46209949288483887	0.5776243661060486	0.44919445871190034	0.34756560985868296	CLU	16
CC	GO:0030672	synaptic vesicle membrane	1	1/106	66/11368	0.46209949288483887	0.5776243661060486	0.44919445871190034	0.34756560985868296	SYT1	16
CC	GO:0099501	exocytic vesicle membrane	1	1/106	66/11368	0.46209949288483887	0.5776243661060486	0.44919445871190034	0.34756560985868296	SYT1	16
CC	GO:0032592	integral component of mitochondrial membrane	1	1/106	67/11368	0.46714439234990757	0.5809663762727277	0.4517934010971588	0.3450601166826321	CHCHD6	16
CC	GO:0010494	cytoplasmic stress granule	1	1/106	68/11368	0.4721424185786407	0.5812808670943064	0.4520379675362812	0.34482508642975995	CIRBP	16
CC	GO:0098573	intrinsic component of mitochondrial membrane	1	1/106	68/11368	0.4721424185786407	0.5812808670943064	0.4520379675362812	0.34482508642975995	CHCHD6	16
CC	GO:0005769	early endosome	3	3/106	275/11368	0.4749459997601272	0.5818088497061559	0.4524485576662264	0.344430791910076	EPHA4/WDFY1/GJA1	16
CC	GO:0044853	plasma membrane raft	1	1/106	71/11368	0.4868595522164231	0.5934357726021077	0.4614903322920794	0.33583739252795125	CDH2	16
CC	GO:0030134	COPII-coated ER to Golgi transport vesicle	1	1/106	72/11368	0.4916743603482332	0.5963377142837482	0.463747051709381	0.33371883841283745	LMAN1	16
CC	GO:0031234	extrinsic component of cytoplasmic side of plasma membrane	1	1/106	74/11368	0.5011701230701064	0.6018954909420395	0.46806910358972786	0.3296900249339462	GNG8	16
CC	GO:0043679	axon terminus	1	1/106	74/11368	0.5011701230701064	0.6018954909420395	0.46806910358972786	0.3296900249339462	EPHA4	16
CC	GO:0031301	integral component of organelle membrane	3	3/106	290/11368	0.5103901857689943	0.6071363350070776	0.47214469016662114	0.3259248901127418	CHCHD6/LFNG/SYT1	16
CC	GO:0031225	anchored component of membrane	1	1/106	76/11368	0.5104901429039103	0.6071363350070776	0.47214469016662114	0.3259248901127418	CA4	16
CC	GO:0030667	secretory granule membrane	2	2/106	184/11368	0.51443460231572	0.6088718723060454	0.47349434538085594	0.32468520311172205	SYT1/CA4	16
CC	GO:0005802	trans-Golgi network	2	2/106	189/11368	0.5288566401417076	0.6229321001669152	0.48442840012980304	0.3147704038070526	GCNT1/CA4	16
CC	GO:0030018	Z disc	1	1/106	83/11368	0.5417722317377294	0.6334885872158571	0.49263774129353444	0.307472319643384	PDLIM7	16
CC	GO:0036464	cytoplasmic ribonucleoprotein granule	2	2/106	194/11368	0.5429902176135918	0.6334885872158571	0.49263774129353444	0.307472319643384	TUBA1A/CIRBP	16
CC	GO:0031985	Golgi cisterna	1	1/106	85/11368	0.5503404473187827	0.639020898545506	0.49693998984634413	0.30369605322269905	GCNT1	16
CC	GO:0030117	membrane coat	1	1/106	87/11368	0.5587499327201646	0.6426935845842269	0.49979608511168666	0.3012071500123911	NCALD	16
CC	GO:0048475	coated membrane	1	1/106	87/11368	0.5587499327201646	0.6426935845842269	0.49979608511168666	0.3012071500123911	NCALD	16
CC	GO:0031300	intrinsic component of organelle membrane	3	3/106	314/11368	0.5644208215904096	0.6461827163067774	0.5025094378153672	0.298855777185793	CHCHD6/LFNG/SYT1	16
CC	GO:0035770	ribonucleoprotein granule	2	2/106	204/11368	0.5703768917513484	0.6477447240232681	0.5037241462866232	0.297807230504817	TUBA1A/CIRBP	16
CC	GO:0031674	I band	1	1/106	90/11368	0.5710728995470445	0.6477447240232681	0.5037241462866232	0.297807230504817	PDLIM7	16
CC	GO:0042383	sarcolemma	1	1/106	91/11368	0.5751043122663221	0.6493113203006863	0.504942423090974	0.2967581402168999	CDH2	16
CC	GO:0098798	mitochondrial protein complex	2	2/106	207/11368	0.578361441781611	0.6499761388842943	0.50545942486813	0.296313701127637	CHCHD6/IMMP1L	16
CC	GO:0005770	late endosome	2	2/106	208/11368	0.5809990792475936	0.6499761388842943	0.50545942486813	0.296313701127637	GJA1/PMEL	16
CC	GO:0030139	endocytic vesicle	2	2/106	218/11368	0.6067168294897769	0.6756619237499788	0.5254341920461704	0.27948166939956476	LRP2/WNT5B	16
CC	GO:0031902	late endosome membrane	1	1/106	110/11368	0.6449490145932082	0.7149887265852308	0.5560170118664952	0.25491192056412826	PMEL	16
CC	GO:0005925	focal adhesion	3	3/106	358/11368	0.6536395039142855	0.7201421374036313	0.5600246052419218	0.2517928914115839	PDLIM7/GJA1/CDH2	16
CC	GO:0030666	endocytic vesicle membrane	1	1/106	114/11368	0.6581350414192004	0.7201421374036313	0.5600246052419218	0.2517928914115839	WNT5B	16
CC	GO:0030055	cell-substrate junction	3	3/106	361/11368	0.6592296654234445	0.7201421374036313	0.5600246052419218	0.2517928914115839	PDLIM7/GJA1/CDH2	16
CC	GO:0072686	mitotic spindle	1	1/106	115/11368	0.6613550241461921	0.7201421374036313	0.5600246052419218	0.2517928914115839	TFDP2	16
CC	GO:0031901	early endosome membrane	1	1/106	117/11368	0.6677051318213918	0.7238396340541637	0.5628999946887374	0.24956875543759854	EPHA4	16
CC	GO:0005743	mitochondrial inner membrane	3	3/106	374/11368	0.682712119968782	0.7339995976883392	0.5708009760755721	0.2435152929087003	CHCHD6/CLU/IMMP1L	16
CC	GO:0009898	cytoplasmic side of plasma membrane	1	1/106	122/11368	0.6830690133589443	0.7339995976883392	0.5708009760755721	0.2435152929087003	GNG8	16
CC	GO:0090575	RNA polymerase II transcription regulator complex	1	1/106	135/11368	0.7197997804406613	0.7700914681570393	0.5988681234647653	0.22266880291476748	TFDP2	16
CC	GO:0098562	cytoplasmic side of membrane	1	1/106	141/11368	0.7352981846509687	0.7832524140847277	0.6091028440358139	0.21530937267691277	GNG8	16
CC	GO:0008021	synaptic vesicle	1	1/106	145/11368	0.7451555503055984	0.7903164927483619	0.6145962843714438	0.21141006966027293	SYT1	16
CC	GO:0019866	organelle inner membrane	3	3/106	415/11368	0.7489390114804046	0.7909054216064618	0.6150542698636717	0.21108656217177793	CHCHD6/CLU/IMMP1L	16
CC	GO:0055037	recycling endosome	1	1/106	150/11368	0.7569673052127193	0.7959527458245331	0.6189793640998518	0.20832382950484649	TUBA1A	16
CC	GO:0030496	midbody	1	1/106	160/11368	0.778987903152608	0.8156069926170469	0.6342636548386057	0.1977301742328025	CRMP1	16
CC	GO:0005667	transcription regulator complex	2	2/106	312/11368	0.7924758464315047	0.8261982228753986	0.6425000143520821	0.19212685829545384	SOX2/TFDP2	16
CC	GO:0005819	spindle	2	2/106	323/11368	0.808261852268474	0.835652109293341	0.6498519088382158	0.18718560105259033	TFDP2/CRMP1	16
CC	GO:0005681	spliceosomal complex	1	1/106	175/11368	0.8083655098062115	0.835652109293341	0.6498519088382158	0.18718560105259033	CIRBP	16
CC	GO:0010008	endosome membrane	2	2/106	385/11368	0.8788692942188991	0.9047183911076903	0.7035618852437892	0.15269769604326477	EPHA4/PMEL	16
CC	GO:0031965	nuclear membrane	1	1/106	238/11368	0.8949486294829132	0.9174159590933628	0.7134362560511222	0.1466448240657347	CCNI	16
CC	GO:0000151	ubiquitin ligase complex	1	1/106	259/11368	0.9140892165793655	0.9331327419247689	0.7256585447406366	0.13926768648802634	UBE3D	16
CC	GO:0005765	lysosomal membrane	1	1/106	296/11368	0.9397809769363288	0.9514311543363659	0.7398884594409548	0.13083374662101058	LRP2	16
CC	GO:0098852	lytic vacuole membrane	1	1/106	296/11368	0.9397809769363288	0.9514311543363659	0.7398884594409548	0.13083374662101058	LRP2	16
CC	GO:0005774	vacuolar membrane	1	1/106	337/11368	0.9594369337242781	0.9673335340018441	0.7522550790733997	0.12363487130991034	LRP2	16
CC	GO:0005635	nuclear envelope	1	1/106	373/11368	0.9713631133675463	0.9753441097338067	0.758484570834883	0.12005324924695987	CCNI	16
CC	GO:0005759	mitochondrial matrix	1	1/106	398/11368	0.9775286389482243	0.9775286389482243	0.7601833883979746	0.11908162487487596	ME3	16
